Articles of Interest

New Articles of Interest in Endocrine Surgery

December 18, 2020


  1. Trends in blood pressure-related outcomes after adrenalectomy in patients with primary aldosteronism: A systematic review. Suurd DPD, Vorselaars WMCM, Van Beek DJ, Spiering W, Borel Rinkes IHM, Valk GD, Vriens MR. Am J Surg. 2020 Dec 3:S0002-9610(20)30781-9. PMID: 33298320

Gastroinstestinal Neuroendocrine

  1. Surgical treatment for gastrointestinal neuroendocrine tumors. Eto K, Yoshida N, Iwagami S, Iwatsuki M, Baba H. Ann Gastroenterol Surg. 2020 Sep 12;4(6):652-659. PMID: 33319155
  2. PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3. Ali AS, Langer SW, Federspiel B, Hjortland GO, Grønbæk H, Ladekarl M, Welin S, Weber Vestermark L, Arola J, Osterlund P, Knigge U, Sørbye H, Micke P, Grimelius L, Grönberg M, Tiensuu Janson E. PLoS One. 2020 Dec 14;15(12):e0243900. PMID: 33315908


  1. Influence of secretory phenotype and preoperative preparation on surgical outcome in pheochromocytoma. Furnica RM, Dusoruth MM, Persu A, Gruson D, Mourad M, Maiter D. Endocr Connect. 2020 Dec 1:EC-20-0537. PMID: 33320109


  1. Short-Term Outcomes of Surgery for Graves' Disease in Germany. Maurer E, Vorländer C, Zielke A, Dotzenrath C, von Frankenberg M, Köhler H, Lorenz K, Weber T, Jähne J, Hammer A, Böttcher KA, Schwarz K, Klinger C, Buhr HJ, Bartsch DK. J Clin Med. 2020 Dec 11;9(12):E4014. PMID: 33322553
  2. ThyroidEx: Development and Preliminary Validation of a Thyroid Surgery Expectations Measure. Patel SG, Atkinson TM, Tuttle RM, Pusic AL, Shah JP, Shaha AR, Lynch K, DiLorenzo M, Ali S, Wong RJ, Cracchiolo JR. Otolaryngol Head Neck Surg. 2020 Dec 15:194599820976317. PMID: 33320788
  3. Differentiated Thyroid Cancer: The Role of ATA Nodal Risk Factors in N1b Patients. Taboni S, Paderno A, Giordano D, Albano D, Piana S, Zanetti E, Bertagna F, Grammatica A, Ghidini A, Cappelli C, Bozzola A, Baronchelli C, Nicolai P, Lombardi D. Laryngoscope. 2020 Sep 10. PMID: 33319385
  4. Is there adenoma-carcinoma sequence between benign adenoma and papillary cancer of thyroid: A genomic linkage study. Bangaraiahgari R, Panchangam RB, Puthenveetil P, Mayilvaganan S, Bangaraiahgari R, Banala RR, Karunakaran P, Md R. Ann Med Surg (Lond). 2020 Dec 2;60:695-700. PMID: 33318795
  5. Rising Cost of Thyroid Surgery in Adult Patients. Sahli ZT, Zhou S, Sharma AK, Segev DL, Massie A, Zeiger MA, Mathur A. J Surg Res. 2020 Dec 11;260:28-37. PMID: 33316757
  6. Histone Deacetylase Inhibitors and Papillary Thyroid Cancer. Spartalis E, Kotrotsios K, Chrysikos D, Spartalis M, Paschou SA, Schizas D, Tsamakis K, Dimitroulis D, Troupis T, Nikiteas N. Curr Pharm Des. 2020 Dec 10. PMID: 33308111
  7. Physiological and Pathophysiological Roles of Ion Transporter-Mediated Metabolism in the Thyroid Gland and in Thyroid Cancer. Wang H, Ma Z, Cheng X, Tuo B, Liu X, Li T. Onco Targets Ther. 2020 Dec 3;13:12427-12441. PMID: 33299328
  8. Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules: A Randomized Clinical Trial. Livhits MJ, Zhu CY, Kuo EJ, Nguyen DT, Kim J, Tseng CH, Leung AM, Rao J, Levin M, Douek ML, Beckett KR, Cheung DS, Gofnung YA, Smooke-Praw S, Yeh MW. JAMA Oncol. 2020 Dec 10. PMID: 33300952
  9. Thyroid cancer after hysterectomy and oophorectomy: a nationwide cohort study. Kim M, Kim BH, Lee H, Nam H, Park S, Jang MH, Kim JM, Kim EH, Jeon YK, Kim SS, Kim IJ. Eur J Endocrinol. 2021 Jan;184(1):143-151. PMID: 33112277
  10. Robotic surgery versus open surgery for thyroid neoplasms: a systematic review and meta-analysis. Liu H, Wang Y, Wu C, Fei W, Luo E. J Cancer Res Clin Oncol. 2020 Dec;146(12):3297-3312. PMID: 33108513
  11. Postablative 131I SPECT/CT Is Much More Sensitive Than Cervical Ultrasonography for the Detection of Thyroid Remnants in Patients After Total Thyroidectomy for Differentiated Thyroid Cancer. Bulzacka I, Makarewicz J. Clin Nucl Med. 2020 Dec;45(12):948-953. PMID: 32969911

December 11, 2020


  1. Operative intervention for recurrence of adrenocortical carcinoma: A single-center experience. Zhang F, Liu Z, Liang J, Tang Y, Liu S, Zhou C, Zhang F, Wu K, Lu Y, Wang X. Surgery. 2020 Dec 2:S0039-6060(20)30753-4. PMID: 33279225
  2. Cystic adrenal lesions: A report of five cases. Goel D, Enny L, Rana C, Ramakant P, Singh K, Babu S, Mishra A. Cancer Rep (Hoboken). 2020 Dec 9:e1314. PMID: 33295135
  3. Primary aldosteronism concurrent with subclinical Cushing's syndrome: a case report and review of the literature. Zhang Y, Tan J, Yang Q, Du Z, Yang S, He W, Song Y, Hu J, Yang Y, Li Q, Zhang Y, He Y, Cheng Q; Chongqing Primary Aldosteronism Study (CONPASS) Group. J Med Case Rep. 2020 Feb 20;14(1):32. PMID: 32075693


  1. Gene expression profile in metastatic and non-metastatic parathyroid carcinoma. Condello V, Cetani F, Denaro M, Torregrossa L, Pardi E, Piaggi P, Borsari S, Poma AM, Muscarella LA, Graziano P, Grazia Chiofalo M, Repaci A, Tallini G, Boi F, Materazzi G, Basolo F, Marcocci C. Endocr Relat Cancer. 2020 Dec 1:ERC-20-0450. PMID: 33290252
  2. Ultrasound-guided ethanol injection for the treatment of parathyroid adenoma: A prospective self-controlled study. Yazdani AA, Khalili N, Siavash M, Shemian A, Goharian AR, Karimifar M, Tavakoli B, Yazdi M. J Res Med Sci. 2020 Oct 28;25:93. PMID: 33273938


  1. Two cases of pheochromocytoma in pregnancy: a multidisciplinary challenge. Chmielewski G, Walczyk A, Kowalska A. Endokrynol Pol. 2020;71(1):98-99. PMID: 31566249


  1. Recent advances in the management of anaplastic thyroid cancer. De Leo S, Trevisan M, Fugazzola L. Thyroid Res. 2020 Nov 24;13(1):17. PMID: 33292371
  2. Metastatic Anaplastic Thyroid Carcinoma in Complete Remission: Morphological, Molecular, and Clinical Work-Up of a Rare Case. Stenman A, Hellgren LS, Jatta K, Hysek M, Zemmler M, Altena R, Nilsson IL, Bränström R, Zedenius J, Juhlin CC. Endocr Pathol. 2020 Mar;31(1):77-83. PMID: 32016808

December 4, 2020


  1. KCNJ5 Somatic Mutations in Aldosterone-Producing Adenoma Are Associated With a Worse Baseline Status and Better Recovery of Left Ventricular Remodeling and Diastolic Function. Chang YY, Tsai CH, Peng SY, Chen ZW, Chang CC, Lee BC, Liao CW, Pan CT, Chen YL, Lin LC, Chang YR, Peng KY, Chou CH, Wu VC, Hung CS, Lin YH; TAIPAI Study Group*. Hypertension. 2020 Nov 30:HYPERTENSIONAHA12015679. PMID: 33249859


  1. A Review of Parathyroid Surgery for Primary Hyperparathyroidism from the United Kingdom Registry of Endocrine and Thyroid Surgery (UKRETS). Ishii H, Stechman MJ, Watkinson JC, Aspinall S, Kim DS. World J Surg. 2020 Dec 2. PMID: 33263777
  2. Correlation of perioperative biochemical variables with single adenoma weight in patients with primary hyperparathyroidism. Papadakis M, Weyerbrock N, Zirngibl H, Dotzenrath C. BMC Surg. 2020 Nov 30;20(1):303. PMID: 33256695
  3. Normocalcemic Primary Hyperparathyroidism Presenting with Muscle Weakness and Body Pain. Mihashi I, Ishii K, Ogawa Y, Uchida A, Hara H, Tamaokat A. Intern Med. 2020 Nov 30. PMID: 33250466
  4. A Nomogram to Predict Hungry Bone Syndrome After Parathyroidectomy in Patients With Secondary Hyperparathyroidism. Wang M, Chen B, Zou X, Wei T, Gong R, Zhu J, Li Z. J Surg Res. 2020 Nov;255:33-41. PMID: 32540578


  1. Perioperative outcomes of laparoscopic, robotic, and open approaches to pheochromocytoma. Fang AM, Rosen J, Saidian A, Bae S, Tanno FY, Chambo JL, Bloom J, Gordetsky J, Srougi V, Phillips J, Rais-Bahrami S. J Robot Surg. 2020 Dec;14(6):849-854. PMID: 32112185


  1. The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice. Kaliszewski K, Diakowska D, Nowak Ł, Wojtczak B, Rudnicki J. BMC Cancer. 2020 Nov 30;20(1):1166. PMID: 33256657
  2. Growth differentiation factor 15 is a cancer cell-induced mitokine that primes thyroid cancer cells for invasiveness. Kang YE, Kim JM, Lim MA, Lee SE, Yi S, Kim JT, Oh C, Liu L, Jin Y, Jung SN, Won HR, Chang JW, Lee JH, Kim HJ, Koh HY, Jun S, Cho SW, Shong M, Koo BS. Thyroid. 2020 Nov 30. PMID: 33256569
  3. Value of thyroglobulin post hemithyroidectomy for cancer: a literature review. Tourani SS, Fleming B, Gundara J.
  4. ANZ J Surg. 2020 Nov 26. PMID: 33244886
  5. Ultrasound visualization of the vagus nerve for intraoperative neuromonitoring in thyroid surgery. Hartl DM, Bidault S, Girard E, Guerlain J, Breuskin I, Lamartina L, Terroir M, Leboulleux S. Eur Radiol. 2020 Nov 25. PMID: 33241516
  6. Practice Patterns and Outcomes of Pediatric Thyroid Surgery: An NSQIP Analysis. Utria AF, Goffredo P, Belding-Schmitt M, Liao J, Shilyansky J, Lal G. J Surg Res. 2020 Nov;255:181-187. PMID: 32563758
  7. Impact of Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features on Revised Bethesda System Malignancy Rates at a Single Institution. Linhares SM, Whitfield BW, Lee AF, Gordillo D, Picado O, Jeraq M, Farrá JC, Lew JI. J Surg Res. 2020 Nov;255:152-157. PMID: 32563006
  8. Recurrent Laryngeal Nerve Injury After Thyroid Surgery: An Analysis of 11,370 Patients. Gunn A, Oyekunle T, Stang M, Kazaure H, Scheri R. J Surg Res. 2020 Nov;255:42-49. PMID: 32540579

November 27, 2020


  1. Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Possible Prognostic Markers for Patients Undergoing Resection of Adrenocortical Carcinoma. de Jong MC, Mihai R, Khan S. World J Surg. 2020 Nov 21. PMID: 33221947
  2. A Critical Analysis of Computed Tomography Washout in Lipid-Poor Adrenal Incidentalomas. Akbulut S, Erten O, Kahramangil B, Gokceimam M, Kim YS, Li P, Remer EM, Berber E. Ann Surg Oncol. 2020 Nov 18. PMID: 33210268

Pancreatic Neuroendocrine

  1. Prognosis after surgery for multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: Functionality matters. van Beek DJ, Nell S, Verkooijen HM, Borel Rinkes IHM, Valk GD; DutchMEN Study Group (DMSG), Vriens MR; International MEN1 Insulinoma Study Group, Goudet P; French Endocrine Tumor Study Group (GTE), Santucci N, Bartsch DK, Manoharan J, Perrier ND, Zagzag J, Brandi ML, Giusti F, Nilubol N, Brunaud L, Pasternak JD, Hsiao R, Sturgeon C, Giri S, Conemans EB, Brosens LA; DutchMEN Surgery Study Group, Bonsing BA, van Eijck CH, van Goor H, de Kleine RHJ, Nieveen van Dijkum EJ, Kazemier G, Dejong CHC. Surgery. 2020 Nov 18:S0039-6060(20)30676-0. PMID: 33220975
  2. CT-Based Radiomics Score for Distinguishing Between Grade 1 and Grade 2 Nonfunctioning Pancreatic Neuroendocrine Tumors. Bian Y, Jiang H, Ma C, Wang L, Zheng J, Jin G, Lu J. AJR Am J Roentgenol. 2020 Oct;215(4):852-863. PMID: 32755201


  1. Re-operative parathyroidectomy: How many positive localization studies are required? Ramonell KM, Chen H, Lindeman B, Fazendin J. Am J Surg. 2020 Nov 17:S0002-9610(20)30750-9. PMID: 33220935
  2. Muscle strength, physical performance, and metabolic changes after subtotal parathyroidectomy for secondary hyperparathyroidism. Jimeno-Fraile J, Cao H, Sancho-Insenser J, Lorente-Poch L, Sitges-Serra A. Surgery. 2020 Nov 17:S0039-6060(20)30680-2. PMID: 33218703
  3. Use of Intraoperative Parathyroid Hormone in Minimally Invasive Parathyroidectomy for Primary Hyperparathyroidism: A Systematic Review and Meta-analysis. Quinn AJ, Ryan ÉJ, Garry S, James DL, Boland MR, Young O, Kerin MJ, Lowery AJ. JAMA Otolaryngol Head Neck Surg. 2020 Nov 19. PMID: 33211086


  1. Bi-national Review of Phaeochromocytoma Care: Is ICU Admission Always Necessary? Papachristos AJ, Cherry TJ, Nyandoro MG, Lisewski D, Stevenson SJ, Mercer P, Subramaniam S, Sidhu SB, Sywak MS, Blefari NDA, O'Neill CJ, Gundara JS, Miller JA. World J Surg. 2020 Nov 20. PMID: 33219416
  2. Characteristics of germline mutations in Korean patients with pheochromocytoma/paraganglioma. Kim JH, Kim MJ, Kong SH, Kim SJ, Kang H, Shin CS, Park SS, Lee KE, Seong MW. J Med Genet. 2020 Nov 20:jmedgenet-2020-107102. PMID: 33219105


  1. Thyroid Cancer Active Surveillance Program Retention and Adherence in Japan. Davies L, Chang CH, Sirovich B, Tuttle RM, Fukushima M, Ito Y, Miyauchi A. JAMA Otolaryngol Head Neck Surg. 2020 Nov 25. PMID: 33237264
  2. Updates in the advances of sporadic medullary thyroid carcinoma: from the molecules to the clinic. Bai Y, Niu D, Yao Q, Lin D, Kakudo K. Gland Surg. 2020 Oct;9(5):1847-1856. PMID: 33224860
  3. Radioactive iodine treatment of papillary thyroid carcinoma in Japan. Okamoto T, Omi Y, Yoshida Y, Horiuchi K, Abe K. Gland Surg. 2020 Oct;9(5):1698-1707. PMID: 33224847
  4. The Japanese reporting system for thyroid aspiration cytology 2019 (JRSTAC2019). Hirokawa M, Suzuki A, Higuchi M, Hayashi T, Kuma S, Ito Y, Miyauchi A. Gland Surg. 2020 Oct;9(5):1653-1662. PMID: 33224843
  5. Effects of excitation light intensity on parathyroid autofluorescence with a novel near-infrared fluorescence imaging system: two surgical case reports. Aoyama M, Takizawa H, Yamamoto K, Inui T, Miyamoto N, Sakamoto S, Kobayashi T, Uehara H, Tangoku A. Gland Surg. 2020 Oct;9(5):1584-1589. PMID: 33224835
  6. Ectopic thyroid tissue in adrenal gland, case report and review of literature. Paunovic I, Rovcanin B, Jovanovic M, Buzejic M, Dundjerovic D, Zivaljevic V. Gland Surg. 2020 Oct;9(5):1573-1578. PMID: 33224833
  7. Narrative review of proving the causal link of recurrent laryngeal nerve injury and thyroidectomy: a medico legal appraisal. Gualniera P, Scurria S, Mondello C, Asmundo A, Sapienza D, Gianlorenzo D. Gland Surg. 2020 Oct;9(5):1564-1572. PMID: 33224832
  8. Shaw scalpel use for recurrent laryngeal nerve dissection: safety parameter findings from continuous intraoperative neuromonitoring in swine models. Park D, You JY, Yang HW, Tufano RP, Kim HY. Gland Surg. 2020 Oct;9(5):1363-1369. PMID: 33224811
  9. Prophylactic neck surgery for second-generation multiple endocrine neoplasia type 2B. Machens A, Lorenz K, Weber F, Dralle H. Eur J Surg Oncol. 2020 Nov 13:S0748-7983(20)30902-1. PMID: 33223415
  10. The Clinical Utility of Molecular Testing in the Management of Thyroid Follicular Neoplasms (Bethesda IV Nodules). Carty SE, Ohori NP, Hilko DA, McCoy KL, French EK, Manroa P, Morariu E, Sridharan S, Seethala RR, Yip L. Ann Surg. 2020 Oct;272(4):621-627. PMID: 32773640

November 20, 2020


  1. Circular RNA circ-CCAC1 Facilitates Adrenocortical Carcinoma Cell Proliferation, Migration, and Invasion through Regulating the miR-514a-5p/C22orf46 Axis. Li W, Liu R, Wei D, Zhang W, Zhang H, Huang W, Hao L. Biomed Res Int. 2020 Oct 26;2020:3501451. PMID: 33195693
  2. AN INTRA-OPERATIVE VIDEO COMPARISON OF LAPAROSCOPIC VERSUS ROBOTIC TRANSABDOMINAL LATERAL ADRENALECTOMY. Gokceimam M, Akbulut S, Erten O, Kahramangil B, Kim YS, Li P, Berber E. Int J Med Robot. 2020 Nov 13:e2203. PMID: 33185308

Pancreatic Neuroendocrine

  1. Clinical Characteristics and Management of Functional Pancreatic Neuroendocrine Neoplasms: A Single Institution 20-Year Experience with 286 Patients. Qu Y, Li H, Wang X, Chen Y, Guo Q, Pei Y, Du J, Dou J, Ba J, Lv Z, Mu Y. Int J Endocrinol. 2020 Nov 6;2020:1030518. PMID: 33204258
  2. Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors. Partelli S, Landoni L, Andreasi V, Nessi C, Muffatti F, Crippa S, Cingarlini S, Bassi C, Falconi M. Surgery. 2020 Nov;168(5):816-824. PMID: 32778411


  1. Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative imaging versus bilateral neck exploration for primary hyperparathyroidism in adults. Ahmadieh H, Kreidieh O, Akl EA, El-Hajj Fuleihan G. Cochrane Database Syst Rev. 2020 Oct 21;10:CD010787. PMID: 33085088
  2. Variation in surgical management of primary hyperparathyroidism in the US Department of Veterans Affairs healthcare system: A 15-year observational study. Alore EA, Massarweh NN, Ramsey DJ, Chen L, Chai CY, Singh H, Makris KI. Surgery. 2020 Nov;168(5):838-844. PMID: 32665141


  1. Transoral Thyroidectomy: Safety and Outcomes of 200 Consecutive North American Cases. Russell JO, Razavi CR, Shaear M, Liu RH, Chen LW, Pace-Asciak P, Tanavde V, Tai KY, Ali K, Fondong A, Kim HY, Tufano RP. World J Surg. 2020 Nov 17. PMID: 33205227
  2. Spatial distribution patterns of clinically relevant TERT promoter mutations in follicular thyroid tumors of uncertain malignant potential (FT-UMPs): advantages of the digital droplet PCR (ddPCR) technique. Hysek M, Jatta K, Hellgren LS, Stenman A, Larsson C, Zedenius J, Juhlin CC. J Mol Diagn. 2020 Nov 13:S1525-1578(20)30539-0. PMID: 33197629
  3. Management of the Neck in Well-Differentiated Thyroid Cancer. Asimakopoulos P, Shaha AR, Nixon IJ, Shah JP, Randolph GW, Angelos P, Zafereo ME, Kowalski LP, Hartl DM, Olsen KD, Rodrigo JP, Vander Poorten V, Mäkitie AA, Sanabria A, Suárez C, Quer M, Civantos FJ, Robbins KT, Guntinas-Lichius O, Hamoir M, Rinaldo A, Ferlito A. Curr Oncol Rep. 2020 Nov 14;23(1):1. PMID: 33190176
  4. KPNA4 regulated by miR-548b-3p promotes the malignant phenotypes of papillary thyroid cancer. Feng L, Wang R, Yang Y, Shen X, Shi Q, Lian M, Ma H, Fang J. Life Sci. 2020 Nov 11:118743. PMID: 33188837
  5. Diagnosis of thyroid neoplasm using support vector machine algorithms based on platelet RNA-seq. Shen Y, Lai Y, Xu D, Xu L, Song L, Zhou J, Song C, Wang J. Endocrine. 2020 Nov 12. PMID: 33179221

November 13, 2020


  1. ENSAT Registry-Based Randomized Clinical Trials for Adrenocortical Carcinoma. Crona J, Baudin E, Terzolo M, Chrisoulidou A, Angelousi AG, Ronchi CL, Lamas C, Nieveen van Dijkum E, Ceccato F, Borson-Chazot F, Reimondo G, Tiberi GA, Ettaieb H, Kiriakopoulos A, Canu L, Kastelan D, Osher E, Yiannakopoulou E, Arnaldi G, Assie G, Paiva I, Bourdeau I, Newell-Price J, Nowak KM, Romero MT, De Martino MC, Bugalho MJ, Sherlock M, Vantyghem MC, Dennedy MC, Loli P, Rodien P, Feelders RA, de Krijger RR, Van Slycke S, Aylwin S, Morelli V, Vroonen L, Shafigullina Z, Bancos I, Trofimiuk-Müldner M, Quinkler M, Luconi M, Kroiss M, Naruse M, Igaz P, Mihai R, Della Casa S, Berruti A, Fassnacht M, Beuschlein F. Eur J Endocrinol. 2020 Nov 1:EJE-20-0800.R1. PMID: 33166271
  2. Genomic classification of benign adrenocortical lesions. Faillot S, Foulonneau T, Néou M, Espiard S, Garinet S, Vaczlavik A, Jouinot A, Rondof W, Septier A, Drougat L, Hecale-Perlemoine K, Ragazzon B, Rizk-Rabin M, Sibony M, Bonnet-Serrano F, Guibourdenche J, Libé R, Groussin L, Dousset B, De Reynies A, Bertherat J, Assié G. Endocr Relat Cancer. 2020 Nov 1:ERC-20-0128.R2. PMID: 33151900
  3. Adrenalectomy during pregnancy: A 15-year experience at a tertiary referral center. Gaujoux S, Hain É, Marcellin L, de Carbonnieres A, Goffinet F, Bertherat J, Dousset B. Surgery. 2020 Aug;168(2):335-339. PMID: 32434659

Pancreatic Neuroendocrine

  1. Distinctive features of pancreatic neuroendocrine neoplasms exhibiting an increment in proliferative activity during the course of the disease. Alexandraki KI, Kaltsatou M, Kyriakopoulos G, Mavroeidi V, Kostopoulou A, Atlan K, Theocharis S, Rindi G, Grossman AB, Grozinsky-Glasberg S, Kaltsas GA. Endocrine. 2020 Nov 11. PMID: 33175321


  1. Expression profile of serum-related exosomal miRNAs from parathyroid tumor. Wang J, Wang Q, Zhao T, Liu X, Bai G, Xin Y, Shen H, Wei B. Endocrine. 2020 Nov 8. PMID: 33161496
  2. MiR-126-3p contributes to parathyroid tumor angiogenesis. Verdelli C, Forno I, Morotti A, Maggiore R, Mari G, Vicentini L, Ferrero S, Kuhn E, Vaira VA, Corbetta S. Endocr Relat Cancer. 2020 Nov 1:ERC-20-0313.R1. PMID: 33151903
  3. Risk Factors of Redo Surgery After Unilateral Focused Parathyroidectomy: Conclusions From a Comprehensive Nationwide Database of 13,247 Interventions Over 6 Years. Donatini G, Marciniak C, Lenne X, Clément G, Bruandet A, Sebag F, Mirallié E, Mathonnet M, Brunaud L, Lifante JC, Tresallet C, Ménégaux F, Theis D, Pattou F, Caiazzo R; on the behalf of AFCE Study Group. Ann Surg. 2020 Nov;272(5):801-806. PMID: 32833757


  1. The impact of operative duration and intraoperative fluid dynamics on postoperative hypocalcemia after total thyroidectomy: a prospective non-randomized study. Karunakaran P, Abraham DT, Devadas G, Ramalingam S, Balu S, Hussain Z. Langenbecks Arch Surg. 2020 Nov 11. PMID: 33174169
  2. Thyroid Lobectomy for Low to Intermediate Risk Differentiated Thyroid Cancer. Hartl DM, Guerlain J, Breuskin I, Hadoux J, Baudin E, Al Ghuzlan A, Terroir-Cassou-Mounat M, Lamartina L, Leboulleux S. Cancers (Basel). 2020 Nov 6;12(11):E3282. PMID: 33171949
  3. CSN5 promotes carcinogenesis of thyroid carcinoma cells through ANGPTL2. Xie P, Wang H, Fang J, Du D, Tian Z, Zhen J, Liu Y, Ding Y, Fu B, Liu F, Huang D, Yu J. Endocrinology. 2020 Nov 10:bqaa206. PMID: 33170208
  4. Neoadjuvant selpercatinib for advanced medullary thyroid cancer. Jozaghi Y, Zafereo M, Williams MD, Gule-Monroe MK, Wang J, Grubbs EG, Vaporciyan A, Hu MI, Busaidy N, Dadu R, Waguespack SG, Subbiah V, Cabanillas M.
  5. Head Neck. 2020 Nov 9. PMID: 33169506
  6. Can thyroidectomy be considered safe in obese patients? A retrospective cohort study. Canu GL, Medas F, Cappellacci F, Podda MG, Romano G, Erdas E, Calò PG. BMC Surg. 2020 Nov 7;20(1):275. PMID: 33160350
  7. Distinguishing Recurrent Thyroid Cancer from Residual Nonmalignant Thyroid Tissue Using Multiphasic Multidetector CT. Debnam JM, Guha-Thakurta N, Sun J, Wei W, Zafereo ME, Cabanillas ME, Buisson NM, Schellingerhout D. AJNR Am J Neuroradiol. 2020 May;41(5):844-851. PMID: 32327435

November 6, 2020


  1. Association of Adrenal Venous Sampling With Outcomes in Primary Aldosteronism for Unilateral Adenomas. Thiesmeyer JW, Ullmann TM, Stamatiou AT, Limberg J, Stefanova D, Beninato T, Finnerty BM, Vignaud T, Leclerc J, Fahey TJ 3rd, Brunaud L, Mirallie E, Zarnegar R. JAMA Surg. 2020 Nov 4. PMID: 33146695
  2. Adrenal-sparing surgery for a hormonally active tumour - a single-centre experience. Toutounchi S, Pogorzelski R, Wołoszko T, Krajewska E, Celejewski K, Legocka M, Jakuczun W, Gałązka Z. Endokrynol Pol. 2020;71(5):388-391. PMID: 33140380
  3. Adropin Stimulates Proliferation and Inhibits Adrenocortical Steroidogenesis in the Human Adrenal Carcinoma (HAC15) Cell Line. Stelcer E, Milecka P, Komarowska H, Jopek K, Tyczewska M, Szyszka M, Lesniczak M, Suchorska W, Bekova K, Szczepaniak B, Ruchala M, Karczewski M, Wierzbicki T, Szaflarski W, Malendowicz LK, Rucinski M. Front Endocrinol (Lausanne). 2020 Oct 8;11:561370. PMID: 33133015
  4. Recurrence rate of sporadic pheochromocytomas after curative adrenalectomy - a systematic review and meta-analysis. Holscher I, van den Berg TJ, Dreijerink KMA, Engelsman AF, Nieveen van Dijkum EJM. J Clin Endocrinol Metab. 2020 Oct 30:dgaa794. PMID: 33125073


  1. Current state of intraoperative use of near infrared fluorescence for parathyroid identification and preservation. Solórzano CC, Thomas G, Berber E, Wang TS, Randolph GW, Duh QY, Triponez F. Surgery. 2020 Oct 30:S0039-6060(20)30617-6. PMID: 33139065
  2. Effects of Parathyroidectomy on Quality of Life: 10 years Data from a Prospective Randomized Controlled Trial on Primary Hyperparathyroidism (the SIPH-study). Pretorius M, Lundstam K, Hellström M, Fagerland MW, Godang K, Mollerup C, Fougner SL, Pernow Y, Aas T, Hessman O, Rosén T, Nordenström J, Jansson S, Heck A, Bollerslev J. J Bone Miner Res. 2020 Oct 30. PMID: 33125769
  3. Flow cytometric DNA analysis of parathyroid benign lesions. Gawrychowska A, Kowalski G, Nabrdalik M, Buła G, Lackowska B, Bednarczyk A, Werbowski M, Polczyk J, Gawrychowski J. Endokrynol Pol. 2020 Oct 30. PMID: 33125694
  4. Use of Preoperative Imaging in Primary Hyperparathyroidism. Broome DT, Naples R, Bailey R, Tekin Z, Hamidi M, Bena JF, Morrison SL, Berber E, Siperstein AE, Scharpf J, Skugor M. J Clin Endocrinol Metab. 2020 Oct 29:dgaa779. PMID: 33119066


  1. Papillary thyroid carcinoma in Ukraine after Chernobyl and in Japan after Fukushima: different histopathological scenarios. Bogdanova TI, Saenko VA, Hashimoto Y, Hirokawa M, Zurnadzhy LY, Hayashi T, Ito M, Iwadate M, Mitsutake N, Rogounovitch T, Sakamoto A, Naganuma H, Miyauchi A, Tronko MD, Thomas G, Yamashita S, Suzuki S. Thyroid. 2020 Nov 4. PMID: 33143557
  2. A Single Surgeon's 10-Year Experience in Remote-Access Thyroid and Parathyroid Surgery. Kandil E, Akkera M, Shalaby H, Munshi R, Attia A, Elnahla A, Shalaby M, Abdelgawad M, Grace L, Kang SW. Am Surg. 2020 Nov 3:3134820950300. PMID: 33142070
  3. Advances in the Management of Medullary Thyroid Carcinoma: Focus on Peptide Receptor Radionuclide Therapy. Grossrubatscher E, Fanciulli G, Pes L, Sesti F, Dolci C, de Cicco F, Colao A, Faggiano A, Nike Group. J Clin Med. 2020 Oct 29;9(11):E3507. doi: 10.3390/jcm9113507. PMID: 33138305
  4. Perioperative diagnostics of patients referred for radioiodine therapy of differentiated thyroid carcinoma: referral center experience in an iodine-insufficient country. Eilsberger F, Tuttle RM, Librizzi D, Pfestroff A, Luster M, Verburg FA. Endocrine. 2020 Nov 1. PMID: 33135124
  5. Impact of expert review of histological diagnosis of papillary and follicular thyroid cancer. Hescot S, Sheikh-Alard H, Kordahi M, Hartl D, Hadoux J, Terroir M, Breuskin I, Baudin E, Scoazec JY, Schlumberger M, Al Ghuzlan A, Leboulleux S. Endocrine. 2020 Oct 31. PMID: 33128670
  6. Risk Score of Neck Hematoma: How to Select Patients for Ambulatory Thyroid Surgery? Chereau N, Godiris-Petit G, Noullet S, Di Maria S, Tezenas du Montcel S, Menegaux F. World J Surg. 2020 Oct 30. PMID: 33128087
  7. Immediate Intraoperative Repair of the Recurrent Laryngeal Nerve in Thyroid Surgery. Simó R, Nixon IJ, Rovira A, Vander Poorten V, Sanabria A, Zafereo M, Hartl DM, Kowalski LP, Randolph GW, Kamani D, Shaha AR, Shah J, Marie JP, Rinaldo A, Ferlito A. Laryngoscope. 2020 Oct 29. PMID: 33118630

October 30, 2020


  1. Percutaneous Bilateral Adrenal Radiofrequency Ablation in Severe Adrenocorticotropic Hormone-dependent Cushing Syndrome. Rosiak G, Milczarek K, Konecki D, Otto M, Rowinski O, Zgliczynski W. J Clin Imaging Sci. 2020 Oct 3;10:60. PMID: 33094002


  1. Prevalence of Parathyroid Carcinoma and Atypical Parathyroid Neoplasms in 153 Patients With Multiple Endocrine Neoplasia Type 1: Case Series and Literature Review. Song A, Yang Y, Liu S, Nie M, Jiang Y, Li M, Xia W, Wang O, Xing X. Front Endocrinol (Lausanne). 2020 Sep 30;11:557050. PMID: 33101196


  1. Current status of the prognostic molecular markers in medullary thyroid carcinoma. Oczko-Wojciechowska M, Czarniecka A, Gawlik T, Jarzab B, Krajewska J. Endocr Connect. 2020 Oct 1:EC-20-0374. PMID: 33112827
  2. Transoral robotic thyroidectomy versus transoral endoscopic thyroidectomy: a propensity-score-matched analysis of surgical outcomes. Chen YH, Kim HY, Anuwong A, Huang TS, Duh QY. Surg Endosc. 2020 Oct 27. PMID: 33111192
  3. Prognostic significance of the sum of the diameters of single foci in multifocal papillary thyroid cancer: the concept of new-old tumor burden. Manso J, Censi S, Roberti A, Iacobone M, Barollo S, Bertazza L, Galuppini F, Vianello F, Albinger N, Scaroni C, Pennelli G, Mian C. Ther Adv Endocrinol Metab. 2020 Oct 12;11:2042018820964326. PMID: 33110488
  4. "Impact of cytological pitfalls in Bethesda system of Thyroid on surgical decision making of patients with Thyroid nodules: Can these pitfalls be avoided?". Rana C, Singh KR, Ramakant P, Babu S, Mishra A. Cytopathology. 2020 Oct 26. PMID: 33103287
  5. Total thyroidectomy versus lobectomy: surgical approach to T1-T2 papillary thyroid cancer. Di Filippo L, Giugliano G, Tagliabue M, Gandini S, Sileo F, Allora A, Grosso E, Proh M, Basso V, Scaglione D, Manzoni MF, Ansarin M. Acta Otorhinolaryngol Ital. 2020 Aug;40(4):254-261. PMID: 33100336
  6. Complications after medullary thyroid carcinoma surgery: multicentre study of the SQRTPA and EUROCRINE® databases. van Beek DJ, Almquist M, Bergenfelz AO, Musholt TJ, Nordenström E;  on behalf of the EUROCRINE® Council. Br J Surg. 2020 Oct 14. PMID: 33090495
  7. LINC00106 prevents against metastasis of thyroid cancer by inhibiting epithelial-mesenchymal transition. Wang XJ, Zheng HT, Xu J, Guo YW, Zheng GB, Ma C, Hao SL, Liu XC, Chen HJ, Wei SJ, Wu GC. Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):10015-10021. PMID: 33090406
  8. Evaluation of Quality of Life in Patients with Differentiated Thyroid Cancer by Means of the Thyroid-Specific Patient-Reported Outcome Questionnaire: A 5-Year Longitudinal Study. Giusti M, Gay S, Conte L, Cecoli F, Mortara L, Vera L, Monti E. Eur Thyroid J. 2020 Sep;9(5):247-255. PMID: 33088793
  9. Management of Graves Thyroidal and Extrathyroidal Disease: An Update. Kahaly GJ. J Clin Endocrinol Metab. 2020 Dec 1;105(12):dgaa646. PMID: 32929476
  10. Crowdfunding Campaigns and Thyroid Surgery: Who, What, Where, and How Much? Fong A, Jain M, Sacks W, Ho A, Chen Y. J Surg Res. 2020 Sep;253:63-68. PMID: 32320898
  11. Pre-Ablation rhTSH-Stimulated F-18 FDG PET/CT Changes Patient Management in Increased-Risk Thyroid Cancer. Rendl G, Rettenbacher L, Schweighofer-Zwink G, Hehenwarter L, Pirich C. Horm Metab Res. 2020 Mar;52(3):158-167. PMID: 32215887

October 23, 2020


  1. Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism. Soinio M, Luukkonen AK, Seppänen M, Kemppainen J, Seppänen J, Pienimäki JP, Leijon H, Vesterinen T, Arola J, Lantto E, Helin S, Tikkanen I, Metso S, Mirtti T, Heiskanen I, Norvio L, Tiikkainen M, Tikkanen T, Sane T, Välimäki M, Gomez-Sanchez CE, Pörsti I, Nuutila P, Nevalainen PI, Matikainen N. Eur J Endocrinol. 2020 Dec;183(6):539-550. PMID: 33055298

Pancreatic Neuroendocrine

  1. Middle-segment preserving pancreatectomy for multifocal neuroendocrine pancreatic tumors. Addeo P, Julliard O, Imperiale A, Goichot B, Bachellier P. Surg Oncol. 2020 Oct 14;35:466-467. PMID: 33080546
  2. Clinical characteristics and incidence of glucose metabolism disorders during the follow-up of surgically treated insulinomas. Neves JS, Teles L, Guerreiro V, Lau E, Oliveira AI, Graça L, Lopes JM, Freitas P, Carvalho D. Endocrine. 2020 Oct 17. PMID: 33068253


  1. Parathyroidectomy for patients with secondary hyperparathyroidism in a changing landscape for the management of end-stage renal disease. van der Plas W, Kruijff S, Sidhu SB, Delbridge LW, Sywak MS, Engelsman AF. Surgery. 2020 Oct 12:S0039-6060(20)30546-8. PMID: 33059930
  2. 4D-Dynamic Contrast-Enhanced MRI for Preoperative Localization in Patients with Primary Hyperparathyroidism. Becker JL, Patel V, Johnson KJ, Guerrero M, Klein RR, Ranvier GF, Owen RP, Pawha P, Nael K. AJNR Am J Neuroradiol. 2020 Mar;41(3):522-528. PMID: 32165367


  1. Detection of STRN-ALK fusion in thyroid nodules with indeterminate cytopathology facilitates papillary thyroid cancer diagnosis. Jurkiewicz M, Cimic A, Murty VV, Kuo JH, Hsiao S, Fazlollahi L, Fernandes H. Diagn Cytopathol. 2020 Oct 21. PMID: 33085842
  2. Papillary Thyroid Carcinoma in Children: Clinicopathological Profile and Outcomes of Management. Thomas JK, Kurian JJ, Cherian AJ, Hephzibah J, Paul MJ, Abraham DT. World J Surg. 2020 Oct 19. PMID: 33078217
  3. MiR-506-3p suppresses papillary thyroid cancer cells tumorigenesis by targeting YAP1. Chen L, Wang X, Ji C, Hu J, Fang L. Pathol Res Pract. 2020 Sep 28;216(12):153231. PMID: 33059240
  4. Long non-coding RNA DIO3OS/let-7d/NF-κB2 axis regulates cells proliferation and metastasis of thyroid cancer cells. Wang M, Li J, Zuo Z, Ren C, Tang T, Long C, Gong Y, Ye F, Wang Z, Huang J. J Cell Commun Signal. 2020 Oct 15. PMID: 33058043
  5. Thyroid hormones modulate irisin concentrations in patients with recently onset hypothyroidism following total thyroidectomy. Bocale R, Barini A, D'Amore A, Boscherin M, Necozione S, Barini A, Desideri G, Lombardi CP. J Endocrinol Invest. 2020 Oct 14. PMID: 33058006
  6. Notch Signaling in Thyroid Cancer. Guenter R, Patel Z, Chen H. Adv Exp Med Biol. 2021;1287:155-168. PMID: 33034031
  7. The impact of radioactive iodine treatment on survival among papillary thyroid cancer patients according to the 7th and 8th editions of the AJCC/TNM staging system: a SEER-based study. Liu X, Fan Y, Liu Y, He X, Zheng X, Tan J, Jia Q, Meng Z. Updates Surg. 2020 Sep;72(3):871-884. PMID: 32342347
  8. Pediatric thyroid cancer: Risk factors for central lymph node metastasis in patients with cN0 papillary carcinoma. Ngo DQ, Ngo QX, Van Le Q. Int J Pediatr Otorhinolaryngol. 2020 Jun;133:110000. PMID: 32200312

October 15, 2020


  1. In-Practice Endocrine Surgery Fellowship: A Novel Training Model.
    Tierney HT, Eldeiry LS, Garber JR, Haddad CA, Varvares MA, Iannuzzi RA, Randolph GW.
    Otolaryngol Head Neck Surg. 2020 Oct 13:194599820962791. PMID: 33048614 


  1. Outcomes of laparoscopic tumor ablation for neuroendocrine liver metastases: a 20-year experience.
    Kose E, Kahramangil B, Aydin H, Donmez M, Takahashi H, Aucejo F, Siperstein A, Berber E.
    Surg Endosc. 2020 Jan;34(1):249-256. PMID: 30945061 


  1. Pediatric Primary Hyperparathyroidism: Experience in a Tertiary Care Referral Center in a Developing Country Over Three Decades.
    Sharanappa V, Mishra A, Bhatia V, Mayilvagnan S, Chand G, Agarwal G, Agarwal A, Mishra SK.
    World J Surg. 2020 Oct 12. PMID: 33047232 
  2. Parathyroidectomy for Tertiary Hyperparathyroidism: A Multi-Institutional Analysis of Outcomes.
    Patel A, Lee CY, Sloan DA, Randle RW.
    J Surg Res. 2020 Oct 9:S0022-4804(20)30663-6. PMID: 33046234 
  3. Parathyroid Imaging.
    Itani M, Middleton WD.
    Radiol Clin North Am. 2020 Nov;58(6):1071-1083. PMID: 33040849
  4. Diagnosis and Management of Primary Hyperparathyroidism.
    Zhu CY, Sturgeon C, Yeh MW.
    JAMA. 2020 Mar 24;323(12):1186-1187. PMID: 32031566 


  1. Targeting pheochromocytoma/paraganglioma with polyamine inhibitors.
    Rai SK, Bril F, Hatch HM, Xu Y, Shelton L, Kalavalapalli S, Click A, Lee D, Beecher C, Kirby A, Kong K, Trevino J, Jha A, Jatav S, Kriti K, Luthra S, Garrett TJ, Guingab-Cagmat J, Plant D, Bose P, Cusi K, Hromas RA, Tischler AS, Powers JF, Gupta P, Bibb J, Beuschlein F, Robledo M, Calsina B, Timmers H, Taieb D, Kroiss M, Richter S, Langton K, Eisenhofer G, Bergeron R Jr, Pacak K, Tevosian SG, Ghayee HK.
    Metabolism. 2020 Sep;110:154297. PMID: 32562798 


  1. Development and validation of a new model for predicting hypocalcaemia after total thyroidectomy: the NuGra model.
    Triguero Cabrera J, Fernández Segovia E, González Martínez S, Muñoz Pérez NV, Arcelus Martínez JI, Expósito Ruiz M, Villar Del Moral JM.
    Langenbecks Arch Surg. 2020 Oct 13. PMID: 33048225 
  2. Notch Signaling in Thyroid Cancer.
    Guenter R, Patel Z, Chen H.
    Adv Exp Med Biol. 2021;1287:155-168. PMID: 33034031
  3. Clinical characteristics, surgical approach, BRAFV600E mutation and sodium iodine symporter expression in pediatric patients with thyroid carcinoma.
    Castro P, Patiño E, Fierro F, Rojas C, Buitrago G, Olaya N.
    J Pediatr Endocrinol Metab. 2020 Oct 8. PMID: 33031052 
  4. Combined molecular and mathematical analysis of long noncoding RNAs expression in fine needle aspiration biopsies as novel tool for early diagnosis of thyroid cancer.
    Possieri C, Locantore P, Salis C, Bacci L, Aiello A, Fadda G, De Crea C, Raffaelli M, Bellantone R, Grassi C, Strigari L, Farsetti A, Pontecorvi A, Nanni S.
    Endocrine. 2020 Oct 8. PMID: 33030666 

October 8, 2020


  1. Resolution of drug-resistant hypertension by adrenal vein sampling-guided adrenalectomy: a proof-of-concept study.
    Torresan F, Rossitto G, Bisogni V, Lerco S, Maiolino G, Cesari M, Zhu R, Iacobone M, Seccia TM, Rossi GP.
    Clin Sci (Lond). 2020 Jun 12;134(11):1265-1278. PMID: 32452518 


  1. Optimal extent of initial parathyroid resection in patients with multiple endocrine neoplasia syndrome type 1: A meta-analysis.
    Nastos C, Papaconstantinou D, Kofopoulos-Lymperis E, Peppa M, Pikoulis A, Lykoudis P, Palazzo F, Patapis P, Pikoulis E.
    Surgery. 2020 Sep 29:S0039-6060(20)30553-5. PMID: 33008613 


  1. Full percutaneous intraoperative neuromonitoring technique in remote thyroid surgery: Porcine model feasibility study.
    Huang TY, Lin YC, Tseng HY, Kim HY, Dionigi G, Lu IC, Chang PY, Chiang FY, Wu CW.
    Head Neck. 2020 Oct 7. PMID: 33026701  
  2. Hobnail variant of papillary thyroid carcinoma: a systematic review and meta-analysis.
    Donaldson LB, Yan F, Morgan PF, Kaczmar JM, Fernandes JK, Nguyen SA, Jester RL, Day TA.
    Endocrine. 2020 Oct 6. PMID: 33025563  
  3. Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan Association of Endocrine Surgery task force on management for papillary thyroid microcarcinoma.
    Sugitani I, Ito Y, Takeuchi D, Nakayama H, Masaki C, Shindo H, Teshima M, Horiguchi K, Yoshida Y, Kanai T, Hirokawa M, Hames KY, Tabei I, Miyauchi A.
    Thyroid. 2020 Oct 6. PMID: 33023426  
  4. Blood polyphenol concentrations and differentiated thyroid carcinoma in women from the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
    Zamora-Ros R, Lujan-Barroso L, Achaintre D, Franceschi S, Kyrø C, Overvad K, Tjønneland A, Truong T, Lecuyer L, Boutron-Ruault MC, Katzke V, Johnson TS, Schulze MB, Trichopoulou A, Peppa E, La Vechia C, Masala G, Pala V, Panico S, Tumino R, Ricceri F, Skeie G, Quirós JR, Rodriguez-Barranco M, Amiano P, Chirlaque MD, Ardanaz E, Almquist M, Hennings J, Vermeulen R, Wareham NJ, Tong TYN, Aune D, Byrnes G, Weiderpass E, Scalbert A, Rinaldi S, Agudo A.
    Am J Clin Nutr. 2020 Oct 6:nqaa277. PMID: 33021645  
  5. Association between age and disease specific mortality in medullary thyroid cancer.
    Sahli ZT, Canner JK, Zeiger MA, Mathur A.
    Am J Surg. 2020 Sep 26:S0002-9610(20)30594-8. PMID: 33010878 
  6. Retrospective analysis of the ultrasound features of resected thyroid nodules.
    Pagano L, Falco EC, Bisceglia A, Gambella A, Rossetto R, Garberoglio S, Maletta F, Pacchioni D, Garberoglio R, Ghigo E, Papotti MG.
    Endocrine. 2020 Oct 2. PMID: 33006725  
  7. Psychological nursing intervention reduces psychological distress in patients with thyroid cancer: A randomized clinical trial protocol.
    Wu L, Zou Y.
    Medicine (Baltimore). 2020 Sep 18;99(38):e22346. PMID: 32957406 
  8. Predicting non-small-volume central lymph node metastases (>5 or ≥2 mm) preoperatively in cN0 papillary thyroid microcarcinoma without extrathyroidal extension.
    Shou JD, Li FB, Shi LH, Zhou L, Xie L, Wang JB.
    Medicine (Baltimore). 2020 Sep 18;99(38):e22338. PMID: 3295740 
  9. Performance of the ACR TI-RADS and EU TI-RADS scoring systems in the diagnostic work-up of thyroid nodules in a real-life series using histology as reference standard.
    Magri F, Chytiris S, Croce L, Molteni M, Bendotti G, Gruosso G, Tata Ngnitejeu S, Agozzino M, Rotondi M, Chiovato L.
    Eur J Endocrinol. 2020 Nov;183(5):521-528. PMID: 32841935  
  10. Thyroid cancer in the age of COVID-19.
    Venessa HMT, Matti G, Anthony G, Roderick CB, Bruce GR.
    Endocr Relat Cancer. 2020 Nov;27(11):R407-R416. PMID: 32810844 

September 24, 2020


  1. Long-term outcome success after operative treatment for primary aldosteronism.
    Picado O, Whitfield BW, Khan ZF, Jeraq M, Farrá JC, Lew JI.
    Surgery. 2020 Sep 15:S0039-6060(20)30519-5. PMID: 32948336 
  2. Factors associated with prolonged hospital stay after laparoscopic adrenalectomy.
    Rodríguez-Hermosa JI, Delisau O, Planellas-Giné P, Cornejo L, Ranea A, Maldonado E, Fernández-Real JM, Codina-Cazador A.
    Updates Surg. 2020 Sep 17. PMID: 32940830 

Endocrine Surgery Education

  1. Repeat Attending Exposure Influences Operative Autonomy in Endocrine Surgical Procedures.
    Mullins CH, MacLennan P, Wagle A, Chen H, Lindeman B.
    J Surg Educ. 2020 Sep 18:S1931-7204(20)30335-4. PMID: 32958422 


  1. Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy.
    Bodei L, Schöder H, Baum RP, Herrmann K, Strosberg J, Caplin M, Öberg K, Modlin IM.
    Lancet Oncol. 2020 Sep;21(9):e431-e443. PMID: 32888472 


  1. European multicentre study on outcome of surgery for sporadic primary hyperparathyroidism.
    Bergenfelz A, van Slycke S, Makay Ö, Brunaud L.
    Br J Surg. 2020 Sep 17. PMID: 32944972 


  1. USP7 promotes proliferation of papillary thyroid carcinoma cells through TBX3-mediated p57KIP2 repression.
    Xie P, Wang H, Xie J, Huang Z, Chen S, Cheng X, Zhang X, Liu F, Li Y, Huang D.
    Mol Cell Endocrinol. 2020 Sep 20:111037. PMID: 32966862  
  2. Robotic thyroid surgery using bilateral axillo-breast approach: From a trainees' point of view.
    Chand G, Yi JW, Johri G.
    J Minim Access Surg. 2020 Sep 8. PMID: 32964870
  3. Risk Factors for Lateral Lymph Node Metastases in Patients With Sporadic Medullary Thyroid Carcinoma.
    Wu X, Li B, Zheng C, Liu W, Hong T, He X.
    Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820962089. PMID: 32964812 
  4. Lymph node metastasis in hereditary medullary thyroid cancer is independent of the underlying RET germline mutation.
    Machens A, Lorenz K, Weber F, Dralle H.
    Eur J Surg Oncol. 2020 Sep 8:S0748-7983(20)30746-0. PMID: 32962888 
  5. Long non-coding RNA AGAP2-AS1 increases the invasiveness of papillary thyroid cancer.
    Shao L, Sun W, Zhang H, Zhang P, Wang Z, Dong W, He L, Zhang T, Qin Y.
    Aging (Albany NY). 2020 Sep 18;12. PMID: 32960785 
  6. Truncal vs Branch Ligation of Inferior Thyroid Arteries in Total Thyroidectomy: Does It Affect Postoperative Hypoparathyroidism?
    Waseem T, Ahmed SZ, Baig H, Ashraf MH, Azim A, Azim KM.
    Otolaryngol Head Neck Surg. 2020 Sep 22:194599820957283. PMID: 32957817 
  7. Immediate and partial neural dysfunction after thyroid and parathyroid surgery: Need for recognition, laryngeal exam, and early treatment.
    Dhillon VK, Randolph GW, Stack BC Jr, Lindeman B, Bloom G, Sinclair CF, Woodson G, Brooks JA, Childs LF, Esfandiari NH, Evangelista L, Guardiani E, Quintanilla-Dieck L, Naunheim MR, Shindo M, Singer M, Tolley N, Angelos P, Kupfer R, Banuchi V, Liddy W, Tufano RP.
    Head Neck. 2020 Sep 21. PMID: 32954575 
  8. Non-coding RNA in thyroid cancer - Functions and mechanisms.
    Cao J, Zhang M, Zhang L, Lou J, Zhou F, Fang M.
    Cancer Lett. 2020 Sep 16:S0304-3835(20)30433-X. PMID: 32949678 
  9. LOC389641 promotes papillary thyroid cancer progression by regulating the EMT pathway.
    Chen CZ, Wen JL, Lin BY, Zheng C, Quan RD, Zhang XH, Qu JM.
    Biomark Med. 2020 Jul;14(11):969-980. PMID: 32940082 
  10. Impact of COVID-19 on thyroid cancer surgery and adjunct therapy.
    Bakkar S, Al-Omar K, Aljarrah Q, Al-Dabbas M, Al-Dabbas N, Samara S, Miccoli P.
    Updates Surg. 2020 Sep;72(3):867-869. PMID: 32537687

September 17, 2020


  1. Three-dimensional (3D) system versus two-dimensional (2D) system for laparoscopic resection of adrenal tumors: a case-control study.
    Rodríguez-Hermosa JI, Ranea A, Delisau O, Planellas-Giné P, Cornejo L, Pujadas M, Codony C, Gironès J, Codina-Cazador A.
    Langenbecks Arch Surg. 2020 Sep 9. PMID: 3290907 
  2. The non-responding adrenal metastasis in melanoma: The case for minimally invasive adrenalectomy in the age of modern therapies.
    Zippel D, Yalon T, Nevo Y, Markel G, Asher N, Schachter J, Goitein D, Segal TA, Nissan A, Hazzan D.
    Am J Surg. 2020 Aug;220(2):349-353. PMID: 31801652 
  3. Health-related quality of life in patients undergoing adrenalectomy: report from a Swedish National Audit.
    Thompson LH, Nordenström E, Almquist M, Bergenfelz A.
    Langenbecks Arch Surg. 2019 Nov;404(7):807-814. PMID: 31773244 

Gastrointestinal Neuroendocrine

  1. Driver mutations occur frequently in metastases of well-differentiated small intestinal neuroendocrine tumours.
    Samsom KG, Levy S, van Veenendaal LM, Roepman P, Kodach LL, Steeghs N, Valk GD, Dercksen MW, Kuhlmann KFD, Verbeek WHM, Meijer GA, Tesselaar MET, van den Berg JG.
    Histopathology. 2020 Sep 15. PMID: 32931025 

Genetic Syndrome

  1. Uncommon tumors in multiple endocrine neoplasia (MEN) type 1: Do they have a relationship with the prognosis of these patients?
    Febrero B, Segura P, Ruiz-Manzanera JJ, Teruel E, Ros I, Ríos A, Hernández AM, Rodríguez JM.
    J Endocrinol Invest. 2020 Sep 9. PMID: 32909176 


  1. Exploring the link between tumour metabolism and succinate dehydrogenase deficiency: A 18 F-FDOPA PET/CT study in head and neck paragangliomas.
    Reichert T, Fakhry N, Lavieille JP, Amodru V, Sebag F, Romanet P, Loundou A, Castinetti F, Pacak K, Montava M, Taïeb D.
    Clin Endocrinol (Oxf). 2019 Dec;91(6):879-884. doi: 10.1111/cen.14086. Epub 2019 Oct 1. PMID: 31479526 


  1. Practice patterns for surgical management of low-risk papillary thyroid cancer from 2014 to 2019: A CESQIP analysis.
    Wrenn SM, Wang TS, Toumi A, Kiernan CM, Solórzano CC, Stephen AE.
    Am J Surg. 2020 Aug 21:S0002-9610(20)30487-6. PMID: 32933747 
  2. Gene expression profile of epithelial-mesenchymal transition mediators in papillary thyroid cancer.
    Lopez-Campistrous A, Adewuyi EE, Williams DC, McMullen TPW.
    Endocrine. 2020 Sep 10. PMID: 32914379 
  3. Predicting factors for central or lateral lymph node metastasis in conventional papillary thyroid microcarcinoma.
    Sheng L, Shi J, Han B, Lv B, Li L, Chen B, Liu N, Cao Y, Turner AG, Zeng Q.
    Am J Surg. 2020 Aug;220(2):334-340. PMID: 31818425 

September 10, 2020


  1. Racial Disparities of Adrenalectomy.
    Holoubek SA, Maxwell J, Fingeret AL.
    J Endocr Soc. 2020 Aug 7;4(9):bvaa110. PMID: 32885127 
  2. Obesity and postoperative outcomes of the patients with laparoscopic adrenalectomy: a systematic review and meta-analysis.
    Danwang C, Agbor VN, Bigna JJ.
    BMC Surg. 2020 Aug 31;20(1):194. PMID: 32867744 
  3. Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism.
    Satoh M, Maruhashi T, Yoshida Y, Shibata H.
    Hypertens Res. 2019 Jun;42(6):817-824. PMID: 30948836 


  1. Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy.
    Bodei L, Schöder H, Baum RP, Herrmann K, Strosberg J, Caplin M, Öberg K, Modlin IM.
    Lancet Oncol. 2020 Sep;21(9):e431-e443. PMID: 32888472 

Pancreatic Neuroendocrine

  1. Distinct Clinical Characteristics in Young-Onset Pancreatic Neuroendocrine Tumor.
    Goksu SY, Ozer M, Kazmi SMA, Sanford NN, Aguilera TA, Ahn C, Hsiehchen D, Sanjeevaiah A, Khosama L, Bleeker J, Atiq M, Beg MS.
    Cancers (Basel). 2020 Sep 3;12(9):E2501. PMID: 32899271 


  1. Use of Indocyanine Green and Fluorescence Angiography in Parathyroid Surgery: A Feasibility Study.
    Maser C, Kohlbrenner AH, Dirks R.
    Surg Innov. 2020 Sep 5:1553350620956437. PMID: 32892716 
  2. Will 18F-fluorocholine PET/CT replace other methods of preoperative parathyroid imaging?
    Giovanella L, Bacigalupo L, Treglia G, Piccardo A.
    Endocrine. 2020 Sep 6. PMID: 32892309 


  1. Machine Learning Prediction of Radiofrequency Thermal Ablation Efficacy: A New Option to Optimize Thyroid Nodule Selection.
    Negro R, Rucco M, Creanza A, Mormile A, Limone PP, Garberoglio R, Spiezia S, Monti S, Cugini C, El Dalati G, Deandrea M.
    Eur Thyroid J. 2020 Jul;9(4):205-212. PMID: 32903883 
  2. Immunohistochemical basigin expression level in thyroid cancer tissues.
    Guo WP, Tang D, Pang YY, Li XJ, Chen G, Huang ZG, Tang XZ, Lai QQ, Gan JY, Huang XL, Liu XF, Wei ZX, Ma W.
    World J Surg Oncol. 2020 Sep 5;18(1):240. PMID: 32891152 
  3. Frequent Neck US in Papillary Thyroid Cancer Likely Detects Non-Actionable Findings.
    Sek KS, Tsang I, Lee XY, Albaqmi OH, Morosan Allo YJ, Rosmarin MC, Mahrous AK, Parameswaran R, Ng DCE, Tong AKT, Loke KSH, Brenta G, Alghamdi AH, Albati NA, Fish SA, Tuttle RM, Yang SP.
    Clin Endocrinol (Oxf). 2020 Sep 4. PMID: 32886805 
  4. ALDH5A1 acts as a tumour promoter and has a prognostic impact in papillary thyroid carcinoma.
    Deng XY, Gan XX, Feng JH, Cai WS, Wang XQ, Shen L, Luo HT, Chen Z, Guo M, Cao J, Shen F, Xu B.
    Cell Biochem Funct. 2020 Sep 2. PMID: 32881051 
  5. Prophylactic central lymph node dissection informs the decision of radioactive iodine ablation in papillary thyroid cancer.
    Nylén C, Eriksson FB, Yang A, Aniss A, Turchini J, Learoyd D, Robinson BG, Gill AJ, Clifton-Bligh RJ, Sywak MS, Glover AR, Sidhu SB.
    Am J Surg. 2020 Aug 18:S0002-9610(20)30504-3. PMID: 32878695 
  6. Medullary thyroid cancer: epidemiological pattern and factors contributing to recurrence and metastasis.
    Hamdy O, Awny S, Metwally IH.
    Ann R Coll Surg Engl. 2020 Sep;102(7):499-503. PMID: 32233867 
  7. miR-206 inhibits thyroid cancer proliferation and invasion by targeting RAP1B.
    Wang P, Gu J, Wang K, Shang J, Wang W.
    J Cell Biochem. 2019 Nov;120(11):18927-18936. PMID: 31245877

September 3, 2020


  1. Optimizing the fellowship interview process: Perspectives from applicants and program directors of the comprehensive endocrine surgery fellowship program.
    Drake FT, Lyden ML, Kuo JH, Shen WT, Morris-Wiseman LF, Carty SE, Wang TS.
    Surgery. 2020 Aug 25:S0039-6060(20)30431-1. PMID: 32854969 


  1. Discrepancies in the Recommended Management of Adrenal Incidentalomas by Various Guidelines.
    Maas M, Nassiri N, Bhanvadia S, Carmichael JD, Duddalwar V, Daneshmand S.
    J Urol. 2020 Aug 28:101097. PMID: 32856984 
  2. Posterior Retroperitoneoscopic Versus Laparoscopic Transperitoneal Adrenalectomy: A Systematic Review by an Updated Meta-Analysis.
    Gavriilidis P, Camenzuli C, Paspala A, Di Marco AN, Palazzo FF.
    World J Surg. 2020 Aug 27. PMID: 32856097 
  3. Adrenal artery ablation for primary aldosteronism without apparent aldosteronoma: An efficacy and safety, proof-of-principle trial.
    Zhang H, Li Q, Liu X, Zhao Z, He H, Sun F, Hong Y, Zhou X, Li Y, Shen R, Bu X, Yan Z, Zheng H, Yang G, Zhu Z; Chongqing Endocrine Hypertension Collaborative Team.
    J Clin Hypertens (Greenwich). 2020 Aug 27. PMID: 32852871 
  4. Basal contralateral aldosterone suppression is rare in lateralized primary aldosteronism.
    Desrochers MJ, St-Jean M, El Ghorayeb N, Bourdeau I, So B, Therasse É, Kline G, Lacroix A.
    Eur J Endocrinol. 2020 Oct;183(4):399-409. PMID: 32698132 

Pancreatic Neuroendocrine

  1. High pre-operative fasting blood glucose levels predict a poor prognosis in patients with pancreatic neuroendocrine tumour.
    Gong Y, Fan Z, Zhang P, Qian Y, Huang Q, Deng S, Luo G, Cheng H, Jin K, Ni Q, Yu X, Liu C.
    Endocrine. 2020 Aug 29. PMID: 32862321 


  1. Clinical decision making in small non-functioning VHL-related incidentalomas.
    Därr R, Kater J, Sekula P, Bausch B, Krauss T, Bode C, Walz G, Neumann HP, Zschiedrich S.
    Endocr Connect. 2020 Aug;9(8):834-844. PMID: 32869749 
  2. Usefulness of FDG-PET/CT-Based Radiomics for the Characterization and Genetic Orientation of Pheochromocytomas Before Surgery.
    Ansquer C, Drui D, Mirallié E, Renaudin-Autain K, Denis A, Gimenez-Roqueplo AP, Leux C, Toulgoat F, Kraeber-Bodéré F, Carlier T.
    Cancers (Basel). 2020 Aug 26;12(9):E2424. PMID: 32859070 


  1. Diagnostic value of modified systemic inflammation score for prediction of malignancy in patients with indeterminate thyroid nodules.
    Ataş H, Korukluoğlu B, Özdemir BA, Yakşi N, Saylam B, Tez M.
    Am J Surg. 2020 Aug 21:S0002-9610(20)30489-X. PMID: 32868026 
  2. Treatment of anaplastic thyroid cancer with tyrosine kinase inhibitors targeted on the tumor vasculature: initial experience in clinical practice.
    Ishihara S, Onoda N, Noda S, Tauchi Y, Morisaki T, Asano Y, Kashiwagi S, Takashima T, Ohira M.
    Endocr J. 2020 Aug 29. PMID: 32863283 
  3. Diagnostic Value of Molecular Testing in Sonographically Suspicious Thyroid Nodules.
    Wang MM, Beckett K, Douek M, Masamed R, Patel M, Tseng CH, Yeh MW, Leung AM, Livhits MJ.
    J Endocr Soc. 2020 Jun 20;4(9):bvaa081. PMID: 32856009 
  4. Impact of Surgeon-Performed Ultrasound on Treatment of Thyroid Cancer Patients.
    Shalaby M, Hadedeya D, Lee GS, Toraih E, Kandil E.
    Am Surg. 2020 Aug 27:3134820945229. PMID: 32853031 
  5. New national recommendations for the treatment of pediatric differentiated thyroid carcinoma in the Netherlands.
    Lebbink CA, Dekker BL, Bocca G, Braat AJAT, et. al.
    Eur J Endocrinol. 2020 Oct;183(4):P11-P18. PMID: 32698145 
  6. No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH.
    Campopiano MC, Podestà D, Bianchi F, Giani C, Agate L, Bottici V, Cappagli V, Lorusso L, Matrone A, Puleo L, Valerio L, Viola D, Piaggi P, Elisei R, Molinaro E.
    Eur J Endocrinol. 2020 Oct;183(4):411-417. PMID: 32688334 
  7. Comparison Study of Robotic Thyroidectomies Through a Bilateral Axillo-Breast Approach and a Transoral Approach.
    Chae S, Min SY, Park WS.
    J Laparoendosc Adv Surg Tech A. 2020 Feb;30(2):175-182. PMID: 31663817 
  8. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
    Gou L, Zou H, Li B.
    Cancer Biol Ther. 2019;20(11):1355-1365. doi: 10.1080/15384047.2019.1617567. Epub 2019 Sep 10. PMID: 31500506 

August 27, 2020


  1. The ups and downs of general surgery resident experience in endocrine surgery: Analysis of 30 years of American Association of Endocrine Surgeons graduate case logs.
    Ramirez AG, Fashandi AZ, Hanks JB, Smith PW, Potts JR 3rd.
    Surgery. 2020 Aug 15:S0039-6060(20)30449-9. PMID: 32811696 


  1. Evaluation of Adrenal Vein Sampling Use and Outcomes in Patients With Primary Aldosteronism.
    Yeung A, Friedmann P, In H, Bloomgarden N, McAuliffe JC, Libutti SK, Laird AM.
    J Surg Res. 2020 Aug 19;256:673-679. PMID: 32827833 
  2. Influence of fellowship educational experience on practice patterns for adrenalectomy: A survey of recent AAES fellowship graduates.
    Fazendin J, Chen H, Lindeman B.
    Am J Surg. 2020 Aug 12:S0002-9610(20)30481-5. PMID: 32819675 


  1. Risk Factors of Redo Surgery After Unilateral Focused Parathyroidectomy: Conclusions From a Comprehensive Nationwide Database of 13,247 Interventions Over 6 Years.
    Donatini G, Marciniak C, Lenne X, Clément G, Bruandet A, Sebag F, Mirallié E, Mathonnet M, Brunaud L, Lifante JC, Tresallet C, Ménégaux F, Theis D, Pattou F, Caiazzo R; on the behalf of AFCE Study Group.
    Ann Surg. 2020 Aug 21. PMID: 32833757 
  2. The changing face of reoperative parathyroidectomy: a single-centre comparison of 147 parathyroid reoperations.
    Camenzuli C, DiMarco AN, Isaacs KE, Grant Y, Jackson J, Alsafi A, Harvey C, Barwick TD, Tolley N, Palazzo FF.
    Ann R Coll Surg Engl. 2020 Aug 24:1-6. PMID: 32829647 


  1. Treating papillary and follicular thyroid cancer in children and young people: Single UK-center experience between 2003 and 2018.
    de Jong MC, Gaze MN, Szychot E, Rozalén García V, Brain C, Dattani M, Spoudeas H, Hindmarsh P, Abdel-Aziz TE, Bomanji J, Shankar A, Stoneham S, Morley S, Beale T, Jawad S, Otero S, Proctor I, Amin S, Butler G, Hewitt RJ, Kurzawinski TR.
    J Pediatr Surg. 2020 Aug 4:S0022-3468(20)30538-8. PMID: 32838975 
  2. Pure Transoral Robotic Thyroidectomy; Institutional Adaptation and Early Results from a Tertiary Endocrine Surgery Center.
    Tunca F, Dural AC, Sahbaz NA, Akarsu C, Sormaz IC, Emir NS, Guzey D, Senyurek YG.
    Int J Med Robot. 2020 Aug 24:e2151. PMID: 32835431 
  3. MiRNA let-7 from TPO(+) Extracellular Vesicles is a Potential Marker for a Differential Diagnosis of Follicular Thyroid Nodules.
    Zabegina L, Nazarova I, Knyazeva M, Nikiforova N, Slyusarenko M, Titov S, Vasilyev D, Sleptsov I, Malek A.
    Cells. 2020 Aug 18;9(8):E1917. PMID: 32824820 
  4. Modulating the extension of thyroidectomy in patients with papillary thyroid carcinoma pre-operatively eligible for lobectomy: reliability of ipsilateral central neck dissection.
    Raffaelli M, De Crea C, Sessa L, Tempera SE, Fadda G, Pontecorvi A, Bellantone R.
    Endocrine. 2020 Aug 20. PMID: 32820358 
  5. Membrane type 1 matrix metalloproteinase regulates anaplastic thyroid carcinoma cell growth and invasion into the collagen matrix.
    Yoshida T, Suganuma N, Sato S, Toda S, Nakayama H, Masudo K, Okubo Y, Hayashi H, Yokose T, Koshikawa N, Rino Y, Iwasaki H, Miyagi Y, Masuda M, Hoshino D.
    Biochem Biophys Res Commun. 2020 Sep 3;529(4):1195-1200. PMID: 32819585 
  6. Comparative efficacy and safety of tyrosine kinase inhibitors for thyroid cancer: a systematic review and meta-analysis.
    Oba T, Chino T, Soma A, Shimizu T, Ono M, Ito T, Kanai T, Maeno K, Ito KI.
    Endocr J. 2020 Aug 18. PMID: 32814730 
  7. The Integrated Analyses of Driver Genes Identify Key Biomarkers in Thyroid Cancer.
    Xu Q, Song A, Xie Q.
    Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820940440. PMID: 32812852 
  8. Salivary and lacrimal dysfunction after radioactive iodine for differentiated thyroid cancer: American Head and Neck Society Endocrine Surgery Section and Salivary Gland Section joint multidisciplinary clinical consensus statement of otolaryngology, ophthalmology, nuclear medicine and endocrinology.
    Singer MC, Marchal F, Angelos P, Bernet V, Boucai L, Buchholzer S, Burkey B, Eisele D, Erkul E, Faure F, Freitag SK, Gillespie MB, Harrell RM, Hartl D, Haymart M, Leffert J, Mandel S, Miller BS, Morris J, Pearce EN, Rahmati R, Ryan WR, Schaitkin B, Schlumberger M, Stack BC, Van Nostrand D, Wong KK, Randolph G.
    Head Neck. 2020 Aug 19. PMID: 32812307 

Endocrine Surgery History

  1. Edward D. Churchill (1895-1972): An Innovative Surgeon, His Work, and His Contribution to Parathyroid Surgery.
    Spartalis ED, Kouriannidi E, Athanasiadis DI, Chrysikos DT, Makay Ö, Troupis T.
    Surg Innov. 2020 Aug 18:1553350620950908. PMID: 32808916 


  1. Low grade cortisol co-secretion has limited impact on ACTH-stimulated AVS parameters in primary aldosteronism.
    O'Toole SM, Sze WC, Chung TT, Akker SA, Druce MR, Waterhouse M, Pitkin S, Dawnay A, Sahdev A, Matson M, Parvanta L, Drake WM.
    J Clin Endocrinol Metab. 2020 Aug 12: 519. PMID: 32785656 


  1. Clinicopathological Features of Gastroesophageal Neuroendocrine Neoplasms.
    Liu M, Popa EC, Finnerty BM, Fahey TJ 3rd, Zarnegar R.
    Curr Gastroenterol Rep. 2020 Aug 14;22(10):50. PMID: 32797314 
  2. Magnetic resonance imaging radiomic analysis can preoperatively predict G1 and G2/3 grades in patients with NF-pNETs.
    Bian Y, Li J, Cao K, Fang X, Jiang H, Ma C, Jin G, Lu J, Wang L.
    Abdom Radiol (NY). 2020 Aug 17. PMID: 32808056 
  3. The clinical features and molecular mechanisms of ACTH-secreting pancreatic neuroendocrine tumors.
    Zhang C, Jin J, Xie J, Ye L, Su T, Jiang L, Zhou W, Jiang Y, Wu L, Wang T, Zhong X, Ning G, Shen B, Wang W.
    J Clin Endocrinol Metab. 2020 Aug 12: 507. PMID: 32785672 
  4. Association of a Palliative Surgical Approach to Stage IV Pancreatic Neuroendocrine Neoplasms with Survival: A Systematic Review and Meta-Analysis.
    Tsoli M, Spei ME, Wallin G, Kaltsas G, Daskalakis K.
    Cancers (Basel). 2020 Aug 11;12(8):E2246. PMID: 32796714 


  1. Histologic hypercellularity in a biopsied normal parathyroid gland does not correlate with hyperfunction in primary hyperparathyroidism.
    McCoy KL, Yip L, Dhir M, Langenborg K, Seethala RR, Carty SE.
    Surgery. 2020 Aug 14:S0039-6060(20)30438-4. PMID: 32807505 
  2. Normocalcemic Primary Hyperthyroidism: An Update on Diagnostic and Management Challenges.
    Dawood NB, Yan KL, Shieh A, Livhits MJ, Yeh MW, Leung AM.
    Clin Endocrinol (Oxf). 2020 Aug 16. PMID: 32803770 
  3. Evaluation of an optimal cutoff of parathyroid venous sampling gradient for localizing primary hyperparathyroidism.
    Lee J, Hong N, Kim BM, Kim DJ, Yun M, Jeong JJ, Rhee Y.
    J Bone Miner Metab. 2020 Jul;38(4):570-580. doi: 10.1007/s00774-020-01085-2. Epub 2020 Feb 25. PMID: 32100109 


  1. One genotype, many phenotypes: SDHB p.R90X mutation-associated paragangliomas.
    Alzahrani AS, Alswailem M, Moria Y, Aldeheshi A, Al-Hindi H.
    Endocrine. 2020 Aug 17. PMID: 32804377 
  2. MYO5B mutations in pheochromocytoma/paraganglioma promote cancer progression.
    Tomić TT, Olausson J, Rehammar A, Deland L, Muth A, Ejeskär K, Nilsson S, Kristiansson E, Wassén ON, Abel F.
    PLoS Genet. 2020 Jun 8;16(6):e1008803. PMID: 32511227 


  1. Antibiotic Prophylaxis for Thyroid and Parathyroid Surgery: A Systematic Review and Meta-analysis.
    Medas F, Canu GL, Cappellacci F, Romano G, Amato G, Erdas E, Calò PG.
    Otolaryngol Head Neck Surg. 2020 Aug 18:194599820947700. PMID: 32807010 
  2. Cytological features and nuclear scores: diagnostic tools in preoperative fine-needle aspiration of indeterminate thyroid nodules with RAS or BRAF K601E mutations?
    Ravella L, Lopez J, Descotes F, Giai J, Lapras V, Denier ML, Borson-Chazot F, Lifante JC, Decaussin-Petrucci M.
    Cytopathology. 2020 Aug 16. PMID: 32803788 
  3. Thyroid Ultrasound Reports: Will TI-RADS Improve Natural Language Processing Capture of Critical Thyroid Nodule Features?
    Chen KJ, Dedhia PH, Imbus JR, Schneider DF.
    J Surg Res. 2020 Aug 13;256:557-563. PMID: 32799005 
  4. Endoscopic versus Conventional Thyroid Surgery: A Comparison of Quality of Life, Cosmetic Outcomes and Overall Patient Satisfaction with Treatment.
    Johri G, Chand G, Mishra A, Mayilvaganan S, Agarwal G, Agarwal A, Mishra SK.
    World J Surg. 2020 Aug 13. PMID: 32789681 
  5. Investigation of recurrent laryngeal palsy rates for potential associations during thyroidectomy.
    Moreira A, Forrest E, Lee JC, Paul E, Yeung M, Grodski S, Serpell JW.
    ANZ J Surg. 2020 Aug 11. PMID: 32783252 

August 13, 2020


  1. New endocrine fellowship programs do not decrease the endocrine surgery experience of residents in co-located general surgery programs.
    Fashandi AZ, Hanks JB, Ramirez AG, Potts JR 3rd, Smith PW.
    Surgery. 2020 Aug 5:S0039-6060(20)30356-1. PMID: 32771297 


  1. Outcomes following minimally invasive imagine-guided percutaneous ablation of adrenal glands.
    Ierardi AM, Carnevale A, Angileri SA, Pellegrino F, Renzulli M, Golfieri R, Zhang D, Sun H, Giganti M, Dionigi G, Carrafiello G.
    Gland Surg. 2020 Jun;9(3):859-866. PMID: 32775281 
  2. Current status of robotic adrenalectomy in the United States.
    Grogan RH.
    Gland Surg. 2020 Jun;9(3):840-843. PMID: 32775277 
  3. Risk factors for complications after robotic adrenalectomy: a review.
    Inversini D, Manfredini L, Galli F, Zhang D, Dionigi G, Rausei S.
    Gland Surg. 2020 Jun;9(3):826-830. PMID: 32775275 
  4. Robotic transperitoneal adrenalectomy from inception to ingenuity: the perspective on two high volume endocrine surgery centers.
    Ozdemir M, Dural AC, Sahbaz NA, Akarsu C, Uc C, Sertoz B, Alis H, Makay O.
    Gland Surg. 2020 Jun;9(3):815-825. PMID: 32775274 
  5. Recommendation for laparoscopic ultrasound guided laparoscopic left lateral transabdominal adrenalectomy.
    Sebastian M, Rudnicki J.
    Gland Surg. 2020 Jun;9(3):689-694. PMID: 32775258 


  1. The oncosuppressors MEN1 and CDC73 are involved in lncRNAs deregulation in human parathyroid tumors.
    Morotti A, Forno I, Chiara Verdelli BS, Vito Guarnieri BS, Cetani F, Andrea Terrasi BS, Rosamaria Silipigni BS, Silvana Guerneri BS, Andrè V, Scillitani A, Vicentini L, Ferrero S, Corbetta S, Vaira V.
    J Bone Miner Res. 2020 Aug 11. PMID: 32780442 
  2. Environmental chemicals and metabolic disruption in primary and secondary human parathyroid tumors.
    Hu X, Saunders N, Safley S, Smith MR, Liang Y, Tran V, Sharma J, Jones DP, Weber CJ.
    Surgery. 2020 Aug 5:S0039-6060(20)30370-6. PMID: 32771296 
  3. Outcome of Clinical Genetic Testing in Patients with Features Suggestive for Hereditary Predisposition to PTH-Mediated Hypercalcemia.
    Khairi S, Osborne J, Jacobs MF, Clines GT, Miller BS, Hughes DT, Else T.
    Horm Cancer. 2020 Aug 5. PMID: 32761341


  1. The Clinical Utility of Molecular Testing in the Management of Thyroid Follicular Neoplasms (Bethesda IV Nodules).
    Carty SE, Ohori NP, Hilko DA, McCoy KL, French EK, Manroa P, Morariu E, Sridharan S, Seethala RR, Yip L.
    Ann Surg. 2020 Jul 8. PMID: 32773640 
  2. Hyperthermal liquid, spray, and smog may be potential risk factors for recurrent laryngeal nerve thermal injury during thyroid surgeries.
    Yu X, Liu C, Yan M, Gong W, Wang Y.
    Endocrine. 2020 Aug 10. PMID: 32779090 
  3. Safety of Ligasure exact dissector in thyroidectomy with continuous neuromonitoring: a porcine model.
    Huang TY, Lin YC, Tseng HY, Dionigi G, Kim HY, Lu IC, Chang PY, Chiang FY, Wu CW.
    Gland Surg. 2020 Jun;9(3):702-710. PMID: 32775260 
  4. Cause-specific mortality after diagnosis of thyroid cancer: a large population-based study.
    Du B, Wang F, Wu L, Wang Z, Zhang D, Huang Z, Gao L, Li Y, Liang C, Li P, Yao R.
    Endocrine. 2020 Aug 8. PMID: 32770440 
  5. Superiority of continuous over intermittent intraoperative nerve monitoring in preventing vocal cord palsy.
    Schneider R, Machens A, Sekulla C, Lorenz K, Elwerr M, Dralle H.
    Br J Surg. 2020 Aug 8. PMID: 32770679 
  6. Upregulation of TRIAP1 by the lncRNA MFI2-AS1/miR-125a-5p Axis Promotes Thyroid Cancer Tumorigenesis.
    Yu T, Tong L, Ao Y, Zhang G, Liu Y, Zhang H.
    Onco Targets Ther. 2020 Jul 17;13:6967-6974. PMID: 32764987 
  7. Is Familial Nonmedullary Thyroid Cancer A More Aggressive Type of Thyroid Cancer?
    Muallem Kalmovich L, Jabarin B, Koren S, Or K, Marcus E, Tkacheva I, Benbassat C, Steinschneider M.
    Laryngoscope. 2020 Aug 6. PMID: 32761812 
  8. Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019.
    Maniakas A, Dadu R, Busaidy NL, Wang JR, Ferrarotto R, Lu C, Williams MD, Gunn GB, Hofmann MC, Cote G, Sperling J, Gross ND, Sturgis EM, Goepfert RP, Lai SY, Cabanillas ME, Zafereo M.
    JAMA Oncol. 2020 Aug 6. PMID: 32761153 

August 6, 2020

Pancreatic Neuroendocrine

  1. Functionality is not an independent prognostic factor for pancreatic neuroendocrine tumors.
    Chen HY, Zhou YL, Chen YH, Wang X, Zhang H, Ke NW, Liu XB, Tan CL.
    World J Gastroenterol. 2020 Jul 7;26(25):3638-3649. PMID: 32742132 
  2. Predicting Aggressive Behavior in Nonfunctional Pancreatic Neuroendocrine Tumors With Emphasis on Tumor Size Significance and Survival Trends: A Population-Based Analysis of 1787 Patients.
    Fathi AH, Romanyshyn J, Barati M, Choudhury U, Chen A, Sosa JA.
    Am Surg. 2020 May;86(5):458-466. PMID: 32684030 


  1. The Utility of the Cl:PO4 Ratio in Patients With Variant Versions of Primary Hyperparathyroidism.
    Wright C, King D, Small M, Gibson C, Gardner R, Stack BC Jr.
    Otolaryngol Head Neck Surg. 2020 Aug 4:194599820947009. PMID: 32746759 
  2. Timing of parathyroidectomy for tertiary hyperparathyroidism with end-stage renal disease: A cost-effectiveness analysis.
    McManus C, Oh A, Lee JA, Hur C, Kuo JH.
    Surgery. 2020 Jul 27:S0039-6060(20)30375-5. PMID: 32732069 


  1. Tumor detection rates in screening of individuals with SDHx-related hereditary paraganglioma-pheochromocytoma syndrome.
    Greenberg SE, Jacobs MF, Wachtel H, Anson A, Buchmann L, Cohen DL, Bonanni M, Bennett B, Naumer A, Schaefer AM, Kohlmann W, Nathanson KL, Else T, Fishbein L.
    Genet Med. 2020 Aug 3. PMID: 32741965 


  1. Reappraising the Diagnostic Accuracy of Post-Treatment Whole-Body Scans for Differentiated Thyroid Carcinoma.
    Nava CF, Scheffel RS, Zanella AB, Zelmanovitz F, Maia AL, Dora JM.
    Horm Metab Res. 2020 Aug 4. PMID: 32750721 
  2. Single-session High-Intensity Focused Ultrasound (HIFU) ablation for benign thyroid nodules: A Systematic Review.
    Spartalis E, Karagiannis SP, Plakopitis N, Theodori MA, Chrysikos D, Paschou SA, Boutzios G, Schizas D, Spartalis M, Troupis T, Nikiteas N.
    Expert Rev Med Devices. 2020 Aug 4. PMID: 32749167 
  3. Real-world experience of lenvatinib in patients with advanced anaplastic thyroid cancer.
    Kim M, Ahn J, Song DE, Yoon JH, Kang HC, Lim DJ, Kim WG, Kim TY, Kim WB, Shong YK, Jeon MJ, Kim BH.
    Endocrine. 2020 Jul 29. PMID: 32729092 
  4. The effects of radioiodine therapy on parathyroid function among patients with papillary thyroid cancer: a retrospective cohort study.
    Fei Y, Qiu Y, Xing Z, Zhao W, Su A, Zhu J.
    Endocrine. 2020 Jul 28. PMID: 32725445 
  5. PTC located in the upper pole is more prone to lateral lymph node metastasis and skip metastasis.
    Dou Y, Hu D, Chen Y, Xiong W, Xiao Q, Su X.
    World J Surg Oncol. 2020 Jul 28;18(1):188. PMID: 32723382 
  6. The Potential of Metabolomics in the Diagnosis of Thyroid Cancer.
    Coelho M, Raposo L, Goodfellow BJ, Atzori L, Jones J, Manadas B.
    Int J Mol Sci. 2020 Jul 24;21(15):E5272. PMID: 32722293 
  7. The effect of dexmedetomidine and remifentanil on the postoperative sore throat after thyroidectomy.
    Kim H, Kwon H, Jeon S, Choi EK.
    Medicine (Baltimore). 2020 Jul 17;99(29):e21060. PMID: 32702848 
  8. Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas.
    Krishnan A, Berthelet J, Renaud E, Rosigkeit S, Distler U, Stawiski E, Wang J, Modrusan Z, Fiedler M, Bienz M, Tenzer S, Schad A, Roth W, Thiede B, Seshagiri S, Musholt TJ, Rajalingam K.
    Nat Commun. 2020 Apr 28;11(1):2056. PMID: 32345963 

July 30, 2020


  1. Reducing Opioid Use in Endocrine Surgery Through Patient Education and Provider Prescribing Patterns.|
    Kwan SY, Lancaster E, Dixit A, Inglis-Arkell C, Manuel S, Suh I, Shen WT, Seib CD.
    J Surg Res. 2020 Jul 23;256:303-310. PMID: 32712445


  1. The impact of adrenal tumor multidisciplinary team meetings on clinical outcomes.
    Fukuoka H, Shigemura K, Kanzawa M, Kanda T, Yamamoto M, Kitagawa K, Sakamoto M, Iguchi G, Ogawa W, Fujisawa M, Takahashi Y.
    Endocrine. 2020 Jul 23. PMID: 32700134 
  2. Defining Nonfunctioning Adrenal Adenomas on the Basis of the Occurrence of Hypocortisolism after Adrenalectomy.
    Eller-Vainicher C, Morelli V, Aresta C, Salcuni AS, Falchetti A, Carnevale V, Persani L, Scillitani A, Chiodini I.
    J Endocr Soc. 2020 Jun 19;4(8):bvaa079. PMID: 32699828 
  3. Intratumor heterogeneity of prognostic DNA-based molecular markers in adrenocortical carcinoma.
    Jouinot A, Lippert J, Fassnacht M, de La Villeon B, Septier A, Neou M, Perlemoine K, Appenzeller S, Sibony M, Gaujoux S, Dousset B, Libe R, Groussin L, Ronchi CL, Assié G, Bertherat J.
    Endocr Connect. 2020 Jul;9(7):705-714. PMID: 32698135 

Genetic Syndrome

  1. Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies.
    Pieterman CRC, Hyde SM, Wu SY, Landry JP, Chiang YJ, Christakis I, Grubbs EG, Fisher SB, Graham PH, Waguespack SG, Perrier ND.
    Surgery. 2020 Jul 20:S0039-6060(20)30292-0. PMID: 32703679 


  1. Exendin-4 based imaging in endogenous hyperinsulinemic hypoglycemia cohort: A tertiary Endocrine center experience.
    Garg R, Shah R, Tiwari A, Purandare N, Lele VR, Malhotra G, Verma P, Gosavi V, Dalvi A, Jaiswal SK, Patil V, Ramteke-Jadhav S, Lila A, Shah N, Bandgar T.
    Clin Endocrinol (Oxf). 2020 Jul 27. PMID: 32716527 
  2. CUX1-Transcriptional Master Regulator of Tumor Progression in Pancreatic Neuroendocrine Tumors.
    Krug S, Weissbach J, Blank A, Perren A, Haybaeck J, Fendrich V, Rinke A, Gress TM, Rosendahl J, Michl P.
    Cancers (Basel). 2020 Jul 19;12(7):E1957. PMID: 32707646 
  3. Distinct DNA methylation signatures in neuroendocrine tumors specific for primary site and inherited predisposition.
    Tirosh A, Killian JK, Petersen D, Zhu YJ, Walker RL, Blau JE, Nilubol N, Patel D, Agarwal SK, Weinstein LS, Meltzer P, Kebebew E.
    J Clin Endocrinol Metab. 2020 Jul 24:dgaa477. PMID: 32706863 


  1. Serum Klotho levels in primary hyperparathyroidism patients before and after parathyroidectomy.
    Su C, Meng L, Trooskin SZ, Shapses SA, He Y, Al-Dayyeni A, Wang X.
    Endocrine. 2020 Jul 24. PMID: 32710436 


  1. IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis.
    Haase J, Misiak D, Bauer M, Pazaitis N, Braun J, Pötschke R, Mensch A, Bell JL, Dralle H, Siebolts U, Wickenhauser C, Lorenz K, Hüttelmaier S.
    Mod Pathol. 2020 Jul 27. PMID: 32719445 
  2. Influence of Care Pathway on Thyroid Nodule Surgery Relevance: A Historical Cohort Study.
    Castellnou S, Lifante JC, Polazzi S, Pascal L, Borson-Chazot F, Duclos A.
    J Clin Med. 2020 Jul 17;9(7):E2271. PMID: 32708905 
  3. New National Recommendations for the Treatment of Pediatric Differentiated Thyroid Carcinoma in the Netherlands.
    Lebbink CA, Dekker BL, Bocca G, Braat AJ, Derikx JP, Dierselhuis MP, de Keizer B, Kruijff S, Kwast AB, van Nederveen FH, Nieveen van Dijkum E, Nievelstein RA, Peeters RP, Terwisscha van Scheltinga CE, Tissing WJ, van der Tuin K, Vriens MR, Zsiros J, van Trotsenburg AS, Links TP, van Santen HM.
    Eur J Endocrinol. 2020 Jul 1:EJE-20-0191.R1. PMID: 32698145 
  4. Management of Graves' hyperthyroidism and orbitopathy in time of COVID-19 pandemic.
    Bartalena L, Chiovato L, Marcocci C, Vitti P, Piantanida E, Tanda ML.
    J Endocrinol Invest. 2020 Aug;43(8):1149-1151. PMID: 32441005 

July 23, 2020


  1. Can the Use of Video-Based Interventions Increase Public Knowledge About Endocrine Surgeons?
    Barnes K, Davies HC, Fazendin JM, Chen H, Lindeman B.
    J Surg Res. 2020 Jul 16;256:119-123. PMID: 32683052 


  1. Guidance for the prevention and emergency management of adult patients with adrenal insufficiency.
    Simpson H, Tomlinson J, Wass J, Dean J, Arlt W.
    Clin Med (Lond). 2020 Jul;20(4):371-378. PMID: 32675141 


  1. Anti-SSTR2 antibody-drug conjugate for neuroendocrine tumor therapy.
    Si Y, Kim S, Ou J, Lu Y, Ernst P, Chen K, Whitt J, Carter AM, Markert JM, Bibb JA, Chen H, Zhou L, Jaskula-Sztul R, Liu XM.
    Cancer Gene Ther. 2020 Jul 20. PMID: 32684623 


  1. 18F-fluorocholine PET/CT in MEN1 Patients with Primary Hyperparathyroidism.
    Gauthé M, Dierick-Gallet A, Delbot T, Bricaire L, Bertherat J, North MO, Cochand-Priollet B, Bouchard P, Talbot JN, Groussin L, Gaujoux S.
    World J Surg. 2020 Jul 17. PMID: 32681321 


  1. Cancer screening activity results in overdiagnosis and overtreatment of papillary thyroid cancer: A 10-year experience at a single institution.
    Kaliszewski K, Diakowska D, Wojtczak B, Rudnicki J.
    PLoS One. 2020 Jul 21;15(7):e0236257. PMID: 32692768 
  2. Parathyroid allotransplantation to treat post-thyroidectomy hypoparathyroidism: A review of case studies.
    Parameswaran R, Samuel M, Satish RL, Kripesh A, Moorthy V, Vajjhala R, Ng XL, Yip GW, Voon FCT, Chandran M.
    Surgeon. 2020 Jul 14:S1479-666X(20)30080-9. PMID: 32680813 
  3. A specific enhanced recovery protocol decreases opioid use after thyroid and parathyroid surgery.
    Yip L, Carty SE, Holder-Murray JM, Recker A, Nicholson KJ, Boisen ML, Esper SA, McCoy KL.
    Surgery. 2020 Jul 17:S0039-6060(20)30285-3. PMID: 32690334 
  4. Duration of exposure to thyrotoxicosis increases mortality of compromised AIT patients: the role of early thyroidectomy.
    Cappellani D, Papini P, Di Certo AM, Morganti R, Urbani C, Manetti L, Tanda ML, Cosentino G, Marconcini G, Materazzi G, Martino E, Bartalena L, Bogazzi F.
    J Clin Endocrinol Metab. 2020 Jul 17. PMID: 32678873 
  5. Safety and Effectiveness of Lenvatinib in 594 Patients with Unresectable Thyroid Cancer in an All-Case Post-Marketing Observational Study in Japan.
    Takahashi S, Tahara M, Ito K, Tori M, Kiyota N, Yoshida K, Sakata Y, Yoshida A.
    Adv Ther. 2020 Jul 16. PMID: 32676927 
  6. Correlation of ThyroSeq Results with Surgical Histopathology in Cytologically Indeterminate Thyroid Nodules.
    Chin PD, Zhu CY, Sajed DP, Fishbein GA, Yeh MW, Leung AM, Livhits MJ.
    Endocr Pathol. 2020 Jul 15. PMID: 32671653 
  7. TMPO-AS1 promotes cell proliferation of thyroid cancer via sponging miR-498 to modulate TMPO.
    Li Z, Feng Y, Zhang Z, Cao X, Lu X.
    Cancer Cell Int. 2020 Jul 8;20:294. PMID: 32669970 
  8. Racial disparities in surgical outcomes for benign thyroid disease.
    Maduka RC, Gibson CE, Chiu AS, Jean RA, Wills-Johnson N, Azar SA, Oliveira K, Ahuja V.
    Am J Surg. 2020 Jul 6:S0002-9610(20)30409-8. PMID: 32669203 
  9. Involvement of HMGB1 in vemurafenib resistance in thyroid cancer cells harboring BRAF (V600E) mutation by regulating excessive autophagy.
    Run L, Wang L, Nong X, Li N, Huang X, Xiao Y.
    Endocrine. 2020 Jul 14. PMID: 32666385 
  10. Up-regulated ANP32E promotes the thyroid carcinoma cell proliferation and migration via activating AKT/mTOR/HK2-mediated glycolysis.
    Huang J, Gao W, Liu H, Yin G, Duan H, Huang Z, Zhang Y.
    Gene. 2020 Aug 5;750:144681. PMID: 32304784 

May 14, 2020


  1. Adrenal-sparing surgery: current concepts on a theme from the past.
    Perysinakis I, Aggeli C, Kaltsas G, Zografos GN.
    Hormones (Athens). 2020 May 9. PMID: 32388629

  2. Surgery decreases the long-term incident stroke risk in patients with primary aldosteronism.
    Chang YH, Chung SD, Wu CH, Chueh JS, Chen L, Lin PC, Lin YH, Huang KH, Wu VC, Chu TS; TAIPAI Study Group.
    Surgery. 2020 Feb;167(2):367-377. PMID: 31676114 


  1. Simulations and simulators in head and neck endocrine surgery.
    Razavi CR, Tanavde V, Shaear M, Richmon JD, Russell JO.
    Ann Thyroid. 2020 Mar;5. PMID: 32395699 

  2. Genetic testing in endocrine surgery: Opportunities for precision surgery.
    Alobuia W, Annes J, Kebebew E.
    Surgery. 2020 May 3. PMID: 32376047 


  1. Intraoperative parathyroid hormone (IOPTH) assay might be better than the second-generation assay in parathyroidectomy for primary hyperparathyroidism.
    Lang BH, Fung MMH.
    Surgery. 2020 May 10. PMID: 32402543 


  1. MEN2-related pheochromocytoma: current state of knowledge, specific characteristics in MEN2B, and perspectives.
    Vincent A, David T, Carole G, Pauline R, Nunzia P, Thierry B, Thomas C, Anne B, Frederic S, Frederic C.
    Endocrine. 2020 May 10. PMID: 32388798 


  1. Higher TSH is not associated with thyroid cancer risk in the presence of thyroid autoimmunity.
    Paparodis RD, Bantouna D, Karvounis E, Imam S, Jaume JC.
    J Clin Endocrinol Metab. 2020 May 11. PMID: 32391913 

  2. The American Association of Endocrine Surgeons (AAES) Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults
    Hodak SP, Duh QY.
    Thyroid. 2020 May 10. PMID: 32390572 

  3. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study.
    Rozenblat T, Hirsch D, Robenshtok E, Grozinsky-Glasberg S, Gross DJ, Mazeh H, Benbassat C, Twito O, Levy S, Mizrachi A, Shpitzer T, Bachar G.
    Eur J Surg Oncol. 2020 Apr 18. PMID: 32389525 

  4. Metastases to the thyroid gland: review of incidence, clinical presentation, diagnostic problems and surgery, our experience.
    Battistella E, Pomba L, Mattara G, Franzato B, Toniato A.
    J Endocrinol Invest. 2020 May 8. PMID: 32385850 

  5. Strategies for superior thyroid pole dissection in transoral thyroidectomy: a video operative guide.
    Zhang D, Wang T, Kim HY, Wang P, Dionigi G, Pino A, Sun H.
    Surg Endosc. 2020 May 7. PMID: 32382884 

  6. Diagnostic value of circulating microRNAs in thyroid carcinoma: a systematic review and meta-analysis.
    Shi-Lin X, Yu-Yang T, Zhou Y, Li-Qiao L.
    Clin Endocrinol (Oxf). 2020 May 7. PMID: 32379941 

May 7, 2020


  1. Utility of the 10 Hounsfield unit threshold for identifying adrenal adenomas: Can we improve?
    Kirsch MJ, Kohli MW, Long KL, Pitt SC, Schneider DF, Sippel RS, Dedhia PH.
    Am J Surg. 2020 Apr 21. PMID: 32359690

  2. Cosyntropin stimulation in adrenal vein sampling improves the judgment of successful adrenal vein catheterization and outcome prediction for primary aldosteronism.
    Yatabe M, Bokuda K, Yamashita K, Morimoto S, Yatabe J, Seki Y, Watanabe D, Morita S, Sakai S, Ichihara A.
    Hypertens Res. 2020 Apr 30. PMID: 32355223 

Pancreatic Neuroendocrine

  1. Long-term outcome of surgical resection in patients with gastroenteropancreatic neuroendocrine neoplasia: results from a German nation-wide multi-centric registry.
    Begum N, Maasberg S, Pascher A, Plöckinger U, Gress TM, Wurst C, Weber F, Raffel A, Krausch M, Holzer K, Bartsch DK, Musholt TJ, Keck T, Anlauf M, Rinke A, Pape UF, Goretzki PE; German NET-Registry.
    Langenbecks Arch Surg. 2020 May 5. PMID: 32372309
  2. Selective intra-arterial calcium stimulation test for the localization of insulinomas: an Australian hospital experience.
    Graf A, Sarlos S, Farrell SG, MacIsaac RJ, Inder WJ, Sachithanandan N.
    ANZ J Surg. 2020 May 1. PMID: 32356594 

  3. Surgery for multiple endocrine neoplasia type 1-related insulinoma: long-term outcomes in a large international cohort.
    van Beek DJ, Nell S, Verkooijen HM, Borel Rinkes IHM, Valk GD; (on behalf of the DutchMEN study group), Vriens MR; International MEN1 Insulinoma Study Group.
    Br J Surg. 2020 Apr 30. PMID: 32352164 


  1. Primary hyperparathyroidism as first manifestation in MEN 2A: an international multicenter study.
    Larsen LV, Mirebeau-Prunier D, Imai T, Alvarez-Escola C, Hasse-Lazar K, Censi S, Castroneves LA, Sakurai A, Kihara M, Horiuchi K, Barbu VD, Borson-Chazot F, Gimenez-Roqueplo AP, Pigny P, Pinson S, Wohllk N, Eng C, Aydoğan Bİ, Saranath D, Dvorakova S, Castinetti F, Attila P, Bergant D, Links TP, Peczkowska M, Hoff AO, Mian C, Dwight T, Jarzab B, Neumann HPH, Robledo M, Uchino S, Barlier A, Godballe C, Mathiesen JS.
    Endocr Connect. 2020 May 1. PMID: 32375120
  2. Increasing trend of bilateral neck exploration in primary hyperparathyroidism.
    Khokar AM, Kuchta KM, Moo-Young TA, Winchester DJ, Prinz RA.
    Am J Surg. 2020 Mar;219(3):466-470. PMID: 31630823 


  1. Lymphocyte-to-monocyte ratio prior to radioiodine ablation in low- and intermediate-risk, papillary thyroid cancer.
    Kim K, Pak K, Kim IJ, Kim M, Kim BH, Lee BJ, Kim SJ.
    Endocrine. 2020 May 5. PMID: 32372305 

  2. Continuous Laryngeal Adductor Reflex Versus Intermittent Nerve Monitoring in Neck Endocrine Surgery.
    Sinclair CF, Téllez MJ, Ulkatan S.
    Laryngoscope. 2020 May 4. PMID: 32364626 

April 30, 2020


  1. Obesity predicts persistence of resistant hypertension after surgery in patients with primary aldosteronism.
    Nakamaru R, Yamamoto K, Rakugi H, Akasaka H, Kurihara I, Ichijo T, Takeda Y, Katabami T, Tsuiki M, Wada N, Ogawa Y, Kawashima J, Sone M, Yoshimoto T, Okamoto R, Fujita M, Kobayashi H, Tamura K, Kamemura K, Okamura S, Kakutani M, Tanabe A, Naruse M; JPAS/JRAS Study Group.
    Clin Endocrinol (Oxf). 2020 Apr 23. PMID: 32324297 

General Endocrine Surgery

  1. Screening guidelines and recommendations for patients at high risk of developing endocrine cancers.
    Geurts JL, Strong EA, Wang TS, Evans DB, Clarke CN.
    J Surg Oncol. 2020 May;121(6):975-983. PMID: 32090344 


  1. Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas.
    Krishnan A, Berthelet J, Renaud E, Rosigkeit S, Distler U, Stawiski E, Wang J, Modrusan Z, Fiedler M, Bienz M, Tenzer S, Schad A, Roth W, Thiede B, Seshagiri S, Musholt TJ, Rajalingam K.
    Nat Commun. 2020 Apr 28;11(1):2056. PMID: 32345963

  2. An easier option for "invisible scar" thyroidectomy: hybrid-transoral endoscopic thyroidectomy submental access (H-TOETSA)-experience on twenty-two consecutive patients.
    Perigli G, Cianchi F, Badii B, Staderini F, Skalamera I, Cupellini C, Nelli T, Foppa C.
    Surg Endosc. 2020 Apr 27. PMID: 32342219

  3. Transoral endocrine surgery: Considerations for adopting a new technique.
    James BC, Angelos P, Grogan RH.
    J Surg Oncol. 2020 Apr 25. PMID: 32334445
  4. High rate incidence of post-surgical adverse events in patients with low-risk papillary thyroid cancer who did not accept active surveillance.
    Smulever A, Pitoia F.
    Endocrine. 2020 Apr 24. PMID: 32328966
  5. Distinguishing Recurrent Thyroid Cancer from Residual Nonmalignant Thyroid Tissue Using Multiphasic Multidetector CT.
    Debnam JM, Guha-Thakurta N, Sun J, Wei W, Zafereo ME, Cabanillas ME, Buisson NM, Schellingerhout D.
    AJNR Am J Neuroradiol. 2020 Apr 23. PMID: 32327435 

  6. ETV5 overexpression contributes to tumor growth and progression of thyroid cancer through PIK3CA.
    Meng D, Li Z, Ma X, Wu L, Fu L, Qin G.
    Life Sci. 2020 Apr 20:117693. PMID: 32325133 

  7. Mid-Term and Long-Term Impact of Permanent Hypoparathyroidism After Total Thyroidectomy.
    Ponce de León-Ballesteros G, Bonilla-Ramírez C, Hernández-Calderón FJ, Pantoja-Millán JP, Sierra-Salazar M, Velázquez-Fernández D, Herrera MF.
    World J Surg. 2020 Apr 22. PMID: 32322939 

  8. Prediction mode of more than 5 central lymph nodes metastases in clinically node-negative ipsilateral papillary thyroid carcinoma with tumor size 1 to 4 cm.
    Jin L, Sun HL, Zhou L, Xie L, Zhuang YY, Wang JB.
    Medicine (Baltimore). 2020 Apr;99(16):e19809. PMID: 32311998 

  9. Low-risk papillary thyroid microcarcinoma: Optimal management toward a more conservative approach.
    Ramundo V, Sponziello M, Falcone R, Verrienti A, Filetti S, Durante C, Grani G.
    J Surg Oncol. 2020 May;121(6):958-963. PMID: 32189352


April 23, 2020


  1. Cardiovascular and metabolic risk factors in patients with subclinical Cushing.
    Petramala L, Olmati F, Concistrè A, Russo R, Mezzadri M, Soldini M, De Vincentis G, Iannucci G, De Toma G, Letizia C.
    Endocrine. 2020 Apr 16. PMID: 32300953

  2. Surgical Approach to Endocrine Hypertension in Patients with Adrenal Disorders.
    Shank J, Prescott JD, Mathur A.
    Endocrinol Metab Clin North Am. 2019 Dec;48(4):875-885. PMID: 31655782 

  3. Adrenal Venous Sampling: Where Do We Stand?
    Rossi GP, Maiolino G, Seccia TM.
    Endocrinol Metab Clin North Am. 2019 Dec;48(4):843-858. PMID: 31655780 


  1. The Diagnostic Dilemma of GATA3 Immunohistochemistry in Pheochromocytoma and Paraganglioma.
    Kimura N, Shiga K, Kaneko K, Sugisawa C, Katabami T, Naruse M.
    Endocr Pathol. 2020 Apr 17. PMID: 32303954 


  1. Impact of the Tumor Microenvironment on the Gene Expression Profile in Papillary Thyroid Cancer.
    Oczko-Wojciechowska M, Pfeifer A, Jarzab M, Swierniak M, Rusinek D, Tyszkiewicz T, Kowalska M, Chmielik E, Zembala-Nozynska E, Czarniecka A, Jarzab B, Krajewska J.
    Pathobiology. 2020 Apr 22:1-12. PMID: 32320975 

  2. Contemporary Considerations in Adjuvant Radioiodine Treatment of Adults with Differentiated Thyroid Cancer.
    Juweid ME, Tulchinsky M, Mismar A, Momani M, Zayed AA, Al Hawari H, Albsoul N, Mottaghy FM.
    Int J Cancer. 2020 Apr 22. PMID: 32319676 

  3. Noninvasive follicular neoplasm with papillary-like nuclear features (NIFTP): a 13-year retrospective review at Jordan University Hospital.
    Zurikat RO, Khader M, Azzam MI, Zahid ZM, Daoud SF, Nusirat SF, Albsoul N, Al-Natsheh MA, Al-Abbadi MA.
    Endocrine. 2020 Apr 22. PMID: 32319013 

  4. Inflammatory biomarkers and dynamics of neutrophil-to-lymphocyte ratio in anaplastic thyroid carcinoma.
    Yamazaki H, Sugino K, Matsuzu K, Masaki C, Akaishi J, Hames K, Tomoda C, Suzuki A, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Masuda M, Ito K.
    Endocrine. 2020 Apr 19. PMID: 32307657 

  5. The impact of surgery refusal on thyroid cancer survival: a SEER-based analysis.
    van Gerwen M, Sinclair C, Rahman M, Genden E, Taioli E.
    Endocrine. 2020 Apr 19. PMID: 32307656 

  6. Up-regulated ANP32E promotes the thyroid carcinoma cell proliferation and migration via activating AKT/mTOR/HK2-mediated glycolysis.
    Huang J, Gao W, Liu H, Yin G, Duan H, Huang Z, Zhang Y.
    Gene. 2020 Apr 15:144681. PMID: 32304784 

  7. Association of Patient Age With Progression of Low-Risk Papillary Thyroid Carcinoma Under Active Surveillance: A Systematic Review and Meta-analysis.
    Koshkina A, Fazelzad R, Sugitani I, Miyauchi A, Thabane L, Goldstein DP, Ghai S, Sawka AM.
    JAMA Otolaryngol Head Neck Surg. 2020 Apr 16. PMID: 32297926 

  8. Strategy to reduce unnecessary surgeries in thyroid nodules with cytology of Bethesda category III (AUS/FLUS): a retrospective analysis of 667 patients diagnosed by surgery.
    Suh YJ, Choi YJ.
    Endocrine. 2020 Apr 15. PMID: 32297204 

  9. Altered Serum MicroRNA Profile May Serve as an Auxiliary Tool for Discriminating Aggressive Thyroid Carcinoma from Nonaggressive Thyroid Cancer and Benign Thyroid Nodules.
    Zhang A, Wang C, Lu H, Chen X, Ba Y, Zhang C, Zhang CY.
    Dis Markers. 2019 Sep 16;2019:3717683. PMID: 31636734


April 16, 2020

Gastrointestinal Pancreatic Neuroendocrine

  1. Evaluation of circulating transcript analysis (NETest) in small intestinal neuroendocrine neoplasms after surgical resection.
    Laskaratos FM, Liu M, Malczewska A, Ogunbiyi O, Watkins J, Luong TV, Mandair D, Caplin M, Toumpanakis C.
    Endocrine. 2020 Apr 14. PMID: 32291735

  2. Complications of surgery for gastro-entero-pancreatic neuroendocrine neoplasias.
    Albers MB, Almquist M, Bergenfelz A, Nordenström E.
    Langenbecks Arch Surg. 2020 Apr 15. PMID: 32291468

  3. Clinicopathological features and menin expression of pancreatic neuroendocrine neoplasm associated with multiple endocrine neoplasia type 1.
    Sonoda A, Yamashita YI, Kondo T, Hayashi H, Imai K, Higashi T, Yamamura K, Yamao T, Hashimoto D, Baba H.
    J Hepatobiliary Pancreat Sci. 2020 Apr 11. PMID: 32278331

  4. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.’
    Pavel M, Öberg K, Falconi M, Krenning E, Sundin A, Perren A, Berruti A; ESMO Guidelines Committee.
    Ann Oncol. 2020 Apr 6. pii: S0923-7534(20)36394-8. PMID: 32272208


  1. Novel Findings on SPECT-CT Tc-99 Sestamibi Imaging for Primary Hyperparathyroidism.
    Mallick R, Malik J, Yip L, Muthukrishnan A, Carty SE, McCoy KL.
    J Surg Res. 2020 Apr 11;252:216-221. PMID: 32289578

  2. Short-term medical treatment of hypercalcaemia in primary hyperparathyroidism predicts symptomatic response after parathyroidectomy.
    Koman A, Ohlsson S, Bränström R, Pernow Y, Bränström R, Nilsson IL.
    Br J Surg. 2019 Dec;106(13):1810-1818. PMID: 31595982 


  1. Association between thyroid function and serum cortisol in cortisol-producing adenoma patients.
    Cai R, Zhou W, Jiang L, Jiang Y, Su T, Zhang C, Zhou W, Ning G, Wang W.
    Endocrine. 2020 Apr 14. PMID: 32291738

  2. Effect of type 2 diabetes and antihyperglycemic drug therapy on signs of tumor invasion in papillary thyroid cancer.
    Li C, Kuang J, Zhao Y, Sun H, Guan H.
    Endocrine. 2020 Apr 14. PMID: 32291737

  3. MicroRNA-574-5p directly targets FOXN3 to mediate thyroid cancer progression via Wnt/β-catenin signaling pathway.
    Zhang ZJ, Xiao Q, Li XY.
    Pathol Res Pract. 2020 Mar 31:152939. PMID: 32284251

  4. Comparison of outcomes after differentiated thyroid cancer surgery performed with and without energy devices: a population-based cohort study using a nationwide database in Japan.
    Konishi T, Fujiogi M, Niwa T, Morita K, Matsui H, Fushimi K, Tanabe M, Seto Y, Yasunaga H.
    Int J Surg. 2020 Apr 9. pii: S1743-9191(20)30286-7. PMID: 32278784

  5. Outpatient thyroidectomy in the pediatric population.
    Dream S, Wang R, Lovell K, Iyer P, Chen H, Lindeman B.
    Am J Surg. 2020 Apr 2. pii: S0002-9610(20)30182-3. PMID: 32276716

  6. Thyroid cancer histological subtypes based on tumor size: National perspective.
    Al-Qurayshi Z, Foggia MJ, Pagedar N, Lee GS, Tufano R, Kandil E.
    Head Neck. 2020 Apr 10. PMID: 32275122

  7. The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: Core questions and recommendations for treatments of thyroid cancer.
    Ito Y, Onoda N, Okamoto T.
    Endocr J. 2020 Apr 9. PMID: 32269182

  8. Preoperative Computed Tomography Changes Surgical Management for Clinically Low-Risk Well-Differentiated Thyroid Cancer.
    Bongers PJ, Verzijl R, Dzingala M, Vriens MR, Yu E, Pasternak JD, Rotstein LE.
    Ann Surg Oncol. 2019 Dec;26(13):4439-4444. PMID: 31583547

  9. Long-Term Oncologic Outcomes After Curative Resection of Familial Medullary Thyroid Carcinoma.
    Spanheimer PM, Ganly I, Chou J, Capanu M, Ghossein RA, Tuttle RM, Wong RJ, Shaha AR, Untch BR.
    Ann Surg Oncol. 2019 Dec;26(13):4423-4429. PMID: 31549322 

April 9, 2020


  1. Adrenal Incidentaloma.
    Sherlock M, Scarsbrook A, Abbas A, Fraser S, Limumpornpetch P, Dineen R, Stewart PM.
    Endocr Rev. 2020 Apr 8. PMID: 32266384

  2. Nadir Aldosterone Levels After Confirmatory Tests Are Correlated With Left Ventricular Hypertrophy in Primary Aldosteronism.
    Ohno Y, Sone M, Inagaki N, Kawashima A, Takeda Y, Yoneda T, Kurihara I, Itoh H, Tsuiki M, Ichijo T, Katabami T, Wada N, Sakamoto R, Ogawa Y, Yoshimoto T, Yamada T, Kawashima J, Matsuda Y, Kobayashi H, Kamemura K, Yamamoto K, Otsuki M, Okamura S, Izawa S, Okamoto R, Tamura K, Tanabe A, Naruse M; JPAS/JRAS Study Group*.
    Hypertension. 2020 Apr 6. PMID: 32248705


  1. Hyperparathyroidism in patients over 75: Clinical characteristics and outcome. Is conservative treatment a safe alternative?
    Duskin-Bitan H, Nemirovsky N, Slutzky-Shraga I, Gorshtein A, Masri-Iraqi H, Robenshtok E, Diker-Cohen T, Singer J, Shimon I, Hirsch D, Tsvetov G.
    Maturitas. 2020 May;135:47-52. PMID: 32252964

  2. Intrapericardial parathyroid carcinoma: a case report.
    Xin Y, Zhao T, Wei B, Gu H, Jin M, Shen H, Liu X, Wang J, Wang Q.
    Endocrine. 2020 Apr 4. PMID: 32248393

  3. Parathyroid cancer: An update.
    Rodrigo JP, Hernandez-Prera JC, Randolph GW, Zafereo ME, Hartl DM, Silver CE, Suárez C, Owen RP, Bradford CR, Mäkitie AA, Shaha AR, Bishop JA, Rinaldo A, Ferlito A.
    Cancer Treat Rev. 2020 Mar 19;86:102012. PMID: 32247225


  1. The systems of metastatic potential prediction in pheochromocytoma and paraganglioma.
    Wang Y, Li M, Deng H, Pang Y, Liu L, Guan X.
    Am J Cancer Res. 2020 Mar 1;10(3):769-780. PMID: 32266090


  1. Does Tumor Size Affect Surgical Outcomes of Transoral Robotic Thyroidectomy for Patients with Papillary Thyroid Carcinoma? A Retrospective Cohort Study.
    Tai DKC, Kim HY, Park D, Russell JO, Tufano RP, Kandil E.
    Ann Surg Oncol. 2020 Apr 6. PMID: 32253671

  2. Thyroid squamous cell carcinoma: a unique type of cancer in World Health Organization classification.
    Lam AK.
    Endocr Relat Cancer. 2020 Apr 1. PMID: 32252028

  3. Clinical performance of multiplatform mutation panel and microRNA risk classifier in indeterminate thyroid nodules.
    Sistrunk JW, Shifrin A, Frager M, Bardales RH, Thomas J, Fishman N, Goldberg P, Guttler R, Grant E.
    J Am Soc Cytopathol. 2020 Mar 10. pii: S2213-2945(20)30040-5. PMID: 32247769

  4. Total Thyroidectomy Versus Lobectomy in Small Nodules Suspicious for Papillary Thyroid Cancer: Cost-Effectiveness Analysis.
    Al-Qurayshi Z, Farag M, Shama MA, Ibraheem K, Randolph GW, Kandil E.
    Laryngoscope. 2020 Apr 2. PMID: 32239764

  5. Postoperative Hypoparathyroidism After Total Thyroidectomy in Children.
    Zobel MJ, Long R, Gosnell J, Sosa JA, Padilla BE.
    J Surg Res. 2020 Mar 29;252:63-68. PMID: 32234570

  6. Radiomics signature for prediction of lateral lymph node metastasis in conventional papillary thyroid carcinoma.
    Park VY, Han K, Kim HJ, Lee E, Youk JH, Kim EK, Moon HJ, Yoon JH, Kwak JY.
    PLoS One. 2020 Jan 15;15(1):e0227315. PMID: 31940386


April 2, 2020


  1. Approach to patients with bilateral adrenal incidentalomas.
    Vassiliadi DA, Partsalaki E, Tsagarakis S.
    Curr Opin Endocrinol Diabetes Obes. 2020 Mar 23. PMID: 32209820

Gastric Neuroendocrine

  1. Response and relapse rates after treatment with long-acting somatostatin analogs in multifocal or recurrent type-1 gastric carcinoids: A systematic review and meta-analysis.
    Rossi RE, Invernizzi P, Mazzaferro V, Massironi S.
    United European Gastroenterol J. 2020 Mar;8(2):140-147. PMID: 32213066

Pancreatic Neuroendocrine

  1. Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature.
    Sadowski SM, Pieterman CRC, Perrier ND, Triponez F, Valk GD.
    Endocr Relat Cancer. 2020 Mar 1. PMID: 32229700


  1. Immunocyte density in parathyroid carcinoma is correlated with disease relapse.
    Hu Y, Cui M, Bi Y, Zhang X, Wang M, Hua S, Liao Q, Zhao Y.
    J Endocrinol Invest. 2020 Mar 26. PMID: 32219691


  1. Pheochromocytoma with Adrenergic Biochemical Phenotype Shows Decreased Glp-1 Secretion and Impaired Glucose Tolerance.
    Petrák O, Klímová J, Mráz M, Haluzíková D, Petráková Doležalová R, Kratochvílová H, Lacinová Z, Novák K, Michalský D, Waldauf P, Holaj R, Widimský J, Zelinka T, Haluzík M.
    J Clin Endocrinol Metab. 2020 Mar 28. PMID: 32222768


  1. Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodules.
    Sponziello M, Brunelli C, Verrienti A, Grani G, Pecce V, Abballe L, Ramundo V, Damante G, Russo D, Lombardi CP, Durante C, Rossi ED, Straccia P, Fadda G, Filetti S.
    Endocrine. 2020 Mar 30. PMID: 32232767

  2. ANGPTL4 Promotes the Proliferation of Papillary Thyroid Cancer via AKT Pathway.
    Yang L, Wang Y, Sun R, Zhang Y, Fu Y, Zheng Z, Ji Z, Zhao D.
    Onco Targets Ther. 2020 Mar 17;13:2299-2309. PMID: 32231436

  3. Preoperative Role of RAS or BRAF K601E in the Guidance of Surgery for Indeterminate Thyroid Nodules.
    Ravella L, Lopez J, Descotes F, Giai J, Lapras V, Denier ML, Borson-Chazot F, ifante JC, Decaussin-Petrucci M.
    World J Surg. 2020 Mar 29. PMID: 32227276

  4. Wolf in Sheep's Clothing: Papillary Thyroid Microcarcinoma in the US.
    Al-Qurayshi Z, Nilubol N, Tufano RP, Kandil E.
    J Am Coll Surg. 2020 Apr;230(4):484-491. PMID: 32220437

  5. NF-κB-activated miR-574-5p promotes multiple malignant and metastatic phenotypes by targeting BNIP3 in thyroid carcinoma.
    Zhang ZJ, Xiao Q, Li XY.
    Mol Cancer Res. 2020 Mar 26. pii: molcanres.1020.2019. PMID: 32217689

  6. Acquired secondary RAS mutation in BRAFV600E mutated thyroid cancer patients treated with BRAF inhibitors.
    Cabanillas M, Dadu R, Iyer PC, Wanland KB, Busaidy N, Ying AK, Gule-Monroe M, Wang JR, Zafereo M, Hofmann MC.
    Thyroid. 2020 Mar 26. PMID: 32216548

  7. Institutional experience of 200 consecutive papillary thyroid carcinoma patients in transoral robotic thyroidectomy surgeries.
    Park D, Kim HY, Kim HK, You JY, Dionigi G, Russell JO, Tufano RP.
    Head Neck. 2020 Mar 25. PMID: 32212355

March 26, 2020


  1. Surgical approach to patients with hypercortisolism.
    Kiernan CM, Solórzano CC.
    Gland Surg. 2020 Feb;9(1):59-68. PMID: 32206599

  2. Surgical approach to patients with primary aldosteronism.
    McManus C, Kuo JH.
    Gland Surg. 2020 Feb;9(1):25-31. PMID: 32206596

  3. Primary aldosteronism.
    Wrenn SM, Vaidya A, Lubitz CC.
    Gland Surg. 2020 Feb;9(1):14-24. PMID: 32206595

  4. Minimally Invasive Adrenalectomy: Technical Aspects of the Laparoscopic and the Robotic Approach.
    Makkai-Popa ST, Pascotto B, Arru L, Blasi V, Goergen M, Azagra JS. Chirurgia (Bucur).
    2020 Jan-Feb;115(1):80-88. PMID: 32155402

  5. The safety and efficiency of retroperitoneal laparoscopic adrenalectomy via extra and intra perinephric fat approaches: a retrospective clinical study.
    Wang X, Liu J, Ji A, Liu C, Nahayo S, Wang L, Zhu X, Fan W, Song X, Wang J, Yang D.
    BMC Surg. 2019 Dec 21;19(1):198. PMID: 31864326


  1. The role of parathyroidectomy in treating hypertension and other cardiac manifestations of primary hyperparathyroidism.
    Nelson JA, Alsayed M, Milas M.
    Gland Surg. 2020 Feb;9(1):136-141. PMID: 32206605

  2. Intraoperative Autofluorescence and Indocyanine Green Angiography for the Detection and Preservation of Parathyroid Glands.
    Demarchi MS, Karenovics W, Bédat B, Triponez F.
    J Clin Med. 2020 Mar 18;9(3). PMID: 32197500

  3. Lipoadenoma of the Parathyroid Gland: Characterization of an Institutional Series Spanning 28 Years.
    Juhlin CC, Falhammar H, Zedenius J, Nilsson IL, Höög A.
    Endocr Pathol. 2020 Mar 19. PMID: 32193823

  4. Cardiovascular consequences of parathyroid disorders in adults.
    Bollerslev J, Sjöstedt E, Rejnmark L.
    Ann Endocrinol (Paris). 2020 Feb 28. PMID: 32192790


  1. Surgical approach to patients with pheochromocytoma.
    Patel D.
    Gland Surg. 2020 Feb;9(1):32-42. PMID: 32206597


  1. Continuous Neural Monitoring in Endoscopic Thyroidectomy: Feasibility Experimental Study for Transcutaneous Vagal Nerve Stimulation.
    Zhao Y, Li C, Zhang D, Li S, Wang T, Dionigi G, Sun H.
    J Laparoendosc Adv Surg Tech A. 2020 Mar 24. PMID: 32208046

  2. Hyperthyroidism.
    Doubleday AR, Sippel RS.
    Gland Surg. 2020 Feb;9(1):124-135. PMID: 32206604

  3. Quality of life of patients more than 1 year after surgery for thyroid cancer.
    Büttner M, Hinz A, Singer S, Musholt TJ.
    Hormones (Athens). 2020 Mar 23. PMID: 32201929

  4. Upregulation of OIP5-AS1 Predicts Poor Prognosis and Contributes to Thyroid Cancer Cell Proliferation and Migration.
    Li Q, Chen W, Luo R, Zhang Z, Song M, Chen W, Yang Z, Yang Y, Guo Z, Yang A.
    Mol Ther Nucleic Acids. 2020 Jan 11;20:279-291. PMID: 32193154

March 5, 2020


  1. Risk factors associated with positive resection margins in patients with adrenocortical carcinoma.
    Skertich NJ, Tierney JF, Chivukula SV, Babazadeh NT, Hertl M, Poirier J, Keutgen XM.
    Am J Surg. 2020 Feb 22. pii: S0002-9610(20)30121-5. PMID: 32111342


  1. Plasma levels of acylated ghrelin in patients with insulinoma and expression of ghrelin and its receptor in insulinomas.
    Wu HY, Li NS, Song YL, Bai CM, Wang Q, Zhao YP, Xiao Y, Yu S, Li M, Chen YJ.
    Endocrine. 2020 Mar 2. PMID: 32124259

  2. Increased autophagy/mitophagy levels in primary tumours of patients with pancreatic neuroendocrine neoplasms.
    Daskalakis K, Alexandraki KI, Kloukina I, Kassi E, Felekouras E, Xingi E, Pagakis SN, Tsolakis AV, Andreakos E, Kaltsas G, Kambas K.
    Endocrine. 2020 Feb 29. PMID: 32114655

  1. Influence of common clinical variables on intraoperative parathyroid hormone monitoring during surgery for primary hyperparathyroidism.
    Shawky MS, Sakr MF, Nabawi AS, Abdel-Aziz TE, De Jong MC, García VR, Lam F, Soromani C, Smart J, Honour JW, Kurzawinski TR.
    J Endocrinol Invest. 2020 Mar 2. PMID: 32124267

  1. Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma.
    Patel D, Phay JE, Yen TWF, Dickson PV, Wang TS, Garcia R, Yang AD, Solórzano CC, Kim LT.
    Ann Surg Oncol. 2020 Feb 28. PMID: 32112212

  2. Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma.
    Patel D, Phay JE, Yen TWF, Dickson PV, Wang TS, Garcia R, Yang AD, Kim LT, Solórzano CC.
    Ann Surg Oncol. 2020 Feb 28. PMID: 32112213

  1. A prospective mixed-methods study of decision-making on surgery or active surveillance for low risk papillary thyroid cancer.
    Sawka AM, Ghai S, Yoannidis T, Rotstein L, Gullane PJ, Gilbert RW, Pasternak JD, Brown DH, Eskander A, de Almeida JR, Irish JC, Higgins KM, Enepekides DJ, Monteiro E, Banerjee A, Shah M, Gooden E, Zahedi A, Korman M, Ezzat S, Jones J, Rac V, Tomlinson G, Stanimirovic A, Gafni A, Baxter N, Goldstein DP.

  2. Thyroid. 2020 Mar 4. PMID: 32126932
    Indeterminate thyroid nodules. The role of 18F-FDG PET/CT in the "era" of ultrasonography risk stratification systems and new thyroid cytology classifications.
    Piccardo A, Puntoni M, Dezzana M, Bottoni G, Foppiani L, Marugo A, Catrambone U, Ugolini M, Sola S, Gatto M, Treglia G, Giovanella L, Trimboli P.
    Endocrine. 2020 Mar 2. PMID: 32124261

  3. Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up.
    Giani C, Torregrossa L, Piaggi P, Matrone A, Viola D, Molinaro E, Agate L, Romei C, Ugolini C, De Napoli L, Materazzi G, Basolo F, Elisei R.
    Endocrine. 2020 Mar 2. PMID: 32124258

  4. Post-thyroidectomy emergency room visits and readmissions: Assessment from the Collaborative Endocrine Surgery Quality Improvement Program (CESQIP).
    Taye A, Inabnet WB 3rd, Pan S, Carty SE, Cotton T, Czako P, Doherty G, Gauger P, Hanks J, McAneny D, Milas M, Perrier N, Rosen J, Schneider DF, Sharma J, Siperstein A, Sosa JA.
    Am J Surg. 2020 Feb 19. PMID: 32115176

  5. Prediction of biochemical cure in patients with medullary thyroid cancer.
    Machens A, Lorenz K, Dralle H.
    Br J Surg. 2020 Feb 28. PMID: 32108330

  6. Online Information for Treatment for Low-Risk Thyroid Cancer: Assessment of Timeliness, Content, Quality, and Readability.
    Doubleday AR, Novin S, Long KL, Schneider DF, Sippel RS, Pitt SC.
    J Cancer Educ. 2020 Feb 27. PMID: 32108292

February 27, 2020


  1. Small adrenal incidentaloma becoming an aggressive adrenocortical carcinoma in a patient carrying a germline APC variant.
    Gagnon N, Boily P, Alguire C, Corbeil G, Bancos I, Latour M, Beauregard C, Caceres K, El Haffaf Z, Saad F, Olney HJ, Bourdeau I.
    Endocrine. 2020 Feb 22. PMID: 32088909 

Endocrine Syndromes

  1. 100-Year evolution of precision medicine and surgery for multiple endocrine neoplasia type 2A.
    Machens A, Elwerr M, Lorenz K, Weber F, Dralle H.
    Endocrine. 2020 Feb 25. PMID: 32100189 


  1. Screening guidelines and recommendations for patients at high risk of developing endocrine cancers.
    Geurts JL, Strong EA, Wang TS, Evans DB, Clarke CN.
    J Surg Oncol. 2020 Feb 23. PMID: 32090344 


  1. Evaluation of an optimal cutoff of parathyroid venous sampling gradient for localizing primary hyperparathyroidism.
    Lee J, Hong N, Kim BM, Kim DJ, Yun M, Jeong JJ, Rhee Y.
    J Bone Miner Metab. 2020 Feb 25. PMID: 32100109 

  2. Confirmation of Parathyroid Tissue: Are Surgeons Aware of New and Novel Techniques?
    Coan KE, Yen TWF, Carr AA, Evans DB, Wang TS.
    J Surg Res. 2020 Feb;246:139-144. PMID: 31569035

  3. Hyperparathyroidism during pregnancy. Is it a diagnostic and therapeutic challenge?
    Godínez-Vidal AR, Oca-Durán ÉM, Aguirre-Rojano VI, Pulido-Cejudo A, Paul-Basurto-Kuba EO, Hurtado-López LM.
    Cir Cir. 2019;87(S1):62-67. PMID: 31501633 


  1. Medullary thyroid carcinoma of unknown primary origin with synchronous finding of papillary thyroid carcinoma.
    Hellmann AR, Patel A, Śledziński M, Obołończyk Ł, Bieńkowski M, Mikaszewski B, Kaska Ł.
    Endokrynol Pol. 2020 Feb 25. PMID: 32096551
  2. The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults.
    Patel KN, Yip L, Lubitz CC, Grubbs EG, Miller BS, Shen W, Angelos P, Chen H, Doherty GM, Fahey TJ 3rd, Kebebew E, Livolsi VA, Perrier ND, Sipos JA, Sosa JA, Steward D, Tufano RP, McHenry CR, Carty SE.
    Ann Surg. 2020 Mar;271(3):e21-e93. PMID: 32079830 

  3. Carcinomas of the Thyroid with Ewing Family Tumor Elements (CEFTEs): A Diagnostic Challenge Before Surgery.
    Taccogna S, Guglielmi R, Persichetti A, Morano C, Angelini F, Ienzi S, Scarpino S, Liverani A, Annovazzi A, Papini E.
    Head Neck Pathol. 2020 Feb 19. PMID: 32077055 

  4. Surufatinib in Chinese patients with locally advanced or metastatic differentiated thyroid cancer and medullary thyroid cancer: A multicenter, open-label, Phase II trial.
    Chen JY, Ji QH, Bai C, Zheng X, Zhang Y, Shi F, Li X, Tang PZ, Xu Z, Huang R, Huang T, Pan Y, Fan S, Zhou J, Su W.
    Thyroid. 2020 Feb 19. PMID: 32075524

  5. Thyroidectomy Remains a Safe Option for Graves' Disease.
    Feaster A, DeCapua-Guarino A, Wolf M, Dove J, Fluck M, Oxenberg J.
    Am Surg. 2019 Aug 1;85(8):851-854. PMID: 32051065

  6. Increasing Use of Thyroidectomy as Definitive Treatment for Hyperthyroidism.
    Asban A, Anue A, Xie R, Chen H.
    J Surg Res. 2020 Feb;246:435-441. PMID: 31630881 

  7. Does microscopic positive tumor margin in papillary thyroid cancer really matter?
    Back K, Kim SK, Chai YJ, Kim JH, Choe JH, Kim JS.
    Surgery. 2019 Dec;166(6):1160-1167. PMID: 31582308 

December 19, 2019

Gastro-entero-pancreatic Neuroendocrine 

  1. The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors.
    Malczewska A, Kos-Kudła B, Kidd M, Drozdov I, Bodei L, Matar S, Oberg K, Modlin
    IM. Adv Med Sci. 2019 Dec 13;65(1):18-29. PMID: 31841822

  2. Treatment Patterns and Survival among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumours in Sweden - a Population-based Register-linkage and Medical Chart Review Study.
    Lesén E, Granfeldt D, Berthon A, Dinet J, Houchard A, Myrenfors P, Björstad Å, Björholt I, Elf AK, Johanson V
    J Cancer. 2019 Nov 17;10(27):6876-6887. PMID: 31839822

  3. Endocrinological Toxicity Secondary to Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs).
    Alexandraki KI, Daskalakis K, Tsoli M, Grossman AB, Kaltsas
    GA. Trends Endocrinol Metab. 2019 Dec 12. pii: S1043-2760(19)30225-5. PMID: 31839442



  1. Angiotensin converting enzymes ACE and ACE2 in thyroid cancer progression.
    Narayan SS, Lorenz K, Ukkat J, Hoang-Vu C, Trojanowicz B.
    Neoplasma. 2019 Dec 17. PMID: 31847529

  2. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
    Zhang C, Bo C, Guo L, Yu P, Miao S, Gu X.
    World J Surg Oncol. 2019 Dec 16;17(1):221. PMID: 31842912

  3. Early detection of recurrent laryngeal nerve damage using intraoperative nerve monitoring during thyroidectomy.
    Yu T, Wang FL, Meng LB, Li JK, Miao G.
    J Int Med Res. 2019 Dec 16:300060519889452. PMID: 31840556

  4. A Survey of American Thyroid Association Members Regarding the 2015 Adult Thyroid Nodule and Differentiated Thyroid Cancer Clinical Practice Guidelines.
    Sawka AM, Gagliardi AR, Haymart MR, Sturgeon C, Bernet V, Hoff KC, Angelos P, Brito JP, Haugen BR MD, Kim BW, Kopp PA, Mandel SJ, Ross DS, Samuels M, Sarne DH MD, Sinclair CF, Jonklaas
    J. Thyroid. 2019 Dec 13. PMID: 31830853

  5. Safety of central compartment neck dissection for transoral endoscopic thyroid surgery in papillary thyroid carcinoma.
    Wang T, Wu Y, Xie Q, Yan H, Zhou X, Yu X, Chen Y, Xiang C, Yan H, Zhao Q, Zhang M, Qi M, Wang P, Wang Y. Jpn
    J Clin Oncol. 2019 Dec 12. PMID: 31829423

  6. Comparison of parathyroid hormone kinetics in endoscopic thyroidectomy via bilateral areola with open thyroidectomy.
    Zhang D, Wang T, Dionigi G, Zhang J, Zhao Y, Xue G, Liang N, Sun H.
    BMC Surg. 2019 Dec 11;19(1):190. PMID: 31829211

  7. Is Vocal Cord Assessment before Total Thyroidectomy Required for All Patients?
    Birben B, Özden S, Er S, Saylam B.
    Am Surg. 2019 Nov 1;85(11):1265-1268. PMID: 31775969

  8. Nodules with nonspecific ultrasound pattern according to the 2015 American Thyroid Association malignancy risk stratification system: A comparison to the Thyroid Imaging Reporting and Data System (TIRADS-Na).
    Xiang P, Chu X, Chen G, Liu B, Ding W, Zeng Z, Wu X, Wang J, Xu S, Liu C.
    Medicine (Baltimore). 2019 Nov;98(44):e17657. PMID: 31689776

  9. A Practical Mathematic Method to Predict and Manage Hypocalcemia After Parathyroidectomy and Thyroidectomy.
    Liu C, Tang L, Goel P, Chambers T, Kokot N, Sinha U, Maceri D. Ann
    Otol Rhinol Laryngol. 2020 Jan;129(1):70-77. PMID: 31510765

December 5, 2019


  1. The clinical utility of 'GRAS' parameters in stage I-III adrenocortical carcinomas: long-term data from a high-volume institution.
    Liang J, Liu Z, Zhou L, Tang Y, Zhou C, Wu K, Zhang F, Zhang F, Wei X, Lu Y, Zhu Y.
    Endocrine. 2019 Nov 30. PMID: 31786772

  2. Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
    Liang J, Liu Z, Wei X, Zhou L, Tang Y, Zhou C, Wu K, Zhang F, Zhang F, Lu Y, Zhu Y.
    BMC Cancer. 2019 Nov 29;19(1):1165. PMID: 31783819


Gastro-entero-pancreatic Neuroendocrine 

  1. Imaging-guided precision medicine in non-resectable gastro-entero-pancreatic neuroendocrine tumors: A step-by-step approach.
    Rozenblum L, Mokrane FZ, Yeh R, Sinigaglia M, Besson FL, Seban RD, Zadro C, Dierickx L, Chougnet CN, Partouche E, Revel-Mouroz P, Zhao B, Otal P, Schwartz LH, Dercle L.
    Eur J Radiol. 2019 Nov 12;122:108743. PMID: 31783345

  2. Experience of an endocrine surgeon in laparoscopic transperitoneal adrenalectomy.
    Teksöz S, Kılboz BB, Bükey Y.
    BMC Surg. 2019 Sep 11;19(1):134. PMID: 31510984



  1. Increased risk for tooth extraction in primary hyperparathyroidism and hypercalcemia: a population study.
    Koman A, Näsman P, Discacciati A, Ekbom A, Nilsson IL, Sandborgh-Englund G.
    Clin Oral Investig. 2019 Dec 2. PMID: 31792613

  2. Metabolic profile of human parathyroid adenoma.
    di Masi A, Leboffe L, Sodo A, Tabacco G, Cesareo R, Sbroscia M, Giovannoni I, Taffon C, Crucitti P, Longo F, Manfrini S, Ricci MA, Ascenzi P, Crescenzi A, Palermo A.
    Endocrine. 2019 Nov 30. PMID: 31786773

  3. Long-term remission of disseminated parathyroid cancer following immunotherapy.
    Sarquis M, Marx SJ, Beckers A, Bradwell AR, Simonds WF, Bicalho MAC, Daly AF, Betea D, Friedman E, De Marco L.
    Endocrine. 2019 Nov 28. PMID: 31782130

  4. Effects of parathyroidectomy on tumoral calcinosis in uremic patients with secondary hyperparathyroidism.
    Wang J, Zeng M, Yang G, Huang Y, Wu B, Guo J, Wang N, Xing C.
    BMC Surg. 2019 Sep 11;19(1):133. PMID: 31510980



  1. A Novel Technique for Performing Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA): A Single-port Platform.
    Park JH, Bilegsaikhan SE, Suh YJ.
    Surg Laparosc Endosc Percutan Tech. 2019 Nov 26. PMID: 31790081

  2. Subset analysis of the Japanese risk classification guidelines for papillary thyroid carcinoma.
    Ito Y, Miyauchi A, Yamamoto M, Masuoka H, Higashiyama T, Kihara M, Miya A.
    Endocr J. 2019 Nov 27. PMID: 31776303


November 28, 2019


  1. AT1AA (Angiotensin II Type-1 Receptor Autoantibodies): Cause or Consequence of Human Primary Aldosteronism?
    Piazza M, Seccia TM, Caroccia B, Rossitto G, Scarpa R, Persichitti P, Basso D, Rossi GP.
    Hypertension. 2019 Oct;74(4):793-799. PMID: 31476908

  2. Clinical Outcomes of 1625 Patients With Primary Aldosteronism Subtyped With Adrenal Vein Sampling.
    Rossi GP, Rossitto G, Amar L, Azizi M, Riester A, Reincke M, Degenhart C, Widimsky J Jr, Naruse M, Deinum J, Schultze Kool L, Kocjan T, Negro A, Rossi E, Kline G, Tanabe A, Satoh F, Christian Rump L, Vonend O, Willenberg HS, Fuller PJ, Yang J, Chee NYN, Magill SB, Shafigullina Z, Quinkler M, Oliveras A, Dun Wu K, Wu VC, Kratka Z, Barbiero G, Battistel M, Chang CC, Vanderriele PE, Pessina AC.
    Hypertension. 2019 Oct;74(4):800-808. PMID: 31476901

  3.  Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function. 
    Kobayashi H, Abe M, Nakamura Y, Takahashi K, Fujita M, Takeda Y, Yoneda T, Kurihara I, Itoh H, Tsuiki M, Wada N, Ichijo T, Katabami T, Ogawa Y, Kawashima J, Yoshimoto T, Sone M, Inagaki N, Watanabe M, Kamemura K, Matsuda Y, Izawa S, Tanabe M, Tanabe A, Suzuki T, Naruse M; JPAS/JRAS Study Group. 
    Hypertension. 2019 Sep;74(3):630-638. PMID: 31327258


  1. The Significance of Histologically "Large Normal" Parathyroid Glands in Primary Hyperparathyroidism.
    Krawitz R, Glover A, Koneru S, Jiang J, Di Marco A, Gill AJ, Aniss A, Sywak M, Delbridge L, Sidhu S.
    World J Surg. 2019 Nov 26. PMID: 31773224

  2. Robust, quick, and convenient intraoperative method to differentiate parathyroid tissue. 

    Kikumori T, Inaishi T, Miyajima N, Shibata M, Takeuchi D.
    Surgery. 2019 Nov 18. PMID: 31753324 

    Song A, Wang W, Chen S, Wang Y, Liu S, Nie M, Jiang Y, Li M, Xia W, Meng X, Xing X, Wang O.
    Endocr Pract. 2019 Nov;25(11):1127-1136. PMID: 31414909

  4. Timing of Parathyroidectomy Does Not Influence Renal Function After Kidney Transplantation.
    van der Plas WY, El Moumni M, von Forstner PJ, Koh EY, Dulfer RR, van Ginhoven TM, Rotmans JI, Appelman-Dijkstra NM, Schepers A, Hoorn EJ, Plukker JTM, Vogt L, Engelsman AF, Nieveen van Dijkum EJM, Kruijff S, Pol RA, de Borst MH; Dutch Hyperparathyroidism Study Group.
    World J Surg. 2019 Aug;43(8):1972-1980. PMID: 30798418


  1. Clinical and Biochemical Features of Pheochromocytoma Characteristic of Von Hippel-Lindau Syndrome.
    Li SR, Nicholson KJ, Mccoy KL, Carty SE, Yip L.
    World J Surg. 2019 Nov 26. PMID: 31773218



  1. New placement of recording electrodes on the thyroid cartilage in intra-operative neuromonitoring during thyroid surgery.
    Van Slycke S, Van Den Heede K, Magamadov K, Brusselaers N, Vermeersch H. Langenbecks
    Arch Surg. 2019 Nov 20. PMID: 31748870

  2. Diagnostic value of cytology, thyroglobulin, and combination of them in fine-needle aspiration of metastatic lymph nodes in patients with differentiated thyroid cancer: A systematic review and network meta-analysis.
    Xu Y, Wu D, Wu W, Jiang J, Xi C, Ye N, Wang Y, Xu X.
    Medicine (Baltimore). 2019 Nov;98(45):e17859. PMID: 31702649

  3. Coexistent papillary thyroid carcinoma diagnosed in surgically treated patients for primary versus secondary hyperparathyroidism: same incidence, different characteristics.
    Preda C, Branisteanu D, Armasu I, Danila R, Velicescu C, Ciobanu D, Covic A, Grigorovici A.
    BMC Surg. 2019 Jul 16;19(1):94. PMID: 31311533

  4. Total thyroidectomy vs completion thyroidectomy for thyroid nodules with indeterminate cytology/follicular proliferation: a single-centre experience.
    Sena G, Gallo G, Innaro N, Laquatra N, Tolone M, Sacco R, Sammarco G.
    BMC Surg. 2019 Jul 10;19(1):87. PMID: 31291921


November 21, 2019


  1. Circulating miRNA Expression Profiling in Primary Aldosteronism.
    Decmann A, Nyírö G, Darvasi O, Turai P, Bancos I, Kaur RJ, Pezzani R, Iacobone M, Kraljevic I, Kastelan D, Parasiliti-Caprino M, Maccario M, Nirschl N, Heinrich D, Reincke M, Patócs A, Igaz P.
    Front Endocrinol (Lausanne). 2019 Oct 29;10:739. PMID: 31736877


  1. Atypical presentations of parathyroid gland pathology: A pictorial review.
    Kowa XY, Richards P, Waterhouse M, Parvanta L, Adams A. Eur
    J Radiol Open. 2019 Nov 8;6:320-329. PMID: 31737749

  2. Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms.
    Silva-Figueroa AM, Bassett R Jr, Christakis I, Moreno P, Clarke CN, Busaidy NL, Grubbs EG, Lee JE, Perrier ND, Williams MD.
    Endocr Pathol. 2019 Nov 16. PMID: 31734935

  3. Pediatric Parathyroid Carcinoma: A Case Report and Review of the Literature.
    Dutta A, Pal R, Jain N, Dutta P, Rai A, Bhansali A, Behera A, Saikia UN, Vishwajeet V, Collier D, Boon H, Korbonits M, Bhadada SK.
    J Endocr Soc. 2019 Sep 16;3(12):2224-2235. PMID: 31723720 


  1. Multifocal papillary thyroid cancer in children and adolescents: 12-year experience in a single center.
    Chen J, Huang N, Ji Q, Wang Y, Zhu Y, Li D.
    Gland Surg. 2019 Oct;8(5):507-515. PMID: 31741881

  2. Vascular flow on doppler sonography may not be a valid characteristic to distinguish colloid nodules from papillary thyroid carcinoma even when accounting for nodular size.
    Debnam JM, Vu T, Sun J, Wei W, Krishnamurthy S, Zafereo ME, Weitzman SP, Garg N, Ahmed S.
    Gland Surg. 2019 Oct;8(5):461-468. PMID: 31741876

  3. The anti-cancer effects of phenformin in thyroid cancer cell lines and in normal thyrocytes.
    Coperchini F, Croce L, Denegri M, Awwad O, Ngnitejeu ST, Magri F, Chiovato L, Rotondi M.
    Oncotarget. 2019 Nov 5;10(60):6432-6443. PMID: 31741708

  4. A randomized trial comparing health-related quality-of-life and utility measures between routine fine-needle aspiration cytology (FNAC) and surveillance alone in patients with thyroid incidentaloma measuring 1-2 cm.
    Wong CKH, Lang BHH.
    Endocrine. 2019 Nov 18. PMID: 31741168

  5. Single Dose Steroid Injection After Loss of Signal (LOS) During Thyroid Surgery is Effective to Recover Electric Signal Avoiding Vocal Cord Palsy and the Need of Staged Thyroidectomy: Prospective Evaluation on 702 Patients.
    Donatini G, Danion J, Zerrweck C, Etienne P, Lacoste L, Kraimps JL.
    World J Surg. 2019 Nov 18. PMID: 31741073

  6. Evaluating risk factors for re-exploration due to postoperative neck hematoma after thyroid surgery: a nested case-control study.
    Salem FA, Bergenfelz A, Nordenström E, Dahlberg J, Hessman O, Lundgren CI, Almquist M. Langenbecks
    Arch Surg. 2019 Nov 18. PMID: 31741031

  7. A Multidisciplinary Head-to-Head Comparison of American College of Radiology Thyroid Imaging and Reporting Data System and American Thyroid Association Ultrasound Risk Stratification Systems.
    Huang BL, Ebner SA, Makkar JS, Bentley-Hibbert S, McConnell RJ, Lee JA, Hecht EM, Kuo JH.
    Oncologist. 2019 Nov 18. pii: theoncologist.2019-0362. PMID: 31740569

  8. Outcomes of surgery and postoperative radiation therapy in managing medullary thyroid carcinoma.
    Groen AH, Beckham TH, Links TP, Goldman DA, Sherman EJ, Tuttle MM, Bijl HP, Wong RJ, Plukker JTM, Lee NY; and other Group/Consortium Members.
    J Surg Oncol. 2019 Nov 16. PMID: 31733124

  9. Video-assisted neck surgery (VANS) using a gasless lifting procedure for thyroid and parathyroid diseases: "The VANS method from A to Z".
    Shimizu K, Shimizu K, Okamura R, Igarashi T, Nagaoka R, Sanada M, Sugitani I, Fukumori T, Yamada T.
    Surg Today. 2019 Nov 14. PMID: 31728730

November 14, 2019


  1. Training in endocrine surgery.
    Gimm O, Barczyński M, Mihai R, Raffaelli M. Langenbecks 
    Arch Surg. 2019 Nov 7. PMID: 31701231


  1. Volume-outcome correlation in adrenal surgery-an ESES consensus statement.
    Mihai R, Donatini G, Vidal O, Brunaud L. Langenbecks 
    Arch Surg. 2019 Nov 7. PMID: 31701230

Gastrointestinal Neuroendocrine 

  1. Grade is a Dominant Risk Factor for Metastasis in Patients with Rectal Neuroendocrine Tumors.
    Folkert IW, Sinnamon AJ, Concors SJ, Bennett BJ, Fraker DL, Mahmoud NN, Metz DC, Stashek KM, Roses RE. Ann
    Surg Oncol. 2019 Nov 7. PMID: 31701298

Pancreatic Neuroendocrine 

  1. Impact of tumor size and nodal status on recurrence of nonfunctional pancreatic neuroendocrine tumors ≤2 cm after curative resection: A multi-institutional study of 392 cases.
    Dong DH, Zhang XF, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Pawlik TM; other members of the US Neuroendocrine Tumor Study Group. J
    Surg Oncol. 2019 Dec;120(7):1071-1079. PMID: 31571225


  1. Stepwise Approach for Parathyroid Localisation in Primary Hyperparathyroidism.
    Korwar V, Yuen Chang F, Teasdale E, Suchett-Kaye I, Edwards A, Morgan J. World
    Surg. 2019 Nov 11. PMID:

  2. The Clinicopathological Spectrum of Parathyroid Carcinoma.
    Akirov A, Asa SL, Larouche V, Mete O, Sawka AM, Jang R, Ezzat S. Front Endocrinol (Lausanne).
    2019 Oct 23;10:731. PMID: 31708875

  3. Differences in primary hyperparathyroidism characteristics between children and adolescents.
    Zivaljevic V, Jovanovic M, Diklic A, Zdravkovic V, Djordjevic M, Paunovic I. J
    Pediatr Surg. 2019 Oct 25. pii: S0022-3468(19)30670-0. PMID: 31706616

  4. Parathyromatosis: a very rare cause of recurrent primary hyperparathyroidism - case report and review of the literature.
    Haciyanli M, Karaisli S, Gucek Haciyanli S, Atasever A, Arikan Etit D, Gur EO, Acar T. Ann R Coll
    Surg Engl. 2019 Nov;101(8):e178-e183. PMID: 31509000


  1. Efficacy of α-blockers on hemodynamic control during pheochromocytoma resection - a randomized controlled trial.
    Buitenwerf E, Osinga TE, Timmers HJLM, Lenders JWM, Feelders RA, Eekhoff EMW, Haak HR, Corssmit EPM, Bisschop PHLT, Valk GD, GrooteVeldman R, Dullaart RPF, Links TP, Voogd MF, Wietasch GJKG, Kerstens MN; PRESCRIPT-investigators. J
    Clin Endocrinol Metab. 2019 Nov 12. PMID: 31714582 


  1. A novel gene panel for prediction of lymph-node metastasis and recurrence in patients with thyroid cancer.
    Ruiz EML, Niu T, Zerfaoui M, Kunnimalaiyaan M, Friedlander PL, Abdel-Mageed AB, Kandil E.
    Surgery. 2019 Nov 8. pii: S0039-6060(19)30584-7. PMID: 31711617

  2. Lymphocyte-Monocyte Ratio Significantly Predicts Recurrence in Papillary Thyroid Cancer.
    Yokota M, Katoh H, Nishimiya H, Kikuchi M, Kosaka Y, Sengoku N, Watanabe M, Yamashita K.
    J Surg Res. 2019 Nov 8. pii: S0022-4804(19)30679-1. PMID: 31711613

  3. Morbidity and long-term survival in patients with cervical re-exploration for papillary thyroid carcinoma.
    Baerbock N, Mittelstädt A, Jähne J.
    Innov Surg Sci. 2019 Mar 27;4(3):91-99. PMID: 31709300

  4. Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines.
    Thomas CM, Asa SL, Ezzat S, Sawka AM, Goldstein D. Curr
    Oncol. 2019 Oct;26(5):338-344. PMID: 31708652


November 7, 2019


  1. Synchronous aldosterone- and cortisol-producing adrenocortical adenomas diagnosed using CYP11B immunohistochemistry.
    Stenman A, Shabo I, Ramström A, Zedenius J, Juhlin CC.
    SAGE Open Med Case Rep. 2019 Oct 18. PMID: 31666955


    Golingan H, Samuels SK, Camacho P, Dadhania DM, Pedraza-Taborda FE, Randolph G, Parangi S, Bimston DN, Harrell RM.
    Endocr Pract. 2019 Nov 4. PMID: 31682519


  1. 18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma.
    Lugat A, Drui D, Mirallié E, Kraeber-Bodéré F, Ansquer C.
    Clin Nucl Med. 2019 Sep;44(9):738-740. PMID: 31306205

  2. Pheochromocytoma diagnosed during pregnancy: lessons learned from a series of ten patients.
    Donatini G, Kraimps JL, Caillard C, Mirallie E, Pierre F, De Calan L, Hamy A, Larin O, Tovkay O, Cherenko S.
    Surg Endosc. 2018 Sep;32(9):3890-3900. Surg Endosc. 2018 Mar 20;:PMID: 29488089


  1. Impact of intraoperative remifentanil on postoperative pain and opioid use in thyroid surgery.
    Wu JX, Assel M, Vickers A, Afonso AM, Twersky RS, Simon BA, Cohen MA, Rieth EF, Cracchiolo JR. J
    Surg Oncol. 2019 Nov 3. PMID: 31680250

  2. Intraoperative nerve monitoring in endocrine surgery: prevalence and reasons for its use in Australia and New Zealand.
    Leong DCW, Lo J, Ryan S, Nguyen H, Lisewski D. ANZ
    J Surg. 2019 Oct 30. PMID: 31668000

  3. Epigenetic silencing of HOPX is critically involved in aggressive phenotypes and patient prognosis in papillary thyroid cancer.
    Ooizumi Y, Katoh H, Yokota M, Watanabe M, Yamashita K.
    Oncotarget. 2019 Oct 15;10(57):5906-5918. PMID: 31666923

  4. Postoperative Hypoparathyroidism in Thyroid Surgery: Anatomic-Surgical Mapping of the Parathyroids and Implications for Thyroid Surgery.
    Burger F, Fritsch H, Zwierzina M, Prommegger R, Konschake M.
    Sci Rep. 2019 Oct 30;9(1):15700. PMID: 31666619

  5. Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin America.
    Smulever A, Pitoia F.
    Arch Endocrinol Metab. 2019 Sep 2;63(5):462-469 PMID: 31482955

  6. Thyroid nodules ≤ 1 cm and papillary thyroid microcarcinomas: Brazilian experts opinion.
    Rosario PW, Ward LS, Graf H, Vaisman F, Mourão GF, Vaisman M.
    Arch Endocrinol Metab. 2019 Sep 2;63(5):456-461. PMID: 31482953

  7. Subcategorisation of AUS/FLUS thyroid lesions as per the 2017 Bethesda System for Reporting Thyroid Cytopathology: a retrospective study from a tertiary care centre analysing risk of malignancy (ROM) of the different subcategories.
    Guleria P, Agarwal S, Iyer VK, Jain D, Mathur SR, Yadav D.
    J Clin Pathol. 2019 Nov;72(11):771-777. PMID: 31375535

  8. Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a.
    Ryu YJ, Cho JS, Park MH, Yoon JH.
    BMC Surg. 2019 Jul 5;19(1):78. doi: 10.1186/s12893-019-0541-5. PMID: 31277631


October 31, 2019


  1. Comparative prospective study on the presentation of normocalcemic primary hyperparathyroidism. Is it more aggressive than the hypercalcemic form?
    Gómez-Ramírez J, Gómez-Valdazo A, Luengo P, Porrero B, Osorio I, Rivas S.
    Am J Surg. 2019 Oct 22. PMID: 31662196

  2. Parathyroid Cancer: A Review.
    Machado NN, Wilhelm SM. Cancers (Basel).
    2019 Oct 28;11(11). PMID: 31661917

  3. Multimodal Preoperative Localization Improves Outcomes in Reoperative Parathyroidectomy: A 25-Year Surgical Experience.
    Patel SG, Saunders ND, Jamshed S, Weber CJ, Sharma J.
    Am Surg. 2019 Sep 1;85(9):939-943. PMID: 31638503


  1. Real World Comparison of Afirma GEC and GSC for the Assessment of Cytologically Indeterminate Thyroid Nodules.
    San Martin VT, Lawrence L, Bena J, Madhun NZ, Berber E, Elsheikh TM, Nasr CE.
    J Clin Endocrinol Metab. 2019 Oct 26. PMID: 31665322

  2. Cardiovascular Incidence in 6900 Patients with Differentiated Thyroid Cancer: a Swedish Nationwide Study.
    Zoltek M, Andersson TM, Hedman C, Ihre-Lundgren C, Nordenvall C.
    World J Surg. 2019 Oct 28. PMID: 31659412

  3. Long non-coding RNA TNRC6C-AS1 promotes methylation of STK4 to inhibit thyroid carcinoma cell apoptosis and autophagy via Hippo signalling pathway.
    Peng X, Ji C, Tan L, Lin S, Zhu Y, Long M, Luo D, Li H.
    J Cell Mol Med. 2019 Oct 27. PMID: 31657132

  4. Surgical training in video-assisted neck surgery-based thyroidectomy using fresh frozen human cadavers.
    Aoyama M, Takizawa H, Tsuboi M, Yamasaki S, Tsuruo Y, Tangoku A.
    J Med Invest. 2019;66(3.4):293-296. PMID: 31656292

  5. Association between TERT promoter mutations and clinical behaviors in differentiated thyroid carcinoma: a systematic review and meta-analysis.
    Yang J, Gong Y, Yan S, Chen H, Qin S, Gong R.
    Endocrine. 2019 Oct 26. PMID: 31655978

  6. Financial burden of thyroid cancer in the United States: An estimate of economic and psychological hardship among thyroid cancer survivors.
    Barrows CE, Belle JM, Fleishman A, Lubitz CC, James BC.
    Surgery. 2019 Oct 22. PMID: 31653488

  7. Quantifying the differences in surgical management of patients with definitive and indeterminate thyroid nodule cytology.
    Stewart R, Leang YJ, Bhatt CR, Grodski S, Serpell J, Lee JC.
    Eur J Surg Oncol. 2019 Oct 7. PMID: 31648951

  8. Validation of Reference Genes for Normalization of Relative qRT-PCR Studies in Papillary Thyroid Carcinoma.
    Razavi SA, Afsharpad M, Modarressi MH, Zarkesh M, Yaghmaei P, Nasiri S, Tavangar SM, Gholami H, Daneshafrooz A, Hedayati M.
    Sci Rep. 2019 Oct 23;9(1):15241. PMID: 31645594

  9. Renal dysfunction in patients with radioactive iodine-refractory thyroid cancer treated with tyrosine kinase inhibitors: A retrospective study.
    Iwasaki H, Yamazaki H, Takasaki H, Suganuma N, Sakai R, Nakayama H, Toda S, Masudo K.
    Medicine (Baltimore). 2019 Oct;98(42):e17588. PMID: 31626129


October 24, 2019


  1. Predictors of Clinical Success After Surgery for Primary Aldosteronism in the Japanese Nationwide Cohort.
    Morisaki M, Kurihara I, Itoh H, Naruse M, Takeda Y, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y, Sone M, Tsuiki M, Shibata H, Kawashima J, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Suzuki T; JPAS Study Group.
    J Endocr Soc. 2019 Aug 22;3(11):2012-2022. PMID: 31637342


  1. Single gland excision for MEN1-associated primary hyperparathyroidism.
    Manoharan J, Albers MB, Bollmann C, Maurer E, Mintziras I, Wächter S, Bartsch DK.
    Clin Endocrinol (Oxf). 2019 Oct 18. PMID: 31626728
  2. Cognition and cerebrovascular function in primary hyperparathyroidism before and after parathyroidectomy.
    Liu M, Sum M, Cong E, Colon I, Bucovsky M, Williams J, Kepley A, Kuo J, Lee JA, Lazar RM, Marshall R, Silverberg S, Walker MD.
    J Endocrinol Invest. 2019 Oct 16. PMID: 31621051


  1. Altered Serum MicroRNA Profile May Serve as an Auxiliary Tool for Discriminating Aggressive Thyroid Carcinoma from Nonaggressive Thyroid Cancer and Benign Thyroid Nodules.
    Zhang A, Wang C, Lu H, Chen X, Ba Y, Zhang C, Zhang CY.
    Dis Markers. 2019 Sep 16;2019:3717683. PMID: 31636734
  2. Total thyroidectomy for Graves' disease-what do our patients think? A qualitative cohort study to evaluate the surgical management of Graves' disease.
    Hamilton LOW, Lim AE, Clark LJ.
    Surgeon. 2019 Oct 18. PMID: 31636036
  3. The incidence and survival analysis for anaplastic thyroid cancer: a SEER database analysis.
    Lin B, Ma H, Ma M, Zhang Z, Sun Z, Hsieh IY, Okenwa O, Guan H, Li J, Lv W.
    Am J Transl Res. 2019 Sep 15;11(9):5888-5896. PMID: 31632557
  4. Renal dysfunction in patients with radioactive iodine-refractory thyroid cancer treated with tyrosine kinase inhibitors: A retrospective study.
    Iwasaki H, Yamazaki H, Takasaki H, Suganuma N, Sakai R, Nakayama H, Toda S, Masudo K.
    Medicine (Baltimore). 2019 Oct;98(42):e17588. PMID: 31626129
  5. Differences in long-term quality of life between hemithyroidectomy and total thyroidectomy in patients treated for low-risk differentiated thyroid carcinoma.
    Bongers PJ, Greenberg CA, Hsiao R, Vermeer M, Vriens MR, Lutke Holzik MF, Goldstein DP, Devon K, Rotstein LE, Sawka AM, Pasternak JD.
    Surgery. 2019 Oct 14. PMID: 31623853
  6. Whole-genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation.
    Paulsson JO, Backman S, Wang N, Stenman A, Crona J, Thutkawkorapin J, Ghaderi M, Tham E, Stålberg P, Zedenius J, Juhlin CC.
    J Pathol. 2019 Oct 17. PMID: 31621921
  7. The extent of extrathyroidal extension is a key determinant of prognosis in T4a papillary thyroid cancer.
    Abraham E, Roshan D, Tran B, Wykes J, Campbell P, Ebrahimi A.
    J Surg Oncol. 2019 Nov;120(6):1016-1022. PMID: 31452204
  8. Effect of Graves' disease on the prognosis of differentiated thyroid carcinoma: a meta-analysis.
    Song Y, Fu L, Wang P, Sun N, Qiu X, Li J, Zheng S, Ren S, Ding X, Li L, Du J, Wang C, Jiao Z, Zhao W.
    Endocrine. 2019 Oct 21. PMID: 31637658

October 17, 2019

Pancreatic Neuroendocrine

  1. Prognostic Assessment of Non-functioning Neuroendocrine Pancreatic Neoplasms as a Basis for Risk-Adapted Resection Strategies.
    Watzka FM, Meyer F, Staubitz JI, Fottner C, Schad A, Lang H, Musholt TJ.
    World J Surg. 2019 Oct 11. PMID: 31605171


  1. Factors associated with late recurrence after parathyroidectomy for primary hyperparathyroidism.
    Mallick R, Nicholson KJ, Yip L, Carty SE, McCoy KL.
    Surgery. 2019 Oct 9. PMID: 31606193
  2. Derivation of a cost-saving screening strategy for asymptomatic primary hyperparathyroidism.
    Nguyen-Lee JJ, Paciuc M, Guerra R, Esnaola N, Zanocco KA, Zheng F.
    Surgery. 2019 Oct 8. PMID: 31604587
  3. Pre-operative Localisation of the Parathyroid Glands in Secondary Hyperparathyroidism: A Retrospective Cohort Study.
    Hiramitsu T, Tomosugi T, Okada M, Futamura K, Tsujita M, Goto N, Narumi S, Watarai Y, Tominaga Y, Ichimori T.
    Sci Rep. 2019 Oct 10;9(1):14634. PMID: 31602011
  4. Preoperative localisation of adenomas in primary hyperparathyroidism: the value of 11C-choline PET/CT in patients with negative or discordant ultrasonography and 99mTc-Sesta-MIBI-SPECT/CT.
    Liu Y, Dang Y, Huo L, Hu Y, Wang O, Liu H, Chang X, Liu Y, Xing X, Li F, Liao Q, Hacker M, Li X, Kreissl M.
    J Nucl Med. 2019 Oct 10. PMID: 31601698


  1. Clinical Presentation and Outcomes of Phaeochromocytomas/Paragangliomas in Neurofibromatosis Type 1.
    Al-Sharefi A, Javaid U, Perros P, Ealing J, Truran P, Nag S, Kamaruddin S, Abouglila K, Cains F, Lewis L, James RA.
    Eur Endocrinol. 2019 Aug;15(2):95-100. PMID: 31616500
  2. Metabolic impact of pheochromocytoma/paraganglioma: Targeted metabolomics in patients before and after tumor removal.
    Erlic Z, Kurlbaum M, Deutschbein T, Nölting S, Prejbisz A, Timmers HJ, Richter S, Prehn C, Weismann D, Adamski J, Januszewicz A, Reincke M, Fassnacht M, Robledo M, Eisenhofer G, Beuschlein F, Kroiss M.
    Eur J Endocrinol. 2019 Oct 1. PMID: 31614337
  3. Pheochromocytoma arising from an ectopic adrenal tissue in multiple endocrine neoplasia type 2A.
    Ohsugi H, Takizawa N, Kinoshita H, Matsuda T.
    Endocrinol Diabetes Metab Case Rep. 2019 Oct 12;2019. PMID: 31610522


  1. Thyroid hormone therapy in differentiated thyroid cancer.
    Grani G, Ramundo V, Verrienti A, Sponziello M, Durante C.
    Endocrine. 2019 Oct;66(1):43-50. PMID: 31617165
  2. Surgical Management of Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma. Experience in 25 Patients.
    Spinelli C, Strambi S, Bakkar S, Nosiglia A, Elia G, Bertocchini A, Calani C, Leoni M, Morganti R, Materazzi G.
    World J Surg. 2019 Oct 11. PMID: 31605177
  3. A novel therapeutic approach for anaplastic thyroid cancer through inhibition of LAT1.
    Enomoto K, Sato F, Tamagawa S, Gunduz M, Onoda N, Uchino S, Muragaki Y, Hotomi M.
    Sci Rep. 2019 Oct 10;9(1):14616. PMID: 31601917

October 10, 2019


  1. Adrenalectomy Risk Score: An Original Preoperative Surgical Scoring System to Reduce Mortality and Morbidity After Adrenalectomy.
    Caiazzo R, Marciniak C, Lenne X, Clément G, Theis D, Ménégaux F, Sebag F, Brunaud L, Lifante JC, Mirallie E, Bruandet A, Pattou F; AFCE Study group.
    Ann Surg. 2019 Oct 7. PMID: 31592809
  2. Synchronous bilateral adrenalectomy in ACTH-dependent hypercortisolism: predictors, biomarkers and outcomes.
    Chiloiro S, Giampietro A, Raffaelli M, D'Amato G, Bima C, Lauretti L, Anile C, Lombardi CP, Rindi G, Bellantone R, De Marinis L, Pontecorvi A, Bianchi A. Endocrine.
    2019 Oct 3. PMID: 31583577


  1. 68Ga-DOTATOC PET/CT in detecting neuroendocrine tumours responsible for initial or recurrent paraneoplastic Cushing's syndrome.
    Bélissant Benesty O, Nataf V, Ohnona J, Michaud L, Zhang-Yin J, Bertherat J, Chanson P, Reznik Y, Talbot JN, Montravers F.
    Endocrine. 2019 Oct 3. PMID: 31583575


  1. Short-term medical treatment of hypercalcaemia in primary hyperparathyroidism predicts symptomatic response after parathyroidectomy.
    Koman A, Ohlsson S, Bränström R, Pernow Y, Bränström R, Nilsson IL.
    Br J Surg. 2019 Oct 9. PMID: 31595982
  2. Parathyroid surgery: an evidence-based volume-outcomes analysis : European Society of Endocrine Surgeons (ESES) positional statement.
    Iacobone M, Scerrino G, Palazzo FF.
    Langenbecks Arch Surg. 2019 Oct 8. PMID: 31595330
  3. Risk factors for vertebral fracture in primary hyperparathyroidism.
    Liu M, Williams J, Kuo J, Lee JA, Silverberg SJ, Walker MD.
    Endocrine. 2019 Oct 3. PMID: 31583576


  1. Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy.
    Parasiliti-Caprino M, Lucatello B, Lopez C, Burrello J, Maletta F, Mistrangelo M, Migliore E, Tassone F, La Grotta A, Pia A, Reimondo G, Giordano R, Giraudo G, Piovesan A, Ciccone G, Deandreis D, Limone P, Orlandi F, Borretta G, Volante M, Mulatero P, Papotti M, Aimaretti G, Terzolo M, Morino M, Pasini B, Veglio F, Ghigo E, Arvat E, Maccario M.
    Hypertens Res. 2019 Oct 4. PMID: 31586159


  1. Impact of the change from the seventh to eighth edition of the AJCC TNM classification of malignant tumours and comparison with the MACIS prognostic scoring system in non-medullary thyroid cancer.
    Dwamena S, Patel N, Egan R, Stechman M, Scott-Coombes D.
    BJS Open. 2019 Jun 28;3(5):623-628. PMID: 31592514
  2. LncRNA LUCAT1 as a novel prognostic biomarker for patients with papillary thyroid cancer.
    Luzón-Toro B, Fernández RM, Martos-Martínez JM, Rubio-Manzanares-Dorado M, Antiñolo G, Borrego S.
    Sci Rep. 2019 Oct 7;9(1):14374. PMID: 31591432
  3. Preoperative metabolic classification of thyroid nodules using mass spectrometry imaging of fine-needle aspiration biopsies.
    DeHoog RJ, Zhang J, Alore E, Lin JQ, Yu W, Woody S, Almendariz C, Lin M, Engelsman AF, Sidhu SB, Tibshirani R, Suliburk J, Eberlin LS.
    Proc Natl Acad Sci U S A. 2019 Oct 7. PMID: 31591199
  4. Oral steroid prophylaxis for Graves' orbitopathy after radioactive iodine treatment for Graves' disease is not only effective, but also safe.
    Rosetti S, Tanda ML, Veronesi G, Masiello E, Premoli P, Gallo D, Cusini C, Donati S, Sabatino J, Ippolito S, Piantanida E, Bartalena L.
    J Endocrinol Invest. 2019 Oct 5. PMID: 31587179
  5. Inhibition of Cancer Stem-Like Phenotype by Curcumin and Deguelin in CAL-62 Anaplastic Thyroid Cancer Cells.
    Kocdor MA, Cengiz H, Ates H, Kocdor H.
    Anticancer Agents Med Chem. 2019 Oct 4. PMID: 31584382
  6. Preoperative Computed Tomography Changes Surgical Management for Clinically Low-Risk Well-Differentiated Thyroid Cancer.
    Bongers PJ, Verzijl R, Dzingala M, Vriens MR, Yu E, Pasternak JD, Rotstein LE.
    Ann Surg Oncol. 2019 Oct 3. PMID: 31583547

October 3, 2019

Pancreatic Neuroendocrine

  1. Should 68Ga-DOTATATE PET/CT be Performed Routinely in Patients with Neuroendocrine Tumors Before Surgical Resection?
    Babazadeh NT, Schlund DJ, Cornelius T, Singh JS, Tierney JF, Chen M, Keutgen XM.
    World J Surg. 2019 Oct 1. PMID: 31576440


  1. Confirmation of Parathyroid Tissue: Are Surgeons Aware of New and Novel Techniques?
    Coan KE, Yen TWF, Carr AA, Evans DB, Wang TS.
    J Surg Res. 2019 Sep 27;246:139-144. PMID: 31569035
  2. 18F-Fluorocholine PET/CT in primary hyperparathyroidism: superior diagnostic performance to conventional scintigraphic imaging for localization of hyperfunctioning parathyroid glands.
    Cuderman A, Senica K, Rep S, Hocevar M, Kocjan T, Jensterle Sever M, Zaletel K, Lezaic L.
    J Nucl Med. 2019 Sep 27. PMID:31562221
  3. Recognition of primary hyperparathyroidism: Delayed time course from hypercalcemia to surgery.
    Naples R, Shin JJ, Berber E, Jin J, Krishnamurthy VD, Siperstein AE.
    Surgery. 2019 Sep 24. PMID: 31561989


  1. Smartphone-Based Application for Tele-follow-up of Patients with Endocrine Disorders in Context of a LMIC: A Compliance, Satisfaction, Clinical Safety and Outcome Assessment.
    Yadav SK, Jha CK, Mishra SK, Mishra A.
    World J Surg. 2019 Oct 1. PMID: 31576439
  2. Analytical and Clinical Validation of Expressed Variants and Fusions From the Whole Transcriptome of Thyroid FNA Samples.
    Angell TE, Wirth LJ, Cabanillas ME, Shindo ML, Cibas ES, Babiarz JE, Hao Y, Kim SY, Walsh PS, Huang J, Kloos RT, Kennedy GC, Waguespack SG.
    Front Endocrinol (Lausanne). 2019 Sep 11;10:612. PMID: 31572297
  3. Linc01278 inhibits the development of papillary thyroid carcinoma by regulating miR-376c-3p/DNM3 axis.
    Lin S, Tan L, Luo D, Peng X, Zhu Y, Li H.
    Cancer Manag Res. 2019 Sep 19;11:8557-8569. PMID: 31572010
  4. Long noncoding RNA ZFAS1 promotes progression of papillary thyroid carcinoma by sponging miR-590-3p and upregulating HMGA2 expression.
    Tong H, Zhuang X, Cai J, Ding Y, Si Y, Zhang H, Shen M.
    Onco Targets Ther. 2019 Sep 13;12:7501-7512. PMID: 31571903
  5. Histopathological characteristics and post-operative follow-up of patients with potentially radiogenic papillary thyroid carcinoma depending on oncocytic changes availability in the tumor cells.
    Bogdanova T, Zurnadzhy L, Masiuk S, Burko S, Degtyaryova T, Kovalenko A, Bolgov M, Chernyshov S, Gulevatyi S, Thomas G, Tronko M.
    Exp Oncol. 2019 Sep;41(3):235-241. PMID: 31569930
  6. Appropriate Timing of Early Postoperative Botulinum Toxin Type A Injection for Thyroidectomy Scar Management: A Split-Scar Study.
    An MK, Cho EB, Park EJ, Kim KH, Kim LS, Kim KJ.
    Plast Reconstr Surg. 2019 Oct;144(4):659e-668e. PMID: 31568312
  7. Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease.
    Hysek M, Paulsson JO, Jatta K, Shabo I, Stenman A, Höög A, Larsson C, Zedenius J, Juhlin CC.
    Cancers (Basel). 2019 Sep 26;11(10). PMID: 31561592

September 26, 2019


  1. Challenges in obesity and primary aldosteronism: Diagnosis and treatment.
    Gershuni VM, Herman DS, Kelz RR, Roses RE, Cohen DL, Trerotola SO, Fraker DL, Wachtel H.
    Surgery. 2019 Sep 18. PMID: 31542169
  2. Patient selection and outcomes of laparoscopic transabdominal versus posterior retroperitoneal adrenalectomy among surgeons in the Collaborative Endocrine Surgery Quality Improvement Program (CESQIP).
    Marrero AP, Kazaure HS, Thomas SM, Stang MT, Scheri RP.
    Surgery. 2019 Sep 19. PMID: 31543324

Pancreatic Neuroendocrine

  1. Operative resection in early stage pancreatic neuroendocrine tumors in the United States: Are we over- or undertreating patients?
    Chivukula SV, Tierney JF, Hertl M, Poirier J, Keutgen XM.
    Surgery. 2019 Sep 16. PMID: 31537303


  1. Normocalcemic hyperparathyroidism: A Collaborative Endocrine Surgery Quality Improvement Program analysis.
    Pandian TK, Lubitz CC, Bird SH, Kuo LE, Stephen AE.
    Surgery. 2019 Sep 19. PMID: 31543325


  1. Changes in Tracheal Tube Cuff Pressure and Recurrent Laryngeal Nerve Conductivity During Thyroid Surgery.
    Taylor JW, Soeyland K, Ball C, Lee JC, Serpell J.
    World J Surg. 2019 Sep 24. PMID:31552459
  2. Risk factors of post-surgery complications in children with thyroid cancer.
    Babala J, Zahradníková P, Béder I, Fedorová L, Lindák M, Košťálová Ľ, Pribilincová Z, Staník J, Králik R.
    Int J Pediatr Otorhinolaryngol. 2019 Sep 10;127:109673. PMID: 31546062
  3. Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status.
    Ishihara S, Onoda N, Noda S, Asano Y, Tauchi Y, Morisaki T, Kashiwagi S, Takashima T, Ohira M.
    Int J Oncol. 2019 Sep 19. PMID: 31545405
  4. Comparison between total thyroidectomy and medical therapy for amiodarone-induced thyrotoxicosis.
    Cappellani D, Papini P, Pingitore A, Tomisti L, Mantuano M, Di Certo AM, Manetti L, Marconcini G, Scattina I, Urbani C, Morganti R, Marcocci C, Materazzi G, Iervasi G, Martino E, Bartalena L, Bogazzi F.
    J Clin Endocrinol Metab. 2019 Sep 23. PMID: 31545358
  5. Surgery alone for papillary thyroid microcarcinoma is less costly and more effective than long term active surveillance.
    Lin JF, Jonker PKC, Cunich M, Sidhu SB, Delbridge LW, Glover AR, Learoyd DL, Aniss A, Kruijff S, Sywak MS.
    Surgery. 2019 Sep 19. PMID: 31543327
  6. Should total thyroidectomies be performed by high-volume endocrine surgeons? A cost-effectiveness analysis.
    Anagnostis P, Pliakos I, Panidis S, Chorti A, Stelmach V, Michalopoulos A, Papavramidis TS.
    Endocrine. 2019 Sep 20. PMID: 31541389
  7. Characterization of Thyroid Cancer Driven by Known and Novel ALK Fusions.
    Panebianco F, Nikitski AV, Nikiforova M, Kaya C, Yip L, Condello V, Wald AI, Nikiforov YE, Chiosea SI.
    Endocr Relat Cancer. 2019 Sep 1. PMID: 31539879
  8. Selective use of Molecular Testing Based on Sonographic Features of Cytologically Indeterminate Thyroid Nodules: A Decision Analysis.
    Zanocco KA, Wang MM, Yeh MW, Livhits MJ.
    World J Surg. 2019 Sep 19. PMID: 31538250

September 19, 2019


  1. Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy.
    Buishand FO, Liu-Chittenden Y, Fan Y, Tirosh A, Gara SK, Patel D, Meerzaman D, Kebebew E.
    Surgery. 2019 Sep 12. PMID: 31522749
  2. Posterior retroperitoneoscopic approach is feasible in selected patients requiring revision adrenal surgery.
    Gartland RM, Di Marco A, Sywak M.
    ANZ J Surg. 2019 Sep;89(9):1175-1176. PMID: 31522478

GI Neuroendocrine

  1. Surgical management of Zollinger-Ellison syndrome: Classical considerations and current controversies.
    Shao QQ, Zhao BB, Dong LB, Cao HT, Wang WB.
    World J Gastroenterol. 2019 Aug 28;25(32):4673-4681. PMID: 31528093


  1. Autofluorescence imaging of parathyroid glands: An assessment of potential indications.
    Kose E, Rudin AV, Kahramangil B, Moore E, Aydin H, Donmez M, Krishnamurthy V, Siperstein A, Berber E.
    Surgery. 2019 Sep 13. PMID: 31526579


  1. Need for Completion Thyroidectomy in Patients Undergoing Lobectomy for Indeterminate and High-Risk Nodules: Impact of Intra-Operative Findings and Final Pathology.
    Moore EC, Zolin S, Krishnamurthy V, Jin J, Shin J, Berber E, Siperstein A.
    World J Surg. 2019 Sep 17. PMID: 31531727
  2. Utility of subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance category in ultrasound-guided thyroid fine-needle aspiration in a large referral cancer center.
    Gan Q, Edeiken BS, Chen MM, Grubbs EG, Busaidy NL, Zafereo M, Perrier ND, Gule-Monroe MD, Krishnamurthy S.
    J Am Soc Cytopathol. 2019 Aug 19. PMID: 31526696
  3. Clinical-pathological issues in thyroid pathology: study on the routine application of NIFTP diagnostic criteria.
    Canini V, Leni D, Pincelli AI, Scardilli M, Garancini M, Villa C, Di Bella C, Capitoli G, Cimini R, Leone BE, Pagni F.
    Sci Rep. 2019 Sep 12;9(1):13179. PMID: 31515532
  4. A stepwise analysis of the diagnostic algorithm for the prediction of malignancy in thyroid nodules.
    Huang BL, Chabot JA, Lee JA, Kuo JH.
    Surgery. 2019 Sep 9. PMID: 31515126
  5. Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma?
    Harries V, Wang LY, McGill M, Xu B, Tuttle RM, Wong RJ, Shaha AR, Shah JP, Ghossein R, Patel SG, Ganly I.
    Surgery. 2019 Sep 9. PMID: 31515125
  6. A comparative cost-utility analysis of postoperative calcium supplementation strategies used in the current management of hypocalcemia.
    Nicholson KJ, Smith KJ, McCoy KL, Carty SE, Yip L.
    Surgery. 2019 Sep 9. PMID: 31515122
  7. Early postoperative stimulated serum thyroglobulin quantifies risk of recurrence in papillary thyroid cancer.
    Jayasekara J, Jonker P, Lin JF, Engelsman AF, Wong MS, Kruijff S, Aniss A, Learoyd D, Bligh RC, Glover A, Delbridge L, Sidhu S, Sywak M.
    Surgery. 2019 Sep 9. PMID: 31515121
  8. Immunomorphological Pattern of Molecular Chaperones in Normal and Pathological Thyroid Tissues and Circulating Exosomes: Potential Use in Clinics.
    Caruso Bavisotto C, Cipolla C, Graceffa G, Barone R, Bucchieri F, Bulone D, Cabibi D, Campanella C, Marino Gammazza A, Pitruzzella A, Porcasi R, San Biagio PL, Tomasello G, Conway de Macario E, Macario AJL, Cappello F, Rappa F.
    Int J Mol Sci. 2019 Sep 11;20(18). PMID: 31514388

September 12, 2019

Pancreatic Neuroendocrine

  1. What is the appropriate management of non-functioning pancreatic neuroendocrine tumours disclosed on screening in adult patients with multiple endocrine neoplasia type 1?
    Challis BG, Casey RT, Grossman A, Newell-Price J, Newey P, Thakker RV.
    Clin Endocrinol (Oxf). 2019 Sep 10. PMID: 31505044


  1. Long-Term Outcomes of Parathyroidectomy in Hyperparathyroidism-Jaw Tumor Syndrome: Analysis of Five Families with CDC73 Mutations.
    Iacobone M, Camozzi V, Mian C, Pennelli G, Pagetta C, Casal Ide E, Masi G, Zovato S, Torresan F.
    World J Surg. 2019 Sep 6. PMID: 31493194
  2. Ultrasound combined with biochemical parameters can predict parathyroid carcinoma in patients with primary hyperparathyroidism.
    Liu R, Xia Y, Chen C, Ye T, Huang X, Ma L, Hu Y, Jiang Y.
    Endocrine. 2019 Sep 5. PMID: 31489590
  3. Preoperative Risk Index Among Patients Undergoing Thyroid or Parathyroid Surgery.
    Mascarella MA, Milad D, Richardson K, Mlynarek A, Payne RJ, Forest VI, Hier M, Sadeghi N, Mayo N.
    JAMA Otolaryngol Head Neck Surg. 2019 Sep 5. PMID: 31486838


  1. Anti-Thyroid Antibodies and TSH as Potential Markers of Thyroid Carcinoma and Aggressive Behavior in Patients with Indeterminate Fine-Needle Aspiration Cytology.
    Adhami M, Michail P, Rao A, Bhatt CR, Grodski S, Serpell JW, Lee JC.
    World J Surg. 2019 Sep 9. PMID: 31502005
  2. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
    Gou L, Zou H, Li B.
    Cancer Biol Ther. 2019 Sep 10:1-11. PMID: 31500506
  3. Thyroglobulin washout from cervical lymph node fine needle aspiration biopsies in patients with differentiated thyroid cancer: an analysis of different expressions to use in post-total thyroidectomy follow-up.
    Kahramangil B, Kose E, Donmez M, Aydin H, Reynolds JP, Krishnamurthy V, Jin J, Shin J, Siperstein A, Berber E.
    Surgery. 2019 Sep 5. PMID: 31495510
  4. Impact of fluorescence and autofluorescence on surgical strategy in benign and malignant neck endocrine diseases.
    Rudin AV, Berber E.
    Best Pract Res Clin Endocrinol Metab. 2019 Aug 10:101311. PMID: 31494052
  5. Calcium, vitamin D or recombinant parathyroid hormone for managing post-thyroidectomy hypoparathyroidism.
    Edafe O, Mech CE, Balasubramanian SP.
    Cochrane Database Syst Rev. 2019 May 22;5. PMID: 31116878
  6. Long-Term Efficacy of Lymph Node Reoperation for Persistent Papillary Thyroid Cancer: 13-Year Follow-Up.
    Onuma AE, Beal EW, Nabhan F, Hughes T, Farrar WB, Phay J, Ringel MD, Kloos RT, Shirley LA.
    Ann Surg Oncol. 2019 Jun;26(6):1737-1743. PMID: 30820785

September 5, 2019


  1. Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism-a Review.
    Holler F, Heinrich DA, Adolf C, Lechner B, Bidlingmaier M, Eisenhofer G, Williams TA, Reincke M.
    Curr Hypertens Rep. 2019 Sep 3;21(10):77. PMID: 31482378


  1. Relationship between parathyroid gland scintigraphy and its histopathology, oxyphil cell content and volume: a retrospective study.
    Kobylecka M, Koperski Ł, Chudziński W, Pihowicz P, Mączewska J, Płazińska MT, Bogdańska M, Królicki L.
    Nucl Med Rev Cent East Eur. 2019;22(1):29-33. PMID: 31482540


  1. Exploring the link between tumor metabolism and succinate dehydrogenase deficiency: a 18 F-FDOPA PET/CT study in head and neck paragangliomas.
    Reichert T, Fahkry N, Lavieille JP, Amodru V, Sebag F, Romanet P, Loundou A, Castinetti F, Pacak K, Montava M, Taïeb D.
    Clin Endocrinol (Oxf). 2019 Sep 3.


  1. An update on the management of low risk differentiated thyroid cancer.
    Lamartina L, Leboulleux S, Terroir M, Hartl D, Schlumberger M.
    Endocr Relat Cancer. 2019 Sep 1. PMID: 31484161
  2. Resection of liver metastases from differentiated thyroid cancer: who might benefit?
    A report of 2 cases with review of literature. Ligocka J, Patkowski W, Szparecki G, Ostrowski T, Wiechno W, Zieniewicz K.
    Pol Przegl Chir. 2018 Nov 15;91(4):52-56. PMID: 31481645
  3. Role of frozen section in the surgical management of indeterminate thyroid nodules.
    Najah H, Tresallet C.
    Gland Surg. 2019 Aug;8(Suppl 2):S112-S117. PMID: 31475098
  4. Validation of molecular biomarkers for preoperative diagnostics of human papillary thyroid carcinoma in fine needle aspirates.
    Sadowski SM, Petrenko V, Meyer P, Pusztaszeri M, Brulhart-Meynet MC, Heddad Masson M, Triponez F, Philippe J, Dibner C.
    Gland Surg. 2019 Aug;8(Suppl 2):S62-S76. PMID: 31475093
  5. Diagnosis and management of indeterminate thyroid nodules.
    Sadowski SM, Triponez F.
    Gland Surg. 2019 Aug;8(Suppl 2):S60-S61. PMID: 31475092
  6. Transoral robotic thyroidectomy on two human cadavers using the Intuitive da Vinci single port robotic surgical system and CO2 insufflation: Preclinical feasibility study.
    Park D, Shaear M, Chen YH, Russell JO, Kim HY, Tufano RP.
    Head Neck. 2019 Aug 30. PMID: 31469475
  7. Mts1 Up-regulation is Associated With Aggressive Pathological Features in Thyroid Cancer.
    Cheon MG, Son YW, Lee JH, Jang HH, Chung YS.
    Cancer Genomics Proteomics. 2019 Sep-Oct;16(5):369-376. PMID: 31467231
  8. Analysis of activity uptake, effective half-life and time-integrated activity for low- and high-risk papillary thyroid cancer patients treated with 1.11 GBq and 3.7 GBq of 131I-NaI respectively.
    Mínguez P, Rodeño E, Genollá J, Domínguez M, Expósito A, Sjögreen Gleisner K.
    Phys Med. 2019 Aug 28;65:143-149. PMID: 31473501

August 29, 2019


  1. Four decades of the American Association of Endocrine Surgeons (AAES): Past, present, and future.
    Chen HA, Krishnamurthy VD, Siperstein A, Carty S, Chen H.
    Surgery. 2019 Aug 23. PMID: 31451295


  1. Adrenal venous sampling in patients with ACTH-independent hypercortisolism.
    Papakokkinou E, Jakobsson H, Sakinis A, Muth A, Wängberg B, Ehn O, Johannsson G, Ragnarsson O.
    Endocrine. 2019 Aug 22. PMID: 31440949


  1. Updates on the Role of Molecular Alterations and NOTCH Signalling in the Development of Neuroendocrine Neoplasms.
    von Arx C, Capozzi M, López-Jiménez E, Ottaiano A, Tatangelo F, Di Mauro A, Nasti G, Tornesello ML, Tafuto S.
    J Clin Med. 2019 Aug 22;8(9). PMID: 31443481

Pancreatic Neuroendocrine​

  1. A rational approach to postoperative surveillance for resected non-functional pancreatic neuro-endocrine tumours.
    Feretis M, Wang T, Ghorani E, Balakrishnan A, Harper SJ, Jah A, Huguet EL, Praseedom RK, Liau SS.
    Pancreatology. 2019 Aug 16. PMID: 31445889


  1. Continuous intraoperative neuromonitoring for thyroid cancer surgery: A prospective study.
    Onoda N, Noda S, Tauchi Y, Asano Y, Kusunoki Y, Ishihara S, Morisaki T, Kashiwagi S, Takashima T, Ohira M.
    Laryngoscope Investig Otolaryngol. 2019 Jul 18;4(4):455-459. PMID: 31453357
  2. Original tumour suppressor gene polycystic kidney and hepatic disease 1-like 1 is associated with thyroid cancer cell progression.
    Zheng C, Quan R, Xia EJ, Bhandari A, Zhang X.
    Oncol Lett. 2019 Sep;18(3):3227-3235. PMID: 31452800
  3. High Rates of Underlying Thyroid Cancer in Patients Undergoing Thyroidectomy for Hyperthyroidism.
    Alvarez AL, Mulder M, Handelsman RS, Lew JI, Farra JC.
    J Surg Res. 2019 Aug 23;245:523-528. PMID: 31450040
  4. Active Surveillance versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-risk Papillary Thyroid Microcarcinoma in Japan.
    Sugitani I, Ito Y, Miyauchi A, Imai T, Suzuki S.
    Thyroid. 2019 Aug 23. PMID: 31441377
  5. Immune cell infiltrate-associated dysregulation of DNA repair machinery may predispose to papillary thyroid carcinogenesis.
    Nicolson NG, Brown TC, Korah R, Carling T.
    Surgery. 2019 Aug 19. PMID: 31439400
  6. Active Surveillance of Low-Risk Thyroid Cancer.
    Zanocco KA, Hershman JM, Leung AM.
    JAMA. 2019 May 28;321(20):2020-2021. PMID: 31038662

August 22, 2019


  1. Outcomes of surgery for benign and malignant adrenal disease from the British Association of Endocrine and Thyroid Surgeons' national registry.
    Patel N, Egan RJ, Carter BR, Scott-Coombes DM, Stechman MJ; British Association of Endocrine and Thyroid Surgeons.
    Br J Surg. 2019 Aug 19. PMID: 31424578

GI Neuroendocrine​

  1. Chemotherapy in resected neuroendocrine carcinomas of the digestive tract: a national study from the French Group of Endocrine Tumours (GTE).
    Pellat A, Walter T, Augustin J, Hautefeuille V, Hentic O, Do Cao C, Lièvre A, Coriat R, Hammel P, Dubreuil O, Cohen R, Couvelard A, André T, Svrcek M, Baudin E, Afchain P.
    Neuroendocrinology. 2019 Aug 21. PMID: 31430756

Pancreatic Neuroendocrine​

  1. Avoiding Pitfalls in Insulinomas by Preoperative Localization with a Dual Imaging Approach.
    Ramonell KM, Saunders ND, Sarmiento J, Bercu Z, Martin L, Weber CJ, Sharma J, Patel SG.
    Am Surg. 2019 Jul 1;85(7):742-746. PMID: 31405420


    Foley CS, Moore EC, Milas M, Berber E, Shin J, Siperstein AE.
    Endocr Pract. 2019 Aug 15. PMID: 31414903


  1. ANKRD26-RET - A novel gene fusion involving RET in papillary thyroid carcinoma.
    Staubitz JI, Musholt TJ, Schad A, Springer E, Lang H, Rajalingam K, Roth W, Hartmann N.
    Cancer Genet. 2019 Jul 5;238:10-17. PMID: 3142592
  2. Metabolic reprogramming and its clinical application in thyroid cancer.
    Wen SS, Zhang TT, Xue DX, Wu WL, Wang YL, Wang Y, Ji QH, Zhu YX, Qu N, Shi RL.
    Oncol Lett. 2019 Aug;18(2):1579-1584. PMID: 31423225
  3. Chronic Lymphocytic Thyroiditis May Lower Accuracy of AUS/FLUS Cytopathology in Surgical Patients.
    Mulder MB, Khazeni KC, Sussman MS, Lew JI, Farrá JC.
    J Surg Res. 2019 Aug 14;245:244-248. PMID: 31421369
  4. Increased Incidental Thyroid Cancer in Patients With Subclinical Chronic Lymphocytic Thyroiditis.
    Jackson D, Handelsman RS, Farrá JC, Lew JI.
    J Surg Res. 2019 Aug 12;245:115-118. PMID: 31415932
  5. Factors Associated with Diagnosis and Treatment of Thyroid Microcarcinomas.
    Esfandiari NH, Hughes DT, Reyes-Gastelum D, Ward KC, Hamilton AS, Haymart MR.
    J Clin Endocrinol Metab. 2019 Aug 15. PMID: 31415089
  6. Patterns of Lymph Node Metastasis in Differentiated Thyroid Cancer; Clinical Implications with Particular Emphasis on the Emerging Role of Compartment-Oriented Lymph Node Dissection.
    Sakorafas GH, Koureas A, Mpampali I, Balalis D, Nasikas D, Ganztzoulas S.
    Oncol Res Treat. 2019;42(3):143-147. PMID: 30799429
  7. Recurrent laryngeal nerve paralysis after thyroid cancer surgery and intraoperative nerve monitoring.
    Mizuno K, Takeuchi M, Kanazawa Y, Kitamura M, Ide K, Omori K, Kawakami K.
    Laryngoscope. 2019 Aug;129(8):1954-1960. PMID: 30582628

August 15, 2019

GI Neuroendocrine​

  1. Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG).
    van Beek DJ, Nell S, Pieterman CRC, de Herder WW, van de Ven AC, Dekkers OM, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Borel Rinkes IHM, Vriens MR, Valk GD.
    J Surg Oncol. 2019 Aug 10. PMID: 31401809
  2. Proteomics identifies neddylation as a potential therapy target in small intestinal neuroendocrine tumors.
    Fotouhi O, Kjellin H, Juhlin CC, Pan Y, Vesterlund M, Ghaderi M, Yousef A, Andersson-Sand H, Kharaziha P, Caramuta S, Kjellman M, Zedenius J, Larsson C, Orre LM.
    Oncogene. 2019 Aug 12. PMID: 31406256


  1. Comparison of Pre- and Post-transplant Parathyroidectomy in Renal Transplant Recipients and the Impact of Parathyroidectomy Timing on Calcium Metabolism and Renal Allograft Function: A Retrospective Single-Center Analysis.
    Okada M, Hiramitsu T, Ichimori T, Goto N, Narumi S, Watarai Y, Sato T, Tominaga Y.
    World J Surg. 2019 Aug 9. PMID: 31399797


  1. Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome.
    Y-Hassan S, Falhammar H.
    Endocrine. 2019 Aug 9. PMID: 31399912
  2. Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing Adrenalectomy.
    Neumann HPH, Tsoy U, Bancos I, Amodru V, Walz MK, et. al. International Bilateral-Pheochromocytoma-Registry Group.
    JAMA Netw Open. 2019 Aug 2;2(8). PMID: 31397861
  3. Surgical approaches and results of treatment for hereditary paragangliomas.
    Iacobone M, Belluzzi A, Torresan F.
    Best Pract Res Clin Endocrinol Metab. 2019 Jul 27:101298. PMID: 31401056


  1. Assessing American Thyroid Association Guidelines for Total Thyroidectomy in Graves' Disease.
    Akram S, Elfenbein DM, Chen H, Schneider DF, Sippel RS.
    J Surg Res. 2019 Aug 8;245:64-71. PMID: 31401249
  2. Molecular Testing Versus Diagnostic Lobectomy in Bethesda III/IV Thyroid Nodules: A Cost-Effectiveness Analysis.
    Nicholson K, Roberts MS, McCoy KL, Carty SE, Yip L.
    Thyroid. 2019 Aug 13. PMID: 31407625
  3. Characterization of activating mutations of the MEK1 gene in papillary thyroid carcinomas.
    Borrelli N, Panebianco F, Condello V, Barletta JA, Kaya C, Yip L, Nikiforova MN, Nikiforov YE.
    Thyroid. 2019 Aug 13. PMID: 31407636
  4. Outcomes After Urgent Thyroidectomy Following Rapid Control of Thyrotoxicosis in Graves' Disease are Similar to Those After Elective Surgery in Well-Controlled Disease.
    Ali A, Debono M, Balasubramanian SP.
    World J Surg. 2019 Aug 12. PMID: 31407090
  5. Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma.
    Wong KS, Lorch J, Alexander EK, Marqusee E, Cho NL, Nehs MA, Doherty GM, Barletta J.
    Thyroid. 2019 Aug 9. PMID: 31397224

August 8, 2019


  1. Presentation, Treatment, Histology, and Outcomes in Adrenal Medullary Hyperplasia Compared With Pheochromocytoma. 
    Falhammar H, Stenman A, Calissendorff J, Juhlin CC. 
    J Endocr Soc. 2019 Jun 11;3(8):1518-1530. PMID: 31384714

Pancreatic Neuroendocrine​

  1. One-Year Postoperative Mortality in MEN1 Patients Operated on Gastric and Duodenopancreatic Neuroendocrine Tumors: An AFCE and GTE Cohort Study. 
    Christou N, Mathonnet M, Gaujoux S, Cadiot G, Deguelte S, Kraimps JL, Lifante JC, Menegaux F, Mirallié E, Muscari F, Carnaille B, Pattou F, Sauvanet A, Goudet P. 
    World J Surg. 2019 Aug 5. PMID: 31384998


  1. Intraoperative Autofluorescence Parathyroid Identification in Patients With Multiple Endocrine Neoplasia Type 1. 
    Squires MH, Shirley LA, Shen C, Jarvis R, Phay JE. 
    JAMA Otolaryngol Head Neck Surg. 2019 Aug 1. PMID: 31369053


  1. A New Imaging Technique for the Diagnosis of Thyroid Cancer: Thyroidography.
    Aysan E, Aydin O, Ercivan M, Aksoy D, Yavuz AE. 
    J Invest Surg. 2019 Aug 7:1-6. PMID: 31387418
  2. Case report: lenvatinib in neoadjuvant setting in a patient affected by invasive poorly differentiated thyroid carcinoma. 
    Gay S, Monti E, Trambaiolo Antonelli C, Mora M, Spina B, Ansaldo G, Teliti M, Comina M, Conte L, Minuto M, Varaldo E, Zupo S, Massa B, Morbelli S, Giusti M. 
    Future Oncol. 2019 Aug 6. PMID: 31385546
  3. Children are at a High Risk of Hypocalcaemia and Hypoparathyroidism after Total Thyroidectomy. 
    de Jong M, Nounou H, Rozalén García V, Christakis I, Brain C, Abdel-Aziz TE, Hewitt RJ, Kurzawinski TR. 
    J Pediatr Surg. 2019 Jul 19. PMID: 31383578 
  4. Tailored approach for recurrent laryngeal nerve dissection according to different endoscopic endocrine surgery. 
    Miccoli P, Dionigi G. 
    Head Neck. 2019 Aug 5. PMID: 31381202 
  5. Recurrent Papillary Thyroid Carcinoma to the Cervical Lymph Nodes: Outcomes of Compartment-Oriented Lymph Node Resection. 
    Rivera-Robledo CG, Velázquez-Fernández D, Pantoja JP, Sierra M, Pérez-Enriquez B, Rivera-Moscoso R, Chapa M, Herrera MF. 
    World J Surg. 2019 Aug 1. PMID: 31372725 
  6. Recurrent Laryngeal Nerve Morbidity: Lessons from Endoscopic via Bilateral Areola and Open Thyroidectomy Technique. 
    Zhang D, Zhang J, Dionigi G, Li F, Wang T, Li H, Liang N, Sun H. 
    World J Surg. 2019 Jul 31. PMID: 31367782 
  7. A Population-Based Study on NIFTP Incidence and Survival: Is NIFTP Really a "Benign" Disease? 
    Eskander A, Hall SF, Manduch M, Griffiths R, Irish JC. 
    Ann Surg Oncol. 2019 May;26(5):1376-1384. PMID: 30690683 

August 1, 2019


  1. National Treatment Practice for Adrenocortical Carcinoma: Have they changed and have we made any progress?
    Tierney JF, Chivukula SV, Poirier J, Pappas SG, Schadde E, Hertl M, Kebebew E, Keutgen X. 
    J Clin Endocrinol Metab. 2019 Jul 30. PMID: 31361313
  2. Identification of Seven Aberrantly Methylated and Expressed Genes in Adrenocortical Carcinoma.
    Xiao H, He W, Chen P, Xu D, Zeng G, Li Z, Huang M, Wang X, DiSanto ME, Zhang X. 
    Front Endocrinol (Lausanne). 2019 Jul 12;10:472. PMID: 31354635

Endocrine Surgery

  1. Narcotic Free Cervical Endocrine Surgery: A Shift in Paradigm. 
    Ruffolo LI, Jackson KM, Juviler P, Kaur R, Chennell T, Glover DM, Linehan DC, Moalem J. 
    Ann Surg. 2019 Jul 6. PMID: 31356280

Pancreatic Neuroendocrine​

  1. Pre- and intraoperative diagnostic requirements, benefits and risks of minimally invasive and robotic surgery for neuroendocrine tumors of the pancreas. 
    Gharios J, Hain E, Dohan A, Prat F, Terris B, Bertherat J, Coriat R, Dousset B, Gaujoux S. 
    Best Pract Res Clin Endocrinol Metab. 2019 Jul 10:101294. PMID: 31351817
  2. Reappraisal of a 2-Cm Cut-Off Size for the Management of Cystic Pancreatic Neuroendocrine Neoplasms: A Multicenter International Study. 
    Maggino L, Schmidt A, Käding A, Westermark S, Ceppa EP, Falconi M, Javed AA, Landoni L, Pergolini I, Perinel J, Vollmer CM Jr, Sund M, Gaujoux S; on the behalf on the Pancreas 2000 research group. 
    Ann Surg. 2019 Jul 24. PMID: 31348038


  1. Is There an Optimal Time for Parathyroidectomy in Patients with Secondary Hyperparathyroidism? 
    Wang TS. 
    World J Surg. 2019 Aug;43(8):1989-1990. PMID: 31201495


  1. Pheochromocytomas and Paragangliomas: New Developments with Regard to Classification, Genetics, and Cell of Origin. 
    Koopman K, Gaal J, de Krijger RR. 
    Cancers (Basel). 2019 Jul 29;11(8). PMID: 31362359


  1. Increased prevalence of neural monitoring during thyroidectomy: Global surgical survey. 
    Feng AL, Puram SV, Singer MC, Modi R, Kamani D, Randolph GW. 
    Laryngoscope. 2019 Jul 30. PMID: 31361342
  2. Association between Thyroid-Stimulating Hormone Level after Total Thyroidectomy and Hypercholesterolemia in Female Patients with Differentiated Thyroid Cancer: A Retrospective Study. 
    Lee YK, Lee H, Han S, Jung H, Shin DY, Nam KH, Chung WY, Lee EJ. 
    J Clin Med. 2019 Jul 25;8(8). PMID: 31349714
  3. Completion thyroidectomy: A risky undertaking? 
    Nicholson KJ, Teng CY, McCoy KL, Carty SE, Yip L.
    Am J Surg. 2019 Jul 18. PMID: 31345503
  4. Risk factors for neck hematoma requiring surgical re-intervention after thyroidectomy: a systematic review and meta-analysis. 
    Fan C, Zhou X, Su G, Zhou Y, Su J, Luo M, Li H. 
    BMC Surg. 2019 Jul 24;19(1):98. PMID: 31340806

July 25, 2019


  1. Volume-outcome relationship in adrenal surgery: A review of existing literature.
    Kazaure HS, Sosa JA.
    Best Pract Res Clin Endocrinol Metab. 2019 Jul 12:101296. PMID: 31331729
  2. Adrenalectomy impairs vasoactive intestinal peptide-induced changes in food intake and plasma parameters.
    Garnica-Siqueira MC, Martins AB, Dos Stopa LR, de Souza CF, Zaia DAM, Leite CM, Zaia CTBV, Uchôa ET.
    Endocrine. 2019 Jul 19. PMID: 31325084

Endocrine Surgery

  1. What Does the Average Person Know About Endocrine and Vascular Surgeons?
    Aune A, Fazendin JM, Asban A, Mallick R, Chen H, Lindeman B.
    J Surg Res. 2019 Jul 16;244:348-351. PMID: 31323389


  1. Surgical treatment in patients with single and multiple gland primary hyperparathyroidism with the use of intraoperative parathyroid hormone monitoring: extensive single-center experience.
    Christoforides C, Vamvakidis K, Miliaras S, Tsoulfas G, Misichronis G, Goulis DG.
    Hormones (Athens). 2019 Jul 22. PMID: 31332766
  2. Near-infrared imaging in re-operative parathyroid surgery: first description of autofluorescence from cryopreserved parathyroid glands.
    Moore EC, Rudin A, Alameh A, Berber E.
    Gland Surg. 2019 Jun;8(3):283-286. PMID: 31328107
  3. Primary hyperparathyroidism with surgical indication and negative or equivocal scintigraphy: safety and reliability of PTH washout. A systematic review and meta-analysis.
    Castellana M, Virili C, Palermo A, Giorgino F, Giovanella L, Trimboli P.
    Eur J Endocrinol. 2019 Sep 1;181(3):245-253. PMID: 31311003


  1. Routine Pre-operative Laryngoscopy for Thyroid Surgery is not Necessary Without Risk Factors.
    Maher DI, Goare S, Forrest E, Grodski S, Serpell JW, Lee JC.
    Thyroid. 2019 Jul 23. PMID: 31333068
  2. Long-term quality of voice is usually acceptable after initial hoarseness caused by a thyroidectomy or a parathyroidectomy.
    Christakis I, Klang P, Talat N, Galata G, Schulte KM.
    Gland Surg. 2019 Jun;8(3):226-236. PMID: 31328101
  3. Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study.
    Premoli P, Tanda ML, Piantanida E, Veronesi G, Gallo D, Masiello E, Rosetti S, Cusini C, Boi F, Bulla J, Rodia R, Mariotti S, Capelli V, Rotondi M, Magri F, Chiovato L, Rocchi R, Campopiano MC, Elisei R, Vitti P, Barbato F, Pilli T, Castagna MG, Pacini F, Bartalena L.
    J Endocrinol Invest. 2019 Jul 20. PMID: 31327128
  4. Complete surgical resection following neoadjuvant dabrafenib plus trametinib in BRAFV600E-mutated anaplastic thyroid carcinoma.
    Wang JR, Zafereo M, Dadu R, Ferrarotto R, Busaidy N, Lu C, Ahmed S, Gule-Monroe M, Williams MD, Sturgis E, Goepfert RP, Gross ND, Lai SY, Gunn B, Phan J, Rosenthal DI, Fuller C, Morrison WH, Iyer PC, Cabanillas M.
    Thyroid. 2019 Jul 18. PMID: 31319771
  5. Molecular Testing for Indeterminate Thyroid Nodules-When the Rubber Meets the Road.
    Marti JL, Shaha AR.
    JAMA Otolaryngol Head Neck Surg. 2019 Jul 18. PMID: 31318432
  6. Assessment of Voice Outcomes Following Surgery for Thyroid Cancer.
    Kovatch KJ, Reyes-Gastelum D, Hughes DT, Hamilton AS, Ward KC, Haymart MR.
    JAMA Otolaryngol Head Neck Surg. 2019 Jul 18. PMID: 31318375

July 18, 2019


  1. Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma.
    Assié G, Jouinot A, Fassnacht M, Libé R, Garinet S, Jacob L, Hamzaoui N, Neou M, Sakat J, de La Villéon B, Perlemoine K, Ragazzon B, Sibony M, Tissier F, Gaujoux S, Dousset B, Sbiera S, Ronchi CL, Kroiss M, Korpershoek E, De Krijger R, Waldmann J, Quinkler M, Haissaguerre M, Tabarin A, Chabre O, Luconi M, Mannelli M, Groussin L, Bertagna X, Baudin E, Amar L, Coste J, Beuschlein F, Bertherat J.
    JAMA Oncol. 2019 Jul 11. PMID: 31294750

Pancreatic Neuroendocrine

  1. Early detection of cognitive impairment in patients with insulinoma.
    Dai H, Chen H, Hong X, Han X, Xu Q, Pang H, Yuan J, Wang X, Xu P, Jiang J, Jiang R, Zhuang Z, Zhao Y, Wu W.
    Endocrine. 2019 Jul 10. PMID: 31292840
  2. 68Ga-exendin-4 PET/CT detects insulinomas in patients with endogenous hyperinsulinemic hypoglycemia in MEN-1.
    Antwi K, Nicolas G, Fani M, Heye T, Pattou F, Grossman A, Chanson P, Reubi JC, Aurrel P, Gloor B, Vogt DR, Wild D, Christ E.
    J Clin Endocrinol Metab. 2019 Jul 12. PMID: 31298706


  1. Long-term outcomes and management considerations after parathyroidectomy in the dialysis patient.
    Kakani E, Sloan D, Sawaya BP, El-Husseini A, Malluche HH, Rao M.
    Semin Dial. 2019 Jul 16. PMID: 31313380
  2. Genetic profiling as a clinical tool in advanced parathyroid carcinoma.
    Kutahyalioglu M, Nguyen HT, Kwatampora L, Clarke C, Silva A, Ibrahim E, Waguespack SG, Cabanillas ME, Jimenez C, Hu MI, Sherman SI, Kopetz S, Broaddus R, Dadu R, Wanland K, Williams M, Zafereo M, Perrier N, Busaidy NL.
    J Cancer Res Clin Oncol. 2019 Jul 15. PMID: 31309300


  1. Prognosis of patients with differentiated thyroid carcinomas having a preoperative cytological report of indeterminate at low or high risk. A multicenter study.
    Trimboli P, Palermo A, Deandrea M, Piccardo A, Campennì A, Valabrega S, Grani G, Santolamazza G, Bottoni G, Barnabei A, Ramundo V, Lauretta R, Monte L, Ferrarazzo G, Paone G, Crosetto C, Ruggeri RM, Baldari S, Chiefari A, Vottari S, Giarnieri E, Perrella E, Limone P, Durante C, Giovanella L, Appetecchia M, Crescenzi A.
    Endocrine. 2019 Jul 16. PMID: 31313225
  2. Baicalein induced apoptosis and autophagy of undifferentiated thyroid cancer cells by the ERK/PI3K/Akt pathway.
    Wang M, Qiu S, Qin J.
    Am J Transl Res. 2019 Jun 15;11(6):3341-3352. PMID: 31312348
  3. Predicting factors of lateral neck lymph node metastases in patients with papillary thyroid microcarcinoma.
    Wu X, Li B, Zheng C, He X.
    Medicine (Baltimore). 2019 Jul;98(27):e16386.  PMID: 31277195
  4. Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis.
    Guo F, Fu Q, Wang Y, Sui G.
    J Cell Mol Med. 2019 Jul 14. PMID: 31304680
  5. Quality of Voice and Prognostic Markers for the Recovery of Vocal Fold Paralysis After Thyroid Surgery.
    Reiter R, Heyduck A, Hoffmann TK, Brosch S, Buchberger MA, Schorer K, Weber T, Pickhard A.
    Ann Otol Rhinol Laryngol. 2019 Jul 11. PMID: 31296025

July 11, 2019


  1. Robotic-assisted adrenalectomy using da Vinci Xi vs. Si: are there differences?
    Feng Z, Feng MP, Feng DP, Solórzano CC.
    J Robot Surg. 2019 Jul 4. PMID: 31273609
  2. Validation of the Aldosteronoma Resolution Score Within Current Clinical Practice.
    Vorselaars WMCM, van Beek DJ, Postma EL, Spiering W, Borel Rinkes IHM, Valk GD, Vriens MR; International CONNsortium Study Group.
    World J Surg. 2019 Jul 3. PMID: 31270571

Pancreatic Neuroendocrine

  1. Pancreatic neuroendocrine microadenomatosis presenting as a functional VIPoma.
    Krainev AA, Mathavan VK, Klink DF, Saxe JM, Ong GKB, Murphy JK.
    J Surg Case Rep. 2019 Jun 28;2019(6). PMID: 31275551


  1. Volume-outcome relationship in parathyroid surgery.
    Erinjeri NJ, Udelsman R.
    Best Pract Res Clin Endocrinol Metab. 2019 Jun 15:101287. PMID: 31285151
  2. Intraoperative parathyroid hormone monitoring in parathyroidectomy for tertiary hyperparathyroidism.
    Ermer JP, Kelz RR, Fraker DL, Wachtel H.
    J Surg Res. 2019 Jul 4;244:77-83. PMID: 31279997
  3. Parathyroid Glands Hyperplasias Mimicking Medullary Thyroid Carcinoma Metastatic Lymph Nodes on 18F-DOPA PET/CT.
    Terroir M, Grimaldi S, Hartl D, Leboulleux S, Deandreis D.
    Clin Nucl Med. 2019 Aug;44(8):e497-e498. PMID: 31274634


  1. Hemithyroidectomy for benign euthyroid asymmetric nodular goitre.
    Barczyński M, Stopa-Barczyńska M.
    Best Pract Res Clin Endocrinol Metab. 2019 Jun 14:101288. PMID: 31281088
  2. Inverse Relationship of BMI to TSH and Risk of Papillary Thyroid Cancer in Surgical Patients.
    Handelsman RS, Alvarez AL, Picado O, Farrá JC, Lew JI.
    J Surg Res. 2019 Jul 4;244:96-101. PMID: 31280000
  3. Variation in the Quality of Thyroid Nodule Evaluations Before Surgical Referral.
    Jiang L, Lee CY, Sloan DA, Randle RW.
    J Surg Res. 2019 Jul 3;244:9-14. PMID: 31279266
  4. Performance of the American Thyroid Association Risk Classification in a Single Center Cohort of Pediatric Patients with Differentiated Thyroid Cancer: A Retrospective Study.
    Alwithenani R, DeBrabandere S, Rachinsky I, MacNeil SD, Badreddine M, Van Uum S.
    J Thyroid Res. 2019 Jun 2;2019:5390316. PMID: 31275541
  5. Medullary thyroid carcinoma treated with percutaneous ultrasound-guided radiofrequency ablation.
    Biamonte E, Solbiati L, Ierace T, Colombo P, Lavezzi E, Mazziotti G, Lania A.
    Endocrine. 2019 Jul 4. PMID: 31273680

July 5, 2019

Gastric Neuroendocrine:

  1. Recurrence and Metastatic Potential in Type 1 Gastric Neuroendocrine Neoplasms.
    Daskalakis K, Tsoli M, Karapanagioti A, Chrysochoou M, Thomas D, Sougioultzis S, Karoumpalis I, Kaltsas GA, Alexandraki KI.
    Clin Endocrinol (Oxf). 2019 Jun 29. PMID: 31254407


  1. Utility of surgeon-performed pre-operative ultrasound in the localisation of parathyroid adenomas.
    Thomas PR, Beggs AD, Han TS.
    JRSM Cardiovasc Dis. 2019 Jun 19. PMID: 31258895
  2. Programmed death ligand 1 (PD-L1) expression in parathyroid tumors.
    Pan B, Wang A, Pang J, Zhang Y, Cui M, Sun J, Liang Z.
    Endocr Connect. 2019 Jul 1;8(7):887-897. PMID: 31252398

Pancreatic Neuroendocrine:

  1. Diagnostic and Management Challenges in Vasoactive Intestinal Peptide Secreting Tumors: A Series of 15 Patients.
    Angelousi A, Koffas A, Grozinsky-Glasberg S, Gertner J, Kassi E, Alexandraki K, Caplin ME, Kaltsas G, Toumpanakis C.
    Pancreas. 2019 Jan 1. PMID: 31268974
  2. Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors.
    Cejas P, Drier Y, Dreijerink KMA, Brosens LAA, Deshpande V, Epstein CB, Conemans EB, Morsink FHM, Graham MK, Valk GD, Vriens MR, Castillo CF, Ferrone CR, Adar T, Bowden M, Whitton HJ, Da Silva A, Font-Tello A, Long HW, Gaskell E, Shoresh N, Heaphy CM, Sicinska E, Kulke MH, Chung DC, Bernstein BE, Shivdasani RA.
    Nat Med. 2019 Jul 1. PMID: 31263286


  1. Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATE.
    Vyakaranam AR, Crona J, Norlén O, Granberg D, Garske-Román U, Sandström M, Fröss-Baron K, Thiis-Evensen E, Hellman P, Sundin A.
    Cancers (Basel). 2019 Jun 28;11(7). PMID: 31261748
  2. Conversion During Laparoscopic Adrenalectomy for Pheochromocytoma: A Cohort Study in 244 Patients.
    Schweitzer ML, Nguyen-Thi PL, Mirallie E, Vriens M, Raffaelli M, Klein M, Zarnegar R, Brunaud L.
    J Surg Res. 2019 Jun 26;243:309-315. PMID: 31254904


  1. Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis.
    Back K, Kim JS, Kim JH, Choe JH.
    Ann Surg Oncol. 2019 Jul 1. PMID: 31264121
  2. The Role of Calcitonin in Predicting the Extent of Surgery in Medullary Thyroid Carcinoma: A Nationwide Population-Based Study in Norway.
    Opsahl EM, Akslen LA, Schlichting E, Aas T, Brauckhoff K, Hagen AI, Rosenlund AF, Sigstad E, Grøholt KK, Jørgensen LH, Bjøro T.
    Eur Thyroid J. 2019 Jun;8(3):159-166. PMID: 31259158
  3. Effect of surgeons' annual operative volume on the risk of permanent Hypoparathyroidism, recurrent laryngeal nerve palsy and Haematoma following thyroidectomy: analysis of United Kingdom registry of endocrine and thyroid surgery (UKRETS).
    Aspinall S, Oweis D, Chadwick D.
    Langenbecks Arch Surg. 2019 Jun 28. PMID: 31254103

June 27, 2019

  1. Retrospective application of the pathologic tumor-node-metastasis classification system for pheochromocytoma and abdominal paraganglioma in a well characterized cohort with long-term follow-up.
    Stenman A, Zedenius J, Juhlin CC.
    Surgery. 2019 Jun 22. PMID: 31239074
  2. Second primary tumors in patients with a head and neck paraganglioma.
    Contrera KJ, Yong V, Reddy CA, Berber E, Lorenz RR.
    Head Neck. 2019 Jun 25. PMID: 31240818
  3. Correlation between iPTH Levels on the First Postoperative Day After Total Thyroidectomy and Permanent Hypoparathyroidism: Our Experience.
    Canu GL, Medas F, Longheu A, Boi F, Docimo G, Erdas E, Calò PG.
    Open Med (Wars). 2019 Jun 7;14:437-442. PMID: 31231683
  4. Surgical management of the compromised recurrent laryngeal nerve in thyroid cancer.
    Russell MD, Kamani D, Randolph GW.
    Best Pract Res Clin Endocrinol Metab. 2019 Jun 4. PMID: 31230919
  5. Can Met-PET/CT Predict Sporadic Multiglandular Hyperparathyroidism? Report of a Case and Review of the Literature.
    Hillenbrand A, Lemke J, Henne-Bruns D, Beer AJ, Prasad V.
    Case Rep Endocrinol. 2019 May 15;2019:1791740. PMID: 31223506
  6. Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical Carcinoma.
    Gharzai LA, Green MD, Griffith KA, Else T, Mayo CS, Hesseltine E, Spratt DE, Ben-Josef E, Sabolch A, Miller BS, Worden F, Giordano TJ, Hammer GD, Jolly S.
    J Clin Endocrinol Metab. 2019 Apr 10. PMID: 31220287
  7. Intraoperative nerve monitoring during thyroidectomy: evaluation of signal loss, prognostic value and surgical strategy.
    Gür EO, Haciyanli M, Karaisli S, Haciyanli S, Kamer E, Acar T, Kumkumoglu Y. Ann R Coll
    Surg Engl. 2019 Jun 20:1-10. PMID: 31219340
  8. Stimulating and dissecting instrument for transoral endoscopic thyroidectomy: proof of concept investigation.
    Zhang D, Li S, Dionigi G, Zhang J, Wang T, Zhao Y, Xue G, Sun H.
    Surg Endosc. 2019 Jun 19. PMID: 31218426
  9. Surgical Treatment of Hyperparathyroidism After Kidney Transplant.
    Kovács DÁ, Fedor R, Asztalos L, Andrási M, Szabó RP, Kanyári Z, Barna S, Nemes B, Győry F.
    Transplant Proc. 2019 May;51(4):1244-1247. PMID: 31101206
  10. Case report of a neuroendocrine tumor of the thyroid gland with limited calcitonin expression: a diagnostic challenge.
    Sukpanich R, Khanafshar E, Suh I, Gosnell J.
    AME Case Rep. 2019 May 14;3:12. PMID: 31231713

June 27, 2019


  1. Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical Carcinoma.
    Gharzai LA, Green MD, Griffith KA, Else T, Mayo CS, Hesseltine E, Spratt DE, Ben-Josef E, Sabolch A, Miller BS, Worden F, Giordano TJ, Hammer GD, Jolly S.
    J Clin Endocrinol Metab. 2019 Apr 10. PMID: 31220287


  1. Correlation between iPTH Levels on the First Postoperative Day After Total Thyroidectomy and Permanent Hypoparathyroidism: Our Experience.
    Canu GL, Medas F, Longheu A, Boi F, Docimo G, Erdas E, Calò PG.
    Open Med (Wars). 2019 Jun 7;14:437-442. PMID: 31231683
  2. Can Met-PET/CT Predict Sporadic Multiglandular Hyperparathyroidism? Report of a Case and Review of the Literature.
    Hillenbrand A, Lemke J, Henne-Bruns D, Beer AJ, Prasad V.
    Case Rep Endocrinol. 2019 May 15;2019:1791740. PMID: 31223506
  3. Surgical Treatment of Hyperparathyroidism After Kidney Transplant.
    Kovács DÁ, Fedor R, Asztalos L, Andrási M, Szabó RP, Kanyári Z, Barna S, Nemes B, Győry F.
    Transplant Proc. 2019 May;51(4):1244-1247. PMID: 31101206


  1. Retrospective application of the pathologic tumor-node-metastasis classification system for pheochromocytoma and abdominal paraganglioma in a well characterized cohort with long-term follow-up.
    Stenman A, Zedenius J, Juhlin CC.
    Surgery. 2019 Jun 22. PMID: 31239074
  2. Second primary tumors in patients with a head and neck paraganglioma.
    Contrera KJ, Yong V, Reddy CA, Berber E, Lorenz RR.
    Head Neck. 2019 Jun 25. PMID: 31240818


  1. Surgical management of the compromised recurrent laryngeal nerve in thyroid cancer.
    Russell MD, Kamani D, Randolph GW.
    Best Pract Res Clin Endocrinol Metab. 2019 Jun 4. PMID: 31230919
  2. Intraoperative nerve monitoring during thyroidectomy: evaluation of signal loss, prognostic value and surgical strategy.
    Gür EO, Haciyanli M, Karaisli S, Haciyanli S, Kamer E, Acar T, Kumkumoglu Y.
    Ann R Coll Surg Engl. 2019 Jun 20:1-10. PMID: 31219340
  3. Stimulating and dissecting instrument for transoral endoscopic thyroidectomy: proof of concept investigation.
    Zhang D, Li S, Dionigi G, Zhang J, Wang T, Zhao Y, Xue G, Sun H.
    Surg Endosc. 2019 Jun 19. PMID: 31218426
  4. Case report of a neuroendocrine tumor of the thyroid gland with limited calcitonin expression: a diagnostic challenge.
    Sukpanich R, Khanafshar E, Suh I, Gosnell J.
    AME Case Rep. 2019 May 14;3:12. PMID: 31231713

June 20, 2019


  1. Efficacy of indocyanine green fluorescence in predicting parathyroid vascularization during thyroid surgery.
    Razavi AC, Ibraheem K, Haddad A, Saparova L, Shalaby H, Abdelgawad M, Kandil E.
    Head Neck. 2019 Jun 17. PMID: 31206817
  2. Risk-oriented concept of treatment for intrathyroid papillary thyroid cancer.
    Hartl DM, Hadoux J, Guerlain J, Breuskin I, Haroun F, Bidault S, Leboulleux S, Lamartina L.
    Best Pract Res Clin Endocrinol Metab. 2019 Jun 4. PMID: 31208873
  3. Thyroid core needle biopsy: patients' pain and satisfaction compared to fine needle aspiration.
    Jin Kim H, Koon Kim Y, Hoon Moon J, Young Choi J, Il Choi S.
    Endocrine. 2019 Jun 15. PMID: 31203562
  4. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
    Lin P, Yao Z, Sun Y, Li W, Liu Y, Liang K, Liu Y, Qin J, Hou X, Chen L.
    J Proteomics. 2019 Jun 10;204:103414. PMID: 31195151


  1. Long-Term Treatment with Calcitriol in Postsurgical Hypoparathyroidism Leads to Renal Function Decline.
    Coudenys E, Meerhaeghe TV, Unuane D, Buyl R, Bravenboer B.
    Horm Metab Res. 2019 Jun;51(6):362-366. PMID: 31207657.


  1. Limited role of carbidopa-assisted 18F-FDOPA PET/CT in patients with sporadic non-functional gastroduodenal neuroendocrine neoplasms.
    Imperiale A, Averous G, Helali M, Taieb D, Pessaux P, Goichot B, Addeo P, Bachellier P.
    Ann Nucl Med. 2019 Jun 15.


  1. Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches.
    Gieldon L, William D, Hackmann K, Jahn W, Jahn A, Wagner J, Rump A, Bechmann N, Nölting S, Knösel T, Gudziol V, Constantinescu G, Masjkur J, Beuschlein F, Timmers HJ, Canu L, Pacak K, Robledo M, Aust D, Schröck E, Eisenhofer G, Richter S, Klink B.
    Cancers (Basel). 2019 Jun 11;11(6).
  2. Transcriptome Analysis Reveals Significant Differences in Gene Expression of Malignant Pheochromocytoma or Paraganglioma.
    Suh YJ, Park JH, Bilegsaikhan SE, Lee DJ.
    Int J Endocrinol. 2019 May 8;2019:7014240.
  3. Biochemically silent sympathetic Paraganglioma, Pheochromocytoma or Metastatic Disease in SDHD mutation carriers.
    Dreijerink KMA, Rijken JA, Compaijen CJAC, Timmers HJLM, van der Horst-Schrivers ANA, van Leeuwaarde RS, Sytze van Dam P, Leemans CR, van Dam EWCM, Dickhoff C, Dommering CJ, de Graaf P, Zwezerijnen GJCB, van der Valk P, Menke-Van der Houven van Oordt CW, Hensen EF, Corssmit EPM, Eekhoff EMW.
    J Clin Endocrinol Metab. 2019 Jun 13.


  1. Importance of localization of insulinomas - A systematic analysis.
    Burghardt L, Meier JJ, Uhl W, Kahle-Stefan M, Schmidt WE, Nauck MA.
    J Hepatobiliary Pancreat Sci. 2019 Jun 18.

June 13, 2019

  1. Molecular prognostic factors in small-intestinal neuro-endocrine tumours.
    Samsom KG, van Veenendaal LM, Valk GD, Vriens MR, Tesselaar M, van den Berg JG.
    Endocr Connect. 2019 Jun 1. PMID: 31189127
  2. Classifying pain in transoral endoscopic thyroidectomy.
    Zhang D, Caruso E, Sun H, Anuwong A, Tufano R, Materazzi G, Dionigi G, Kim HY.
    J Endocrinol Invest. 2019 Jun 11. PMID: 31187465
  3. Treatment outcomes of differentiated thyroid cancer with distant metastasis improve by tyrosine kinase inhibitors.
    Iwasaki H, Yamazaki H, Takasaki H, Suganuma N, Sakai R, Nakayama H, Hatori S, Toda S, Masudo K.
    Oncol Lett. 2019 Jun;17(6):5292-5300. PMID: 31186746
  4. Dysregulation in IGF-1R, FGFR4 and βKlotho signaling in patients with medullary thyroid cancer.
    Motylewska E, Borkowska M, Ławnicka H, Kuzdak K, Siejka A, Świętosławski J, Stepien H, Stepien T.
    Neuro Endocrinol Lett. 2019 Mar 11;40(1):29-35. PMID: 31184820
  5. Comparing the 7th and 8th Editions of the American Joint Committee on Cancer Staging Systems for Differentiated Thyroid Cancer: Improvements Observed and Future Horizons.
    Underwood HJ, Patel KN.
    Ann Surg Oncol. 2019 Jun 10. PMID: 31183638
  6. Risk of needing completion thyroidectomy for low-risk papillary thyroid cancers treated by lobectomy.
    DiMarco AN, Wong MS, Jayasekara J, Cole-Clark D, Aniss A, Glover AR, Delbridge LW, Sywak MS, Sidhu SB.
    BJS Open. 2019 Feb 6;3(3):299-304. PMID: 31183445
  7. IGFBP7 inhibits cell proliferation by suppressing AKT activity and cell cycle progression in thyroid carcinoma.
    Zhang L, Lian R, Zhao J, Feng X, Ye R, Pan L, Wu J, Li M, Huan Y, Cai J.
    Cell Biosci. 2019 Jun 6;9:44. PMID: 31183073
  8. Patients with III and IV category of the Bethesda System under levothyroxine non-suppressive therapy have a lower rate of thyroid malignancy.
    Kaliszewski K, Diakowska D, Wojtczak B, Sutkowski K, Knychalski B, Forkasiewicz Z.
    Sci Rep. 2019 Jun 10;9(1):8409. PMID: 31182752
  9. Metformin induces TPC-1 cell apoptosis through endoplasmic reticulum stress-associated pathways in vitro and in vivo.
    Ye J, Qi L, Chen K, Li R, Song S, Zhou C, Zhai W.
    Int J Oncol. 2019 May 31. PMID: 31180536
  10. MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disorders.
    Bollerslev J, Schalin-Jantti C, Rejnmark L, Siggelkow H, Morreau H, Thakker RV, Sitges-Serra A, Cetani F, Marcocci C.
    Eur J Endocrinol. 2019 Jun 1. Review. PMID: 31176307

June 2, 2019

  1. Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"?
    Kaliszewski K, Diakowska D, Wojtczak B, Forkasiewicz Z, Pupka D, Nowak Ł, Rudnicki J.
    World J Surg Oncol. 2019 May 31;17(1):91. PMID:31146753
  2. Long-Term Outcomes and Aggressiveness of Hereditary Medullary Thyroid Carcinoma: 40 Years of Experience at One Center.
    Raue F, Bruckner T, Frank-Raue K.
    J Clin Endocrinol Metab. 2019 May 30. pii: jc.2019-00516. PMID:31145454
  3. Usefulness of 18F-Fluorocholine Positron Emission Tomography-Computed Tomography in Locating Lesions in Hyperparathyroidism: A Systematic Review.
    Boccalatte LA, Higuera F, Gómez NL, de la Torre AY, Mazzaro EL, Galich AM, Collaud C, Figari MF.
    JAMA Otolaryngol Head Neck Surg. 2019 May 30. PMID:31145436
  4. A surgical and anatomo-histological study on Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA).
    Celik S, Makay O, Yoruk MD, Bayzit Kocer I, Ozdemir M, Kilic KD, Tomruk C, Bilge O, Uyanikgil Y, Dionigi G.
    Surg Endosc. 2019 May 30. PMID:31147826
  5. Current concepts in parathyroid carcinoma: a single Centre experience.
    Ferraro V, Sgaramella LI, Di Meo G, Prete FP, Logoluso F, Minerva F, Noviello M, Renzulli G, Gurrado A, Testini M.
    BMC Endocr Disord. 2019 May 29;19(Suppl 1):46. PMID:31142320
  6. Thyroid nodules over 4 cm do not have higher malignancy or benign cytology false-negative rates.
    Kizilgul M, Shrestha R, Radulescu A, Evasovich MR, Burmeister LA.
    Endocrine. 2019 May 29. PMID:31144224
  7. A large series of hyalinizing trabecular tumors: Cytomorphology and ancillary techniques on fine needle aspiration.
    Dell'Aquila M, Gravina C, Cocomazzi A, Capodimonti S, Musarra T, Sfregola S, Fiorentino V, Revelli L, Martini M, Fadda G, Pantanowitz L, Larocca LM, Rossi ED.
    Cancer Cytopathol. 2019 May 28. PMID:31135104
  8. Transoral endoscopic thyroidectomy for thyroid carcinoma: outcomes and surgical completeness in 150 single-surgeon cases.
    Ahn JH, Yi JW.
    Surg Endosc. 2019 May 28. PMID:31139987
  9. A Clinical Overview of Telomerase-Associated Aberrancies in Follicular Thyroid Tumors as Diagnostic and Prognostic Markers: Tert Alert!
    Juhlin CC.Scand
    J Surg. 2019 May 26:1457496919850434. PMID:31131695
  10. Malignant Pheochromocytomas/Paragangliomas and Ectopic Hormonal Secretion: A Case Series and Review of the Literature.
    Angelousi A, Peppa M, Chrisoulidou A, Alexandraki K, Berthon A, Faucz FR, Kassi E, Kaltsas G.
    Cancers (Basel). 2019 May 24;11(5). pii: E724.

May 26, 2019

  1. METTL7B promotes migration and invasion in thyroid cancer through epithelial-mesenchymal transition.
    Ye D, Jiang Y, Sun Y, Li Y, Cai Y, Wang Q, Wang O, Chen E, Zhang X.
    J Mol Endocrinol. 2019 Jul 1;63(1):51-61. PMID:31121562
  2. Pediatric Thyroid Cancer-Are My Kids at Increased Risk?
    Rastatter JC, Kazahaya K, Randolph GW.
    JAMA Otolaryngol Head Neck Surg. 2019 May 23. PMID:31120481
  3. A novel case of myxoid variant of adrenocortical carcinoma in a patient with multiple endocrineneoplasia type 1.
    Harada K, Yasuda M, Hasegawa K, Yamazaki Y, Sasano H, Otsuka F.
    Endocr J. 2019 May 22. PMID:31118348
  4. Papillary Thyroid Cancers with Focal Tall Cell Change are as Aggressive as Tall Cell Variants and Should Not be Considered as Low-Risk Disease.
    Bongers PJ, Kluijfhout WP, Verzijl R, Lustgarten M, Vermeer M, Goldstein DP, Devon K, Rotstein LE, Asa SL, Brierley JD, Tsang RW, Ezzat S, Vriens MR, Mete O, Pasternak JD.
    Ann Surg Oncol. 2019 May 21. PMID:31115855
  5. Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center.
    Asare EA, Silva-Figueroa A, Hess KR, Busaidy N, Graham PH, Grubbs EG, Lee JE, Williams MD, Perrier ND.
    Ann Surg Oncol. 2019 May 20. PMID:31111352
  6. A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial.
    O'Kane GM, Ezzat S, Joshua AM, Bourdeau I, Leibowitz-Amit R, Olney HJ, Krzyzanowska M, Reuther D, Chin S, Wang L, Brooks K, Hansen AR, Asa SL, Knox JJ.
    Br J Cancer. 2019 May 20. PMID:31105270
  7. From clinic to mechanism: Proteomics-based assessment of angiogenesis in adrenal pheochromocytoma.
    Sun F, Zhuo R, Ma W, Yang D, Su T, Ye L, Xu D, Wang W.
    J Cell Physiol. 2019 May 20. PMID:31106414
  8. Diagnosis and Treatment of Adrenocortical Oncocytoma: Case Report of Five Cases and Review of the Literature.
    Dong D, Liu X, Ji Z, Li H.
    Front Oncol. 2019 May 2;9:338. PMID:31119100
  9. A rare rarity: Neuroendocrine tumor of the esophagus.
    Giannetta E, Guarnotta V, Rota F, de Cicco F, Grillo F, Colao A, Faggiano A; NIKE.
    Crit Rev Oncol Hematol. 2019 May;137:92-107.  PMID:31014519
  10. Pembrolizumab-Induced Thyroiditis.
    Imblum BA, Baloch ZW, Fraker D, LiVolsi VA.
    Endocr Pathol. 2019 May 20. PMID:31111437

May 19, 2019

  1. Use of mind maps and iterative decision trees to develop a guideline-based clinical decision support system for routine surgical practice: case study in thyroid nodules.
    Yu HW, Hussain M, Afzal M, Ali T, Choi JY, Han HS, Lee S.
    J Am Med Inform Assoc. 2019 Jun 1;26(6):524-536. PMID:31087071
  2. Management of primary hyperparathyroidism in pregnancy: a case series.
    McCarthy A, Howarth S, Khoo S, Hale J, Oddy S, Halsall D, Fish B, Mariathasan S, Andrews K, Oyibo SO, Samyraju M, Gajewska-Knapik K, Park SM, Wood D, Moran C, Casey RT.
    Endocrinol Diabetes Metab Case Rep. 2019 May 16;2019. PMID:31096181
  3. Downregulated long noncoding RNA LINC00313 inhibits the epithelial-mesenchymal transition, invasion, and migration of thyroid cancer cells through inhibiting the methylation of ALX4.
    Zhao X, Hu X.
    J Cell Physiol. 2019 May 15. PMID:31093972
  4. Comparison of ultrasonography and CT for preoperative nodal assessment of patients with papillary thyroid cancer: diagnostic performance according to primary tumor size.
    Yang SY, Shin JH, Hahn SY, Lim Y, Hwang SY, Kim TH, Kim JS.
    Acta Radiol. 2019 May 13:284185119847677.PMID:31084186
  5. Targeting EZH2 as a novel therapeutic strategy for sorafenib-resistant thyroid carcinoma.
    Wang Z, Dai J, Yan J, Zhang Y, Yin Z.
    J Cell Mol Med. 2019 May 13. PMID:31087496
  6. Transsphenoidal surgery for pituitary adenomas in pediatric patients: a multicentric retrospective study.
    Locatelli D, Veiceschi P, Castelnuovo P, Tanriover N, Evliyaoglu O, Canaz H, Ugurlar D, Gazioglu N.
    Childs Nerv Syst. 2019 May 11. PMID:31079182
  7. Thyroid nodules with Hürthle cells: the malignancy risk in relation to the FNA outcome category.
    Słowińska-Klencka D, Wysocka-Konieczna K, Woźniak-Oseła E, Sporny S, Popowicz B, Sopiński J, Kaczka K, Kuzdak K, Pomorski L, Klencki M.
    J Endocrinol Invest. 2019 May 10. PMID:31077094
  8. Thyroid diseases increased the risk of type 2 diabetes mellitus: A nation-wide cohort study.
    Chen RH, Chen HY, Man KM, Chen SJ, Chen W, Liu PL, Chen YH, Chen WC.
    Medicine (Baltimore). 2019 May;98(20):e15631.PMID:3109647
  9. The occurrence of and predictive factors for multifocality and bilaterality in patients with papillary thyroid microcarcinoma.
    Kaliszewski K, Diakowska D, Wojtczak B, Migoń J, Kasprzyk A, Rudnicki J.
    Medicine (Baltimore). 2019 May;98(19):e15609. PMID:31083255
  10. The application of subcapsular saline injection during bilateral axillo-breast approach robotic thyroidectomy: a preliminary report.
    Yu HW, Bae IE, Yi JW, Lee JH, Kim SJ, Chai YJ, Choi JY, Lee KE.
    Surg Today. 2019 May;49(5):420-426.PMID:30604214

May 12, 2019

  1. The Clinical Impact of [68 Ga]-DOTATATE PET/CT for the Diagnosis and Management of Ectopic Adrenocorticotropic Hormone - Secreting Tumors.
    Wannachalee T, Turcu AF, Bancos I, Habra MA, Avram AM, Chuang HH, Waguespack SG, Auchus RJ.
    Clin Endocrinol (Oxf). 2019 May 8. doi: 10.1111/cen.14008. PMID:31066920
  2. Naming difficulties after thyroid stimulating hormone suppression therapy in patients with differentiated thyroid carcinoma: a prospective cohort study.
    Jin S, Yang YT, Bao W, Bai Y, Ai JW, Liu Y, Yong H.
    Endocrine. 2019 May 5. doi: 10.1007/s12020-019-01943-8. PMID:31056722
  3. Surgical resection of neuroendocrine tumor liver metastases as part of multimodal treatment strategies: A propensity score matching analysis.
    Schreckenbach T, Hübert H, Koch C, Bojunga J, Schnitzbauer AA, Bechstein WO, Holzer K.
    Eur J Surg Oncol. 2019 May;45(5):808-815. doi: 10.1016/j.ejso.2018.12.022. Epub 2018 Dec 28. PMID:30611565
  4. Clinical outcomes after surgery for primary aldosteronism: Evaluation of the PASO-investigators' consensus criteria within a worldwide cohort of patients.
    Vorselaars WMCM, Beek DV, Postma EL, Spiering W, Borel Rinkes IHM, Valk GD, Vriens MR; International CONNsortium study group.
    Surgery. 2019 Apr 30. pii: S0039-6060(19)30063-7. doi: 10.1016/j.surg.2019.01.031. PMID:31053245
  5. Intraoperative parathyroid hormone (PTH) testing in patients with primary hyperparathyroidism and PTH levels in the normal range.
    Medas F, Erdas E, Loi G, Podda F, Barca L, Pisano G, Calò PG.
    BMC Surg. 2019 Apr 24;18(Suppl 1):124. doi: 10.1186/s12893-018-0459-3.PMID:31074404
  6. Thyroiditis process as a predictive factor of sternotomy in the treatment of cervico-mediastinal goiter.
    Casella C, Molfino S, Cappelli C, Salvoldi F, Benvenuti MR, Portolani N.
    BMC Surg. 2019 Apr 24;18(Suppl 1):20. doi: 10.1186/s12893-019-0474-z.PMID:31074402
  7. The role of prophylactic central compartment lymph node dissection in elderly patients with differentiated thyroid cancer: a multicentric study.
    Gambardella C, Patrone R, Di Capua F, Offi C, Mauriello C, Clarizia G, Andretta C, Polistena A, Sanguinetti A, Calò P, Docimo G, Avenia N, Conzo G.
    BMC Surg. 2019 Apr 24;18(Suppl 1):110. doi: 10.1186/s12893-018-0433-0. PMID:31074400
  8. Effect of unilateral adrenalectomy on the quality of life of patients with lateralized primary aldosteronism.
    Citton M, Viel G, Torresan F, Rossi GP, Iacobone M.
    BMC Surg. 2019 Apr 24;18(Suppl 1):105. doi: 10.1186/s12893-018-0432-1.PMID: 31074381
  9. Transaxillary robotic-assisted thyroid surgery: technique and results of a preliminary experience on the Da Vinci Xi platform.
    Prete FP, Marzaioli R, Lattarulo S, Paradies D, Barile G, d'Addetta MV, Tomasicchio G, Gurrado A, Pezzolla A.
    BMC Surg. 2019 Apr 24;18(Suppl 1):19. doi: 10.1186/s12893-019-0473-0.PMID:31074396
  10. Skip metastases to lateral cervical lymph nodes in differentiated thyroid cancer: a systematic review.
    Attard A, Paladino NC, Lo Monte AI, Falco N, Melfa G, Rotolo G, Rizzuto S, Gulotta E, Salamone G, Bonventre S, Scerrino G, Cocorullo G.
    BMC Surg. 2019 Apr 24;18(Suppl 1):112. doi: 10.1186/s12893-018-0435-y. Review.

May 4, 2019

  1. A full phenotype of paraganglioma linked to a germline SDHB mosaic mutation.
    Cardot-Bauters C, Carnaille B, Aubert S, Crépin M, Boury S, Burnichon N, Pigny P.
    J Clin Endocrinol Metab. 2019 May 2. pii: jc.2019-00175. doi: 10.1210/jc.2019-00175.PMID:31046099
  2. Insulin-Like Growth Factor and SLC12A7 Dysregulation: A Novel Signaling Hallmark of Non-Functional Adrenocortical Carcinomas.
    Brown TC, Nicolson NG, Stenman A, Juhlin CC, Gibson CE, Callender GG, Korah R, Carling T.
    J Am Coll Surg. 2019 Apr 26. pii: S1072-7515(19)30293-5. doi: 10.1016/j.jamcollsurg.2019.04.018. PMID:31034883
  3. Evaluation of recurrent parathyroid carcinoma: A new imaging tool in uncommon entity.
    Thanseer NTK, Parihar AS, Sood A, Bhadada SK, Dahiya D, Singh P, Mittal BR.
    World J Nucl Med. 2019 Apr-Jun;18(2):198-200. doi: 10.4103/wjnm.WJNM_67_18. PMID:31040757
  4. Early Postoperative Fasting Serum Glucose Levels are Useful in Depicting Future Diabetes Mellitus in Patients with Curative Insulinoma Surgery.
    Akca A, Starke AAR, Dobek A, Ulrich A, Goretzki PE.
    Exp Clin Endocrinol Diabetes. 2019 Apr 30. doi: 10.1055/a-0892-4157.PMID: 31039599
  5. Active Surveillance of Low-Risk Thyroid Cancer.
    Zanocco KA, Hershman JM, Leung AM.
    JAMA. 2019 Apr 30. doi:10.1001/jama.2019.5350. PMID:31038662
  6. Extended cycle streptozotocin/5-FU chemotherapy for maintenance therapy in pancreatic neuroendocrine tumors.
    Schrader J, Henes FO, Blaeker M, Zimmermann-Fraedrich K, Pace A, Perez D, Izbicki JR, Lohse AW, Benten D.
    Endocrine. 2019 Apr 29. doi: 10.1007/s12020-019-01941-w.  PMID:31037707
  7. LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer.
    Liang M, Jia J, Chen L, Wei B, Guan Q, Ding Z, Yu J, Pang R, He G.
    Endocrine. 2019 Apr 27. doi: 10.1007/s12020-019-01939-4. PMID:31030335
  8. Considerations for Thyroidectomy as Treatment for Graves Disease.
    Smithson M, Asban A, Miller J, Chen H.
    Clin Med Insights Endocrinol Diabetes. 2019 Apr 24;12:1179551419844523. doi: 10.1177/1179551419844523. 2019. PMID:31040734
  9. HIF-1α facilitates osteocyte-mediated osteoclastogenesis by activating JAK2/STAT3 pathway in vitro.
    Zhu J, Tang Y, Wu Q, Ji YC, Feng ZF, Kang FW.
    J Cell Physiol. 2019 Apr 29. doi: 10.1002/jcp.28721. PMID: 31032948
  10. Is hemi-thyroidectomy adequate in low risk differentiated thyroid cancer?
    Benjamin J, Hephzibah J, Cherian AJ, Mathew D, Shanthly N, Oommen R.
  11. World J Nucl Med. 2019 Apr-Jun;18(2):171-175. doi: 10.4103/wjnm.WJNM_70_18. PMID:31040749

April 27, 2019

  1. Impact of extranodal extension on risk stratification in papillary thyroid carcinoma.
    Kim HI, Hyeon J, Park SY, Ahn HS, Kim K, Han JM, Bae JC, Shin JH, Kim JS, Kim SW, Chung JH, Kim TH, Oh YL.
    Thyroid. 2019 Apr 26. doi: 10.1089/thy.2018.0541. [PMID:31025609]
  2. Predicting recurrence of papillary thyroid cancer using the eighth edition of the AJCC/UICC staging system.
    Chereau N, Oyekunle TO, Zambeli-Ljepović A, Kazaure HS, Roman SA, Menegaux F, Sosa JA.
    Br J Surg. 2019 Apr 23. doi: 10.1002/bjs.11145. PMID:31012500
    Almazrouei R, Meeran K, Palazzo FF. 
    Endocr Pract. 2019 Apr 23. doi: 10.4158/EP-2019-0118. PMID:31013148
  4. Long Non-Coding RNA ZFAS1 as a Novel Potential Biomarker for Predicting the Prognosis of Thyroid Cancer.
    Han CG, Huang Y, Qin L.
    Med Sci Monit. 2019 Apr 23;25:2984-2992. doi: 10.12659/MSM.912921.PMID:31012438
  5. Association of Surgical Volume and Quality Management in Thyroid Surgery: A Two-Nation Multicenter Study.
    Jakob DA, Riss P, Scheuba C, Hermann M, Kim-Fuchs C, Seiler CA, Walter MA, Kaderli RM.
    World J Surg. 2019 Apr 22. doi: 10.1007/s00268-019-05012-z. PMID:31011819
  6. Postoperative Pain and Opioid Use After Thyroid and Parathyroid Surgery-A Pilot, Prospective SMS-Based Survey.
    Chen Y, Nwaogu I, Chomsky-Higgins K, Gosnell JE, Seib C, Shen WT, Duh QY, Suh I.
    Surg Res. 2019 Apr 17;240:236-240. doi: 10.1016/j.jss.2019.03.016. PMID:31004971
  7. Is there a correlation between thyroiditis and thyroid cancer?
    Del Rio P, Montana Montana C, Cozzani F, Rossini M, Loderer T, Dall'Aglio E, Cataldo S, Marina M, Graziano C.
    Endocrine. 2019 Apr 19. doi: 10.1007/s12020-019-01935-8. PMID:31004335
  8. Clinical impact of testing for mutations and microRNAs in thyroid nodules.
    Sistrunk JW, Shifrin A, Frager M, Bardales RH, Thomas J, Fishman N, Goldberg P, Guttler R, Grant E.
    Diagn Cytopathol. 2019 Apr 23. doi: 10.1002/dc.24190. PMID:31013001
  9. Robotic Central Pancreatectomy for Well-Differentiated Neuroendocrine Tumor: Parenchymal-Sparing Procedure.
    Wakabayashi T, Felli E, Cherkaoui Z, Mutter D, Marescaux J, Pessaux P.
    Ann Surg Oncol. 2019 Apr 24. doi: 10.1245/s10434-019-07387-8. PMID:31020502
  10. Extending expressed RNA genomics from surgical decision making for cytologically indeterminate thyroid nodules to targeting therapies for metastatic thyroid cancer.
    Ali SZ, Siperstein A, Sadow PM, Golding AC, Kennedy GC, Kloos RT, Ladenson PW.
    Cancer Cytopathol. 2019 Apr 24. doi: 10.1002/cncy.22132. PMID: 31017745

April 20, 2019

  1. American Head and Neck Society Endocrine Surgery Section update on parathyroid imaging for surgical candidates with primary hyperparathyroidism.
    Zafereo M, Yu J, Angelos P, Brumund K, Chuang HH, Goldenberg D, Lango M, Perrier N, Randolph G, Shindo ML, Singer M, Smith R, Stack BC Jr, Steward D, Terris DJ, Vu T, Yao M, Tufano RP.
    Head Neck. 2019 Apr 19. doi: 10.1002/hed.25781. [Epub ahead of print] Review.
  2. Long-term Risk of Thyroid Cancer After Initially Negative Thyroid Biopsy Results.
    Bongers PJ, Kluijfhout WP, Devon K, Rotstein LE, Vriens MR, Urbach DR, Pasternak JD.
    JAMA Otolaryngol Head Neck Surg. 2019 Apr 18. doi: 10.1001/jamaoto.2019.0386. [Epub ahead of print] No abstract available. 
  3. Adrenocortical carcinoma: presentation and outcome of a contemporary patient series.
    Kostiainen I, Hakaste L, Kejo P, Parviainen H, Laine T, Löyttyniemi E, Pennanen M, Arola J, Haglund C, Heiskanen I, Schalin-Jäntti C.
    Endocrine. 2019 Apr 12. doi: 10.1007/s12020-019-01918-9. [Epub ahead of print]
  4. The role of multimodal imaging in guiding resectability and cytoreduction in pancreatic neuroendocrine tumors: focus on PET and MRI.
    Rozenblum L, Mokrane FZ, Yeh R, Sinigaglia M, Besson F, Seban RD, Chougnet CN, Revel-Mouroz P, Zhao B, Otal P, Schwartz LH, Dercle L.
    Abdom Radiol (NY). 2019 Apr 12. doi: 10.1007/s00261-019-01994-5. [Epub ahead of print] Review.
  5. Retrospective analysis of variant venous anatomy in 303 laparoscopic adrenalectomies and its clinical implications.
    Sun F, Zhuo R, Ma W, He H, Ye L, Xu D, Wang W, Ning G.
    J Surg Oncol. 2019 May;119(6):801-806. doi: 10.1002/jso.25364. Epub 2019 Jan 30.
  6. Survival outcomes following adrenalectomy for isolated metastases to the adrenal gland.
    Ramsingh J, O'Dwyer P, Watson C.
    Eur J Surg Oncol. 2019 Apr;45(4):631-634. doi: 10.1016/j.ejso.2019.01.006. Epub 2019 Jan 4.
  7. Fast-track Radioiodine Ablation Therapy After Thyroidectomy Reduces Sick Leave in Patients With Differentiated Thyroid Cancer (FASTHYNA Trial).
    Waissi F, Kist JW, Lodewijk L, de Wit AG, van der Hage JA, van Dalen T, de Keizer B, Valk GD, Borel Rinkes IHM, Vriens MR.
    Clin Nucl Med. 2019 Apr;44(4):272-275. doi: 10.1097/RLU.0000000000002420.
  8. Prophylactic thyroidectomy in multiple endocrine neoplasia 2 (MEN2) patients with the C634Y mutation: A long-term follow-up in a large single-center cohort.
    Febrero B, Rodríguez JM, Ríos A, Segura P, Pérez-Sánchez B, Torregrosa N, Hernández AM, Parrilla P.
    Eur J Surg Oncol. 2019 Apr;45(4):625-630. doi: 10.1016/j.ejso.2018.09.002. Epub 2018 Oct 17.
  9. Update in adrenal venous sampling for primary aldosteronism.
    Rossi GP.
    Curr Opin Endocrinol Diabetes Obes. 2018 Jun;25(3):160-171. doi: 10.1097/MED.0000000000000407. Review.
  10. Detection of new potentially pathogenic mutations in two patients with primary pigmented nodular adrenocortical disease (PPNAD) - case reports with literature review.
    Pasternak-Pietrzak K, Stratakis CA, Moszczyńska E, Lecka-Ambroziak A, Staniszewski M, Wątrobińska U, Lyssikatos C, Prokop-Piotrkowska M, Grajkowska W, Pronicki M, Szalecki M.
    Endokrynol Pol. 2018;69(6):675-681. doi: 10.5603/EP.a2018.0063. Epub 2018 Sep 27. Review.

March 22, 2019

  1. The immunocytochemical expression of VE-1 (BRAF V600E-related) antibody identifies the aggressive variants of papillary thyroid carcinoma on liquid-based cytology.
    Straccia P, Brunelli C, Rossi ED, Lanza P, Martini M, Musarra T, Lombardi CP, Pontecorvi A, Fadda G.
    Cytopathology. 2019 Mar 15. doi: 10.1111/cyt.12690. [Epub ahead of print]
  2. Recombinant human thyrotropin (rhTSH) versus Levo-thyroxine withdrawal in radioiodine therapy of differentiated thyroid cancer patients: differences in abdominal absorbed dose.
    Straccia P, Brunelli C, Rossi ED, Lanza P, Martini M, Musarra T, Lombardi CP, Pontecorvi A, Fadda G.
    Cytopathology. 2019 Mar 15. doi: 10.1111/cyt.12690. [Epub ahead of print]
  3. Proposition of adjustments to the ACMG-AMP framework for the interpretation of MEN1 missense variants.
    Romanet P, Odou MF, North MO, Saveanu A, Coppin L, Pasmant E, Mohamed A, Goudet P, Borson-Chazot F, Calender A, Béroud C, Lévy N, Giraud S, Barlier A;
    TENGEN group. Hum Mutat. 2019 Mar 14. doi: 10.1002/humu.23746. [Epub ahead of print]
  4. COPPS, a composite score integrating pathological features, PS100 and SDHB losses, predicts the risk of metastasis and progression-free survival in pheochromocytomas/paragangliomas.
    Pierre C, Agopiantz M, Brunaud L, Battaglia-Hsu SF, Max A, Pouget C, Nomine C, Lomazzi S, Vignaud JM, Weryha G, Oussalah A, Gauchotte G, Busby-Venner H.
    Virchows Arch. 2019 Mar 13. doi: 10.1007/s00428-019-02553-5. [Epub ahead of print]
  5. The BRAF-inhibitor PLX4720 inhibits CXCL8 secretion in BRAFV600E mutated and normal thyroid cells: a further anti-cancer effect of BRAF-inhibitors.
    Coperchini F, Croce L, Denegri M, Awwad O, Ngnitejeu ST, Muzza M, Capelli V, Latrofa F, Persani L, Chiovato L, Rotondi M. Coperchini F, Croce L, Denegri M, Awwad O, Ngnitejeu ST, Muzza M, Capelli V, Latrofa F, Persani L, Chiovato L, Rotondi M.
    Amodru V, Taieb D, Guerin C, Paladino NC, Brue T, Sebag F, Castinetti F.
    Endocr Pract. 2019 Mar 13. doi: 10.4158/EP-2018-0616. [Epub ahead of print]
    Hu Y, Bi Y, Cui M, Zhang X, Su Z, Wang M, Hua S, Liao Q, Zhao Y.
    Endocr Pract. 2019 Mar 13. doi: 10.4158/EP-2018-0538. [Epub ahead of print]
    Moore EC, Siperstein A, Gupta S.
    Endocr Pract. 2019 Mar 13. doi: 10.4158/EP-2018-0547. [Epub ahead of print]
  9. Transoral Vestibular Thyroidectomy: Current State of Affairs and Considerations for the Future.
    Russell JO, Razavi CR, Shaear M, Chen LW, Lee AH, Ranganath R, Tufano RP.
    J Clin Endocrinol Metab. 2019 Mar 12. pii: jc.2019-00116. doi: 10.1210/jc.2019-00116. [Epub ahead of print]
  10. Clinical, Diagnostic, and Treatment Characteristics of <i>SDHA</i>-Related Metastatic Pheochromocytoma and Paraganglioma.
    Jha A, de Luna K, Balili CA, Millo C, Paraiso CA, Ling A, Gonzales MK, Viana B, Alrezk R, Adams KT, Tena I, Chen A, Neuzil J, Raygada M, Kebebew E, Taieb D, O'Dorisio MS, O'Dorisio T, Civelek AC, Stratakis CA, Mercado-Asis L, Pacak K.
    Front Oncol. 2019 Feb 22;9:53. doi: 10.3389/fonc.2019.00053. eCollection 2019.

March 7, 2019

  1. Characteristics and outcomes of patients with hyperthyroidism attending a hospital endocrine clinic-A retrospective study.
    Sim SY, Lethem C, Coppini DV.
    Endocrinol Diabetes Metab. 2018 Nov 28;2(1):e00046. doi: 10.1002/edm2.46. eCollection 2019 Jan.
  2. Changes in the size of the thyroid in patients with benign non-toxic multinodular goiter after radioactive iodine therapy.
    HeydarI I, Honardoost M, MoradI S, GolgirI F, Dehnad H, MoradI S, Ziaee A.
    Med J Islam Repub Iran. 2018 Dec 27;32:131. doi: 10.14196/mjiri.32.131. eCollection 2018.
  3. Differences in Chromatin Texture and Nuclear Fractal Dimension Between Hashimoto's and Lymphocytic Thyroiditis Lymphocytes.
    Todorović J, Dinčić M, Nešović Ostojić J, Zaletel I, Lopičić S, Dundjerović D, Tatić S, Kovačević S, Paunović I, Puškaš N, Marković L.
    Microsc Microanal. 2019 Feb 28:1-7. doi: 10.1017/S1431927619000163. [Epub ahead of print]
  4. Prediction of difficult tracheal intubations in thyroid surgery. Predictive value of neck circumference to thyromental distance ratio.
    De Cassai A, Papaccio F, Betteto G, Schiavolin C, Iacobone M, Carron M.
    PLoS One. 2019 Feb 27;14(2):e0212976. doi: 10.1371/journal.pone.0212976. eCollection 2019.
  5. Clinical Outcomes After Unilateral Adrenalectomy for Primary Aldosteronism.
    Vorselaars WMCM, Nell S, Postma EL, Zarnegar R, Drake FT, Duh QY, Talutis SD, McAneny DB, McManus C, Lee JA, Grant SB, Grogan RH, Romero Arenas MA, Perrier ND, Peipert BJ, Mongelli MN, Castelino T, Mitmaker EJ, Parente DN, Pasternak JD, Engelsman AF, Sywak M, D'Amato G, Raffaelli M, Schuermans V, Bouvy ND, Eker HH, Bonjer HJ, Vaarzon Morel NM, Nieveen van Dijkum EJM, Vrielink OM, Kruijff S, Spiering W, Borel Rinkes IHM, Valk GD, Vriens MR; International CONNsortium study group.
    JAMA Surg. 2019 Feb 27:e185842. doi: 10.1001/jamasurg.2018.5842. [Epub ahead of print]
  6. Trends in Diagnostics, Surgical Treatment, and Prognostic Factors for Outcomes in Medullary Thyroid Carcinoma in Norway: A Nationwide Population-Based Study.
    Opsahl EM, Akslen LA, Schlichting E, Aas T, Brauckhoff K, Hagen AI, Rosenlund AF, Sigstad E, Grøholt KK, Mæhle L, Engebretsen LF, Jørgensen LH, Varhaug JE, Bjøro T.
    Eur Thyroid J. 2019 Jan;8(1):31-40. doi: 10.1159/000493977. Epub 2018 Nov 8.
  7. Intravascular B-large cell lymphoma: an unexpected diagnosis of an incidental adrenal mass.
    Kiriakopoulos A, Linos D.
    J Surg Case Rep. 2019 Feb 19;2019(2):rjz048. doi: 10.1093/jscr/rjz048. eCollection 2019 Feb.
  8. Accuracy of the European Thyroid Imaging Reporting and Data System (EU-TIRADS) in the valuation of thyroid nodule malignancy in reference to the post-surgery histological results.
    Skowrońska A, Milczarek-Banach J, Wiechno W, Chudziński W, Żach M, Mazurkiewicz M, Miśkiewicz P, Bednarczuk T.
    Pol J Radiol. 2018 Dec 19;83:e579-e586. doi: 10.5114/pjr.2018.81556. eCollection 2018.
  9. Updates in the management of thyroid nodules.
    Kuo JH, McManus C, Graves CE, Madani A, Khokhar MT, Huang B, Lee JA.
    Curr Probl Surg. 2019 Mar;56(3):103-127. doi: 10.1067/j.cpsurg.2018.12.003. Epub 2018 Dec 23. No abstract available.
  10. Intertumor heterogeneity in 60 pancreatic neuroendocrine tumors associated with multiple endocrine neoplasia type 1.
    Selberherr A, Koperek O, Riss P, Scheuba C, Niederle MB, Kaderli R, Perren A, Niederle B.
    Orphanet J Rare Dis. 2019 Feb 22;14(1):54. doi: 10.1186/s13023-019-1034-4.

February 22, 2019

  1. Enhancing Parathyroid Gland Visualization Using a Near Infrared Fluorescence-Based Overlay Imaging System.
    McWade MA, Thomas G, Nguyen JQ, Sanders ME, Solórzano CC, Mahadevan-Jansen A.
    J Am Coll Surg. 2019 Feb 12. pii: S1072-7515(19)30130-9. doi: 10.1016/j.jamcollsurg.2019.01.017. [Epub ahead of print]
  2. Incidence and malignancy rates of indeterminate pediatric thyroid nodules.
    Wang H, Mehrad M, Ely KA, Liang J, Solórzano CC, Neblett WW 3rd, Coogan AC, Weiss VL.
    Cancer Cytopathol. 2019 Feb 15. doi: 10.1002/cncy.22104. [Epub ahead of print]
  3. Clinico-Pathological Profile of Anaplastic Thyroid Carcinoma in an Endemic Goiter Area.
    Pradhan R, Agarwal A, Lal P, Kumari N, Jain M, Chand G, Mishra A, Agarwal G, Verma AK, Mishra SK.
    Indian J Endocrinol Metab. 2018 Nov-Dec;22(6):793-797. doi: 10.4103/ijem.IJEM_264_18.
  4. Comparative Effects of Proximal and Distal Small Intestinal Glucose Exposure on Glycemia, Incretin Hormone Secretion, and the Incretin Effect in Health and Type 2 Diabetes.
    Zhang X, Young RL, Bound M, Hu S, Jones KL, Horowitz M, Rayner CK, Wu T.
    Diabetes Care. 2019 Feb 14. pii: dc182156. doi: 10.2337/dc18-2156. [Epub ahead of print]
  5. Genotype and phenotype landscape of MEN2 in 554 medullary thyroid cancer patients: the BrasMEN study.
    Maciel RMB, Camacho CP, Assumpcao LV, Bufalo NE, Carvalho AL, de Carvalho GA, Castroneves LA, de Castro FM Jr, Ceolin L, Cerutti JM, Corbo R, Ferraz TMBL, Ferreira CV, França MIC, Galvão HCR, Germano-Neto F, Graf H, Jorge AAL, Kunii IS, Lauria MW, Leal VLG, Lindsey SC, Lourenco-Jr DM, Zanini Maciel LM, Magalhães PKR, Martins JRM, Martins-Costa MC, Mazeto GMFS, Impellizzeri A, Nogueira CR, Palmero EI, Pessoa CC, Prada B, Siqueira DR, Sousa MSA, Toledo R, Valente FOF, Vaisman F, Ward LS, Weber SS, Weiss RV, Yang JH, Dias Da Silva MR, Hoff AO, Toledo SP, Maia AL.
    Endocr Connect. 2019 Feb 1. pii: EC-18-0506.R1. doi: 10.1530/EC-18-0506. [Epub ahead of print]
  6. Evaluating contemporary pain management practices in thyroid and parathyroid surgery: A national survey of head and neck endocrine surgeons.
    Ferrell JK, Singer MC, Farwell DG, Stack BC Jr, Shindo M.
    Head Neck. 2019 Feb 13. doi: 10.1002/hed.25694. [Epub ahead of print]
  7. Autofluorescence in Parathyroidectomy: Signal Intensity Correlates with Serum Calcium and Parathyroid Hormone but Routine Clinical Use is Not Justified.
    DiMarco A, Chotalia R, Bloxham R, McIntyre C, Tolley N, Palazzo FF.
    World J Surg. 2019 Feb 8. doi: 10.1007/s00268-019-04929-9. [Epub ahead of print]
  8. Comprehensive genetic characterization of human thyroid cancer cell lines: a validated panel for preclinical studies.
    Landa I, Pozdeyev N, Korch C, Marlow LA, Smallridge RC, Copland JA, Henderson YC, Lai SY, Clayman GL, Onoda N, Tan AC, Garcia-Rendueles MER, Knauf JA, Haugen BR, Fagin JA, Schweppe RE.
    Clin Cancer Res. 2019 Feb 8. pii: clincanres.2953.2018. doi: 10.1158/1078-0432.CCR-18-2953. [Epub ahead of print]
  9. Histopathological analysis of papillary thyroid carcinoma detected during ultrasound screening examinations in Fukushima.
    Suzuki S, Bogdanova TI, Saenko VA, Hashimoto Y, Ito M, Iwadate M, Rogounovitch TI, Tronko MD, Yamashita S.
    Cancer Sci. 2019 Feb;110(2):817-827. doi: 10.1111/cas.13912. Epub 2019 Jan 20.
  10. Factors predictive of the development of surgical site infection in thyroidectomy - An analysis of NSQIP database.
    Myssiorek D, Ahmed Y, Parsikia A, Castaldi M, McNelis J.
    Int J Surg. 2018 Dec;60:273-278. doi: 10.1016/j.ijsu.2018.11.013. Epub 2018 Nov 16. Review.

February 1, 2019

  1. Bilateral Neck Exploration for Sporadic Primary Hyperparathyroidism: Utilization Patterns in 5,597 Patients Undergoing Parathyroidectomy in the Collaborative Endocrine Surgery Quality Improvement Program.
    Kiernan CM, Wang T, Perrier ND, Grubbs EG, Solórzano CC.
    J Am Coll Surg. 2019 Jan 21. pii: S1072-7515(19)30045-6. doi: 10.1016/j.jamcollsurg.2018.12.034. [Epub ahead of print]
  2. Intraoperative Parathyroid Autofluorescence Detection in Patients with Primary Hyperparathyroidism.
    Squires MH, Jarvis R, Shirley LA, Phay JE.
    Ann Surg Oncol. 2019 Jan 23. doi: 10.1245/s10434-019-07161-w. [Epub ahead of print]
  3. Poorly differentiated thyroid carcinoma and poorly differentiated area in differentiated thyroid carcinoma: is there any difference?
    Bichoo RA, Mishra A, Kumari N, Krishnani N, Chand G, Agarwal G, Agarwal A, Mishra SK.
    Langenbecks Arch Surg. 2019 Jan 23. doi: 10.1007/s00423-019-01753-6. [Epub ahead of print]
  4. The Primary Aldosteronism Surgical Outcome Score for the Prediction of Clinical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism.
    Burrello J, Burrello A, Stowasser M, Nishikawa T, Quinkler M, Prejbisz A, Lenders JWM, Satoh F, Mulatero P, Reincke M, Williams TA.
    Ann Surg. 2019 Jan 18. doi: 10.1097/SLA.0000000000003200. [Epub ahead of print]
  5. Long-Term Endocrine and Exocrine Insufficiency After Pancreatectomy.
    Kusakabe J, Anderson B, Liu J, Williams GA, Chapman WC, Doyle MMB, Khan AS, Sanford DE, Hammill CW, Strasberg SM, Hawkins WG, Fields RC.
    J Gastrointest Surg. 2019 Jan 22. doi: 10.1007/s11605-018-04084-x. [Epub ahead of print]
  6. Case of reversible diabetes mellitus in the setting of benign Pheochromocytoma.
    Cha J, Khurram M, Gellert L, Epstein P, Baregamian N, Hendrickson C.
    J Clin Transl Endocrinol Case Rep. 2018 Dec;10:1-3. doi: 10.1016/j.jecr.2018.07.003. Epub 2018 Aug 2.
  7. Management of familial hyperparathyroidism syndromes: MEN1, MEN2, MEN4, HPT-Jaw tumour, Familial isolated hyperparathyroidism, FHH, and neonatal severe hyperparathyroidism.
    Cristina EV, Alberto F.
    Best Pract Res Clin Endocrinol Metab. 2018 Dec;32(6):861-875. doi: 10.1016/j.beem.2018.09.010. Epub 2018 Sep 28. Review.
  8. Novel TG-FGFR1 and TRIM33-NTRK1 transcript fusions in papillary thyroid carcinoma
    Pfeifer A, Rusinek D, Żebracka-Gala J, Czarniecka A, Chmielik E, Zembala-Nożyńska E, Wojtaś B, Gielniewski B, Szpak-Ulczok S, Oczko-Wojciechowska M, Krajewska J, Polańska J, Jarząb B.
    Genes Chromosomes Cancer. 2019 Jan 21. doi: 10.1002/gcc.22737. [Epub ahead of print].
  9. Protocol driven outcomes in renal parathyroid surgery.
    Walsh NJ, Caten AJ, White JJ, Terris DJ.
    Head Neck. 2019 Jan 21. doi: 10.1002/hed.25413. [Epub ahead of print]
  10. New Paradigms for Neural Monitoring in Thyroid Surgery.
    Sun H, Wu CW, Zhang D, Makay Ö, Zhao Y, Carcofaro P, Kim HY, Dionigi G, Pino A, Caruso E, Pontin A, Pappalardo V.
    Surg Technol Int. 2019 Jan 18;34. pii: sti34/1070. [Epub ahead of print]
  11. Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study.  
    Castinetti F, Waguespack SG, Machens A, Uchino S, Lazaar K, Sanso G, Else T, Dvorakova S, Qi XP, Elisei R, Maia AL, Glod J, Lourenço DM Jr, Valdes N, Mathiesen J, Wohllk N, Bandgar TR, Drui D, Korbonits M, Druce MR, Brain C, Kurzawinski T, Patocs A, Bugalho MJ, Lacroix A, Caron P, Fainstein-Day P, Borson Chazot F, Klein M, Links TP, Letizia C, Fugazzola L, Chabre O, Canu L, Cohen R, Tabarin A, Spehar Uroic A, Maiter D, Laboureau S, Mian C, Peczkowska M, Sebag F, Brue T, Mirebeau-Prunier D, Leclerc L, Bausch B, Berdelou A, Sukurai A, Vlcek P, Krajewska J, Barontini M, Vaz Ferreira Vargas C, Valerio L, Ceolin L, Akshintala S, Hoff A, Godballe C, Jarzab B, Jimenez C, Eng C, Imai T, Schlumberger M, Grubbs E, Dralle H, Neumann HP, Baudin E.
    Lancet Diabetes Endocrinol. 2019 Jan 16. pii: S2213-8587(18)30336-X. doi: 10.1016/S2213-8587(18)30336-X. [Epub ahead of print]
  12. 18F-Fluorocholine PET/CT and Parathyroid 4D Computed Tomography for Primary Hyperparathyroidism: The Challenge of Reoperative Patients.
    Amadou C, Bera G, Ezziane M, Chami L, Delbot T, Rouxel A, Leban M, Herve G, Menegaux F, Leenhardt L, Kas A, Trésallet C, Ghander C, Lussey-Lepoutre C.
    World J Surg. 2019 Jan 18. doi: 10.1007/s00268-019-04910-6. [Epub ahead of print]
  13. Evaluation of Parathyroid Glands with Indocyanine Green Fluorescence Angiography After Thyroidectomy.
    Rudin AV, McKenzie TJ, Thompson GB, Farley DR, Lyden ML.
    World J Surg. 2019 Jan 18. doi: 10.1007/s00268-019-04909-z. [Epub ahead of print]
  14. Effects of Parathyroidectomy on Plasma iPTH and (1-84) PTH Levels in Patients with Stage 5 Chronic Kidney Disease.
    Huimin C, Ying C, Changying X, Xiaoming Z, Yan Z, Qingting W, Haoyang M, Lina Z, Ming Z, Guang Y, Xiaolin L, Purrunsing Y, Ningning W.
    Horm Metab Res. 2018 Oct;50(10):761-767. doi: 10.1055/a-0723-2807. Epub 2018 Sep 17.
  15. Autogenous transplants of adrenal fragments in an animal model.
    Dworzyńska A, Paduszyńska K, Pomorski L.
    Pol Przegl Chir. 2018 Jun 13;90(4):22-28. doi: 10.5604/01.3001.0011.8178.
  16. Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves' ophthalmopathy - a 1-year follow-up: study protocol for a randomized controlled trial.
    Brammen L, Riss P, Lukas J, Gessl A, Dunkler D, Li S, Leisser A, Rezar-Dreindl S, Eibenberger K, Selberherr A, Scheuba C, Papp A.
    Trials. 2018 Sep 15;19(1):495. doi: 10.1186/s13063-018-2876-0.
  17. Lessons Learned From a Faulty Transoral Endoscopic Thyroidectomy Vestibular Approach.
    Zhang D, Wu CW, Inversini D, Kim HY, Anuwong A, Bacuzzi A, Dionigi G.
    Surg Laparosc Endosc Percutan Tech. 2018 Oct;28(5):e94-e99. doi: 10.1097/SLE.0000000000000555.
  18. Clinical presentation and management of patients with primary hyperparathyroidism in Italy.
    Saponaro F, Cetani F, Repaci A, Pagotto U, Cipriani C, Pepe J, Minisola S, Cipri C, Vescini F, Scillitani A, Salcuni A, Palmieri S, Eller-Vainicher C, Chiodini I, Madeo B, Kara E, Castellano E, Borretta G, Gianotti L, Romanelli F, Camozzi V, Faggiano A, Corbetta S, Cianferotti L, Brandi ML, De Feo ML, Palermo A, Vezzoli G, Maino F, Scalese M, Marcocci C.
    J Endocrinol Invest. 2018 Nov;41(11):1339-1348. doi: 10.1007/s40618-018-0879-z. Epub 2018 Apr 3.

January 23, 2019

  1. Significant racial differences in the incidence and behavior of the follicular variant of papillary thyroid carcinoma.
    Mehta V, Ow TJ, Kim S, Tharakan T, Schiff B, Smith RV,
    In H. Head Neck. 2019 Jan 16. doi: 10.1002/hed.25596. [Epub ahead of print]
  2. The patterns and treatment of postoperative hemorrhage and hematoma in total endoscopic thyroidectomy via breast approach: experience of 1932 cases.
    Xie QP, Xiang C, Wang Y, Yan HC, Zhao QZ, Yu X, Zhang ML, Wang P.
    Endocrine. 2019 Jan 16. doi: 10.1007/s12020-018-01837-1. [Epub ahead of print] Review.
  3. Is VTE Prophylaxis Necessary on Discharge for Patients Undergoing Adrenalectomy for Cushing Syndrome?
    Babic B, De Roulet A, Volpe A, Nilubol N.
    J Endocr Soc. 2018 Dec 12;3(2):304-313. doi: 10.1210/js.2018-00278. eCollection 2019 Feb 1.
  4. Preoperative vitamin D levels do not relate with the risk of hypocalcemia following total thyroidectomy. A cohort study.
    Deffain A, Scipioni F, De Rienzo B, Allal S, Castagnet M, Kraimps JL, Donatini G.
    Minerva Chir. 2019 Feb;74(1):14-18. doi: 10.23736/S0026-4733.18.07456-4.
  5. Investigation on EMG Profiles of the Superior Laryngeal Nerve in a In Vivo Porcine Model.
    Zhao Y, Li C, Liu X, Zhou L, Zhang D, Xin J, Wang T, Li S, Sun H, Dionigi G.
    J Invest Surg. 2019 Jan 15:1-9. doi: 10.1080/08941939.2018.1547462. [Epub ahead of print]
  6. Thyroidectomy for thyroid cancer in the elderly: A meta-analysis.
    Joseph KR, Edirimanne S, Eslick GD.
    Eur J Surg Oncol. 2018 Sep 6. pii: S0748-7983(18)31258-7. doi: 10.1016/j.ejso.2018.07.055. [Epub ahead of print] Review.
  7. Can preoperative vitamin D deficiency predict postoperative hypoparathyroidism following thyroid surgery?
    Manzini G, Malhofer F, Weber T.
    Langenbecks Arch Surg. 2019 Jan 14. doi: 10.1007/s00423-019-01748-3. [Epub ahead of print]
  8. CUX2 functions as an oncogene in papillary thyroid cancer.
    Sun Y, Ye D, Li Y, Chen E, Hao R, Cai Y, Wang Q, Wang O, Zhang X.
    Onco Targets Ther. 2018 Dec 24;12:217-224. doi: 10.2147/OTT.S185710. eCollection 2019.
  9. The expression profile of integrin receptors and osteopontin in thyroid malignancies varies depending on the tumor progression rate and presence of BRAF V600E mutation.
    Chernaya G, Mikhno N, Khabalova T, Svyatchenko S, Mostovich L, Shevchenko S, Gulyaeva L.
    Surg Oncol. 2018 Dec;27(4):702-708. doi: 10.1016/j.suronc.2018.09.007. Epub 2018 Sep 22.
  10. Differentiated Thyroid Cancer Outcomes After Surgery and Activity-Adjusted 131I Theragnostics.  
    Avram AM, Rosculet N, Esfandiari NH, Gauger PG, Miller BS, Cohen M, Hughes DT.
    Clin Nucl Med. 2019 Jan;44(1):11-20. doi: 10.1097/RLU.0000000000002321.

January 14, 2019

  1. Appropriateness of the revised Japanese guidelines' risk classification for the prognosis of papillary thyroid carcinoma: a retrospective analysis of 5,845 papillary thyroid carcinoma patients.
    Ito Y, Miyauchi A, Oda H, Masuoka H, Higashiyama T, Kihara M, Miya A.
    Endocr J. 2019 Jan 9. doi: 10.1507/endocrj.EJ17-0061. [Epub ahead of print]
  2. Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas.
    Riccardi A, Aspir T, Shen L, Kuo CL, Brown TC, Korah R, Murtha TD, Bellizzi J, Parham K, Carling T, Costa-Guda J, Arnold A.
    J Clin Endocrinol Metab. 2019 Jan 8. doi: 10.1210/jc.2018-02517. [Epub ahead of print]]
  3. Distinct genome-wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors.
    Tirosh A, Mukherjee S, Lack J, Gara SK, Wang S, Quezado MM, Keutgen XM, Wu X, Cam M, Kumar S, Patel D, Nilubol N, Tyagi MV, Kebebew E.
    Cancer. 2019 Jan 8. doi: 10.1002/cncr.31930. [Epub ahead of print]
  4. Early <sup>18</sup>F-FDOPA PET/CT imaging after carbidopa premedication as a valuable diagnostic option in patients with insulinoma.
    Leroy-Freschini B, Amodru V, Addeo P, Sebag F, Vix M, Brunaud L, Klein M, Bahougne T, Bachellier P, Castinetti F, Goichot B, Chevalier E, Taieb D, Imperiale A.
    Eur J Nucl Med Mol Imaging. 2019 Jan 7. doi: 10.1007/s00259-018-4245-3. [Epub ahead of print]
  5. Selective Laryngeal Examination: Sensitivity of Endocrine Surgeons in Screening Voice Abnormality.
    Al-Yahya SN, Muhammad R, Suhaimi SNA, Azman M, Mohamed AS, Baki MM.
    J Voice. 2019 Jan 3. pii: S0892-1997(18)30395-3. doi: 10.1016/j.jvoice.2018.12.003. [Epub ahead of print].
  6. Surgical resection of neuroendocrine tumor liver metastases as part of multimodal treatment strategies: A propensity score matching analysis.
    Schreckenbach T, Hübert H, Koch C, Bojunga J, Schnitzbauer AA, Bechstein WO, Holzer K.
    Eur J Surg Oncol. 2018 Dec 28. pii: S0748-7983(18)32044-4. doi: 10.1016/j.ejso.2018.12.022. [Epub ahead of print]
  7. Human exposure to bisphenol AF and diethylhexylphthalate increases susceptibility to develop differentiated thyroid cancer in patients with thyroid nodules.
    Marotta V, Russo G, Gambardella C, Grasso M, La Sala D, Chiofalo MG, D'Anna R, Puzziello A, Docimo G, Masone S, Barbato F, Colao A, Faggiano A, Grumetto L.
    Chemosphere. 2019 Mar;218:885-894. doi: 10.1016/j.chemosphere.2018.11.084. Epub 2018 Nov 17.
  8. MicroRNA Expression in the Progression and Aggressiveness of Papillary Thyroid Carcinoma.
    Zembska A, Jawiarczyk-Przybyłowska A, Wojtczak B, Bolanowski M.
    Anticancer Res. 2019 Jan;39(1):33-40. doi: 10.21873/anticanres.13077. Review.
  9. Long-term functional voice outcomes after thyroidectomy, and effect of endotracheal intubation on voice.
    Sung ES, Kim KY, Yun BR, Song CM, Ji YB, Lee JC, Tae K.
    Eur Arch Otorhinolaryngol. 2018 Dec;275(12):3049-3058. doi: 10.1007/s00405-018-5145-7. Epub 2018 Sep 26.
  10. Bioengineered human pseudoislets form efficiently from donated tissue, compare favourably with native islets in vitro and restore normoglycaemia in mice.
    Yu Y, Gamble A, Pawlick R, Pepper AR, Salama B, Toms D, Razian G, Ellis C, Bruni A, Gala-Lopez B, Lu JL, Vovko H, Chiu C, Abdo S, Kin T, Korbutt G, Shapiro AMJ, Ungrin M.
    Diabetologia. 2018 Sep;61(9):2016-2029. doi: 10.1007/s00125-018-4672-5. Epub 2018 Jul 3.

December 31, 2018

  1. Remote-Access Thyroidectomy: A Multi-institutional North American Experience with Transaxillary, Robotic Facelift, and Transoral Endoscopic Vestibular Approach.
    Russell JO, Razavi CR, Garstka ME, Chen LW, Vasiliou E, Kang SW, Tufano RP, Kandil E.
    J Am Coll Surg. 2018 Dec 23. pii: S1072-7515(18)32229-4. doi: 10.1016/j.jamcollsurg.2018.12.005. [Epub ahead of print]
  2. Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1: A GTE and AFCE Cohort Study (Groupe d'étude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne).
    Vinault S, Mariet AS, Le Bras M, Mirallié E, Cardot-Bauters C, Pattou F, Ruszniewski P, Sauvanet A, Chanson P, Baudin E, Elias D, Menegaux F, Gaujoux S, Borson-Chazot F, Lifante JC, Caron P, Carrère N, Tabarin A, Laurent C, Klein M, Brunaud L, Niccoli P, Sebag F, Cadiot G, Kianmanesh R, Luu M, Binquet C, Goudet P.
    Ann Surg. 2018 Dec 21. doi: 10.1097/SLA.0000000000003162. [Epub ahead of print]
  3. Tumor multifocality with vagus nerve involvement as a phenotypic marker of SDHD mutation in patients with head and neck paragangliomas: A <sup>18</sup> F-FDOPA PET/CT study.
    Amodru V, Romanet P, Scemana U, Montava M, Fakhry N, Sebag F, Castinetti F, Lavieille JP, Loundou A, Varoquaux A, Barlier A, Pacak K, Taïeb D.
    Head Neck. 2018 Dec 24. doi: 10.1002/hed.25604. [Epub ahead of print]
  4. Peripheral primitive neuroectodermal tumor associated with paraneoplastic Cushing's syndrome: The rare case.
    Rahbar M, Rahbar M, Bahoush G.
    Ann Med Surg (Lond). 2018 Nov 29;37:21-24. doi: 10.1016/j.amsu.2018.11.018. eCollection 2019 Jan.
  5. Comparison of Intra-Operative Vital Sign Changes during Total Thyroidectomy in Patients with Controlled and Uncontrolled Graves' Disease.
    Yu HW, Bae IE, Kim SJ, Chai YJ, Moon JH, Ryu JH, Oh AY, Choi JY, Lee KE.
    J Clin Med. 2018 Dec 19;7(12). pii: E566. doi: 10.3390/jcm7120566.
  6. Genotypic characteristics and their association with phenotypic characteristics of hereditary medullary thyroid carcinoma in Korea.
    Jung KY, Kim SM, Kim MJ, Cho SW, Kim BW, Lee YS, Jeong JJ, Nam KH, Chung WY, Lee KE, Chung EJ, Kim HJ, Park DJ, Sung MW, Park CS, Cho BY, Park YJ, Chang HS.
    Surgery. World J Surg. 2018 Oct;42(10):3215-3222. doi: 10.1007/s00268-018-4629-3.
  7. Patient Frailty Should Be Used to Individualize Treatment Decisions in Primary Hyperparathyroidism.
    Seib CD, Chomsky-Higgins K, Gosnell JE, Shen WT, Suh I, Duh QY, Finlayson E.
    World J Surg. 2018 Oct;42(10):3215-3222. doi: 10.1007/s00268-018-4629-3.
  8. A cost-conscious approach to robotic adrenalectomy.
    Feng Z, Feng MP, Feng DP, Rice MJ, Solórzano CC.
    J Robot Surg. 2018 Dec;12(4):607-611. doi: 10.1007/s11701-018-0782-9. Epub 2018 Jan 31.
  9. Circulating BRAF<sup>V600E</sup> Levels Correlate with Treatment in Patients with Thyroid Carcinoma.
    Lubitz CC, Zhan T, Gunda V, Amin S, Gigliotti BJ, Fingeret AL, Holm TM, Wachtel H, Sadow PM, Wirth LJ, Sullivan RJ, Panka DJ, Parangi S.
    Thyroid. 2018 Mar;28(3):328-339. doi: 10.1089/thy.2017.0322. Epub 2018 Feb 27.
  10. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.  
    Oh HS, Kwon H, Song E, Jeon MJ, Song DE, Kim TY, Lee JH, Hong SJ, Kim WB, Shong YK, Baek JH, Kim WG.
    Thyroid. 2018 Mar;28(3):362-368. doi: 10.1089/thy.2017.0514. Epub 2018 Feb 15.

December 27, 2018

  1. Successful radiofrequency ablation strategies for benign thyroid nodules.
    Lee GM, You JY, Kim HY, Chai YJ, Kim HK, Dionigi G, Tufano RP.
    Endocrine. 2018 Dec 19. doi: 10.1007/s12020-018-1829-4. [Epub ahead of print]
  2. Cyclic Cushing's syndrome caused by neuroendocrine tumor: a case report.
    Wang K, Liu F, Wu C, Liu Y, Qi L, Yang X, Zheng H, Ma A, Wu J, Yan F, Hou X, Chen L, Dong M,
    Hou W. Endocr J. 2018 Dec 19. doi: 10.1507/endocrj.EJ18-0168. [Epub ahead of print]
  3. Tall Cell Variant of Papillary Thyroid Carcinoma: Impact of Change in WHO Definition and Molecular Analysis.
    Wong KS, Higgins SE, Marqusee E, Nehs MA, Angell T, Barletta JA.
    Endocr Pathol. 2018 Dec 18. doi: 10.1007/s12022-018-9561-4. [Epub ahead of print]
  4. Benign call rate and molecular test result distribution of ThyroSeq v3.
    Ohori NP, Landau MS, Carty SE, Yip L, LeBeau SO, Manroa P, Seethala RR, Schoedel KE, Nikiforova MN, Nikiforov YE
    Cancer Cytopathol. 2018 Dec 18. doi: 10.1002/cncy.22088. [Epub ahead of print]
  5. American Head and Neck Society Endocrine Section clinical consensus statement: North American quality statements and evidence-based multidisciplinary workflow algorithms for the evaluation and management of thyroid nodules.
    Meltzer CJ, Irish J, Angelos P, Busaidy NL, Davies L, Dwojak S, Ferris RL, Haugen BR, Harrell RM, Haymart MR, McIver B, Mechanick JI, Monteiro E, Morris JC 3rd, Morris LGT, Odell M, Scharpf J, Shaha A, Shin JJ, Shonka DC Jr, Thompson GB, Tuttle RM, Urken ML, Wiseman SM, Wong RJ, Randolph G.
    Head Neck. 2018 Dec 18. doi: 10.1002/hed.25526. [Epub ahead of print]
  6. Active surveillance for T1bN0M0 papillary thyroid carcinoma.
    Sakai T, Sugitani I, Ebina A, Fukuoka O, Toda K, Mitani H, Yamada K.
    Thyroid. 2018 Dec 18. doi: 10.1089/thy.2018.0462. [Epub ahead of print]
  7. Continuous Etomidate Infusion for the Management of Severe Cushing Syndrome: Validation of a Standard Protocol.
    Carroll TB, Peppard WJ, Herrmann DJ, Javorsky BR, Wang TS, Patel H, Zarnecki K, Findling JW.
    J Endocr Soc. 2018 Oct 26;3(1):1-12. doi: 10.1210/js.2018-00269. eCollection 2019 Jan 1.
  8. Epidemiology of parathyroid disorders.
    Rao SD.
    Best Pract Res Clin Endocrinol Metab. 2018 Dec 7. pii: S1521-690X(18)30139-8. doi: 10.1016/j.beem.2018.12.003. [Epub ahead of print] Review.
  9. Advanced age does not increase morbidity after total thyroidectomy. Result of a prospective study.
    Sasi Mouli V, Shreyamsa M, Gaurav K, Singh KR, Ramakant P, Mishra AK.
    Am J Surg. 2018 Nov 27. pii: S0002-9610(18)31502-2. doi:10.1016/j.amjsurg.2018.11.013. [Epub ahead of print] No abstract available.
  10. Adherence to ATA 2015 guidelines in the management of unifocal non-invasive papillary thyroid cancer: a clinical survey among endocrinologists and surgeons.
    Or K, Benbassat C, Koren S, Shteinshneider M, Koren R, Cantrell D, Kummer E, Muallem Kalmovich L.
    Eur Arch Otorhinolaryngol. 2018 Nov;275(11):2851-2859. doi: 10.1007/s00405-018-5126-x. Epub 2018  Sep 18.

December 11, 2018

  1. Socioeconomic disparities in a population of patients undergoing total thyroidectomy for benign disease.
    Wu TJ, Ha PK, El-Sayed IH, George JR, Heaton CM, Ryan WR, Russell MD.
    Head Neck. 2018 Dec 6. doi: 10.1002/hed.25421. [Epub ahead of print]
  2. Unexpected discrepancies in hospital administrative databases can impact the accuracy of monitoring thyroid surgery outcomes in France.
    Mercier F, Laplace N, Mitmaker EJ, Colin C, Kraimps JL, Sebag F, Bourdy S, Duclos A, Lifante JC;
    CATHY Study Group. PLoS One. 2018 Dec 6;13(12):e0208416. doi: 10.1371/journal.pone.0208416. eCollection 2018.
  3. How radical is total parathyroidectomy in patients with renal hyperparathyroidism?
    Burgstaller T, Selberherr A, Brammen L, Scheuba C, Kaczirek K, Riss P.
    Langenbecks Arch Surg. 2018 Dec 5. doi: 10.1007/s00423-018-1739-1. [Epub ahead of print]
  4. Parathyroid hormone induces a browning program in human white adipocytes.
    Hedesan OC, Fenzl A, Digruber A, Spirk K, Baumgartner-Parzer S, Bilban M, Kenner L, Vierhapper M, Elbe-Bürger A, Kiefer FW.
    Int J Obes (Lond). 2018 Dec 5. doi: 10.1038/s41366-018-0266-z. [Epub ahead of print]
  5. Carbon dioxide absorption during retroperitoneoscopic adrenalectomy: comparison between monolateral and synchronous bilateral approaches.  
    Perilli V, Aceto P, Punzo G, Lombardi CP, Bellantone R, Sollazzi L.
    Updates Surg. 2018 Dec 1. doi: 10.1007/s13304-018-00610-3. [Epub ahead of print]
  6. Long-term effects of radioiodine treatment on salivary gland function in adult survivors of pediatric differentiated thyroid carcinoma.
    Selvakumar T, Nies M, Klein Hesselink MS, Brouwers AH, van der Horst-Schrivers ANA, Klein Hesselink EN, Tissing WJE, Vissink A, Links TP.
    J Nucl Med. 2018 Nov 30. pii: jnumed.118.212449. doi: 10.2967/jnumed.118.212449. [Epub ahead of print]
  7. Systematic review of cure and recurrence rates following minimally invasive parathyroidectomy
    Ishii H, Mihai R, Watkinson JC, Kim DS.
    BJS Open. 2018 May 28;2(6):364-370. doi: 10.1002/bjs5.77. eCollection 2018 Dec. Review.
  8. How does neural monitoring help during thyroid sugery for Graves' disease?
    Zhou L, Dionigi G, Pontin A, Pino A, Caruso E, Wu CW, Sun H, Tufano RP, Kim HY.
    J Clin Transl Endocrinol. 2018 Nov 20;15:6-11. doi: 10.1016/j.jcte.2018.11.002. eCollection 2019 Mar.
  9. Diversity and inclusion in a surgical society: A longitudinal investigation.
    Kuo LE, Parangi S, Cho NL.
    Surgery. 2018 Nov 30. pii: S0039-6060(18)30742-6. doi: 10.1016/j.surg.2018.10.027. [Epub ahead of print]
  10. The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer.
    Zarkesh M, Zadeh-Vakili A, Akbarzadeh M, Fanaei SA, Hedayati M, Azizi F.
    BMC Cancer. 2018 Dec 3;18(1):1199. doi: 10.1186/s12885-018-5112-0.

December 3, 2018

  1. Prognostic significance of immunohistochemical markers in adrenocortical carcinoma.
    Zlatibor L, Paunovic I, Zivaljevic V, Dundjerovic D, Tatic S, Djukic V.
    Acta Chir Belg. 2018 Nov 30:1-7. doi: 10.1080/00015458.2018.1543822. [Epub ahead of print]
  2. Transcutaneous laryngeal ultrasonography (TLUS) as an alternative to direct flexible laryngoscopy (DFL) in the perioperative evaluation of the vocal cord mobility in thyroid surgery.
    Knyazeva P, Makarin V, Seeliger B, Chernikov R, Sleptsov I, Semenov A, Walz MK, Alesina PF.
    Langenbecks Arch Surg. 2018 Nov 28. doi: 10.1007/s00423-018-1734-6. [Epub ahead of print]
  3. European perspective on the 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Proceedings of an interactive international symposium.
    Luster M, Aktolun C, Amendoeira I, Barczyński M, Bible KC, Duntas LH, Elisei R, Handkiewicz-Junak D, Hoffmann M, Jarzab B, Leenhardt L, Musholt TJ, Newbold K, Nixon IJ, Smit J, Sobrinho-Simões M, Sosa JA, Tuttle RM MD, Verburg F, Wartofsky L, Führer-Sakel D.
    Thyroid. 2018 Nov 28. doi: 10.1089/thy.2017.0129. [Epub ahead of print]
  4. Rapid Relief: Thyroidectomy is a Quicker Cure than Radioactive Iodine Ablation (RAI) in Patients with Hyperthyroidism.
    Davis JR, Dackiw AP, Holt SA, Nwariaku FE, Oltmann SC.
    World J Surg. 2018 Nov 27. doi: 10.1007/s00268-018-4864-7. [Epub ahead of print]
  5. Analysis of the Increase in Bone Mineral Density After Surgical Treatment of Primary Hyperparathyroidism.
    Mendoza-Moreno F, Díez-Alonso M, Ovejero-Merino E, Sánchez-Gollarte A, Alvarado-Hurtado R, Matías-García B, Rodríguez-Pascual Á, Medina-Reinoso C, Ratia-Jiménez T, Hernández-Merlo F, Granell-Vicent J.
    J Clin Densitom. 2018 Nov 9. pii: S1094-6950(18)30189-6. doi: 10.1016/j.jocd.2018.11.001. [Epub ahead of print] Review.
  6. Long-term Endocrine and Metabolic consequences of Cancer Treatment: A Systematic Review.
    Gebauer J, Higham C, Langer T, Denzer C, Brabant G.
    Endocr Rev. 2018 Nov 23. doi: 10.1210/er.2018-00092. [Epub ahead of print]
  7. Risk of severe erectile dysfunction in primary hyperaldosteronism: A population-based propensity score matching cohort study.
    Chang CH, Chueh SJ, Wu VC, Chen L, Lin YH, Hu YH, Wu KD, Tsai YC.
    Surgery. 2018 Nov 22. pii: S0039-6060(18)30556-7. doi: 10.1016/j.surg.2018.08.020. [Epub ahead of print]
  8. Long-term outcomes of renal function after radioactive iodine therapy for thyroid cancer according to preparation method: thyroid hormone withdrawal vs. recombinant human thyrotropin.
    Cho YY, Kim SK, Jung JH, Hahm JR, Kim TH, Chung JH, Kim SW.
    Endocrine. 2018 Nov 23. doi: 10.1007/s12020-018-1807-x. [Epub ahead of print]
  9. Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection.
    Ryu YJ, Cho JS, Yoon JH, Park MH.
    World J Surg Oncol. 2018 Oct 12;16(1):205. doi: 10.1186/s12957-018-1496-1.
  10. Role of positron emission tomography in thyroid and neuroendocrine tumors.
    Treglia G, Kroiss AS, Piccardo A, Lococo F, Santhanam P, Imperiale A.
    Minerva Endocrinol. 2018 Sep;43(3):341-355. doi: 10.23736/S0391-1977.17.02742-0. Epub 2017 Sep 25. Review.

November 28, 2018

  1. TIRADS Interobserver Variability Among Indeterminate Thyroid Nodules: A Single-Institution Study.
    Sahli ZT, Sharma AK, Canner JK, Karipineni F, Ali O, Kawamoto S, Hang JF, Mathur A, Ali SZ, Zeiger MA, Sheth S.
    J Ultrasound Med. 2018 Nov 22. doi: 10.1002/jum.14870. [Epub ahead of print]
  2. Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission.
    Schernthaner-Reiter MH, Siess C, Gessl A, Scheuba C, Wolfsberger S, Riss P, Knosp E, Luger A, Vila G.
    Endocrine. 2018 Nov 22. doi: 10.1007/s12020-018-1819-6. [Epub ahead of print]
  3. Novel rearrangements involving the RET gene in papillary thyroid carcinoma.
    Staubitz JI, Schad A, Springer E, Rajalingam K, Lang H, Roth W, Hartmann N, Musholt TJ.
    Cancer Genet. 2018 Nov 13. pii: S2210-7762(18)30372-7. doi: 10.1016/j.cancergen.2018.11.002. [Epub ahead of print]
  4. Intraoperative Probe-Based Confocal Endomicroscopy to Histologically Differentiate Thyroid From Parathyroid Tissue Before Resection.
    Ignat M, Lindner V, Vix M, Marescaux J, Mutter D.
    Surg Innov. 2018 Nov 23:1553350618814078. doi: 10.1177/1553350618814078. [Epub ahead of print]
  5. Diagnosis, anatomy, and electromyography profiles of 73 nonrecurrent laryngeal nerves.
    Wang T, Dionigi G, Zhang D, Bian X, Zhou L, Fu Y, Zhang G, Liu X, Sun H.
    Head Neck. 2018 Nov 22. doi: 10.1002/hed.25391. [Epub ahead of print]
  6. Timely Evaluation and Management of Primary Hyperparathyroidism in Patients With Kidney Stones.
    Perez AA, Schneider DF, Long KL, Pitt SC, Sippel RS.
    J Surg Res. 2018 Dec;232:564-569. doi: 10.1016/j.jss.2018.07.028. Epub 2018 Aug 7.
  7. Pheochromocytoma Characteristics and Behavior Differ Depending on Method of Discovery.
    Gruber LM, Hartman RP, Thompson GB, McKenzie TJ, Lyden ML, Dy BM, Young WF Jr, Bancos I.
    J Clin Endocrinol Metab. 2018 Nov 19. doi: 10.1210/jc.2018-01707. [Epub ahead of print]
  8. Intraoperative Decision-Making and Technical Aspects of Parathyroidectomy in Young Patients With MEN1 Related Hyperparathyroidism.
    Nobecourt PF, Zagzag J, Asare EA, Perrier ND.
    Front Endocrinol (Lausanne). 2018 Oct 16;9:618. doi: 10.3389/fendo.2018.00618. eCollection 2018.
  9. Neuroendocrine Liver Metastasis-a Specific Set of Markers to Detect Primary Tumor Sites.
    Selberherr A, Koperek O, Riss P, Scheuba C, Kaderli R, Perren A, Niederle B.
    Endocr Pathol. 2018 Nov 19. doi: 10.1007/s12022-018-9558-z. [Epub ahead of print]
  10. Proteinase K treatment improves RNA recovery from thyroid cells fixed with liquid-based cytology solution.
    Jikuzono T, Horikawa A, Ishikawa T, Hirokawa M, Sugitani I, Inui T, Ishibashi O.
    BMC Res Notes. 2018 Nov 20;11(1):822. doi: 10.1186/s13104-018-3914-4.

November 19, 2018

  1. Calcium-stimulated calcitonin - The "new standard" in the diagnosis of thyroid C-cell disease - clinically relevant gender-specific cut-off levels for an "old test".
    Niederle MB, Scheuba C, Gessl A, Li S, Koperek O, Bieglmayer C, Riss P, Selberherr A, Niederle B.
    Biochem Med (Zagreb). 2018 Oct 15;28(3):030710. doi: 10.11613/BM.2018.030710.
  2. Changes of computed tomography-based body composition after adrenalectomy in patients with endogenous hypercortisolism.
    Hong N, Lee J, Ku CR, Han K, Lee CR, Kang SW, Rhee Y.
    Clin Endocrinol (Oxf). 2018 Nov 14. doi: 10.1111/cen.13902. [Epub ahead of print]
  3. Opioid Prescribing Practice and Needs in Thyroid and Parathyroid Surgery.
    Shindo M, Lim J, Leon E, Moneta L, Li R, Quintinalla-Diek L.
    JAMA Otolaryngol Head Neck Surg. 2018 Oct 25. doi: 10.1001/jamaoto.2018.2427. [Epub ahead of print]
  4. NIFT-P: Are they indolent tumors? Results of a multi-institutional study.
    Chereau N, Greilsamer T, Mirallié E, Sadowski SM, Pusztaszeri M, Triponez F, Baud G, Pattou F, Christou N, Mathonnet M, Brunaud L, Santucci N, Goudet P, Guérin C, Sebag F, Donatini G, Kraimps JL, Tissier F, Lussey C, Leenhardt L, Menegaux F.
    Surgery. 2018 Nov 9. pii: S0039-6060(18)30624-X. doi: 10.1016/j.surg.2018.04.089. [Epub ahead of print]
  5. End-organ effects of primary hyperparathyroidism: A population-based study.
    Assadipour Y, Zhou H, Kuo EJ, Haigh PI, Adams AL, Yeh MW.
    Surgery. 2018 Nov 9. pii: S0039-6060(18)30621-4. doi: 10.1016/j.surg.2018.04.088. [Epub ahead of print]
  6. Anterior laryngeal electrodes for recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: New expanded options for neural monitoring.
    Liddy W, Lawson BR, Barber SR, Kamani D, Shama M, Soylu S, Wu CW, Chiang FY, Scharpf J, Barczynski M, Dralle H, Van Slycke S, Schneider R, Dionigi G, Randolph GW.
    Laryngoscope. 2018 Nov 12. doi: 10.1002/lary.27362. [Epub ahead of print]
  7. The effect of total thyroidectomy on the recovery of bone mineral density in subjects with hyperthyroidism.
    Karunakaran P, Maharajan C, Chockalingam R, Asokumar P, Koramadai Karuppusamy K, Sadasivam V.
    Surgery. 2018 Nov 8. pii: S0039-6060(18)30630-5. doi: 10.1016/j.surg.2018.05.082. [Epub ahead of print]
  8. Unilateral benign multinodular versus solitary goiter: Long-term contralateral reoperation rates after lobectomy.
    de Rienzo-Madero B, Sabra JP, Gand E, Donatini G, Kraimps JL.
    Surgery. 2018 Nov 8. pii: S0039-6060(18)30571-3. doi: 10.1016/j.surg.2018.04.074. [Epub ahead of print]
  9. The association between the ultrasonography TIRADS classification system and surgical pathology among indeterminate thyroid nodules.
    Sahli ZT, Karipineni F, Hang JF, Canner JK, Mathur A, Prescott JD, Sheth S, Ali SZ, Zeiger MA.
    Surgery. 2018 Nov 8. pii: S0039-6060(18)30629-9. doi: 10.1016/j.surg.2018.04.094. [Epub ahead of print]
  10. Are PROMs ideally suited for most common endocrine surgical patients and procedures?.
    Oltmann SC, Nwariaku FE.
    Surgery. 2018 Nov 8. pii: S0039-6060(18)30654-8. doi: 10.1016/j.surg.2018.08.034. [Epub ahead of print] No abstract available.

November 5, 2018

  1. Impact of the American Thyroid Association guidelines on the Australian surgical management of papillary thyroid cancer.
    Cole-Clark D, Townend PJ, Engelsman A, Wong MS, Sywak M, Glover A, Sidhu SB.
    ANZ J Surg. 2018 Nov;88(11):1102-1103. doi: 10.1111/ans.14804. No abstract available.
    Koren S, Shteinshnaider M, Or K, Cantrell D, Benbassat CA, Koren R.
    Endocr Pract. 2018 Nov 1. doi: 10.4158/EP-2018-0386. [Epub ahead of print]
    Harrell RM, Eyerly-Webb SA, Golding AC, Edwards CM, Bimston DN.
    Endocr Pract. 2018 Nov 1. doi: 10.4158/EP-2018-0395. [Epub ahead of print]
  4. Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation.
    Capozza M, Chinellato I, Guarnieri V, Di Lorgi N, Accadia M, Traggiai C, Mattioli G, Di Mauro A, Laforgia N.
    BMC Pediatr. 2018 Oct 30;18(1):340. doi: 10.1186/s12887-018-1319-0.
  5. Regeneration of a bioengineered thyroid using decellularized thyroid matrix.
    Pan J, Li H, Fang Y, Shen Y, Zhou X, Zhu F, Zhu L, Du Y, Yu X, Wang Y, Zhou XH, Wang Y, Wu Y.
    Thyroid. 2018 Oct 30. doi: 10.1089/thy.2018.0068. [Epub ahead of print]
  6. Thyroid Swelling: A Common Phenomenon in Art?
    Accorona R, Huskens I, Meulemans J, Cappelli C, Nicolai P, Lombardi D.
    Eur Thyroid J. 2018 Oct;7(5):272-278. doi: 10.1159/000488315. Epub 2018 May 3.
  7. Differentiated Thyroid Cancer Outcomes After Surgery and Activity-Adjusted 131I Theragnostics.
    Avram AM, Rosculet N, Esfandiari NH, Gauger PG, Miller BS, Cohen M, Hughes DT.
    Clin Nucl Med. 2018 Oct 27. doi: 10.1097/RLU.0000000000002321. [Epub ahead of print]
  8. A Systematic Review and Meta-analysis of Subsequent Malignant Neoplasm Risk after Radioactive Iodine Treatment of Thyroid Cancer.
    Yu CY, Saeed O, Goldberg AS, Farooq S, Fazelzad R, Goldstein DP, Tsang RW, Brierley J, Ezzat S, Thabane L, Goldsmith CH, Sawka AM.
    Thyroid. 2018 Oct 27. doi: 10.1089/thy.2018.0244. [Epub ahead of print]
  9. Radial Fracture Due to Parathyroid Carcinoma.
    Suzuki T, Tomiie Y.
    N Engl J Med. 2018 Oct 11;379(15):e24. doi: 10.1056/NEJMicm1710426. No abstract available.
  10. TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma.
    Svahn F, Paulsson JO, Stenman A, Fotouhi O, Mu N, Murtha TD, Korah R, Carling T, Bäckdahl M, Wang N, Juhlin CC, Larsson C.
    Int J Mol Med. 2018 Sep;42(3):1675-1683. doi: 10.3892/ijmm.2018.3735. Epub 2018 Jun 20.

October 29, 2018

  1. Independent predisposing factors for subcutaneous and deep wound collection after total thyroidectomy, a prospective cohort study.
    Eweida AM, Ebeed HM, Sakr MF, Hamza Y, Gabr E, Koraitim T, Al-Wagih HF, Abo-Elwafa W, Abdel-Aziz TE, Nabawi AS.
    Ann Med Surg (Lond). 2018 Oct 14;36:10-16. doi: 10.1016/j.amsu.2018.10.015. eCollection 2018 Dec.
  2. When Parathyroidectomy Should Be Indicated or Postponed in Adolescents With MEN1-Related Primary Hyperparathyroidism.
    Marini F, Giusti F, Tonelli F, Brandi ML
    Front Endocrinol (Lausanne). 2018 Oct 5;9:597. doi: 10.3389/fendo.2018.00597. eCollection 2018.
  3. Preliminary Exploration of Potential Molecular Therapeutic Targets in Recurrent and Metastatic Parathyroid Carcinomas.
    Cui M, Hu Y, Bi Y, Wang W, Wang M, Zhang X, Zhang R, Wang P, Su Z, Gao X, Wang J, Li Q, Liao Q, Zhao Y.
    Int J Cancer. 2018 Oct 26. doi: 10.1002/ijc.31948. [Epub ahead of print]
  4. Galectin-3 targeting in thyroid orthotopic tumors opens new ways to characterize thyroid cancer.
    De Rose F, Braeuer M, Braesch-Andersen S, Otto AM, Steiger K, Reder S, Mall S, Nekolla S, Schwaiger M, Weber WA, Bartolazzi A, D'Alessandria C.
    J Nucl Med. 2018 Oct 25. pii: jnumed.118.219105. doi: 10.2967/jnumed.118.219105. [Epub ahead of print]
  5. Interinstitutional variation in predictive value of the ThyroSeq v2 genomic classifier for cytologically indeterminate thyroid nodules.
    Marcadis AR, Valderrabano P, Ho AS, Tepe J, Swartzwelder CE, Byrd S, Sacks WL, Untch BR, Shaha AR, Xu B, Lin O, Ghossein RA, Wong RJ, Marti JL, Morris LGT.
    Surgery. 2018 Oct 22. pii: S0039-6060(18)30502-6. doi: 10.1016/j.surg.2018.04.062. [Epub ahead of print]
  6. Intraoperative parathyroid hormone testing in primary hyperparathyroidism surgery: time for giving up?
    Sartori PV, Saibene AM, Leopaldi E, Boniardi M, Beretta E, Colombo S, Morenghi E, Pauna J, De Pasquale L.
    Eur Arch Otorhinolaryngol. 2018 Oct 24. doi: 10.1007/s00405-018-5179-x. [Epub ahead of print]
  7. Vocal Cord Palsies Missed by Transcutaneous Laryngeal Ultrasound (TLUSG): Do They Experience Worse Outcomes?
    Wong KP, Au KP, Lam S, Chang YK, Lang BHH.
    World J Surg. 2018 Oct 23. doi: 10.1007/s00268-018-4826-0. [Epub ahead of print]
  8. Laparoscopic Hand Assisted Adrenalectomy for Tumours larger than 5cm.
    Buxton J, Vun SH, van Dellen D, Wadsworth R, Augustine T.
    Clin Endocrinol (Oxf). 2018 Oct 22. doi: 10.1111/cen.13883. [Epub ahead of print]
  9. Surgical treatment of congenital hyperinsulinism: Results from 500 pancreatectomies in neonates and children.
    Adzick NS, De Leon DD, States LJ, Lord K, Bhatti TR, Becker SA, Stanley CA.
    J Pediatr Surg. 2018 Oct 5. pii: S0022-3468(18)30648-1. doi: 10.1016/j.jpedsurg.2018.10.030. [Epub ahead of print]
  10. Longitudinal patterns of recurrence in patients with adrenocortical carcinoma.
    Glenn JA, Else T, Hughes DT, Cohen MS, Jolly S, Giordano TJ, Worden FP, Gauger PG, Hammer GD, Miller BS.
    Surgery. 2018 Oct 18. pii: S0039-6060(18)30530-0. doi: 10.1016/j.surg.2018.04.068. [Epub ahead of print]

October 23, 2018

  1. UMD-MEN1 database: an overview of the 370 MEN1 variants present in 1,676 patients from the French population.
    Romanet P, Mohamed A, Giraud S, Odou MF, North MO, Pertuit M, Pasmant E, Coppin L, Guien C, Calender A, Borson-Chazot F, Béroud C, Goudet P, Barlier A.
    J Clin Endocrinol Metab. 2018 Oct 18. doi: 10.1210/jc.2018-01170. [Epub ahead of print]
  2. Effects of Obesity and Gastric Bypass Surgery on Nutrient Sensors, Endocrine Cells, and Mucosal Innervation of the Mouse Colon.
    Peiris M, Aktar R, Raynel S, Hao Z, Mumphrey MB, Berthoud HR, Blackshaw LA. 
    Nutrients. 2018 Oct 17;10(10). pii: E1529. doi: 10.3390/nu10101529.
  3. Thyroid ultrasonography reporting: consensus of Italian Thyroid Association (AIT), Italian Society of Endocrinology (SIE), Italian Society of Ultrasonography in Medicine and Biology (SIUMB) and Ultrasound Chapter of Italian Society of Medical Radiology (SIRM).
    Rago T, Cantisani V, Ianni F, Chiovato L, Garberoglio R, Durante C, Frasoldati A, Spiezia S, Farina R, Vallone G, Pontecorvi A, Vitti P.
    J Endocrinol Invest. 2018 Oct 16. doi: 10.1007/s40618-018-0935-8. [Epub ahead of print]
  4. Bone mineral density changes after parathyroidectomy are dependent on biochemical profile
    Lee D, Walker MD, Chen HY, Chabot JA, Lee JA, Kuo JH.
    Surgery. 2018 Oct 13. pii: S0039-6060(18)30508-7. doi: 10.1016/j.surg.2018.04.065. [Epub ahead of print]
  5. Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment
    El Lakis M, Giannakou A, Nockel PJ, Wiseman D, Gara SK, Patel D, Sater ZA, Kushchayeva YY, Klubo-Gwiezdzinska J, Nilubol N, Merino MJ, Kebebew E.
    Surgery. 2018 Oct 13. pii: S0039-6060(18)30509-9. doi: 10.1016/j.surg.2018.05.075. [Epub ahead of print]
  6. The devil is in the details: Assessing treatment and outcomes of 6,795 patients undergoing remedial parathyroidectomy in the Collaborative Endocrine Surgery Quality Improvement Program.
    Kazaure HS, Thomas S, Scheri RP, Stang MT, Roman SA, Sosa JA.
    Surgery. 2018 Oct 13. pii: S0039-6060(18)30526-9. doi: 10.1016/j.surg.2018.03.026. [Epub ahead of print]
  7. Contributions of fluorescence to endocrine surgery
    Bonnin-Pascual J, Álvarez-Segurado C, Jiménez-Segovia M, Bianchi A, Bonnin-Pascual F, Molina-Romero FX, González-Argente FX.
    Cir Esp. 2018 Oct 13. pii: S0009-739X(18)30250-1. doi: 10.1016/j.ciresp.2018.09.005. [Epub ahead of print] English, Spanish.
  8. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: What is in a name?
    Lubitz C.
    Cancer Cytopathol. 2018 Oct 16. doi: 10.1002/cncy.22065. [Epub ahead of print] No abstract available.
  9. Postoperative Pain Control and Opioid Usage Patterns among Patients Undergoing Thyroidectomy and Parathyroidectomy.
    Tharakan T, Jiang S, Fastenberg J, Ow TJ, Schiff B, Smith RV, Mehta V.
    Otolaryngol Head Neck Surg. 2018 Oct 16:194599818797574. doi: 10.1177/0194599818797574. [Epub ahead of print]
  10. Dynamic risk stratification in papillary thyroid carcinoma measuring 1 to 4 cm.
    Lee YM, Cho JW, Hong SJ, Yoon JH.
    J Surg Oncol. 2018 Sep;118(4):636-643. doi: 10.1002/jso.25182. Epub 2018 Aug 16.

October 19, 2018

  1. Transoral Robotic Thyroidectomy: Comparison of Surgical Outcomes Between the da Vinci Xi and Si.
    Kim HK, Kim HY, Chai YJ, Dionigi G, Berber E, Tufano RP.
    Surg Laparosc Endosc Percutan Tech. 2018 Oct 11. doi: 10.1097/SLE.0000000000000587. [Epub ahead of print]
  2. The effects of sampling lateralization on bilateral inferior petrosal sinus sampling and desmopressin stimulation test for pediatric Cushing's disease.
    Chen S, Chen K, Lu L, Zhang X, Tong A, Pan H, Zhu H, Lu Z.
    Endocrine. 2018 Oct 11. doi: 10.1007/s12020-018-1779-x. [Epub ahead of print]
  3. TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma.
    Paulsson JO, Olander A, Haglund F, Zedenius J, Juhlin CC.
    Endocr Pathol. 2018 Oct 10. doi: 10.1007/s12022-018-9551-6. [Epub ahead of print] No abstract available.
  4. Medullary Thyroid Carcinoma: Do Ultrasonography and F-DOPA-PET-CT Influence the Initial Surgical Strategy?
    Brammen L, Niederle MB, Riss P, Scheuba C, Selberherr A, Karanikas G, Bodner G, Koperek O, Niederle B.
    Ann Surg Oncol. 2018 Oct 10. doi: 10.1245/s10434-018-6829-3. [Epub ahead of print]
  5. C-cell hyperplasia in sporadic and familial medullary thyroid carcinoma.
    Yadav M, Agrawal V, Pani KC, Verma R, Jaiswal S, Mishra A, Pandey R.
    Indian J Pathol Microbiol. 2018 Oct-Dec;61(4):485-488. doi: 10.4103/IJPM.IJPM_478_17.
  6. Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors.
    Gara SK, Lack J, Zhang L, Harris E, Cam M, Kebebew E.25.
    Nat Commun. 2018 Oct 9;9(1):4172. doi: 10.1038/s41467-018-06366-z.
  7. The effect of surgery on fat mass, lipid and glucose metabolism in mild primary hyperparathyroidism
    Godang K, Lundstam K, Mollerup C, Fougner F, Pernow Y, Nordenström J, Rosén T, Jansson S, Hellström M, Bollerslev J, Heck A;
    The SIPH Study Group. Endocr Connect. 2018 Aug 1;7(8):941-948. doi: 10.1530/EC-18-0259.
  8. Ultrasound Elastography is a Useful Adjunct to Conventional Ultrasonography and Needle Aspiration in Preoperative Prediction of Malignancy in Thyroid Nodules: A Northern India Perspective
    Garg M, Khandelwal D, Aggarwal V, Raja KB, Kalra S, Agarwal B, Dutta D.
    Indian J Endocrinol Metab. 2018 Sep-Oct;22(5):589-596. doi: 10.4103/ijem.IJEM_634_17.
  9. International neuromonitoring study group guidelines 2018: Part II: Optimal recurrent laryngeal nerve management for invasive thyroid cancer-incorporation of surgical, laryngeal, and neural electrophysiologic data.
    Wu CW, Dionigi G, Barczynski M, Chiang FY, Dralle H, Schneider R, Al-Quaryshi Z, Angelos P, Brauckhoff K, Brooks JA, Cernea CR, Chaplin J, Chen AY, Davies L, Diercks GR, Duh QY, Fundakowski C, Goretzki PE, Hales NW, Hartl D, Kamani D, Kandil E, Kyriazidis N, Liddy W, Miyauchi A, Orloff L, Rastatter JC, Scharpf J, Serpell J, Shin JJ, Sinclair CF, Stack BC Jr, Tolley NS, Slycke SV, Snyder SK, Urken ML, Volpi E, Witterick I, Wong RJ, Woodson G, Zafereo M, Randolph GW.
    Laryngoscope. 2018 Oct 6. doi: 10.1002/lary.27360.
  10. Bilateral chylothorax following reoperative central neck dissection for metastatic papillary thyroid cancer.
    Sharma AK, Sahli ZT, Mathur A.
    BMJ Case Rep. 2018 Apr 17;2018. pii: bcr-2018-224916. doi: 10.1136/bcr-2018-224916.

October 10, 2018

  1. International neural monitoring study group guideline 2018 part I: Staging bilateral thyroid surgery with monitoring loss of signal.
    Schneider R, Randolph GW, Dionigi G, Wu CW, Barczynski M, Chiang FY, Al-Quaryshi Z, Angelos P, Brauckhoff K, Cernea CR, Chaplin J, Cheetham J, Davies L, Goretzki PE, Hartl D, Kamani D, Kandil E, Kyriazidis N, Liddy W, Orloff L, Scharpf J, Serpell J, Shin JJ, Sinclair CF, Singer MC, Snyder SK, Tolley NS, Van Slycke S, Volpi E, Witterick I, Wong RJ, Woodson G, Zafereo M, Dralle H.
    Laryngoscope. 2018 Oct 5. doi: 10.1002/lary.27359. [Epub ahead of print]
  2. Results of Duodenopancreatic Reoperations in Multiple Endocrine Neoplasia Type 1.
    Albers MB, Manoharan J, Bollmann C, Chlosta MP, Holzer K, Bartsch DK.
    World J Surg. 2018 Oct 4. doi: 10.1007/s00268-018-4809-1. [Epub ahead of print]
  3. SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for  refractory thyroid Cancer.
    Kim SY, Kim SM, Chang HJ, Kim BW, Lee YS, Park CS, Park KC, Chang HS.
    BMC Cancer. 2018 Oct 4;18(1):956. doi: 10.1186/s12885-018-4854-z.
  4. Bone Health After Bariatric Surgery.
    Gagnon C, Schafer AL.
    JBMR Plus. 2018 May 1;2(3):121-133. doi: 10.1002/jbm4.10048. eCollection 2018 May. Review.
  5. Can Suspicious Ultrasound Features Predict BRAFV600E Status in Papillary Thyroid Cancer?
    Khadra H, Deniwar A, Mohsin K, Monlezun D, Kandil E.
    Eur Thyroid J. 2018 Aug;7(4):205-210. doi: 10.1159/000489851. Epub 2018 Jul 5.
  6. 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism
    Kahaly GJ, Bartalena L, Hegedüs L, Leenhardt L, Poppe K, Pearce SH.
    Eur Thyroid J. 2018 Aug;7(4):167-186. doi: 10.1159/000490384. Epub 2018 Jul 25.
  7. The surgical choice for unilateral thyroid carcinoma in pediatrics: Lobectomy or total thyroidectomy?
    Zong Y, Li K, Dong K, Yao W, Liu G, Xiao X.
    J Pediatr Surg. 2018 Sep 14. pii: S0022-3468(18)30533-5. doi: 10.1016/j.jpedsurg.2018.08.027. [Epub ahead of print]
  8. Large Cytologically Benign Thyroid Nodules Do Not Have High Rates of Malignancy or False-Negative Rates and Clinical Observation Should be Considered: A Meta-Analysis
    Cipriani NA, White MG, Angelos P, Grogan RH.
    Thyroid. 2018 Oct 3. doi: 10.1089/thy.2018.0221. [Epub ahead of print]
  9. Can We Re-Engineer the Endocrine Pancreas?
    Citro A, Ott HC.
    Curr Diab Rep. 2018 Oct 2;18(11):122. doi: 10.1007/s11892-018-1072-7. Review.
  10. The magic of endocrine surgery: Our origins, our legacy, our future.
    Zeiger MA.
    Surgery. 2018 Sep 26. pii: S0039-6060(18)30538-5. doi: 10.1016/j.surg.2018.08.018. [Epub ahead of print] No abstract available.

October 2, 2018

  1. Usefulness of iodine-123 whole-body scan in planning iodine-131 treatment of the differentiated thyroid carcinoma in children and adolescence.
    Villani MF, Grossi A, Cassano B, Pizzoferro M, Ubertini G, Longo M, Garganese MC.
     Nucl Med Commun. 2018 Sep 26. doi: 10.1097/MNM.0000000000000922. [Epub ahead of print]
  2. TEKT4 Promotes Papillary Thyroid Cancer Cell Proliferation, Colony Formation, and Metastasis through Activating PI3K/Akt Pathway.
    Zheng Z, Zhou X, Cai Y, Chen E, Zhang X, Wang O, Wang Q, Liu H.
    Endocr Pathol. 2018 Sep 25. doi: 10.1007/s12022-018-9549-0. [Epub ahead of print]
  3. Current Standards and Recent Advances in Biomarkers of Major Endocrine Tumors.
    Luo Y, Zhu H, Tan T, He J.
    Front Pharmacol. 2018 Sep 10;9:963. doi: 10.3389/fphar.2018.00963. eCollection 2018. Review.
  4. Should the duration of primary hyperparathyroidism impact guidelines for evaluation and treatment?
    Randle RW, Lee CY.
    Surgery. 2018 Sep 22. pii: S0039-6060(18)30541-5. doi: 10.1016/j.surg.2018.07.044. [Epub ahead of print] No abstract available.
  5. Prediction of Postoperative Vocal Fold Function After Intraoperative Recovery of Loss of Signal.
    Schneider R, Randolph G, Dionigi G, Barczynski M, Chiang FY, Wu CW, Musholt T, Uludag M, Makay Ö, Sezer A, Teksöz S, Weber T, Sekulla C, Lorenz K, Özdemir M, Machens A, Dralle H. Laryngoscope.
     2018 Sep 24. doi: 10.1002/lary.27327. [Epub ahead of print]
  6. Thyroid disorders induced by checkpoint inhibitors.
    Ferrari SM, Fallahi P, Galetta F, Citi E, Benvenga S, Antonelli A.
    Rev Endocr Metab Disord. 2018 Sep 21. doi: 10.1007/s11154-018-9463-2. [Epub ahead of print] Review.
  7. Surgical management of large adrenal tumors: impact of different laparoscopic approaches and resection methods on perioperative and long-term outcomes.
    Chen W, Liang Y, Lin W, Fu GQ, Ma ZW.
    BMC Urol. 2018 May 8;18(1):31. doi: 10.1186/s12894-018-0349-0.
  8. Are Cushing's disease patients curable?
    Bertagna X.
    Ann Endocrinol (Paris). 2018 Jun;79(3):153-156. doi: 10.1016/j.ando.2018.03.012. Epub 2018 Apr 9. Review.
  9. Efficacy and safety of metyrosine in pheochromocytoma/paraganglioma: a multi-center trial in Japan.
    Naruse M, Satoh F, Tanabe A, Okamoto T, Ichihara A, Tsuiki M, Katabami T, Nomura M, Tanaka T, Matsuda T, Imai T, Yamada M, Harada T, Kawata N, Takekoshi K.
    Endocr J. 2018 Mar 28;65(3):359-371. doi: 10.1507/endocrj.EJ17-0276. Epub 2018 Jan 20.
  10. Thirty-day readmissions following parathyroidectomy: Evidence from the National Readmissions Database, 2013-2014.
    Kravietz AM, Buicko JL, Parreco JP, Lopez MA, Kozol RA.
    Am J Otolaryngol. 2018 Mar - Apr;39(2):82-87. doi: 10.1016/j.amjoto.2018.01.006. Epub 2018 Jan 10.

September 18, 2018

  1. Limits of continuous neural monitoring in thyroid surgery.  
    Sun H, Wu CW, Catalfamo A, Fabiano V, Dionigi G.
    Updates Surg. 2018 Sep 11. doi: 10.1007/s13304-018-0593-6. [Epub ahead of print]
  2. Coexistence of <i>TERT</i> Promoter Mutations and the <i>BRAF</i> V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients.
    Rusinek D, Pfeifer A, Krajewska J, Oczko-Wojciechowska M, Handkiewicz-Junak D, Pawlaczek A, Zebracka-Gala J, Kowalska M, Cyplinska R, Zembala-Nozynska E, Chekan M, Chmielik E, Kropinska A, Lamch R, Jurecka-Lubieniecka B, Jarzab B, Czarniecka A.
    Int J Mol Sci. 2018 Sep 6;19(9). pii: E2647. doi: 10.3390/ijms19092647.
  3. Parathyroid Carcinoma Causing Mild Hyperparathyroidism in Neurofibromatosis Type 1: A Case Report and Systematic Review.
    Triggiani V, Castellana M, Basile P, Renzulli G, Giagulli VA.
    Endocr Metab Immune Disord Drug Targets. 2018 Sep 10. doi: 10.2174/1871530318666180910123316. [Epub ahead of print]
  4. Intraoperative Neuromonitoring During Thyroid Surgery: The Effect of Surgical Positioning.
    Crowther JE, Ali DB, Bamford J, Kang SW, Kandil E.
    Surg Innov. 2018 Sep 10:1553350618799786. doi: 10.1177/1553350618799786. [Epub ahead of print]
  5. Association Between Age and Patient-Reported Changes in Voice and Swallowing After Thyroidectomy.
    Sahli Z, Canner JK, Najjar O, Schneider EB, Prescott JD, Russell JO, Tufano RP, Zeiger MA, Mathur A.
    Laryngoscope. 2018 Sep 7. doi: 10.1002/lary.27297. [Epub ahead of print]
    Filimon S, Payne RJ, Black MJ, Hier MP, Mlynarek AM, Forest VI, Tamilia M.
    Endocr Pract. 2018 May;24(5):460-467. doi: 10.4158/EP-2017-0236.
  7. Analysis of postoperative biochemical values and clinical outcomes after adrenalectomy for primary aldosteronism.
    Swearingen AJ, Kahramangil B, Monteiro R, Krishnamurthy V, Jin J, Shin J, Siperstein A, Berber
    E. Surgery. 2018 Apr;163(4):807-810. doi: 10.1016/j.surg.2017.10.045. Epub 2017 Dec 15.
  8. Subtyping of primary aldosteronism with adrenal vein sampling: Hormone- and side-specific effects of cosyntropin and metoclopramide.  
    Rossitto G, Maiolino G, Lenzini L, Bisogni V, Seccia TM, Cesari M, Iacobone M, Rossi GP.
    Surgery. 2018 Apr;163(4):789-795. doi: 10.1016/j.surg.2017.09.032. Epub 2017 Dec 1.
  9. Primary aldosteronism: making sense of partial data sets from failed adrenal venous sampling-suppression of adrenal aldosterone production can be used in clinical decision making.
    Strajina V, Al-Hilli Z, Andrews JC, Bancos I, Thompson GB, Farley DR, Lyden ML, Dy BM, Young WF, McKenzie TJ.
    Surgery. 2018 Apr;163(4):801-806. doi: 10.1016/j.surg.2017.10.012. Epub 2017 Nov 22.
  10. Long-term voice quality outcomes after total thyroidectomy: a prospective multicenter study.
    Borel F, Christou N, Marret O, Mathonnet M, Caillard C, Bannani S, Drui D, Espitalier F, Blanchard C, Mirallié E.
    Surgery. 2018 Apr;163(4):796-800. doi: 10.1016/j.surg.2017.09.023. Epub 2017 Nov 20.
  11. β Cell Replacement Therapy: The Next 10 Years.
    Schuetz C, Anazawa T, Cross SE, Labriola L, Meier RPH, Redfield RR 3rd, Scholz H, Stock PG, Zammit NW;
    IPITA YIC Young Investigator Committee. Transplantation. 2018 Feb;102(2):215-229. doi: 10.1097/TP.0000000000001937. Review.

September 13, 2018

  1. Staged Thyroidectomy: A Single Institution Perspective.
    Wu CW, Sun H, Zhang G, Kim HY, Catalfamo A, Portinari M, Carcoforo P, Randolph GW, Chai YJ, Dionigi G.
    Laryngoscope Investig Otolaryngol. 2018 Aug 9;3(4):326-332. doi: 10.1002/lio2.171. eCollection 2018 Aug.
  2. Negative Sestamibi Scans Predict Lower Likelihood of Surgical Referral in Patients with Primary Hyperparathyroidism. 
    Lloyd JQ, Holcombe JM, Rackley AA, Tanner RM,
    Heath Giles W. Am Surg. 2018 Aug 1;84(8):1264-1268.
  3. Graves' disease in children.
    Léger J, Oliver I, Rodrigue D, Lambert AS, Coutant R.
    Ann Endocrinol (Paris). 2018 Aug 16. pii: S0003-4266(18)31214-9. doi: 10.1016/j.ando.2018.08.001. [Epub ahead of print]
  4. Hemostatic agent use in thyroid surgery: a meta-analysis.
    Khadra H, Bakeer M, Hauch A, Hu T, Kandil E.
    Gland Surg. 2018 Aug;7(Suppl 1):S34-S41. doi: 10.21037/gs.2018.03.02.
  5. Intraoperative intermittent neuromonitoring of inferior laryngeal nerve and staged thyroidectomy: our experience.
    Cavicchi O, Burgio L, Cioccoloni E, Piccin O, Macrì G, Schiavon P, Dionigi G.
    Endocrine. 2018 Sep 1. doi: 10.1007/s12020-018-1739-5.
  6. Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin Analogs.
    Kiesewetter B, Duan H, Lamm W, Haug A, Riss P, Selberherr A, Scheuba C, Raderer M.
    Oncologist. 2018 Aug 31. pii: theoncologist.2018-0191.doi:10.1634/the oncologist.2018-0191. [Epub ahead of print]
  7. Adrenal incidentaloma follow-up is influenced by patient, radiologic, and medical provider factors: A review of 804 cases.
    Maher DI, Williams E, Grodski S, Serpell JW, Lee JC.
    Surgery. 2018 Aug 28. pii: S0039-6060(18)30456-2. doi: 10.1016/j.surg.2018.07.011. [Epub ahead of print]
  8. A Prospective Comparative Study on Improvement of Hyperthyroid Cardiovascular Dysfunction in Patients Undergoing Total Thyroidectomy Versus Medical Management.  
    Muthukumar S, Ravikumar K, Dhalapathy S, Gomathy T, Umadevi S, Maruthupandian D.
    World J Surg. 2018 May;42(5):1408-1414. doi: 10.1007/s00268-018-4571-4.
  9. Medullary Thyroid Carcinoma: Survival Analysis and Evaluation of Mutation-Specific Immunohistochemistry in Detection of Sporadic Disease.
    Jayakody S, Reagh J, Bullock M, Aniss A, Clifton-Bligh R, Learoyd D, Robinson B, Delbridge L, Sidhu S, Gill AJ, Sywak M.
    World J Surg. 2018 May;42(5):1432-1439. doi: 10.1007/s00268-018-4551-8.
  10. Adrenalectomy with nephrectomy, right hepatectomy and inferior vena cava thrombectomy for adrenocortical carcinoma (with video).
    Prunel F, Bonnet S, Gaujoux S, Dousset B.
    J Visc Surg. 2018 Sep;155(4):329-331. doi: 10.1016/j.jviscsurg.2018.06.005. Epub 2018 Jul 7. No abstract available.
  11. Disease impacts more than age on operative morbidity in children with Graves' disease after total thyroidectomy.
    Machens A, Elwerr M, Schneider R, Lorenz K, Dralle H.
    Surgery. 2018 Aug 30. pii: S0039-6060(18)30472-0. doi: 10.1016/j.surg.2018.07.021.

September 5, 2018

  1. Translational applications of microRNAs in cancer, and therapeutic implications.
    Kwok GT, Zhao JT, Weiss J, Mugridge N, Brahmbhatt H, MacDiarmid JA, Robinson BG, Sidhu SB.
    Noncoding RNA Res. 2017 Dec 20;2(3-4):143-150. doi: 10.1016/j.ncrna.2017.12.002. eCollection 2017 Sep. Review.
  2. The effects of radioactive iodine therapy on ovarian reserve: A prospective pilot study.                                                                         
    Evranos B, Faki S, Polat SB, Bestepe N, Ünlü Ersoy R, Cakir B.
    Thyroid. 2018 Aug 29. doi: 10.1089/thy.2018.0129. [Epub ahead of print]
  3. Short Stay Thyroid Surgery: Can We Replicate the Same in Low Resource Setting?
    Bansal N, Yadav SK, Mishra SK, Kishore K, Mishra A, Chand G, Agarwal G, Agarwal A, Verma AK.
    J Thyroid Res. 2018 Aug 5;2018:4910961. doi: 10.1155/2018/4910961. eCollection 2018.
  4. Perioperative complications of adrenalectomy - 12 years of experience from a single center/teaching hospital and literature review.
    Aporowicz M, Domosławski P, Czopnik P, Sutkowski K, Kaliszewski K.
    Arch Med Sci. 2018 Aug;14(5):1010-1019. doi: 10.5114/aoms.2018.77257. Epub 2018 Jul 20.
  5. Mutational Profile of Papillary Thyroid Carcinoma in an Endemic Goiter Region of North India.
    George N, Agarwal A, Kumari N, Agarwal S, Krisnani N, Gupta SK.
    Indian J Endocrinol Metab. 2018 Jul-Aug;22(4):505-510. doi: 10.4103/ijem.IJEM_441_17.
  6. Decision making for the central compartment in differentiated thyroid cancer.
    Gonçalves Filho J, Zafereo ME, Ahmad FI, Nixon IJ, Shaha AR, Vander Poorten V, Sanabria A, Hefetz AK, Robbins KT, Kamani D, Randolph GW, Coca-Pelaz A, Simo R, Rinaldo A, Angelos P, Ferlito A, Kowalski LP.
    Eur J Surg Oncol. 2018 Aug 13. pii: S0748-7983(18)31274-5. doi: 10.1016/j.ejso.2018.08.005. [Epub ahead of print] Review.
  7. Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China.
    Du L, Wang Y, Sun X, Li H, Geng X, Ge M, Zhu Y.
    BMC Cancer. 2018 Mar 15;18(1):291. doi: 10.1186/s12885-018-4081-7.
  8. Does hyperthyroidism worsen prognosis of thyroid carcinoma? A retrospective analysis on 2820 consecutive thyroidectomies.
    Medas F, Erdas E, Canu GL, Longheu A, Pisano G, Tuveri M, Calò PG.
    J Otolaryngol Head Neck Surg. 2018 Jan 22;47(1):6. doi: 10.1186/s40463-018-0254-2. Review.
  9. Undiagnosed Primary Hyperparathyroidism and Recurrent Miscarriage: The First Prospective Pilot Study.
    DiMarco A, Christakis I, Constantinides V, Regan L, Palazzo FF.
    World J Surg. 2018 Mar;42(3):639-645. doi: 10.1007/s00268-017-4395-7.
  10. Recovery of Voice After Reconstruction of the Recurrent Laryngeal Nerve and Adjuvant Nimodipine.
    Mattsson P, Frostell A, Björck G, Persson JKE, Hakim R, Zedenius J, Svensson M.
    World J Surg. 2018 Mar;42(3):632-638. doi: 10.1007/s00268-017-4235-9.

August 29, 2018

  1. Factors Predicting Thyroid Malignancy in Fine Needle Aspiration Biopsy Specimens Classified as Atypia of Uncertain Significance/Follicular Lesion of Uncertain Significance.
    Brown C, Mangano W, Thompson S, Richmond B.
    Am Surg. 2018 Jul 1;84(7):1207-1213.
  2. Routine thyroglobulin, neck ultrasound and physical examination in the routine follow up of patients with differentiated thyroid cancer-Where is the evidence?
    Gray JL, Singh G, Uttley L, Balasubramanian SP.
    Endocrine. 2018 Aug 20. doi: 10.1007/s12020-018-1720-3. [Epub ahead of print] Review.
  3. Psychological adjustment, quality of life, and self-perceptions of reproductive health in males with congenital adrenal hyperplasia: a systematic review.
    Daae E, Feragen KB, Nermoen I, Falhammar H.
    Endocrine. 2018 Aug 20. doi: 10.1007/s12020-018-1723-0. [Epub ahead of print] Review.
  4. SSTR2A expression in medullary thyroid carcinoma is correlated with longer survival.
    De Vries LH, Lodewijk L, Willems SM, Dreijerink KMA, de Keizer B, van Diest PJ, Schepers A, Bonenkamp HJ, van Engen-van Grunsven IACH, Kruijff S, van Hemel BM, Links TP, Nieveen van Dijkum EJM, van Eeden S, Valk GD, Borel Rinkes IHM, Vriens MR. 
    Endocrine. 2018 Aug 20. doi: 10.1007/s12020-018-1706-1. [Epub ahead of print]
  5. Primary pigmented nodular adrenocortical disease (PPNAD) as an underlying cause of symptoms in a patient presenting with hirsutism and secondary amenorrhea: case report and literature review.
    Cyranska-Chyrek E, Filipowicz D, Szczepanek-Parulska E, Nowaczyk M, Ambroziak U, Toutounchi S, Koperski Ł, Bednarczuk T, Meczekalski B, Ruchała M.
    Gynecol Endocrinol. 2018 Aug 21:1-5. doi: 10.1080/09513590.2018.1493101. [Epub ahead of print]
  6. Robot-Assisted Endocrine Surgery: Indications and Drawbacks.
    Ruhle BC, Ferguson Bryan A, Grogan RH.
    J Laparoendosc Adv Surg Tech A. 2018 Aug 22. doi: 10.1089/lap.2018.0308. [Epub ahead of print]
  7. Clonal Evolution Analysis of Paired Anaplastic and Well-Differentiated Thyroid Carcinomas Reveals Shared Common Ancestor.
    Dong W, Nicolson NG, Choi J, Barbieri AL, Kunstman JW, Azar SA, Knight J, Bilguvar K, Mane SM, Lifton RP, Korah R, Carling T.
    Genes Chromosomes Cancer. 2018 Aug 22. doi: 10.1002/gcc.22678. [Epub ahead of print]
  8. Clinical validation of the prognostic stage groups of the eighth edition TNM staging for medullary thyroid carcinoma.
    Park SY, Cho YY, Kim HI, Choe JH, Kim JH, Kim JS, Oh YL, Hahn SY, Shin JH, Kim K, Kim SW, Chung JH, Kim TH.
    J Clin Endocrinol Metab. 2018 Aug 17. doi: 10.1210/jc.2018-01386. [Epub ahead of print]
  9. Association of Radioactive Iodine Administration After Reoperation With Outcomes Among Patients With Recurrent or Persistent Papillary Thyroid Cancer.
    Hung ML, Wu JX, Li N, Livhits MJ, Yeh MW.
    JAMA Surg. 2018 Aug 15. doi: 10.1001/jamasurg.2018.2659. [Epub ahead of print]
  10. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging 7th and 8th editions.
    Tam S, Boonsripitayanon M, Amit M, Fellman BM, Li Y, Busaidy N, Cabanillas M, Dadu R, Sherman SI, Waguespack SG, Williams MD, Goepfert RP, Gross ND, Perrier N, Sturgis E, Zafereo M.
    Thyroid. 2018 Aug 24. doi: 10.1089/thy.2017.0572. [Epub ahead of print]

August 23, 2018

  1. Low versus high activity radioiodine remnant ablation for differentiated thyroid carcinoma with gross extrathyroidal extension invading only strap muscles.
    Park SY, Kim HI, Choi JY, Choe JH, Kim JH, Kim JS, Oh YL, Hahn SY, Shin JH, Ahn SH, Kim K, Jeong JG, Kim SW, Chung JH, Kim TH.
    Oral Oncol. 2018 Sep;84:41-45. doi: 10.1016/j.oraloncology.2018.07.002. Epub 2018 Jul 14.
  2. Prospective implementation of a standardized screening protocol for deep venous thrombosis in abdominal surgical oncology patients.
    Sinnamon AJ, Tong JKC, Bailey EA, Brown C, Colbert L, Murray S, Jackson BM, Roses RE.
    J Surg Oncol. 2018 Aug 16. doi: 10.1002/jso.25151. [Epub ahead of print]
  3. Clinical and prognostic role of detection timing of distant metastases in patients with differentiated thyroid cancer.
    Albano D, Panarotto MB, Durmo R, Rodella C, Bertagna F, Giubbini R.
    Endocrine. 2018 Aug 15. doi: 10.1007/s12020-018-1713-2. [Epub ahead of print]
  4. Perioperative Management of Endocrine Active Adrenal Tumors.
    Schreiner F, Anand G, Beuschlein F.
    Exp Clin Endocrinol Diabetes. 2018 Aug 14. doi: 10.1055/a-0654-5251. [Epub ahead of print]
  5. Endocrine-Metabolic Response in Patients Undergoing Multiple Body Contouring Surgeries After Massive Weight Loss.
    Roxo ACW, Roxo CDP, Marques RG, Rodrigues NCP, Vigna Carneiro D, Souto FMDC, Nahas FX.
    Aesthet Surg J. 2018 Aug 10. doi: 10.1093/asj/sjy195. [Epub ahead of print]
  6. Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes.
    Ganly I, Makarov V, Deraje S, Dong Y, Reznik E, Seshan V, Nanjangud G, Eng S, Bose P, Kuo F, Morris LGT, Landa I, Carrillo Albornoz PB, Riaz N, Nikiforov YE, Patel K, Umbricht C, Zeiger M, Kebebew E, Sherman E, Ghossein R, Fagin JA, Chan TA.
    Cancer Cell. 2018 Aug 13;34(2):256-270.e5. doi: 10.1016/j.ccell.2018.07.002.
  7. Surgical Management of Normocalcemic Primary Hyperparathyroidism and the Impact of Intraoperative Parathyroid Hormone Testing on Outcome.
    Trinh G, Rettig E, Noureldine SI, Russell JO, Agrawal N, Mathur A, Prescott JD, Zeiger MA, Tufano RP.
    Otolaryngol Head Neck Surg. 2018 Aug 14:194599818793879. doi: 10.1177/0194599818793879. [Epub ahead of print]
  8. Symptom Burden in Adults with Thyroid Cancer.
    Sawka AM, Watt S, Rodin G, Ezzat S, Howell D, Tsang RW, Brierley JD, Krzyzanowska MK, Goldstein D, Li M.
    Psychooncology. 2018 Aug 13. doi: 10.1002/pon.4853. [Epub ahead of print] No abstract available.
  9. Gastrinomas: Medical or Surgical Treatment.
    Norton JA, Foster DS, Ito T, Jensen RT.
    Endocrinol Metab Clin North Am. 2018 Sep;47(3):577-601. doi: 10.1016/j.ecl.2018.04.009. Review.
  10. Differential expression of miRNA199b-5p as a novel biomarker for sporadic and hereditary parathyroid tumors.
    Hwang S, Jeong JJ, Kim SH, Chung YJ, Song SY, Lee YJ, Rhee Y.
    Sci Rep. 2018 Aug 13;8(1):12016. doi: 10.1038/s41598-018-30484-9.

August 17, 2018

  1. Lithium-induced Symptomatic Hypercalcemia and Hyperparathyroidism in a Patient with Bipolar Affective Disorder: A Case Report and Review of Literature.
    Pamathy G, Jayarajah U, Wangmo T, Banagala ASK.
    Indian J Psychol Med. 2018 Jul-Aug;40(4):378-380. doi: 10.4103/IJPSYM.IJPSYM_305_17.
  2. Papillary-Type Carcinoma of the Thyroglossal Duct Cyst: The Case for Conservative Management.
    Wood CB, Bigcas JL, Alava I, Bischoff L, Langerman A, Kim Y.
    Ann Otol Rhinol Laryngol. 2018 Aug 9:3489418791892. doi: 10.1177/0003489418791892. [Epub ahead of print]
  3. Laparoscopic Transabdominal Adrenalectomy-A Procedure That Has Stood the Test of Time.
    Livhits MJ, Yeh MW.
    JAMA Surg. 2018 Aug 8. doi: 10.1001/jamasurg.2018.2674. [Epub ahead of print] No abstract available.
  4. Risk Factors Associated With Perioperative Complications and Prolonged Length of Stay After Laparoscopic Adrenalectomy.
    Chen Y, Scholten A, Chomsky-Higgins K, Nwaogu I, Gosnell JE, Seib C, Shen WT, Suh I, Duh QY.
    JAMA Surg. 2018 Aug 8. doi: 10.1001/jamasurg.2018.2648. [Epub ahead of print]
  5. The Impact of Uniform Capsular Dissection Technique of Total Thyroidectomy on Postoperative Complications: An Experience of More Than 1000 Total Thyroidectomies from an Endocrine Surgery Training Centre in North India.
    Chand G, Agarwal S, Mishra A, Agarwal G, Verma AK, Mishra SK, Agarwal A, Kumar A. Indian J
    Endocrinol Metab. 2018 May-Jun;22(3):362-367. doi: 10.4103/ijem.IJEM_598_17.
  6. Outpatient versus inpatient thyroidectomy: A systematic review and meta-analysis.
    Lee DJ, Chin CJ, Hong CJ, Perera S, Witterick IJ.
    Head Neck. 2018 Jan;40(1):192-202. doi: 10.1002/hed.24934. Epub 2017 Nov 9. Review.
  7. Management of chyle leakage after thyroidectomy, cervical lymph node dissection, in patients with thyroid cancer.
    Park I, Her N, Choe JH, Kim JS, Kim JH.
    J. Head Neck. 2018 Jan;40(1):7-15. doi: 10.1002/hed.24852. Epub 2017 Nov 9.
  8. Laparoscopic Adrenalectomy in Elderly Patients.< br /> Weinandt M, Gaujoux S, Khayat A, Bertherat J, Baillard C, Dousset B.
    Surg Laparosc Endosc Percutan Tech. 2017 Dec;27(6):e132-e135. doi: 10.1097/SLE.0000000000000465.
  9. The utility of <sup>68</sup>Ga-DOTATATE positron-emission tomography/computed tomography in the diagnosis, management, follow-up and prognosis of neuroendocrine tumors.
    Tirosh A, Kebebew E.
    Future Oncol. 2018 Jan;14(2):111-122. doi: 10.2217/fon-2017-0393. Epub 2017 Oct 26. Review.
  10. Heterotopic thyroid autotransplantation: A preliminary clinical study.
    Sakr M, El-Kerm Y, Abo-Elwafa W, Mahmoud A, Fathi I.
    Head Neck. 2018 Jan;40(1):34-45. doi: 10.1002/hed.24904. Epub 2017 Oct 27.
    ivas AM, Nassar A, Zhang J, Casler JD, Chindris AM, Smallridge R, Bernet V.
    Endocr Pract. 2018 Aug 7. doi: 10.4158/EP-2018-0212. [Epub ahead of print]
  12. Characterization of fluorescence patterns exhibited by different adrenal tumors: Determining the indications for indocyanine green use in adrenalectomy.
    Kahramangil B, Kose E, Berber E. 
    Surgery. 2018 Aug 4. pii: S0039-6060(18)30322-2. doi: 10.1016/j.surg.2018.06.012. [Epub ahead of print]

August 9, 2018

  1. Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives.
    Altieri B, Muscogiuri G, Paschou SA, Vryonidou A, Della Casa S, Pontecorvi A, Fassnacht M, Ronchi CL, Newell-Price J.
    Endocrine. 2018 Aug 2. doi: 10.1007/s12020-018-1696-z. [Epub ahead of print] Review.
  2. Efficacy of surgeon-performed, ultrasound-guided lymph node fine needle aspiration in patients with thyroid pathologic conditions.
    Kahramangil B, Kose E, Donmez M, Aydin H, El-Dabh D, Krishnamurthy V, Jin J, Shin JJM, Siperstein A, Berber E.
    Surgery. 2018 Jul 30. pii: S0039-6060(18)30289-7. doi: 10.1016/j.surg.2018.05.036. [Epub ahead of print]
  3. AHNS Series: Do you know your guidelines? Optimizing outcomes in reoperative parathyroid surgery: Definitive multidisciplinary joint consensus guidelines of the American Head and Neck Society and the British Association of Endocrine and Thyroid Surgeons.
    Stack BC Jr, Tolley NS, Bartel TB, Bilezikian JP, Bodenner D, Camacho P, Cox JPDT, Dralle H, Jackson JE, Morris JC 3rd, Orloff LA, Palazzo F, Ridge JA, Scott-Coombes D, Steward D, Terris DJ, Thompson G, Randolph GW.
    Head Neck. 2018 Aug 2. doi: 10.1002/hed.25023. [Epub ahead of print]
  4. Successful Management of Hypothyroidism in Gastric Outlet Obstruction Using Levothyroxine Rectal Enemas: A Case Report.
    Obeidat KA, Saadeh NA, As'ad A, Bakkar S.
    Am J Case Rep. 2018 Aug 1;19:903-905. doi: 10.12659/AJCR.909437.
  5. Surgical options for thyroid cancer and post-surgical management.
    Doubleday A, Sippel RS.
    Expert Rev Endocrinol Metab. 2018 May;13(3):137-148. doi: 10.1080/17446651.2018.1464910. Epub 2018 Apr 20.
  6. Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper.
    Pilz S, März W, Cashman KD, Kiely ME, Whiting SJ, Holick MF, Grant WB, Pludowski P, Hiligsmann M, Trummer C, Schwetz V, Lerchbaum E, Pandis M, Tomaschitz A, Grübler MR, Gaksch M, Verheyen N, Hollis BW, Rejnmark L, Karras SN, Hahn A, Bischoff-Ferrari HA, Reichrath J, Jorde R, Elmadfa I, Vieth R, Scragg R, Calvo MS, van Schoor NM, Bouillon R, Lips P, Itkonen ST, Martineau AR, Lamberg-Allardt C, Zittermann A.
    Front Endocrinol (Lausanne). 2018 Jul 17;9:373. doi: 10.3389/fendo.2018.00373. eCollection 2018. Review.
  7. Spontaneous and Excellent Healing of Bilateral Brown Tumors in Mandible after Endocrinal Therapy and Subtotal Parathyroidectomy: Case Report with 4-Year Follow-Up.
    Yucesoy T, Kilic E, Dogruel F, Bayram F, Alkan A, Akcan AC, Ozturk F.
    Case Rep Dent. 2018 Jul 2;2018:8070131. doi: 10.1155/2018/8070131. eCollection 2018.
  8. Challenges and controversies in the surgical management of uremic hyperparathyroidism: A systematic review.
    Cabo J, Gallagher KC, Baregamian N.
    Am J Surg. 2018 Jul 24. pii: S0002-9610(18)30090-4. doi: 10.1016/j.amjsurg.2018.07.030. [Epub ahead of print] Review.
  9. Cost effectiveness of immediate biopsy versus surveillance of intermediate-suspicion thyroid nodules.
    Kuo EJ, Wu JX, Zanocco KA.
    Surgery. 2018 Jul 25. pii: S0039-6060(18)30313-1. doi: 10.1016/j.surg.2018.06.003. [Epub ahead of print]
  10. Reduction of arrhythmias in primary hyperparathyroidism, by parathyroidectomy, evaluated with 24-h ECG monitoring.
    Pepe J, Cipriani C, Curione M, Biamonte F, Colangelo L, Danese V, Cecchetti V, Sonato C, Ferrone F, Cilli M, Minisola S.
    Eur J Endocrinol. 2018 Aug;179(2):117-124. doi: 10.1530/EJE-17-0948. Epub 2018 Jun 6.
  11. Multi-center clinical evaluation of streptozocin-based chemotherapy for advanced pancreatic neuroendocrine tumors in Japan: focus on weekly regimens and monotherapy.
    Shibuya H, Hijioka S, Sakamoto Y, Ito T, Ueda K, Komoto I, Kobayashi N, Kudo A, Yasuda H, Miyake H, Arita J, Kiritani S, Ikeda M, Imaoka H, Ueno M, Kobayashi S, Furuta M, Nagashio Y, Murohisa G, Aoki T, Matsumoto S, Motoya M, Azemoto N, Itakura J, Horiguchi S, Yogi T, Kawagoe T, Miyaoka Y, Imamura F, Senju M, Arioka H, Hara K, Imamura M, Okusaka T.
    Cancer Chemother Pharmacol. 2018 Jul 27. doi: 10.1007/s00280-018-3656-y. [Epub ahead of print]
  12. Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study.
    Antwi K, Fani M, Heye T, Nicolas G, Rottenburger C, Kaul F, Merkle E, Zech CJ, Boll D, Vogt DR, Gloor B, Christ E, Wild D.
    Eur J Nucl Med Mol Imaging. 2018 Jul 28. doi: 10.1007/s00259-018-4101-5. [Epub ahead of print]
  13. Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.
    Osswald A, Deutschbein T, Berr CM, Plomer E, Mickisch A, Ritzel K, Schopohl J, Beuschlein F, Fassnacht M, Hahner S, Reincke M.
    Eur J Endocrinol. 2018 Aug;179(2):109-116. doi: 10.1530/EJE-18-0212. Epub 2018 Jun 6.
  14. The Impact of Nodal Dissection on Staging in Adrenocortical Carcinoma.
    Panjwani S, Moore MD, Gray KD, Finnerty BM, Beninato T, Brunaud L, Fahey TJ 3rd, Zarnegar R.
    Ann Surg Oncol. 2017 Nov;24(12):3617-3623. doi: 10.1245/s10434-017-6064-3. Epub 2017 Sep 11.
  15. Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma.
    Dhir M, Li W, Hogg ME, Bartlett DL, Carty SE, McCoy KL, Challinor SM, Yip L.
    Ann Surg Oncol. 2017 Nov;24(12):3624-3630. doi: 10.1245/s10434-017-6074-1. Epub 2017 Sep 7.

July 23, 2018

  1. How I Do It: New Dissector Device Allows for Effective Operative Field in Transoral Endoscopic Thyroid Surgery Using Vestibular Approach.
    Müller V, Mogl M, Seika P, Jöns T, Sauer I, Pratschke J, Anuwong A, Zorron R.
    Sure Innov. 2018 Jul 1:1553350618785281. doi: 10.1177/1553350618785281. [Epub ahead of print]
  2. Extrathyroidal Extension: Does Strap Muscle Invasion Alone Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer?
    Amit M, Boonsripitayanon M, Goepfert RP, Tam S, Busaidy NL, Cabanillas ME, Dadu R, Varghese J, Waguespack SG, Gross ND, Graham P, Williams MD, Sturgis EM, Zafereo ME.
    Ann Surg Oncol. 2018 Jul 18. doi: 10.1245/s10434-018-6563-x. [Epub ahead of print]
  3. Lack of functional remission in Cushing's syndrome.
    Vermalle M, Alessandrini M, Graillon T, Paladino NC, Baumstarck K, Sebag F, Dufour H, Brue T, Castinetti F.
    Endocrine. 2018 Jul 17. doi: 10.1007/s12020-018-1664-7. [Epub ahead of print]
  4. Metyrapone treatment in Cushing's syndrome: a real-life study.
    Ceccato F, Zilio M, Barbot M, Albiger N, Antonelli G, Plebani M, Watutantrige-Fernando S, Sabbadin C, Boscaro M, Scaroni C
    Endocrine. 2018 Jul 16. doi: 10.1007/s12020-018-1675-4. [Epub ahead of print]
  5. Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy.
    Dominguez MLM, Iglesias SG, Arroba CM, Álvarez BL, Diaz-Guerra GM, Martinez-Pueyo JI, Herrero EF, Carranza FH.
    Endocrine. 2018 Jul 16. doi: 10.1007/s12020-018-1671-8. [Epub ahead of print]
  6. Should Symptoms Be Considered an Indication for Parathyroidectomy in Primary Hyperparathyroidism?
    McDow AD, Sippel RS
    Clin Med Insights Endocrinol Diabetes. 2018 Jun 27;11:1179551418785135. doi: 10.1177/1179551418785135. eCollection 2018. Review.
  7. The effect of surgery on fat mass, lipid and glucose metabolism in mild primary hyperparathyroidism.
    Godang K, Lundstam K, Mollerup C, Fougner SL, Pernow Y, Nordenström J, Rosen T, Jansson S, Hellström M, Bollerslev J, Heck A.
    Endocr Connect. 2018 Jul 16. pii: EC-18-0259. doi: 10.1530/EC-18-0259. [Epub ahead of print]
  8. To admit or not to admit? Experience with outpatient thyroidectomy for Graves' disease in a high-volume tertiary care center.
    Mallick R, Asban A, Chung S, Hur J, Lindeman B, Chen H.
    Am J Surg. 2018 Jul 10. pii: S0002-9610(18)30805-5. doi: 10.1016/j.amjsurg.2018.07.002. [Epub ahead of print]
  9. Morbidity in parathyroid surgery for renal disease is under reported: a comparison of outcomes with primary hyperparathyroidism.
    Nastos K, Constantinides V, Mizamtsidi M, Duncan N, Tolley N, Palazzo F.
    Ann R Coll Surg Engl. 2018 Jul;100(6):436-442. doi: 10.1308/rcsann.2018.0032.
  10. Normocalcaemic primary hyperparathyroidism: a diagnostic and therapeutic algorithm.
    Gómez-Ramírez J, Mihai R.
    Langenbecks Arch Surg. 2017 Nov;402(7):1103-1108. doi: 10.1007/s00423-017-1617-2. Epub 2017 Aug 19. Review.

July 13, 2018

  1. Pheochromocytoma and Paraganglioma in Neurofibromatosis type 1: frequent surgeries and cardiovascular crises indicate the need for screening.
    Petr EJ, Else T.
    Clin Diabetes Endocrinol. 2018 Jun 22;4:15. doi: 10.1186/s40842-018-0065-4. eCollection 2018
  2. Improved outcomes for papillary thyroid microcarcinoma care: active surveillance and case volume.
    Freni F, Galletti B, Galletti F, Dionigi G.
    Ther Adv Endocrinol Metab. 2018 Jul;9(7):185-186. doi: 10.1177/2042018818773609. Epub 2018 May 4. No abstract available.
  3. Lessons Learned From a Faulty Transoral Endoscopic Thyroidectomy Vestibular Approach.
    Zhang D, Wu CW, Inversini D, Kim HY, Anuwong A, Bacuzzi A, Dionigi G.
    Surg Laparosc Endosc Percutan Tech. 2018 Jul 2. doi: 10.1097/SLE.0000000000000555. [Epub ahead of print]
  4. Do Anticoagulation Medications Increase The Risk of Hematoma in Ultrasound Guided Fine Needle Aspiration of Thyroid Lesions?
    Khadra H, Kholmatov R, Monlezun D, Kandil E.
    Endocrine. 2018 Jul 3. doi: 10.1111/cyt.12608. [Epub ahead of print]
  5. Sentinel lymph node biopsy in small papillary thyroid cancer. A review on novel surgical techniques.
    Garau LM, Rubello D, Ferretti A, Boni G, Volterrani D, Manca G.
    Endocrine. 2018 Jul 2. doi: 10.1007/s12020-018-1658-5. [Epub ahead of print]
  6. Perioperative serum cortisol levels in ACTH sufficient and ACTH deficient patients during transsphenoidal surgery of pituitary adenoma.
    Borg H, Siesjö P, Kahlon B, Fjalldal S, Erfurth EM.
    Endocrine. 2018 Jul 2. doi: 10.1007/s12020-018-1655-8. [Epub ahead of print]
  7. Therapeutic plasmapheresis in thyrotoxic patients.
    Simsir IY, Ozdemir M, Duman S, Erdogan M, Donmez A, Ozgen AG.
    Endocrine. 2018 Jul 2. doi: 10.1007/s12020-018-1661-x. [Epub ahead of print]
  8. The safety of anaesthetising biochemically hyperthyroid patients undergoing thyroidectomy-a retrospective cohort study.
    Short HL, Tamatea J, Conaglen HM, Furlonger AJ, Meyer-Rochow GY, Conaglen JV, Elston MS
    Anaesth Intensive Care. 2018 Jul;46(4):396-399.
  9. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement.
    Mantovani G, Bastepe M, Monk D, de Sanctis L, Thiele S, Usardi A, Ahmed SF, Bufo R, Choplin T, De Filippo G, Devernois G, Eggermann T, Elli FM, Freson K, García Ramirez A, Germain-Lee EL, Groussin L, Hamdy N, Hanna P, Hiort O, Jüppner H, Kamenický P, Knight N, Kottler ML, Le Norcy E, Lecumberri B, Levine MA, Mäkitie O, Martin R, Martos-Moreno GÁ, Minagawa M, Murray P, Pereda A, Pignolo R, Rejnmark L, Rodado R, Rothenbuhler A, Saraff V, Shoemaker AH, Shore EM, Silve C, Turan S, Woods P, Zillikens MC, Perez de Nanclares G, Linglart A.
    Nat Rev Endocrinol. 2018 Jun 29. doi: 10.1038/s41574-018-0042-0. [Epub ahead of print] Review.
  10. Preventing hypoparathyroidism after total thyroidectomy.
    Serpell JW.
    ANZ J Surg. 2018 Mar;88(3):127-128. doi: 10.1111/ans.14235. No abstract available.

July 5, 2018

  1. TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma.
    Svahn F, Paulsson JO, Stenman A, Fotouhi O, Mu N, Murtha TD, Korah R, Carling T, Bäckdahl M, Wang N, Juhlin CC, Larsson C.
    Int J Mol Med. 2018 Jun 20. doi: 10.3892/ijmm.2018.3735. [Epub ahead of print]
  2. Influence of neural monitoring during thyroid surgery on nerve integrity and postoperative vocal function.
    Engelsman AF, Warhurst S, Fraser S, Novakovic D, Sidhu SB.
    BJS Open. 2018 Apr 25;2(3):135-141. doi: 10.1002/bjs5.50. eCollection 2018 Jun.
  3. Treatment of multiresistant prolactinomas with a combination of cabergoline and octreotide LAR.
    Sosa-Eroza E, Espinosa E, Ramírez-Rentería C, Mendoza V, Arreola R, Mercado M.
    Endocrine. 2018 Jun 11. doi: 10.1007/s12020-018-1638-9. [Epub ahead of print]
  4. AHNS Series: Do you know your guidelines? AHNS Endocrine Section Consensus Statement: State-of-the-art thyroid surgical recommendations in the era of noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
    Ferris RL, Nikiforov Y, Terris D, Seethala RR, Ridge JA, Angelos P, Duh QY, Wong R, Sabra MM, Fagin JA, McIver B, Bernet VJ, Harrell RM, Busaidy N, Cibas ES, Faquin WC, Sadow P, Baloch Z, Shindo M, Orloff L, Davies L, Randolph GW.
    Head Neck. 2018 Jun 26. doi: 10.1002/hed.25141. [Epub ahead of print]
  5. Cushing's Disease in Older Patients: Presentation and Outcome.<
    Qiao N, Swearingen B, Tritos NA.
    Clin Endocrinol (Oxf). 2018 Jun 25. doi: 10.1111/cen.13799. [Epub ahead of print]
  6. Characterization of adrenocortical tumors by <sup>18</sup>F-FDG PET/CT: Does steroid hormone hypersecretion status modify the uptake pattern?
    Paladino NC, Guérin C, Lowery A, Attard A, Essamet W, Slotema E, Morange I, Castinetti F, Brue T, Loundou A, Taïeb D, Sebag F.
    Surg Oncol. 2018 Jun;27(2):231-235. doi: 10.1016/j.suronc.2018.04.003. Epub 2018 Apr 23.
  7. How academically productive are endocrine surgeons in the United States?
    Garner EF, Valsangkar NP, Wang TN, Porterfield JR, Koniaris LG, Chen H.
    J Surg Res. 2018 Sep;229:122-126. doi: 10.1016/j.jss.2018.03.066. Epub 2018 Apr 23.
  8. Retroperitoneal laparoscopic adrenalectomy with transient renal artery occlusion for large adrenal tumors (≥8 cm).
    Gong B, Ma M, Xie W, Yang X, Sun T.
    J Surg Oncol. 2018 Apr;117(5):1066-1072. doi: 10.1002/jso.25002. Epub 2018 Feb 15.
  9. Skeletal fragility induced by overtreatment of adrenal insufficiency.
    Falhammar H.
    Endocrine. 2018 Feb;59(2):239-241. doi: 10.1007/s12020-017-1501-4. Epub 2017 Dec 23
  10. Standing thyroidectomy in 10 horses.
    Marcatili M, Voss SJ, Pollock PJ.
    Vet Surg. 2018 Jan;47(1):86-92. doi: 10.1111/vsu.12744. Epub 2017 Nov 8.

June 26, 2018

  1. Optimal combination of treatment modality to increase survival in patients with anaplastic thyroid carcinoma: A STROBE compliant retrospective study.
    Lee JH, Ahn HK, Seok JY, Lee KC, Chun YS, Chung YS, Lee YD
    Medicine (Baltimore). 2018 Jun;97(25):e11037. doi: 10.1097/MD.0000000000011037.
  2. Incidence and management of postoperative hyperglycemia in patients undergoing insulinoma resection.
    Nockel P, Tirosh A, El Lakis M, Gaitanidis A, Merkel R, Patel D, Nilubol N, Sadowski SM, Cochran C, Gorden P, Kebebew E.
    Endocrine. 2018 Jun 19. doi: 10.1007/s12020-018-1633-1. [Epub ahead of print]
  3. Parathyroid carcinoma in multiple endocrine neoplasm type 1 syndrome: case report and systematic literature review.
    Di Meo G, Sgaramella LI, Ferraro V, Prete FP, Gurrado A, Testini M.
    Clin Exp Med. 2018 Jun 20. doi: 10.1007/s10238-018-0512-7. [Epub ahead of print]
  4. Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluation.
    Renaudin K, Smati S, Wargny M, Al Ghuzlan A, Aubert S, Leteurtre E, Patey M, Sibony M, Sturm N, Tissier F, Amar L, Bertherat J, Berthozat C, Chabre O, Do Cao C, Haissaguerre M, Pierre P, Briet C, Vezzosi D, Lifante JC, Pattou F, Mirallie E, Baudin E, Cariou B, Libe R, Drui D; for Comete-Cancer Network.
    Mod Pathol. 2018 Jun 19. doi: 10.1038/s41379-018-0077-8. [Epub ahead of print]
  5. Long non-coding RNA BANCR regulates cancer stem cell markers in papillary thyroid cancer via the RAF/MEK/ERK signaling pathway.<
    Wang Y, Lin X, Fu X, Yan W, Lin F, Kuang P, Luo Y, Lin E, Hong X, Wu G.
    Oncol Rep. 2018 Jun 18. doi: 10.3892/or.2018.6502. [Epub ahead of print]
  6. Re-operative Surgery for Pheochromocytoma-Paraganglioma: Analysis of 13 Cases from a Single Institution.
    Sonbare DJ, Abraham DT, Rajaratnam S, Thomas N, Manipadam MT, Pai R, Jacob PM.
    Indian J Surg. 2018 Apr;80(2):123-127. doi: 10.1007/s12262-017-1658-3. Epub 2017 Jun 5.
  7. Indeterminate Thyroid Nodule: Mystery Continues Despite Recent Advances.
    Joshi A, Agrawal R.
    Indian J Endocrinol Metab. 2018 Mar-Apr;22(2):290. doi: 10.4103/ijem.IJEM_604_17. No abstract available.
  8. Survival of aggressive variants of papillary thyroid carcinoma in patients under 55 years old: a SEER population-based retrospective analysis.
    Feng J, Shen F, Cai W, Gan X, Deng X, Xu B.
    Endocrine. 2018 Jun 16. doi: 10.1007/s12020-018-1644-y. [Epub ahead of print]
  9. The 2017 WHO classification of pituitary adenoma: overview and comments.
    Inoshita N, Nishioka H.
    Brain Tumor Pathol. 2018 Apr;35(2):51-56. doi: 10.1007/s10014-018-0314-3. Epub 2018 Apr 23. Review.
  10. Initial Clinical Investigation of [18F]Tetrafluoroborate PET/CT in Comparison to [124I]Iodine PET/CT for Imaging Thyroid Cancer.
    Samnick S, Al-Momani E, Schmid JS, Mottok A, Buck AK, Lapa C.
    Clin Nucl Med. 2018 Mar;43(3):162-167. doi: 10.1097/RLU.0000000000001977.

June 21, 2018

  1. DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment.
    Conemans EB, Lodewijk L, Moelans CM, Offerhaus GJA, Pieterman CRC, Morsink FH, Dekkers OM, de Herder WW, Hermus AR, van der Horst-Schrivers ANA, Drent ML, Bisschop PH, Havekes B, Brosens LAA, Dreijerink KMA, Borel Rinkes IHM, Timmers HTM, Valk GD, Vriens MR.
    Eur J Endocrinol. 2018 Jun 14. pii: EJE-18-0195. doi: 10.1530/EJE-18-0195. [Epub ahead of print]
  2. Quality of life in multiple endocrine neoplasia type 2A compared with normative and disease populations.
    Mongelli MN, Peipert BJ, Goswami S, Helenowski I, Yount SE, Sturgeon C.
    Surgery. 2018 Jun 11. pii: S0039-6060(18)30213-7. doi: 10.1016/j.surg.2018.04.036. [Epub ahead of print]
  3. Telomerase reverse transcriptase induced thyroid carcinoma cell proliferation through PTEN/AKT signaling pathway.
    Zhang H, Hu N.
    Mol Med Rep. 2018 Jun 1. doi: 10.3892/mmr.2018.9119. [Epub ahead of print]
  4. NRG1 regulates redox homeostasis via NRF2 in papillary thyroid cancer.
    Zhang TT, Qu N, Sun GH, Zhang L, Wang YJ, Mu XM, Wei WJ, Wang YL, Wang Y, Ji QH, Zhu YX, Shi RL.
    Int J Oncol. 2018 May 31. doi: 10.3892/ijo.2018.4426. [Epub ahead of print]
  5. Appetite changes reveal depression subgroups with distinct endocrine, metabolic, and immune states.
    Simmons WK, Burrows K, Avery JA, Kerr KL, Taylor A, Bodurka J, Potter W, Teague TK, Drevets WC.
    Mol Psychiatry. 2018 Jun 13. doi: 10.1038/s41380-018-0093-6. [Epub ahead of print]
  6. Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines.
    Albano D, Bertagna F, Bonacina M, Durmo R, Cerudelli E, Gazzilli M, Panarotto MB, Formenti AM, Mazziotti G, Giustina A, Giubbini R.
    Eur J Endocrinol. 2018 Jun 13. pii: EJE-18-0253. doi: 10.1530/EJE-18-0253. [Epub ahead of print]
  7. Recent Topics Around Multiple Endocrine Neoplasia Type 1.
    Marx SJ.
    J Clin Endocrinol Metab. 2018 Apr 1;103(4):1296-1301. doi: 10.1210/jc.2017-02340.
  8. Prognostic Evaluations Tailored to Specific Gastric Neuroendocrine Neoplasms: Analysis Of 200 Cases with Extended Follow-Up.
    Vanoli A, La Rosa S, Miceli E, Klersy C, Maragliano R, Capuano F, Persichella A, Martino M, Inzani F, Luinetti O, Di Sabatino A, Sessa F, Paulli M, Corazza GR, Rindi G, Bordi C, Capella C, Solcia E.
    Neuroendocrinology. 2018 Jun 12:1-13. doi: 10.1159/000489902. [Epub ahead of print]
  9. Transcutaneously refillable, 3D-printed biopolymeric encapsulation system for the transplantation of endocrine cells.
    Farina M, Chua CYX, Ballerini A, Thekkedath U, Alexander JF, Rhudy JR, Torchio G, Fraga D, Pathak RR, Villanueva M, Shin CS, Niles JA, Sesana R, Demarchi D, Sikora AG, Acharya GS, Gaber AO, Nichols JE, Grattoni A.
    Biomaterials. 2018 May 30;177:125-138. doi: 10.1016/j.biomaterials.2018.05.047. [Epub ahead of print]
  10. SLC12A7 alters adrenocortical carcinoma cell adhesion properties to promote an aggressive invasive behavior.
    Brown TC, Murtha TD, Rubinstein JC, Korah R, Carling T.
    Cell Commun Signal. 2018 Jun 8;16(1):27. doi: 10.1186/s12964-018-0243-0.

June 13, 2018

  1. New Insights in Cushing Disease Treatment With Focus on a Derivative of Vitamin A.
    Fuertes M, Tkatch J, Rosmino J, Nieto L, Guitelman MA, Arzt E.
    Front Endocrinol (Lausanne). 2018 May 24;9:262. doi: 10.3389/fendo.2018.00262. eCollection 2018. Review.
  2. Highly specific preoperative selection of solitary parathyroid adenoma cases in primary hyperparathyroidism by quantitative image analysis of the early-phase Technetium-99m sestamibi scan.
    Kim D, Rhodes JA, Hashim JA, Rickabaugh L, Brams DM, Pinkus E, Dou Y.
    J Med Imaging Radiat Oncol. 2018 Jun 7. doi: 10.1111/1754-9485.12753. [Epub ahead of print]
  3. Surviving ectopic Cushing's syndrome: Quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.
    Osswald A, Deutschbein T, Berr CM, Plomer E, Mickisch A, Ritzel K, Schopohl J, Beuschlein F, Fassnacht M, Hahner S, Reincke M.
    Eur J Endocrinol. 2018 Jun 6. pii: EJE-18-0212. doi: 10.1530/EJE-18-0212. [Epub ahead of print]
  4. Adrenal Crises in Children: Perspectives and Research Directions.
    Rushworth RL, Torpy DJ, Stratakis CA, Falhammar H.
    Horm Res Paediatr. 2018 Jun 6:1-11. doi: 10.1159/000481660. [Epub ahead of print]
  5. A rural perspective on minimally invasive parathyroidectomy: optimal preoperative imaging and patient outcomes.
    Binks M, Burrows D, Littlejohn D.
    ANZ J Surg. 2018 Jun 5. doi: 10.1111/ans.14374. [Epub ahead of print]
  6. A case-control study of exposure to organophosphate flame retardants and risk of thyroid cancer in women.
    Deziel NC, Yi H, Stapleton HM, Huang H, Zhao N, Zhang Y.
    BMC Cancer. 2018 Jun 5;18(1):637. doi: 10.1186/s12885-018-4553-9.
  7. Histology-proven recurrence in the lateral or central neck after systematic neck dissection for medullary thyroid cancer.
    Machens A, Lorenz K, Dralle H.
    Endocrine. 2018 Jun 5. doi: 10.1007/s12020-018-1625-1. [Epub ahead of print]
  8. Current Knowledge on Endocrine Disrupting Chemicals (EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood: Highlights from a National Italian Meeting.
    Street ME, Angelini S, Bernasconi S, Burgio E, Cassio A, Catellani C, Cirillo F, Deodati A, Fabbrizi E, Fanos V, Gargano G, Grossi E, Iughetti L, Lazzeroni P, Mantovani A, Migliore L, Palanza P, Panzica G, Papini AM, Parmigiani S, Predieri B, Sartori C, Tridenti G, Amarri S.
    Int J Mol Sci. 2018 Jun 2;19(6). pii: E1647. doi: 10.3390/ijms19061647. Review.
  9. TERT promoter mutational screening as a tool to predict malignant behaviour in follicular thyroid tumours-three examples from the clinical routine.
    Hysek M, Paulsson JO, Wang N, Jatta K, Lindh C, Fuentes-Martinez N, Shabo I, Zedenius J, Juhlin CC.
    Virchows Arch. 2018 Jun 2. doi: 10.1007/s00428-018-2386-1. [Epub ahead of print]
  10. Natural History of Contralateral Nodules After Lobectomy in Patients With Papillary Thyroid Carcinoma.
    Ritter A, Bachar G, Hirsch D, Benbassat C, Katz O, Kochen N, Diker-Cohen T, Akirov A, Shimon I, Robenshtok E.
    J Clin Endocrinol Metab. 2018 Feb 1;103(2):407-414. doi: 10.1210/jc.2017-01616.

June 6, 2018

  1. Is serum TSH a biomarker of thyroid carcinoma in patients residing in a mildly iodine-deficient area?
    Swan KZ, Nielsen VE, Godballe C, Thrane JF, Mortensen MR, Schytte S, Pedersen HB, Christiansen P, Bonnema SJ. Endocrine. 2018 May 31. doi: 10.1007/s12020-018-1637-x. [Epub ahead of print]
  2. Effectiveness of medical treatment for Cushing's syndrome: a systematic review and meta-analysis.
    Broersen LHA, Jha M, Biermasz NR, Pereira AM, Dekkers OM.
    Pituitary. 2018 May 31. doi: 10.1007/s11102-018-0897-z. [Epub ahead of print]
  3. Comparing the safety of harmonic ACE and ACE+ around the recurrent laryngeal nerve in swine models.
    Kim HK, Chai YJ, Lee HY, Kim HY, Dionigi G.
    Ann Surg Treat Res. 2018 Jun;94(6):285-290. doi: 10.4174/astr.2018.94.6.285. Epub 2018 May 29.
  4. The Outcome of Papillary Thyroid Cancer Associated with Graves' Disease: A Case Control Study.
    Menon R, Nair CG, Babu M, Jacob P, Krishna GP.
    J Thyroid Res. 2018 May 8;2018:8253094. doi: 10.1155/2018/8253094. eCollection 2018.
  5. Molecular evaluation of a sporadic paraganglioma with concurrent IDH1 and ATRX mutations.
    Zhang J, Jiang J, Luo Y, Li X, Lu Z, Liu Y, Huang J, Hou Y, Pang Y, Sun MYF, Wang TS, Evans DB, Pacak K, Zhuang Z, Gao X. Endocrine. 2018 May 30. doi: 10.1007/s12020-018-1617-1. [Epub ahead of print]
  6. Diabetes after pancreaticoduodenectomy: can we predict it?
    Singh AN, Pal S, Kilambi R, Madhusudhan KS, Dash NR, Tandon N, Sahni P.
    J Surg Res. 2018 Jul;227:211-219. doi: 10.1016/j.jss.2018.02.010. Epub 2018 Mar 20.
  7. Functional adrenal cortex preservation: A good reason for posterior retroperitoneal endoscopic approach.
    Vidal Ó, Delgado-Oliver E, Díaz Del Gobbo R, Hanzu F, Squarcia M, Martínez D, Fuster D, Fondevila C.
    Cir Esp. 2018 May 24. pii: S0009-739X(18)30137-4. doi: 10.1016/j.ciresp.2018.04.008. [Epub ahead of print] English, Spanish
  8. Decreasing Use of Radioactive Iodine for Low-Risk Thyroid Cancer in California, 1999 to 2015.
    Park KW, Wu JX, Du L, Leung AM, Yeh MW, Livhits MJ.
    J Clin Endocrinol Metab. 2018 Mar 1;103(3):1095-1101. doi: 10.1210/jc.2017-02269.
  9. Typical carcinoid involving the main carina managed with arterial embolisation, endobronchial resection and ablation, ultimately followed by carinal resection.
    Tan MWY, Leong P, Antippa P, Jennings BR.
    BMJ Case Rep. 2017 Sep 28;2017. pii: bcr-2017-221800. doi: 10.1136/bcr-2017-221800.
  10. Surgery Significantly Improves Neurocognition, Sleep, and Blood Pressure in Primary Hyperparathyroidism: A 3-Year Prospective Follow-Up Study.
    Storvall S, Ryhänen EM, Heiskanen I, Sintonen H, Roine RP, Schalin-Jäntti C.
    Horm Metab Res. 2017 Oct;49(10):772-777. doi: 10.1055/s-0043-118347. Epub 2017 Sep 18.

June 1, 2018

  1. Transoral endoscopic thyroidectomy vestibular approach: a preliminary framework for assessment and safety.
    Russell J, Anuwong A, Dionigi G, Inabnet WB, Kim HY, Randolph GW, Richmon JD, Tufano RP.
    Thyroid. 2018 May 23. doi: 10.1089/thy.2017.0642. [Epub ahead of print]
  2. Prophylactic Central Compartment Neck Dissection in Papillary Thyroid Cancer and Effect on Locoregional Recurrence.
    Hughes DT, Rosen JE, Evans DB, Grubbs E, Wang TS, Solórzano CC
    Ann Surg Oncol. 2018 May 21. doi: 10.1245/s10434-018-6528-0. [Epub ahead of print]
  3. Genotypic characteristics and their association with phenotypic characteristics of hereditary medullary thyroid carcinoma in Korea.
    Jung KY, Kim SM, Kim MJ, Cho SW, Kim BW, Lee YS, Jeong JJ, Nam KH, Chung WY, Lee KE, Chung EJ, Kim HJ, Park DJ, Sung MW, Park CS, Cho BY, Park YJ, Chang HS.
    Surgery. 2018 May 17. pii: S0039-6060(18)30142-9. doi: 10.1016/j.surg.2018.03.018. [Epub ahead of print]
  4. Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms.
    Stenman A, Zedenius J, Juhlin CC.
    Langenbecks Arch Surg. 2018 May 19. doi: 10.1007/s00423-018-1679-9. [Epub ahead of print]
  5. Anaplastic thyroid cancer and hyperfractionated accelerated radiotherapy (HART) with and without surgery.
    Jacobsen AB, Grøholt KK, Lorntzsen B, Osnes TA, Falk RS, Sigstad E.
    Eur Arch Otorhinolaryngol. 2017 Dec;274(12):4203-4209. doi: 10.1007/s00405-017-4764-8. Epub 2017 Oct 10
  6. Disease Severity at Presentation in Patients with Disease-Related Mortality from Differentiated Thyroid Cancer: Implications for the 2015 ATA Guidelines.
    Robenshtok E, Nachalon Y, Benbassat C, Hirsch D, Shimon I, Grossman A, Diker-Cohen T, Akirov A, Popovtzer A.Eur J Thyroid. 2017 Sep;27(9):1171-1176. doi: 10.1089/thy.2017.0040.
  7. Thyrotropin Suppressive Therapy for Low-Risk Small Thyroid Cancer: A Propensity Score-Matched Cohort Study.
    Park S, Kim WG, Han M, Jeon MJ, Kwon H, Kim M, Sung TY, Kim TY, Kim WB, Hong SJ, Shong YK
    Thyroid. 2017 Sep;27(9):1164-1170. doi: 10.1089/thy.2017.0177. Epub 2017 Aug 8
  8. Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.
    Ito Y, Onoda N, Ito KI, Sugitani I, Takahashi S, Yamaguchi I, Kabu K, Tsukada K.
    Thyroid. 2017 Sep;27(9):1142-1148. doi: 10.1089/thy.2016.0621. Epub 2017 Jul 24.
  9. Imaging of Parathyroid Glands in End Stage Renal Disease.
    Sharma J, Halkar R, Weber CJ.
    Semin Dial. 2017 Jul;30(4):369-372. doi: 10.1111/sdi.12608. Epub 2017 May 30. Review.
  10. Hyperkalemia in both surgically and medically treated patients with primary aldosteronism.
    Wada N, Shibayama Y, Umakoshi H, Ichijo T, Fujii Y, Kamemura K, Kai T, Sakamoto R, Ogo A, Matsuda Y, Fukuoka T, Tsuiki M, Suzuki T, Naruse M.
    J Hum Hypertens. 2017 Oct;31(10):627-632. doi: 10.1038/jhh.2017.38. Epub 2017 May 25.

May 24, 2018

  1. Risk Factors for Central Neck Lymph Node Metastases in Follicular Variant vs. Classic Papillary Thyroid Carcinoma.
    Raffaelli M, De Crea C, Sessa L, Fadda G, Lombardi CP, Bellantone R.
    Endocrine. 2018 May 16. doi: 10.1007/s12020-018-1607-3. [Epub ahead of print]
  2. Risk Factors Associated with Intrathyroid Extension of Thyroid Microcarcinomas.
    Slijepcevic N, Zivaljevic V, Diklic A, Jovanovic M, Oluic B, Paunovic I.
    Langenbecks Arch Surg. 2018 May 17. doi: 10.1007/s00423-018-1680-3. [Epub ahead of print]
  3. Surgical Outcomes Following Repeat Transsphenoidal Surgery for Nonfunctional Pituitary Adenomas: A Retrospective Comparative Study.
    Bakhsheshian J, Wheeler S, Strickland BA, Pham MH, Rennert RC, Carmichael J, Weiss M, Zada G.
    Oper Neurosurg (Hagerstown). 2018 May 15. doi: 10.1093/ons/opy078. [Epub ahead of print]
  4. Endoscopic vs. Microscopic Transsphenoidal Surgery for Cushing’s Disease: A Systematic Review and Meta-Analysis.
    Broersen LHA, Biermasz NR, van Furth WR, de Vries F, Verstegen MJT, Dekkers OM, Pereira AM.
    Pituitary. 2018 May 16. doi: 10.1007/s11102-018-0893-3. [Epub ahead of print]
  5. C-Arm Compound Tomography- Assisted Venous Sampling Improved Right Adrenal Vein Cannulation and Sampling Quality in Primary Aldosteronism.
    Park CH, Hong N, Han K, Kang SW, Lee CR, Park S, Rhee Y.
    Endocrinol Metab (Seoul). 2018 May 4. [Epub ahead of print]
  6. Management of Endocrine Disease: Which Metabolic Procedure? Comparing Outcomes in Sleeve Gastrectomy and Roux-en Y Gastric Bypass.
    Billeter AT, de la Garza Herrera J, Scheurlen KM, Nickel F, Billmann F, Müller-Stich B.
    Eur J Endocrinol. 2018 May 15. pii: EJE-18-0009. doi: 10.1530/EJE-18-0009. [Epub ahead of print]
  7. Differential GIP/GLP-1 Intestinal Cell Distribution in Diabetics’ Yields Distinctive Rearrangements Depending on Roux-en-Y Biliopancreatic Limb Length.
    Palha AM, Pereira SS, Costa MM, Morais T, Maia AF, Guimarães M, Nora M, Monteiro MP.
    J Cell Biochem. 2018 May 15. doi: 10.1002/jcb.27062. [Epub ahead of print]
  8. Co-Existence of <i>BRAF<sup>V600E</sup</i> and <i>TERT</i> Promoter Mutations in Papillary Thyroid Carcinoma is Associated with Tumor Aggressiveness, but not with Lymph Node Metastasis.
    Ren H, Shen Y, Hu D, He W, Zhou J, Cao Y, Mao Y, Dou Y, Xiong W, Xiao Q, Zhang Y, Su X.
    Cancer Manag Res. 2018 May 3;10:1005-1013. doi: 10.2147/CMAR.S159583. eCollection 2018.
  9. Selective Parathyroid Venous Sampling in Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis.
    Ibraheem K, Toraih EA, Haddad AB, Farag M, Randolph GW, Kandil E.
    Laryngoscope. 2018 May 14. doi: 10.1002/lary.27213. [Epub ahead of print] Review.
  10. Early Outcomes in Transoral Vestibular Thyroidectomy: Robotic Versus Endoscopic Techniques.
    Razavi CR, Khadem MGA, Fondong A, Clark JH, Richmon JD, Tufano RP, Russell JO.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25323. [Epub ahead of print]

April 30, 2018

  1. Endocrine Surgery in the Geriatric Population. McIntire JB, McCammon S, Mong ER.  Otolaryngol Clin North Am. 2018 Apr 23. pii: S0030-6665(18)30052-5. 
  2. American Thyroid Association Guidelines and Statements: Past, Present, and Future. Sawka AM, Carty SE, Haugen BR, Hennessey JV, Kopp PA, Pearce EN, Sosa JA, Tufano RP, Jonklaas J. Thyroid. 2018 Apr 26. doi: 10.1089/thy.2018.0070. [Epub ahead of print]
  3. Laparoscopic versus robotic adrenalectomy: a review of the national inpatient sample. Samreen S, Fluck M, Hunsinger M, Wild J, Shabahang M, Blansfield JA. J Robot Surg. 2018 Apr 25. doi: 10.1007/s11701-018-0808-3. 
  4. Patient Frailty Should Be Used to Individualize Treatment Decisions in Primary Hyperparathyroidism. Seib CD, Chomsky-Higgins K, Gosnell JE, Shen WT, Suh I, Duh QY, Finlayson E. World J Surg. 2018 Apr 25. doi: 10.1007/s00268-018-4629-3. 
  5. Predictive Factors of Secondary Normocalcemic Hyperparathyroidism after Roux-en-Y Gastric Bypass. Casella C, Molfino S, Mittempergher F, Cappelli C, Portolani N. Int J Endocrinol. 2018 Mar 6;2018:5010287. doi: 10.1155/2018/5010287. eCollection 2018.
  6. Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of 18F-Fluorocholine PET/CT. Grimaldi S, Young J, Kamenicky P, Hartl D, Terroir M, Leboulleux S, Berdelou A, Hadoux J, Hescot S, Remy H, Baudin E, Schlumberger M, Deandreis D. Eur J Nucl Med Mol Imaging. 2018 Apr 22. doi: 10.1007/s00259-018-4018-z. [Epub ahead of print]
  7. Adrenocorticotropic Hormone Secreting Pheochromocytoma Underlying Glucocorticoid Induced Pheochromocytoma Crisis. Geva GA, Gross DJ, Mazeh H, Atlan K, Ben-Dov IZ, Fischer M. Case Rep Endocrinol. 2018 Feb 20;2018:3963274. doi: 10.1155/2018/3963274. eCollection 2018.
  8. Prognostic significance of gross extrathyroidal extension invading only strap muscles in differentiated thyroid carcinoma. Park SY, Kim HI, Kim JH, Kim JS, Oh YL, Kim SW, Chung JH, Jang HW, Kim TH. Br J Surg. 2018 Apr 17. doi: 10.1002/bjs.10830. [Epub ahead of print]
  9. Prophylactic thyroidectomy in children with multiple endocrine neoplasia type 2. Prete FP, Abdel-Aziz T, Morkane C, Brain C, Kurzawinski TR; MEN2 in Children UK Collaborative Group. Br J Surg. 2018 Apr 17. doi: 10.1002/bjs.10856. [Epub ahead of print]
  10. Quality of life in thyroid cancer-assessment of physician perceptions. James BC, Aschebrook-Kilfoy B, White MG, Applewhite MK, Kaplan SP, Angelos P, Kaplan EL, Grogan RH. J Surg Res. 2018 Jun;226:94-99. doi: 10.1016/j.jss.2017.11.069. Epub 2018 Feb 15.


Training in endocrine surgery. Gimm O, Barczyński M, Mihai R, Raffaelli M. Langenbecks Arch Surg. 2019 Nov 7. PMID: 31701231 



Volume-outcome correlation in adrenal surgery-an ESES consensus statement. Mihai R, Donatini G, Vidal O, Brunaud L. Langenbecks Arch Surg. 2019 Nov 7. PMID: 31701230 


Gastrointestinal Neuroendocrine 

Grade is a Dominant Risk Factor for Metastasis in Patients with Rectal Neuroendocrine Tumors. Folkert IW, Sinnamon AJ, Concors SJ, Bennett BJ, Fraker DL, Mahmoud NN, Metz DC, Stashek KM, Roses RE. Ann Surg Oncol. 2019 Nov 7. PMID: 31701298 


Pancreatic Neuroendocrine 

Impact of tumor size and nodal status on recurrence of nonfunctional pancreatic neuroendocrine tumors ≤2 cm after curative resection: A multi-institutional study of 392 cases. Dong DH, Zhang XF, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Pawlik TM; other members of the US Neuroendocrine Tumor Study Group. J Surg Oncol. 2019 Dec;120(7):1071-1079. PMID: 31571225 



Stepwise Approach for Parathyroid Localisation in Primary Hyperparathyroidism. Korwar V, Yuen Chang F, Teasdale E, Suchett-Kaye I, Edwards A, Morgan J. World J Surg. 2019 Nov 11. PMID: 31712842 


The Clinicopathological Spectrum of Parathyroid Carcinoma. Akirov A, Asa SL, Larouche V, Mete O, Sawka AM, Jang R, Ezzat S. Front Endocrinol (Lausanne). 2019 Oct 23;10:731. PMID: 31708875 


Differences in primary hyperparathyroidism characteristics between children and adolescents. Zivaljevic V, Jovanovic M, Diklic A, Zdravkovic V, Djordjevic M, Paunovic I. Pediatr Surg. 2019 Oct 25. pii: S0022-3468(19)30670-0. PMID: 31706616 


Parathyromatosis: a very rare cause of recurrent primary hyperparathyroidism - case report and review of the literature. Haciyanli M, Karaisli S, Gucek Haciyanli S, Atasever A, Arikan Etit D, Gur EO, Acar T. 

Ann R Coll Surg Engl. 2019 Nov;101(8):e178-e183. PMID: 31509000 



Efficacy of α-blockers on hemodynamic control during pheochromocytoma resection - a randomized controlled trial. Buitenwerf E, Osinga TE, Timmers HJLM, Lenders JWM, Feelders RA, Eekhoff EMW, Haak HR, Corssmit EPM, Bisschop PHLT, Valk GD, GrooteVeldman R, Dullaart RPF, Links TP, Voogd MF, Wietasch GJKG, Kerstens MN; PRESCRIPT-investigators. J Clin Endocrinol Metab. 2019 Nov 12. PMID: 31714582 



A novel gene panel for prediction of lymph-node metastasis and recurrence in patients with thyroid cancer. Ruiz EML, Niu T, Zerfaoui M, Kunnimalaiyaan M, Friedlander PL, Abdel-Mageed AB, Kandil E. Surgery. 2019 Nov 8. pii: S0039-6060(19)30584-7. PMID: 31711617 


Lymphocyte-Monocyte Ratio Significantly Predicts Recurrence in Papillary Thyroid Cancer. Yokota M, Katoh H, Nishimiya H, Kikuchi M, Kosaka Y, Sengoku N, Watanabe M, Yamashita K. J Surg Res. 2019 Nov 8. pii: S0022-4804(19)30679-1. PMID: 31711613 


Morbidity and long-term survival in patients with cervical re-exploration for papillary thyroid carcinoma. Baerbock N, Mittelstädt A, Jähne J. Innov Surg Sci. 2019 Mar 27;4(3):91-99. PMID: 31709300 


Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines. Thomas CM, Asa SL, Ezzat S, Sawka AM, Goldstein D. Curr Oncol. 2019 Oct;26(5):338-344. PMID: 31708652 

  1. A novel gene panel for prediction of lymph-node metastasis and recurrence in patients with thyroid cancer. Ruiz EML, Niu T, Zerfaoui M, Kunnimalaiyaan M, Friedlander PL, Abdel-Mageed AB, Kandil E. Surgery. 2019 Nov 8. pii: S0039-6060(19)30584-7. PMID: 31711617 
Comparative prospective study on the presentation of normocalcemic primary hyperparathyroidism. Is it more aggressive than the hypercalcemic form? Gómez-Ramírez J, Gómez-Valdazo A, Luengo P, Porrero B, Osorio I, Rivas S. Am J Surg. 2019 Oct 22. PMID: 31662196
Parathyroid Cancer: A Review. Machado NN, Wilhelm SM. Cancers (Basel). 2019 Oct 28;11(11). PMID: 31661917
Multimodal Preoperative Localization Improves Outcomes in Reoperative Parathyroidectomy: A 25-Year Surgical Experience. Patel SG, Saunders ND, Jamshed S, Weber CJ, Sharma J. Am Surg. 2019 Sep 1;85(9):939-943. PMID: 31638503
Small adrenal incidentaloma becoming an aggressive adrenocortical carcinoma in a patient carrying a germline APC variant.Gagnon N, Boily P, Alguire C, Corbeil G, Bancos I, Latour M, Beauregard C, Caceres K, El Haffaf Z, Saad F, Olney HJ, Bourdeau I.Endocrine. 2020 Feb 22. PMID: 32088909
Endocrine Syndromes
100-Year evolution of precision medicine and surgery for multiple endocrine neoplasia type 2A.Machens A, Elwerr M, Lorenz K, Weber F, Dralle H.Endocrine. 2020 Feb 25. PMID: 32100189
Screening guidelines and recommendations for patients at high risk of developing endocrine cancers.Geurts JL, Strong EA, Wang TS, Evans DB, Clarke CN.J Surg Oncol. 2020 Feb 23. PMID: 32090344
Evaluation of an optimal cutoff of parathyroid venous sampling gradient for localizing primary hyperparathyroidism.Lee J, Hong N, Kim BM, Kim DJ, Yun M, Jeong JJ, Rhee Y.J Bone Miner Metab. 2020 Feb 25. PMID: 32100109
Confirmation of Parathyroid Tissue: Are Surgeons Aware of New and Novel Techniques?Coan KE, Yen TWF, Carr AA, Evans DB, Wang TS.J Surg Res. 2020 Feb;246:139-144. PMID: 31569035
Hyperparathyroidism during pregnancy. Is it a diagnostic and therapeutic challenge?Godínez-Vidal AR, Oca-Durán ÉM, Aguirre-Rojano VI, Pulido-Cejudo A, Paul-Basurto-Kuba EO, Hurtado-López LM.Cir Cir. 2019;87(S1):62-67. PMID: 31501633
Medullary thyroid carcinoma of unknown primary origin with synchronous finding of papillary thyroid carcinoma.Hellmann AR, Patel A, Śledziński M, Obołończyk Ł, Bieńkowski M, Mikaszewski B, Kaska Ł.Endokrynol Pol. 2020 Feb 25. PMID: 32096551
The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults.Patel KN, Yip L, Lubitz CC, Grubbs EG, Miller BS, Shen W, Angelos P, Chen H, Doherty GM, Fahey TJ 3rd, Kebebew E, Livolsi VA, Perrier ND, Sipos JA, Sosa JA, Steward D, Tufano RP, McHenry CR, Carty SE.Ann Surg. 2020 Mar;271(3):e21-e93. PMID: 32079830
Carcinomas of the Thyroid with Ewing Family Tumor Elements (CEFTEs): A Diagnostic Challenge Before Surgery.Taccogna S, Guglielmi R, Persichetti A, Morano C, Angelini F, Ienzi S, Scarpino S, Liverani A, Annovazzi A, Papini E.Head Neck Pathol. 2020 Feb 19. PMID: 32077055
Surufatinib in Chinese patients with locally advanced or metastatic differentiated thyroid cancer and medullary thyroid cancer: A multicenter, open-label, Phase II trial.Chen JY, Ji QH, Bai C, Zheng X, Zhang Y, Shi F, Li X, Tang PZ, Xu Z, Huang R, Huang T, Pan Y, Fan S, Zhou J, Su W.Thyroid. 2020 Feb 19. PMID: 32075524
Thyroidectomy Remains a Safe Option for Graves' Disease.Feaster A, DeCapua-Guarino A, Wolf M, Dove J, Fluck M, Oxenberg J.Am Surg. 2019 Aug 1;85(8):851-854. PMID: 32051065
Increasing Use of Thyroidectomy as Definitive Treatment for Hyperthyroidism.Asban A, Anue A, Xie R, Chen H.J Surg Res. 2020 Feb;246:435-441. PMID: 31630881
Does microscopic positive tumor margin in papillary thyroid cancer really matter?Back K, Kim SK, Chai YJ, Kim JH, Choe JH, Kim JS.Surgery. 2019 Dec;166(6):1160-1167. PMID: 31582308